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Abstract 
This study examined the use of anaesthetic agents in southern elephant seals (Mirounga leonina). 
The aim was to improve their safety especially when used for the routine chemical restraint required 
for biological investigations. This was to be achieved by more accurately refining drug dose rates, 
determining appropriate drugs to use and developing techniques for the early.recognition and treatment 
of complications. 
Monitoring to detect complications early 
A system of monitoring was developed from reflexes and responses used to measure the depth of 
anaesthesia in terrestrial animals. Heart rate, respiratory rate, rectal temperature, head response, 
palpebral response, withdrawal response, caudal flipper response, muscle top.e, righting response, and 
capillary refill were used as indicators of anaesthetic depth and the status of the animal's respiratory, 
cardiovascular, and thermoregulatory systems. It was more difficult to elicit responses when 
pethidine based drug combinations were used, or with large seals (> 1000 kg), and apnoea made 
assessment of level of restraint unreliable. However, the responses measured usually followed 
predictable sequences as level of restraint increased and the system allowed early recognition of 
complications and comparisons to be made between animals restrained with different drug 
combinations. 
Methods to more accurately estimate animal masses and anaesthetic dntg doses 
Length-mass relationships were established by linear regression of data gathered from southern 
elephant seals which had been weighed and measured at Macquarie Island, South Georgia and Heard 
Island. The relationships differed between locations and with sex and stage of yearly cycle. Although 
the variability was often ~ge, these relationships offer the best current estimate of mass based on 
morphometric data and can be used to improve the accuracy of drug dosage. 
For certain well defined categories of seals, nominal dosages of ketamine and diazepam were 
determined which could be administered when an accurate assessment of mass is not possible. 
Nominal masses, snout-tail lengths, as well as respiratory rates, heart rates. and other variables used 
during monitoring were found for each category of seal. This improved the ability to accurately 
assess the anaesthetic episode by allowing recognition of abnormal responses and facilitated their 
early treatment. 
Pharmacokinetic studies were carried out in animals at different stages of their yearly cycle. Ketamine 
concentrations were measured in venous blood after administration of a single intravenous bolus of 
ketamine to animals which had been sedated with pethidine. The data indicate that apparent volume 
of distribution, total body clearance and half life may not vary with stage of yearly cycle and that 
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additional intravenous ketamine dosage is best based on lean body mass. Recommendations were 
developed for additional drug administration which enable more precise drug dosage, and lessen the 
problem of inappropriate drug dosage. 
Finding the most appropriate anaesthetic drug or combination of drugs 
A comparison was made of the responses of groups of seals to the commonly used anaesthetic agents 
ketamine combined with diazepam, xylazine or midazolam, and tiletamine combined with zolazepam. 
It was found that all of the drug combinations could be safely used to restrain southern elephant seals. 
However, for people with little experience with anaesthetics, tiletamine and zolazepam offered some 
advantages over other combinations with respect to formulation and predictability. However, the 
results indicated that the safety margin for tiletamine plus zolazepam may not be high and its use 
should be approached with caution in animals whose mass is not known. 
Other anaesthetic drugs which had not previously been administered to southern elephant seals, but 
had proved useful in other animals, were also examined. These were combinations of midazolam, 
pethidine, ketamine and thiopentone, and medetomidine combined with ketamine. Pethidine based 
combinations were very useful and versatile, and were rapidly reversible with naloxone or naltrexone. 
However, in some cases apnoea was induced after administering ketamine or thiopentone 
intravenously and the time to maximum sedation was longer than when using cyclohexamine based 
combinations. Hyperthermia, vomiting and unpredictable responses were associated with the use of 
medetomidine combined with ketamine and for this reason ketamine combined with xylazine appears 
preferable. 
Treatment of complications 
A study was carried out to detennine whether antagonists could be used to improve control of the 
anaesthetic episode. Yohimbine antagonised ketamine combined with xylazine, but a,ntagonism was 
unnecessary for the cyclohexamine based drug combinations (those containing ketamine or tiletamine) 
due to the normally rapid recovery from these agents. The use of 4-aminopyridine and sannazenil to 
antagonise ketamine combined with diazepam appears to be contraindicated as their administration 
was associated with prolonged recovery or blindness. Antagonists were not effective in reversing 
apnoea. 
An attempt was made to treat apnoea by firstly detennining an effective dose of the respiratory 
stimulant doxapram in breathing animals and then administering it by a variety of routes to apnoeic 
animals. Doxapram was not always effective, however endotracheal administration appeared to be of 
benefit in some cases and is worth trying if facilities to administer positive pressure ventilation are 
not available. Supportive techniques such as intubation and positive pressure ventilation remain the 
treatment of choice for apnoea. Pharmacokinetic studies of ketamine in apnoeic and breathing seals 
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indicated that apnoea affects apparent volume of distribution and total body clearance of this drug 
during anaesthesia. Recommendations were developed for the prevention and treatment of apnoea. 
This study fulfilled its aims of improving anaesthetic safety for southern elephant seals. However, it 
is still difficult to treat apnoea in large southern elephant seals and techniques for positive pressure 
ventilation in these animals need to be determined. 
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Partial pressure in mmHg of oxygen in venous blood taken from the extradural 
intravertebral vein. Pao2 (partial pressure of 02 in arterial blood expressed in 
mmHg) gives an indication of lung function (West 1985, Cullen 1988). 
Total carbon dioxide. The sum of the C02, carbonic acid and bicarbonate 
dissolved in plasma. . The total C02 or C02 content derived from an arterial 
sample is an estimate of the metabolic component of acid-base balance (Cullen 
1988). 
xxi 
Glossary xxii 
Terms and definitions 
Analeptic 
Anoxia 
Antagonist 
Anxiolytic 
Apnoea 
Asystole 
Barbiturates 
A drug which stimulates respiration (Flecknell 1987). 
Literally means without oxygen. Through common usage, it has come to mean 
inability of tissues to receive or utilize an adequate amount of oxygen. Since a 
literal anoxia seldom if ever exists, the word hypoxia, indicating a state of 
decreased oxygen availability or diminished utilization of oxygen by tissues 
(impaired tissue respiration) has been suggested as being a preferable term (Lumb 
and Jones 1984 p123). 
A drug which inhibits, prevents or reverses the action of another drug. 
A drug which has an anti-anxiety effect (eg diazepam). 
Failure to breath for a period of longer than one min in southern elephant seals 
(Mitchell and Burton 1991). 
Lack of cardiac muscle contractions (Flecknell 1987). 
A group of drugs classed as hypnotics. In the central nervous system they cause 
sedation, hypnosis and medullary depression. They cause a depression in the 
respiratory centre, often producing apnoea, and have a hypotensive effect on the 
cardiovascular system due to peripheral vasodilation and a decreased cardiac 
output (Gales 1989). 
Base excess/ base deficit 
Benzodiazepines 
Blood gases 
Seen in alkalosis or acidosis, respectively. Base excess or deficit refer to the 
quantity of acid or base needed when titrating plasma pH to 7.4 at 37°C while 
the Pco2 is held at 40 mm Hg. Some texts use the term negative base excess 
instead of base deficit (Cullen 1988). In this volume the term base excess is 
used and a minus sign used to indicate deficit 
Benzodiazepine derivatives (eg chlordiazepoxide, diazepam, midazolam, 
zolazepam). Benzodiazepines are used in animals primarily to treat seizures or 
are given prophylactically to prevent the anticipated seizure activity of other 
drugs such as ketamine but are also used as muscle relaxants, anxiolytics, and 
hypnotics (Booth 1982 d, Gleed 1987). 
pH, Pco2. Po2. HC03-, total C02 and base excess values, usually from an 
arterial sample, however in this study they refer to venous values from the 
extradural intravertebral vein. The last 3 values are derived from the pH and 
Pco2. 
Caudal flipper response 
(See Table 4.1 and Chapter 4). 
Chemical restraint Includes tranquillization, sedation, immobilization and anaesthesia which 
represent a continuum of increasing central nervous system depression. Three 
Glossary 
Cyanosis 
Cyclohexamines 
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broad terms have been used to describe levels of chemical restraint: sedation is 
used when the animal is conscious and can move its body or a part of its body 
more than a few cm from the point of touch; immobilization is used when the 
animal is conscious but unable to move its body or a part of its body more than 
a few cm from the point of touch; anaesthesia is used when the animal is 
unconscious and unable to move its body or a part of its body more than a few 
cm from the point of touch. How these different levels of chemical restraint 
have been further divided is described in Chapter 4. 
Blue or purple colouring of the skin or visible membranes due to the presence of 
an increased concentration of reduced haemoglobin in capillary blood, 
symptomatic of hypoxia (Flecknell 1987). 
A common term used to refer to the dissociative anaesthetics (eg ketamine, 
tiletamine and phencyclidine) which are a group of related chemical compounds 
that are capable of producing a state of anaesthesia during which the subject has 
an apparent dissociation from the environment (Short 1987 b). 
Cyclohexamine drug combinations 
Dyspnoea 
Eupnea 
Head response 
Hyperthermia 
Hypoxia 
Menace response 
Narcosis 
Narcotic 
Nociceptive 
Philtrum 
A combination of a cyclohexamine drug with a tranquillizer or sedative, 
administered intramuscularly to chemically restrain an animal (eg ketamine and 
diazepam, ketamine and xylazine, tiletamine and zolazepam). 
Laboured breathing (Lumb and Jones 1984 plOl). 
Ordinary quiet breathing (Lumb and Jones 1984 plOl). 
(See Table4.1 andChapter4). 
Rectal temperature greater than 38.5°C. 
A state of decreased oxygen availability or diminished oxygen utilization by 
tissues (Lumb and Jones 1984 p123). (See also anoxia.) 
The eye preservation or menace response is tested by means of a threatening 
gesture made towards one eye. The normal response is for the eye to blink and 
the head to be averted (Eger et al. 1988). It assesses the optic nerve and is a test 
of vision. One eye is usually tested whilst the other is covered, however in this 
study the opposite eye was not covered. 
A state of insensibility or stupor from which it is difficult to arouse the animal 
(Flecknell 1987). 
A group of drugs which has its action in the central nervous system and spinal 
cord where they alleviate pain and cause some degree of central nervous sytem, 
cardiovascular and respiratory depression (Gales 1989) and includes such drugs as 
pethidine, fentanyl, and morphine. 
Describing nerve fibres, endings, or pathways that are concerned with the 
condition of pain. A nociceptive stimulus is one which stimulates these areas. 
Median groove separating the right and left parts of the upper lip. 
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Prolonged apnoea Apnoea of> 10 min duration. 
Prolonged chemical restraint 
Relapse 
Sedation 
Periods of chemical restraint where the time to recovery (level 1 of chemical 
restraint) was > 60 min. 
Used with respect to narcotic antagonist use. The action of some narcotic 
antagonists is shorter than the narcotic which they. antagonise. When the 
antagonist wears off the animal may therefore become re-narcotised or relapse 
back into narcosis. 
A mild degree of central depression in which the patient is relaxed and 
unconcerned by its surroundings (Lumb and Jones 1984). In this study sedation 
is taken to mean that animals can move forward or swivel around (see chemical 
restraint). 
Suspected hyperthermia 
Sympatric 
Tachypnea 
Due to the relatively low levels of chemical restraint used during most parts of 
this study rectal temperature could not often be measured. Suspected 
hyperthermia was therefore based upon suspicion of behavioural mechanisms of 
cooling, specifically when animals were seen to either flick sand or wallow 
contents over themselves, or move into wallows during or after recovery from 
chemical restraint. Flicking behaviour, however, may be a non-specific sign of 
stress not associated with hyperthermia (Laws 1956b), hence the term 
'suspected'. 
Originating in, or occupying, the same geographical area. 
High respiratory rate (Lumb and Jones 1984 plOl). 
Tranquillizers and sedatives 
Tranquillization 
The distinction between tranquillizers and sedatives is a question of semantic~ 
and of little value except that increased doses of tranquillizers tend to produce side 
effects but not loss of consciousness, whereas increased doses of sedatives 
produces more profound central nervous system depression that resembles 
anaesthesia (Gleed 1987). Tranquillizers administered to southern elephant seals 
include the phenothiazine promazine, and sedatives include the benzodiazepines 
and xylazine (see Tranquillization, and Sedation). 
Is a state of behavioural change in which the animal is relaxed and unconcerned 
by its surroundings (Lumb and Jones 1984 plOl) (similar to sedation). 
Glossary 
Wallow A depression in the ground which adult elephant seals often use when they come 
ashore to moult. Wallow areas are usually established in tussock grassland just 
behind beaches, and are used by more than one seal. Wallows become a foetid 
mixture of living seals, seal urine, faeces and moulted skin. When wallows 
occur on deep peats they may become pools of thick mud (Selkirk et al. 1990). 
Withdrawal response (see Table 4.1 and Chapter 4). 
Nomenclature 
Blood vessels: blood vessels are referred to using the nomenclature used to describe the blood vessels 
of the harp seal Phoca groenlandica (St. Pierre 1974). 
Drugs are referred to in the text by the nonproprietary names listed in Table 3.2. The counterion has 
been dropped unless included in the dose rate. 
For time course data zero time is when initial administration of anaesthetic drugs was completed (eg 
"apnoea commenced at 20 min" indicates that 20 min from completion of initial administration of 
anaesthetic drug apnoea commenced). 
Drug dose 
Unless otherwise indicated drug dose is presented in mg/kg free drug, and otherwise as the salt. Three 
different terms are used to describe drug dosage: (1) intended dose or the dose intended to be 
administered, (2) actual dose or the dose actually administered (determined after weighing the animal) 
and (3) a nominal dose or the approximate dose found to be suitable for a particular category of 
animal. 
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Chapter 1: 
study 
General Introduction and background to the 
Three families of living pinnipeds, or seals, are recognised: Phocidae (known as "true", "earless" or 
"phocid" seals), Otariidae (fur seals and sea lions, collectively known as "otariid" seals) and 
Odobenidae (walrus) (Ling 1983). 
Elephant seals are phocid seals. There are two species, southern (Mirounga leonina) and northern (M. 
angostirostris). Many aspects of the biology of southern elephant seals have been studied (Selkirk et 
al. 1990). They spend most of their lives at sea in Antarctic and subantarctic waters undergoing long 
migrations to feeding grounds to replenish fat reserves that are lost when they go ashore on isolated 
subantarctic islands to breed and moult. 
There has been an estimated 50% decrease in the number of Southern elephant seals at Heard Island 
(53°0l'S, 73023'E) and Macquarie Island (54°30'S, 158°54E) since 1949 (Burton 1986, Hindell and 
Burton 1987). Since 1985 the Australian Antarctic Division has been researching this decline. As 
the animals are large and potentially dangerous, chemical restraint is used to allow weighing, 
measuring, gastric lavage, blood taking, milk sampling, and deployment and retrieval of automatic 
data logging devices such as time-dep~ recorders and satellite tracking devices. 
During the austral summer of 1987, 316 southern elephant seals were anaesthetised at Macquarie or 
Heard Islands with ketamine, ketamine combined with diazepam or xylazine, or tiletamine and 
zolazepam (Woods et al. 1989, Mitchell and Burton 1991). There were 16 fatalities and many 
problems associated with anaesthesia. 
The following problems were found. 
• Apnoea, bradycardia, prolonged anaesthesia, shaking, hyperthennia and fatalities were 
common. 
• The response of the animals to anaesthesia was inconsistent. 
• There was little control over the anaesthetic episode and no effective way of treating 
complications associated with anaesthesia. Large animals (~ 1000 kg) appeared to be a 
particularly high anaesthetic risk. 
• There was little information available on response of elephant seals. to anaesthetics. 
Information was available on response of other seals to anaesthetics (Gales 1989), but prior 
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to 1987 only 3 studies, representing 44 anaesthetic episodes, had been published on the use 
of these drugs in adult southern elephant seals (Morgan et al. 1978, Ryding 1982, Gales and 
Burton 1987a). 
The following possible solutions were proposed to these problems. 
Improve monitoring so that complications could be recognised early 
A system of monitoring could be developed by testing reflexes and responses used to measure the 
depth of anaesthesia in terrestrial animals. Those which are appropriate, and possibly other reflexes 
and responses, specific to seals, could be used as indicators of anaesthetic depth and the status of the 
animal's respiratory, cardiovascular, and thermoregulatory systems. A standard system of monitoring 
might also allow comparison of different drug combinations. (See Chapter 4. Monitoring during 
chemical restraint.) 
Develop methods to more accurately estimate animals' masses and anaesthetic drug 
doses 
More accurate estimates of mass could be made from length-mass relationships for animals of 
different ages and sexes and at different times of the year. An alternative could be to develop 
standardised total drug dosages for seals at different stages of their life cycle. Examination of drug 
kinetics might also aid rational drug dosage. These studies could enable more precise drug dosage, and 
would lessen the problem of inappropriate drug dosage. (See Chapter 5. Length-mass relationships 
in southern elephant seals; Chapter 6. Use of ketamine and diazepam; and Chapter 7. 
Pharmacokinetics of intravenously administered ketamine.) 
Find the most appropriate dntg or combination of drugs 
This could be determined by comparing the responses of groups of seals to commonly used 
anaesthetic agents. The most appropriate anaesthetics would be those which have the lowest fatality 
rate, and cause the least respiratory, central, cardiovascular and thermoregulatory depressant effects. 
Other anaesthetic drugs that had not been administered to southern elephant seals, but had proved 
useful in other animals or seals, could be examined. (See Chapter 8. A comparison of some 
cyclohexamine based drug combinations for chemical restraint of southern elephant seals; Chapter 9. 
Use of midazolam, pethidine, ketamine and thiopentone for chemical restraint of southern elephant 
seals; and Chapter 10. Medetomidine and ketamine use in southern elephant seals.) 
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Develop a course of action to treat complications 
Control of the anaesthetic episode might be improved by using anaesthetic antagonists. Use of 
chemical stimulation of respiration or techniques such as intubation and positive pressure ventilation 
could be used to treat respiratory complications. Neuromuscular blocking agents or skeletal muscle 
relaxant drugs could be used to treat seizures. (See Chapter 11. Use of the respiratory stimulant 
doxapram; Chapter 12. Antagonism of some cyclohexamine based drug combinations used for 
chemical restraint; Chapter 13. Apnoea during chemical restraint; and Appendicies IV and VI, 
fatalities and complications.) 
The study was designed to test the unifying hypothesis that: 
the safety to the animals of the anaesthetic episode could be improved 
by using the most appropriate drugs, more accurately refining drug 
dose rates and developing techniques for the early recognition and 
treatment of complications associated with drug administration. 
Because this study was to act as a guide to anaesthesia of these animals for people without advanced 
training in anaesthetics, techniques were needed that could be used safely and be understood by lay 
people. 
A proposal was submitted to The Antarctic Animal Care and Ionising Radiation Usage Ethics 
Committee (Department of the Arts, Sport, the Environment, Tourism and Territories) to test the 
unifying hypothesis. Approval was granted but with the exclusion of gaseous anaesthesia as a 
decision on the ethics of this could not be reached in the time available. The study was also largely 
restricted to mature pre-moulting females, animals considered to be "low-risk" by the Ethics 
Committee (Appendix I). 
What follows is the result of this work. 
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Chapter 2: Literature Review 
Introduction 
Southern elephant seals are large and potentially dangerous. Many aspects of research, husbandry and 
medicine of these animals require chemical restraint or anaesthesia. 
In the field physical restraint is routinely used for pups and weaners. In captivity elephant seals can 
be conditioned to allow blood sampling (Rogers personal communication) or have been restrained 
physically by throwing a hoop net over the bigger animals and having several people hold the animal 
down by straddling it (Gage personal communication). Physical restraint of older or larger animals in 
the field however can be dangerous, inefficient, have the potential to cause excessive stress to the 
animal and has only rarely been used (Ross and Saayman 1970; Figure 25-12, Cornell 1978). 
Electroimmobilization has not been used with elephant seals. Aversion to electroimmobilization has 
been reported in cattle and sheep (Pascoe 1986, Pascoe and McDonell 1986, Rushen and Congdon 
1986) and it has been suggested that the technique is inhumane when surgery is performed without the 
addition of local anaesthetic (Trim 1987). The National Health and Medical Research Council et al. 
(1990) proposed that electroimmobilization devices should not be used as an alternative to analgesia 
or anaesthesia in animals until there was scientifically acceptable evidence that they are effective. 
In the field situation where numbers of people available are often limited and with difficulties in 
transporting capture equipment over rugged te1rnin or for long distances, chemical restraint is the 
technique of choice for allowing safe access to these animals. 
Many papers have been written on pinniped anaesthesia (Gales 1989), however the majority are 
largely anecdotal, presenting drug dose levels, numbers of animals anaesthetised and numbers which 
died; there are few data regarding the normal response to anaesthesia, ·dosage has largely been 
determined on a trial and error basis and conclusions drawn are largely unsubstantiated. Hammond and 
Elsner (1977) present a very good discussion of the problems of phocid anaesthesia and Gales (1989) 
published a review of the cmTent literature regarding pinniped anaesthesia. Another important 
publication is Mitchell and Burton (1991) which discusses fatalities associated with chemical restraint 
of southern elephant seals. The following review presents information largely on southern elephant 
seal anaesthesia. This information is generally applicable to northern elephant seal anaesthesia. 
However, those interested in northern elephant seal anaesthesia are specifically referred to Gales (1989) 
for general comments and a list of drugs and-dose levels used in this species. There are no specific 
studies of any of the drugs in southern elephant seals. The pham1acology of the drugs mentioned in 
this thesis is described in standard texts of veterinary anaesthesiology and pharmacology such as 
Booth and McDonald (1982) and Lumb and Jones (1984). 
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Methods of drug administration 
General 
Anaesthetic agents have been administered by several routes including intramuscular, intravenous, 
intrapleurally, intralingually and by mouth using a variety of techniques. There are no reports of 
gaseous administration. 
Intramuscular administration 
i. General 
This route of drug administration has been the most commonly used for initial drug administration 
(Table 2.1). 
Elephant seals are so lethargic that they can be stalked quite readily and injected at close range (Ling et 
al. 1967). The seals tend to pivot round to face the operator when d~sturbed, but an assistant 
standing quietly in front of the seal can usually hold the animal's attention long enough to allow 
injection. It has been suggested that more care would probably be needed if adults were approached 
during pupping or breeding seasons (Cline et al. 1969). 
Though drugs have been administered at various sites (Ling et al. 1967), the preferred site for 
intramuscular injection is the gluteal mass in the dorsal hip area or the lumbar muscles (Parry et al. 
1981). These areas have readily accessible muscle with a comparatively thin blubber layer (Trillmich 
and Weisner 1979, Gales 1989). 
The advantages of intramuscular administration are that it is easy, safer for personnel than intravenous 
administration and does not require a detailed knowledge of anatomy. Frequently it is the only option 
available in the field. There are disadvantages. The delay of onset of effects means that dose cannot 
be titrated to effect. Injections are often given in haste and intravenous administration and overdosing 
can occur (Gales 1989). The large volume of drug that is often required to immobilize larger animals 
also presents a problem. This has been reduced to some degree by using highly concentrated 
solutions of drugs such as ketamine C:W oods et al. 1989), increasing the concentration of anaesthetic 
drugs administered by making them up from powder with the other drugs used in the combination 
acting as diluent (Baker et al. 1988), or using lyophilized drugs such as tiletamine and zolazepam 
(Baker et al. 1990). 
Abscessation has been reported after intramuscular drug administration (Gales and Burton 1987 a). 
One animal was unable to use its hind flippers for approximately 2 weeks. The abscesses healed 
within 3 weeks, but the animals remained at the moult site for considerably longer than other 
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Table 2.1. Drugs used ID chemically =tnin sourhcm elephant seals. Wheno possible (unless otherwise stated) a mean± !llndard deviation is presented for drug dose; whCS"e not possible a range is given. Significant figures are rhose presented by 
each aurhor. The dose of tilctamine and zolazeparn is presmted IS rhe dose or combined drug IS rhis wu rhe pnctice adopted by rhe authors. n represents rhe number or animals to which drugs wCS"e administered; the numbCS' in brackets reprosa!ts rhe raw 
numbCS' or inmobilizations. Multiple dose llld additional dose diffCS" in semantics only and are reported IS they weno in lhe specilled texL (l.m. • intnmuscular, i.v. "'intravenous, p. o. "by moulh.) 
Drug or drug Drug Route or n 
combination administntion 
Phencyclidine Phencyclidine 1.m. s 
with Promazine 1.m. 
promuine Phencyclidine l.m. 14 
Promazine l.m. 
Single dose Multiple dose 
for induction• for inductiont 
(m&1£gl (ml1J1rJO 
O.l<Hl.47 
O.l<Hl.47 
0.4 
0.4 
Total~ 
(mgfltg) 
Useful dose§ Add1Uonal dosell 
(mg/1<g) (mg/1<g) 
0.4 
0.4 
Comments Rcfenonce 
Vanable results Cline et al. 1969 
Morgan et al. 1978 
Phencyclidine Phmcyclidine 1.m Ip o. l S40 mg total dose 740 mg total dose 2 doses of I 00 mg Complere immobilisation Ross and Suyman 1970 
Phmcyclidine 1.m. · 23 0.211--0.84 phencyclidme i.m. Violent convulsions, prolonged Morgan et al. 1971 
recovery. Treated with O.S mgl1<g 
Kctomine 
with 
xylozine 
Kctarrunc l.m. 7 8.71:!:0.2.:!, (S.4-12.50) 3.31:!:0 13 (2.38-3.97) mgl1<g/h 
(at Heard Island) 
11.491<1.79 (3.75-18.2) ~gJb 
(at Vestfold Hills) 
Xylazme l.m. 0.41:!:0.0l (0.24-0.85) 
Ketaminc l.m. S 3.594.91 6.10-6.31 
promazme i.v. 
1.31:!:0.15 (0-2.SO) mg/1<gJb Good unmoblli7Jluon 
kelmllne L v. or i.m. 
Xylazme 1.m. 0.67-1.02 1.13-1.20 Relatively we and effective 
Ke11mme 1.m. SS (60) 4.1 :!: 0.8 (2.S-6.5) 2.1-11.4 0.9-3.7 ketommc 1.m. Prolonged 1pnoea, 2 fatalities 
Xylazmc 1.m. 0.2.0.5 0.2-0.S 
Ke11mme 1.m. 181(226) 3.61:!:1.2.:! 8 rualiues including 
Xylazine l.m. O.S5:!:1.S to 0.75:!:0.22 hvocrthamia 
Ketsrrune Kctanunc 1.m. 7 8.71:!:0.2.:!, (S.4-12.50) 3.31:!:0.13 (2.38-3.97) m!!i\l!lh 1.31:!:0 IS (0-2.SO) mgJl<gJb I fat.ality, genc:r1lly 
with (at llc:ard Island) ketomine Lm. or i. v. reliable results 
diazepom 11.491<1.79 (3.75-18.2) m!!i\gJh 
(at Vestfold Hills) 
Diozepam 1.m. 0.09±0.Ql (0 03-1.02) 
Kctanunc l.m. , 26(43) 5.45:1:1.35 (2.67-9.SO) 8.10:!:1.75 (6.02-11.89) 
Diru:cparn 1.m. 
i.m. 
Kewrune 
.!:!!!, 
i.m. s 4.6-13.6 6.06-7.56 
6 
O.oJ 
1.58-2.93 kewrune 1.m. 
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individuals. Hubbard (1969) reported that; because pinnipeds defecate indiscriminately, and the fact 
that in captivity they will defecate in pool water, the skin is usually quite contaminated. He 
experienced needle abscessation in pinnipeds more often than in any other species that he had worked 
with. He found that application of alcohol-saturated cotton to the proposed injection site was 
ineffective in preventing infection. Hubbard (1969) routinely prepared all animals for injection by 
hosing them thoroughly, then dousing the entire body with a bucket of antiseptic. The antiseptic was 
allowed to sit on the skin for ten minutes before an injection was made (Hubbard 1969). Disinfection 
of the skin prior to drug administration in unrestrained animals is considered impractical under field 
conditions and is probably unnecessary given the relatively low incidence of injection abscesses 
reported in the literature. 
ii. Techniques 
Four basic techniques have been used to administer the initial anaesthetic dose intramuscularly: direct 
injection with a hand held needle and syringe (Ross and Saayman 1970, Morgan et al. 1978, Condy 
1980, Ryding 1982, Bester 1988); extension syringes consisting of a long pole with the syringe 
attached to one end (Ling and Nicholls 1963, Ling et al. 1967, Cline et al. 1969, Morgan et al. 1978, 
Griffiths et al. 1979); remote methods using a long length of plastic tubing with a needle at one end 
and the syringe containing the drugs at the other (Ryding 1982, Gales and Burton 1987 a, Bester 
1988, Woods et al. 1989, Mitchell and Burton 1991); and projectile syringes·fired from rifles (Vergani 
1985) or blowpipes (Baker et al. 1988 and 1990). 
Direct injection and use of extension syringes are now rarely used other than on weaners. However, 
Cline et al. (1969) believed the extension sy1inge device to be more workable than projectile syringes 
for drug administration, both in pack ice and shore situations, except in those few instances where 
animals could not be approached to within 3 m. Ryding (1982) found that although direct 
intramuscular injection was satisfactory for females and pups, it was impractical in the case of adult 
males. The aggressive reaction of a large seal, coupled with the long injection time associated with 
the large volume of drug needed, made this method of administration impractical. Use of a spring 
loaded syringe was attempted so that retreat could be effected as soon as the needle had been inserted 
into the hip region. Invaiiably the seal reared, violently withdrew its hind quarters and the syringe 
was displaced. Because of these problems a remote injection technique or administration by projectile 
are now the commonly used techniques for dmg administration. 
Ryding (1982) desc1ibed a remote injection technique which has been the basis for other remote 
injection techniques. A 90 mm, 18 G needle was connected to a series of 2 lengths of transparent 
plastic intravenous drip tubing. The tubing was filled with a dose of ketamine and the operator end of 
the tubing was closed by a clamp to avoid loss until injection commenced. The needle was then 
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inserted into the caudal pelvic musculature and the drugs injected through the lumen of the tube 
followed by water or air to flush them through. The play allowed by the tubing provides enough 
latitude for the dose to be injected in one smooth action should the seal rear and withdraw its hind 
quarters after placement of the needle (Bester 1988). Subsequent authors modified this techniqui; 
(Gales and Burton 1987 a, Bester 1988, Woods et al. 1989, Mitchell and Burton 1991). Despite its 
proven usefulness, problems have been described. Gales and Burton (1987 a) found that the large 
surface area of the tube resulted in the technique becoming unworkable at temperatures less than -
15°C because ice blocked the tube (a problem also reported for extension syringes; Cline ~t al. 
1969). It was found that a hand warmer alleviated the problem. The positioning of the needle in the 
dorsal hip area has also been described as important (Cline et al. 1969, Gales and Burton 1987 a). If 
'the needle was pressed into the muscle off the vertical it was commonly dislodged or bent. A second 
attempt at approaching the s~al added greatly to the difficulties of the procedure. Gales and Burton 
(1987 a) suggested that a small barb on the needle would help alleviate this problem, though barbs 
have been considered unnecessary and their use in southern elephant seals has not been reported (Balcer 
et al. 1988 and 1990). 
Projectile syringes are also commonly used. Balcer et al. (1988 and 1990) administered anaesthetics 
using pressurised projectile syringes, propelled through a blowpipe aimed at the posterior lumbar 
muscles. The technique used was based upon that used by Parry et al. (1981). Darts were made out 
of lOmL disposable syringes. The force which injected the drug was provided by a drop of liquid 
butane in a space behind the plunger. They were delivered by blow-pipe (a 1.5 m length of the 
appropriate internal diameter PVC tube). No barb was required. A 10 cm, 16 G needle whose end 
' 
was blocked with epoxy and which had a small hole drilled into the side 1 cm from the tip was used. 
The hole was covered by a short length of tygon tube which slid clear ~s the needle entered the 
animal. Parry et al. (1981) found that the application of lubricant, such as petroleum jelly, to the 
outside of the needle was essential to ensure that the plastic tubing slid along the needle as it entered 
the animal. 
Tranquillizer rifles have been associated with problems of skin penetration (Cline et al. 1969, Vergani 
1985) and drugs being injected into fat, with prolonged or variable effec~ (Gales 1989). Vergani 
(1985) also found that wind affected dart accuracy. 
Long, large bore needles are used to administer drugs. The needles have to be long enough to pass 
through the over-lying blubber and penetrate the muscle mass below and of sufficient internal 
diameter to allow rapid drug administration. Various needle sizes have been used ranging from 90 to 
150 mm long, and 13 to 18 G (Bester 1988, Balcer et al. 1988, Woods .et al. 1989, Balcer et al. 
1990, Mitchell and Burton 1991). The most commonly used sizes are 100 mm, 16 G (Balcer et al. 
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1988 and 1990) or 90 mm, 18 G (Gales and Burton 1987 a, Woods et al. 1989, Mitchell and Burton 
1991). Needles for projectile use have been prepared after the technique of Parry et al. (1981) 
previously desc1ibed (Bester 1988, Baker et al. 1988 and 1990). 
Accidental intravascular administration has been reported when attempting to give drugs 
intramuscularly. Gales and Burton (1987 a) believed it led to the death of one animal, however Baker 
et al. (1988) believed they inadvertently administered drug intravascularly with no adverse effects. 
Ling et al. (1967) described spectacularly sudden collapse in animals to which suxamethonium was 
administered intravenously. 
Intravenous administration 
i. General 
Intravenous administration requires the seal to be well restrained. In the field situation it is limited in 
its usefulriess to pups, weaners and small yearlings and for administering further drug to adjust or 
deepen the level of chemical restraint. Its advantage is that drugs can be given until the desired effect 
is seen (to effect). 
In southern elephant seals anaesthetic agents have been injected into the extradural intravertebral vein 
(Griffiths 1980, Gales and Burton 1987 a, Baker et al. 1990 ). 
ii. Extradural intravertebral vein 
The extradural intravertebral vein of southern elephant seals lies within the vertebral canal of the 
lumbar vertebrae (Hubbard 1969, Ridgway 1972, St. Pierre 1974, Ronald et al. 1977). Geraci and 
Sweeney (1978) have described venipuncture of the extradural intravertebral vein in phocid seals. The 
subject was placed in ventral recumbency. Using firm digital pressure along the dorsal midline of the 
lower lumbar area, the space between any two vertebral spinous processes was palpated. With the 
probing finger as a guide, a needle was inserted between the processes and pushed down into the 
extradural intravertebral vein. Sometimes there was a feeling of some release in pressure as the vein 
was entered. The extradural intravertebral veins overlie the cauda equina of the spinal cord. Excess 
probing in the area can lead to hind limb paralysis. 
Arterial cannulation has been reported in northern elephant seals (Van Citters et al. 1965). The 
peripheral arteries and veins in elephant seals have not been described in detail. 
iii. Plantar venipuncture 
There are no reports in the literature of plantar venipuncture in elephant seals, however a blood 
sampling technique for the hind flipper of phocid seals has been described which could probably be 
used in southern elephant seals. A 32 mm, 18 G needle was introduced into the ventral (plantar) 
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aspect of the flipper, directly over DII or medial to DIV, at the level of the origin of the interdigital 
webbing. The needle was directed at a 10° to 20° angle from the plane of the flipper and inserted 
until either the main vessel or the complex vascular rete was struck. The blood was often mixed 
arterial and venous. Blood was described as continuing to flow freely following sampling and this 
was controlled by firm pressure (Geraci and Sweeney 1978). 
Inhalation administration 
i. General 
There are no reports of induction or maintenance of anaesthesia in southern elephant seals using 
gaseous agents. However, two northern elephant seals have been anaesthetised using gaseous 
anaesthesia. Hamlin et al. (1972) used halothane to anaesthetise a 165 kg animal. The technique 
used was not clear, however reference was made to anaesthesia of the californian sea lion (Zalophus 
californianus) (Ridgway et al. 1969). In this technique the seals were restrained in a crush cage then 
strapped down. They were then premedicated with atropine (1/60th gr. per 50 kg sea lion), a glass 
hood placed over their head, and halothane introduced through a vaporizer at 10%. Induction occurred 
in 5 to 20 min. Once anaesthetised the hood was removed, the animal intubated, the vaporizer setting 
reduced to 2.5 to 3% and lowered as clinical signs indicated. Halothane concentrations of 0.75 to 
1.5% were required to maintain anaesthesia. Recovery occurred within lb or less post surgery. 
Hammond and Elsner (1977) induced anaesthesia in a 120 kg animal usin'g an anaesthesia box and 
80% nitrous oxide, 5% halothane and 15% oxygen. Induction occurred in 20 to 40 min. Evaluation 
of depth of anaesthesia was difficult because the animal was not accessible for examination. Also, 
premature attempts to intubate resulted in loss of anaesthesia gases and extended the induction period. 
Intubation with 1 to 2% halothane and oxygen maintained anaesthesia. Low ambient temperatures 
and reduced vaporization made inhalation induction difficult and prolonged and moisture can freeze 
movable parts in the expiratory circuit. It was considered desirable to have a rapid induction or 
immobilization so the seal can be placed in a warm field laboratory. 
Hammond and Elsner (1977) described three techniques for induction with gas: 
• Placing the anaesthetic mask directly over the nostrils. 
• Placing the seal in an anaesthetic box. 
• Immobilization with a muscle relaxing drug followed with intubation and artificial 
ventilation. 
Induction with oxygen and 5% halothane and a mask was successful for light levels of anaesthesia. 
Physical contact of the mask on the nostrils increased the frequency of breath-holding. Partial 
withdrawal of the mask diluted the vaporized anaesthetic with atmospheric air and prolonged the 
induction phase. 
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Volatile anaesthetic agents such as halothane and isoflurane have been used for anaesthesia of other 
pinniped species (Gales 1989). Intubation and maintenance using positive pressure ventilation has 
been recommended though is not always essential as pinnipeds maintain some unconscious control of 
respiration (Sweeney 1974, Geraci and Sweeny 1978, Gales 1989). However, periods of apnoea are 
common (Hammond and Elsner 1977) and assisted ventilation helps control the Pco2 which 
commonly rises during anaesthesia (Geraci and Sweeney 1978). Hammond and Elsner (1977) used an 
apneustic plateau during ventilation of "large phocids" with a Bird 9 ventilator but suggested that 
there was no clear indication that such equipment was required. Phocids often require chemical 
induction prior to tracheal intubation because they can breath-hold during gaseous induction (Ridgway 
and Joyce 1975). McDonell (1972) overcame the problem of breath-holding by harp seals during 
induction by using a vaporizer that was able to deliver concentrations of halothane as high as 30%, 
thus making only a few breaths necessary for induction. 
The main advantage of inhalation anaesthesia is that it is relatively safe. There is good control over 
the duration of anaesthesia and positive pressure ventilation can be provided in some cases if breathing 
ceases. Its use needs to be examined in southern elephant seals. 
ii. Intubation 
The anatomy of the larynx and upper respiratory tract of elephant seals has not been described. Pierard 
(1969) described the larynx of the Weddell seal (Leptonychotes weddelli; another phocid seal). He 
stated that the diameter of the glottis was about 25 mm. King (1983) described the pinniped larynx as 
having the normal number of cartilages that compose the mammalian larynx, with individual 
differences in detail in the various seals. The close approximation of the flat medial surfaces of the 
two arytenoid cartilages, which then abut against the posterior surface o~ the epiglottis, provide a 
tight seal against the entry of water into the trachea, and the powerful muscles of the larynx also help 
to keep this entrance closed (Schneider 1962 and 1963, King 1969 and 1972, Pierard 1969). 
Hammond and Elsner (1977) reported that intubation of large phocids can be difficult, because apnoea 
can occur before relaxation of the jaw muscles. 
Southern elephant seals have been intubated (Baker et al. 1990) though few details as to the technique 
or endotracheal tube sizes required were given. Baker et al. (1990) stated that if a prolonged apnoea 
occurred or if there were signs that the animal was becoming anoxic, as indicated by colour changes in 
the gums, tongue and conjunctiva, the animal was intubated with a cuffed veterinary endotracheal tube 
and ventilated by mouth. During apnoea, the larynx was usually found to be clamped tightly shut and 
the tube was placed in the trachea by inserting two fingers between the cartilaginous ridges of the 
larynx in spasm, and sliding the tube into the trachea between the 2 fingers. 
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A description of the technique for intubation and endotracheal tube sizes suitable for southern elephant 
seals is required. 
Other routes of administration 
i. Intrapleural 
Bryden (1971 a) stated that, once immobilised, further drug can be given intramuscularly, 
intravenously or intrapleurally. However, few details were given regarding the intrapleural route. 
ii. Intralingual 
Baker and Gatesman (1985) stated that in apnoeic grey seals the pressure and rate of flow in the 
extradural intravertebral vein is very low, as part of the adaptations to anoxia during diving, and in 
many animals no or minimal response was seen to narcotic antagonists administered into this vessel. 
They considered that if the animals were apnoeic and unresponsive it was necessary to get the 
antagonist into circulation as quickly as possible. They administered drug into the tongue in the 
belief that this was a site where circulation was maintained during apnoea. Gales (1989) cautioned 
that injections given into the tongue may be painful and could affect feeding. However, Baker and 
Gatesman (1985) noticed that in the breeding season animals are not feeding so that any soreness 
produced would not have affected eating. One animal anaesthetised a week after receiving an injection 
into the tongue had only a small area of bruising. However, bruising of the tongue is probably a 
minor consideration when attempts are being made to resuscitate an animal severely depressed by 
anaesthesia. 
iii. By mouth 
Phencyclidine was administered to a young male southern elephant seal in a late stage of moult by 
squirting the drug above the tongue of the seal when it opened its mouth (Ross and Saayman 1970). 
This appeared to have little effect. 
Multiple immobilizations of individual animals 
Multiple immobilizations of individual animals have been reported though few details were given 
(Gales and Burton 1987 a, Baker et al. 1988, Woods et al. 1989, Mitchell and Burton 1991). In 
several cases lower doses of anaesthetic than those used for the initial episode were required. Baker 
(1988) described a seal that had been anaesthetised with ketamine 8 times, each occasion requiring a 
quarter of the normal dose of ketamine. Mitchell and Burton (1991) used doses of 2.8 - 6.5 mg/kg 
ketamine for initial immobilization and 2.1 - 4.5 mg/kg for repeat episodes. Gales and Burton (1987 
a) administered similar doses to 6 animals without any apparent problems. Two seals were 
immobilized on 3 occasions and 1 of these required approximately twice as much ketamine for 
induction-and maintenance as the remaining animals. Because both of these seals also exhibited 
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clinical disease as a possible result of multiple immobilizations (abscessation at injection site), they 
concluded that prolonged anaesthesia on more than 2 occasions was contraindicated, if the intervening 
period was relatively short. Fewer problems have been reported for less prolonged repeat 
immobilization procedures. Baker et al. (1990) also reported multiple immobilizations of single 
animals using tiletarnine and zolazepam with no adverse side effects. 
Anaesthetic drug pharmacokinetics have not been determined in southern elephant seals. A knowledge 
of the pharmacokinetics of anaesthetics in southern elephant seals might help determine guidelines for 
safe, repeated anaesthetic dose administration in this species. 
Pre-anaesthetic and sedative medication 
General 
Premedication is not routinely performed during field immobilization. Premedicants, sedatives or co-
anaesthetics are usually administered simultaneously with the anaesthetic. (Gales, 1989, has reviewed 
the anaesthetic chugs administered to northern elephant seals). 
Atropine 
A dose of 0.005 mg/kg has been recommended by Gales (1989), however this seems very low when 
compared with that used in other species of seal (0.02 to 0.04 mg/kg; Sweeney 1974, Hammond and 
Elsner 1977). Whether administration of atropine is necessary or effective at the 0.005 mg/kg dose is 
not known but this dose has been routinely administered to reduce salivation and bradycardia 
associated with anaesthesia in southern elephant seals (Gales and Burton 1987a, Woods et al. 1989, 
Mitchell and Burton 1991). Because of difficulties in estimating weights of animals prior to drug 
adtninistration, female southern elephant seals have been given nominal doses of 2mL and males 4 
mL of 0.65 mg/mL atropine sulphate intramuscularly combined with anaesthetic drugs \VY oods et al. 
1989). In other phocids it has been noticed that milk samples were difficult to collect after atropine 
adtninistration and its use was suspended (Gales 1989). The effects of atropine on milk let down in 
southern elephant seals has not been described. 
Tranquillizers and sedatives 
i. General 
The distinction between tranquillizers and sedatives is a question of semantics and of little value 
except that increased doses of tranquillizers tend to produce side effects but not loss of consciousness, 
whereas increased doses of sedatives produces more profound central nervous system depression that 
resembles anaesthesia (Gleed 1987). Tranquillizers administered to southern-elephant seals include the 
phenothiazine promazine, and sedatives include the benzodiazepines diazepam and zolazepam, and the 
thiazine derivative xylazine. 
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ii. Promazine 
Promazine has been used in southern elephant seals combined with phencyclidine (Table 2.1). 
Morgan et al. (1978) found that its addition to phencyclidine produced smoother recoveries than when 
phencyclidine was used alone. Cline et al. (1969) administered the drug intravenously to treat 
prolonged or clonic convulsions associated with phencyclidine use. 
Promazine is no longer used as a coanaesthetic for immobilisation of southern elephant seals. 
Hubbard and Poulter (1968) stated that the effect of phenothiazine derivatives on pinnipeds was one of 
depression rather than tranquillization, and Sweeney (1974) and Haigh (1978) noted that the main 
contraindication was that they disrupted thermoregulatory mechanisms. There are, however, no 
published data on which to base these assumptions and further studies are required to determine the 
effect of phenothiazine derivatives on pinnipeds. 
iii. Benzodiazepines 
These drugs have anxiolytic and skeletal muscle relaxant effects and high margins of safety. The 
benzodiazepine is usually combined with a cyclohexamine to alleviate emergence reactions or improve 
skeletal muscle relaxation. Two benzodiazepines have been used in southern elephant seals: diazepam 
and zolazepam. 
Diazepam has been shown to be useful when combined with ketamine (Gales and Burton 1987 a, 
Baker et al. 1988). It can be administered to pinnipeds orally, though this is not possible under field 
conditions. It has also been used intravenously in other pinnipeds to successfully facilitate minor 
procedures such as force feeding (Gage 1984), examination (Greenwood and Taylor 1983) and fibre-
optic gastroscopy (Greenwood and Wild 1977). Hubbard (1969) suggested that diazepam was the best 
tranquilliser then available for phocid seals, though the assesment appeared subjective. 
Use of zolazepam in combination with tiletamine has been described (Baker et al. 1990, Mitchell and 
Burton 1991). Though promising results were seen in initial work with this drug combination in 
other species of pinnipeds, including northern elephant seals (Hammond ai;id Elsner 1977) and other 
animals (Stirling et al. 1985, Haigh et al. 1985, Stirling and Sjare 1988), 2 southern elephant seals 
of 5 to which this combined drug had been administered died in trials at Heard Island (Mitchell and 
BUiton 1991). Despite these findings Baker et al. (1990) successfully immobilized a large number 
of southern elephant seals with this combination and stated that it appeared to be the best 
immobilizing agent available for use in this species. Comparative studies have not been performed in 
southern elephant seals, however they could help determine the most useful drug combination. 
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iv. Xylazine 
Xylazine has been used alone (Vergani 1985) or combined with ketamine (Gales and Burton 1987 a, 
Bester 1988, Woods et al. 1989) to sedate southern elephant seals. Its use has been associated with 
vomiting, hyperthermia, excitement and deaths (Vergani 1985, Woods et al. 1989, Mitchell and 
Burton 1991). Anaesthetic reversal agents such as yohimbine and 4-aminopyridine are available for 
this group of drugs but have not been trialled in southern elephant seals. Woods et al. (1989) 
suggested that this drug might be implicated in initiating diving responses in immobilized animals. 
v. Ketamine 
Ketamine has been used as a sedative by Griffiths et al. (1979) who sedated immature males for 
transportation with 2.5 mg/kg administered intramuscularly. 
Drugs used for chemical restraint or anaesthesia 
General 
A summary of drugs and dose rates used for chemical restraint or anaesthesia of southern elephant 
seals in presented in Table 2.1. The drugs used fall into 3 broad categories: neuromuscular blocking 
agents, barbiturates and cyclohexamines. Use of narcotic analgesics or gaseous anaesthetics have not 
been reported. 
Neuromuscular blocking agents 
Suxamethonium is. the only neuromuscular blocking agent that has been used in southern elephant 
seals. It has been used alone (Ling and Nicholls 1963, Ling et al. 1967, Griffiths et al. 1979, 
Condy 1980) and combined with pentobarbitone (Bryden 1971 a, Griffiths 1980). 
Ling et al. (1967) described a characteristic sequence of muscle paralysis associated with its use: 
1. a rippling shudder along the length of the seal; 
2. limpness of the hind flippers and then the fore flippers; 
3. sagging of the lower jaw; 
4. protrusion of the tongue; 
5. passage of the nictitating membrane across the eye; 
6. intercostal muscular paralysis; 
7. paralysis of the diaphragm with ensuing apnoea for a period of 5 to 10 minutes. 
Recovery followed almost exactly the reverse order of events. 
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It was found that the recovery time could be calculated from the linear relation: 
I= 0.75R - 2.75 
Where I= immobililization time (minutes) and R =recovery time (minutes). 
The relationship was not further defined statistically. However, this approach may be very useful in 
predicting response to various anaesthetic drugs but would require controlled dose response studies. 
Ling et al. (1967) reported little difference in the dose required for immobilization and that which 
induced apnoea but found that at a dose rate of 2.0 mg/kg 95% of elephant seals would be effectively 
immobilised and none would die. Of the 95%, 10% would be immobilized for less than 6.5 minutes, 
80% between 6.5 and 27 minutes, and 10% for more than 27 minutes. 
Despite satisfactory immobilization being reported in some cases, variable results, apnoea, fatalities, 
or the need for additional physical restraint have been reported in all studies using this drug. It has 
been suggested as causing extreme fright in other animals (Lumb and Jones 1984 p344) and the use of 
neuromuscular blocking drugs without any anaesthesia is now generally regarded as inhumane (Gales 
1989). For these reasons suxamethonium is no longer used as the sole agent for chemical restraint. 
Non-depolarising neuromuscular blocking agents have not been administered to southern elephant 
seals but have been used to immobilize a variety of other pinnipeds (Gales 1989). 
Despite the difficulties, neuromuscular blocking drugs are useful in both human and veterinary 
anaesthesia and could be used to improve the balance of anaesthesia, facilitate positive pressure 
ventilation, or for treatment of seizuring in southern elephant seals. 
Barbiturates 
Backhouse (1964) suggested that, because of the depression of the cardiovascular and respiratory 
systems, pinnipeds were fairly sensitive to this group of drugs and recommended that they should 
only be used to induce anaesthesia and that other drugs should be used for maintenance. However, 
dose-response and comparative pharmacodynamic studies have not been performed and there appear to 
be few data to support these statements. This appears to be a common problem in reviewing the 
literature on pinniped anaesthesia; conclusions are usually based on the results of uncontrolled studies 
using small sample sizes. These conclusions appear to become ingrained in the literature after a 
number of years until accepted as fact. Controlled studies of drug usage are indicated in all species. 
Barbiturates have been used less frequently than neuromuscular blocking agents or cyclohexamines for 
immobilization. The high pH of these solutions is associated tissue damage when injected 
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perivascularly, and problems of absorption following intramuscular administration (Lumb and Jones 
1984) preclude them from use as an initial immobilizing agent in unrestrained animals. Only 
pentobarbitone has been used, to induce anaesthesia preceding euthanasia (Bryden 1971 a, Griffiths 
1980). Prior immobilization with suxamethonium was used by both authors to allow drug to be 
administered either intravenously into the extradural intravertebral vein (Griffiths 1980) or 
intrapleurally (Bryden 1971 a). Concentrated solutions were used. Bryden (1971 a) administered a 
solution of 5 g/mL to a roughly third stage anaesthesia and Griffiths (1980) induced anaesthesia using 
a 325 mg/ mL solution at approximately 20 mg/kg (6 mL/ 100 kg). The authors did not discuss the 
effects of these drugs on the animals. 
Gales (1989) reviewed barbiturate use in other seals and concluded that their unwanted side effects 
(such as cardiovascular and respiratory depression), the need for intravenous administration and the 
advent of more appropriate drugs meant that they were rarely used. 
Despite the reported problems, barbiturates are a commonly used group of chugs, many veterinarians 
are familiar with their use and they may be useful if suitable doses could be determined. However, 
techniques to allow intravenous access other than premedication with neuromuscular blocking drugs 
(above) would need to be developed before they could be achninistered to wild animals. 
Cyclohexamines 
i. General 
Cyclohexamines is a common term used to refer to the dissociative anaesthetics which are a group of 
chemical compounds that are capable of producing a state of anaesthesia during which the subject has 
an apparent dissociation from the environment (Short 1987 b). 
The two cyclohexamines which are of clinical importance in elephant seals are ketamine and 
tiletamine; phencyclidine is of historic interest. Phencyclidine was the first to be used as an 
anaesthetic; the latter drugs are analogues of it. These three injectable anaesthetics have been the 
drugs most widely used for pinniped immobilization (Gales 1989). Cyclohexamines have been used 
alone, however they are usually used in combination with other drugs (parasympatholytics or 
sedatives) to diminish unwanted side effects such as poor muscle relaxation, salivation and emergence 
delirium (Short 1987 b). 
ii. Phencyclidine and phencyclidine-promazine 
Phencyclidine, one of the original dissociative anaesthetics, revolutionized chemical restraint and 
handling of animals (particularly nonhuman primates). However, as a result of its drug abuse 
potential it was withdrawn from the veterinary market. The development of other cyclohexamines 
having fewer undesirable side effects (Short 1987 b), has precluded this drug from further use. 
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Phencyclidine has been used alone (Ross and Saayman 1970, Morgan et al. 1978) or with promazine 
(Cline et al. 1969, Morgan et al. 1978) to immobilize southern elephant seals. When used alone 
prolonged recovery, with animals being aware of their surroundings while still paralysed, has been 
described (Morgan et al. 1978). The addition of promazine was reported to give a smoother and more 
rapid recovery from immobilization (Morgan et al. 1978). Cline et al. (1969) also used promazine 
with phencyclidine and found that reaction to the drugs followed a characteristic and predictable 
sequence of events. The animal exhibited progressive ataxia and loss of coordination accompanied by 
increased salivation and watering and rolling of the eyes. Respiration was noticeably slowed during 
the inspiratory phase. Minor tremors (tonic convulsions) frequently became evident in the neck 
region, and along the tail and hind flippers. Whenever prolonged or clonic convulsions appeared, 
additional promazine was given. 
iii. Ketamine 
Ketamine has been used for chemical restraint of southern elephant seals (Morgan et al. 1978, 
Griffiths et al. 1979, Ryding 1982, Woods 1991). There is little information available on its 
usefulness and effects in southern elephant seals though it has been widely used in a number of other 
pinniped species (Gales 1989). The few southern elephant seals to which it has been administered 
were handled relatively easily and s~ely and there was little change in heart rate, respiratory rate, or 
rectal temperature (Ryding 1982). Hyperthermia has not been associated with its use as it has been in 
other seals (Sweeney 1985), however trem01ing, wide individual tolerance, lacrimation (Ryding 
(1982) and deaths (Woods 1991) have been reported. 
It was found that the addition of a sedative such as diazepam or xylazine masked some of the 
undesirable effects ofketamine in other seals (Geraci et al. 1981) and thus ketamine is no longer used 
alone for initial immobilization of southern elephant seals. Comparative studies to determine the 
most suitable sedative to combine with ketamine have not been performed. Gales and Burton (1987 
a) found that diazepam and xylazine were both suitable combinative drugs with ketamine; neither 
appeared superior, with both effectively preventing the reported side effects of ketamine. However 
Baker et al. (1988) suggested that ketamine combined with diazepam provided the best and safest 
anaesthetic combination then available. This combination caused fewer adverse side effects than 
ketamine and xylazine although severe respiratory depression was sometimes seen with either 
sedative. 
Ketamine alone has been used to prolong chemical restraint (Gales and Burton 1987 a, Mitchell and 
Burton 1991). 
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iv. Ketamine and diazepam 
Ketamine and diazepam have been used to chemically restrain southern elephant seals (Gales and 
Burton 1987 a and b, McCann et al. 1989, Baker et al. 1988, Woods 1991). The drugs have been 
administered in various ratios (Baker et al. 1988, 20:1; McCann et al. 1989, 50:1; Woods 1991, 
100:1; Gales and Burton 1987 a, not stated). It is not known which of these ratios, and what dose 
rate, is most appropriate. However, Baker et al. (1988) suggested that 6 mg/kg ketamine and 0.3 
mg/kg diazepam provided the best and safest anaesthetic combination then available for immobilizing 
southern elephant seals in the field. Gales and Burton (1987 a) used a combination of ketamine 
(5.4 - 14.95 mg/kg) and diazepam (0.03 - 0.11 mg/kg) and, despite one fatality, considered that 
results were generally "reliable". 
v. Ketamine and xylazine 
Ketamine and xylazine have been used to immobilize southern elephant seals (Gales and Burton 1987 
a, Bester 1988, Woods et al. 1989, Mitchell and Burton 1991). Reports vary as to its usefulness. 
Gales and Burton (1987 a) found it produced good immobilization and Bester (1988) believed it to be 
relatively safe and effective, however Woods et al. (1989) and Mitchell and Burton (1991) reported 
deaths and complications such as vomiting and hyperthermia. Mitchell and Burton (1991) suggested 
that the fatalities were due to regurgitation and aspiration of stomach contents associated with 
anaesthesia and stomach lavaging and concluded that the xylazine component was responsible. 
vi. Tiletamine and zalazepam 
Tiletamine is a more recent analogue of phencyclidine. It has been administered to southern elephant 
seals combined with the sedative zolazepam (Baker et al. 1990, Mitchell and Burton 1991). Reports 
of its usefulness for immobilization vary. Two of 5 southern elephant seals died when administered 
doses that were successful in polar bears (Mitchell and Burton 1991). However, Baker et al. (1990) 
successfully immobilized 90 southern elephant seals (including 3 adult males) a total of 195 times 
using a combined dose of 1 mg/kg of tiletamine and zolazepam with no fatalities. Recovery time, 
though not recorded, was thought to be faster than that after ketamine based drug mixtures. Six 
animals became apnoeic but recovered. It was thought that the effects of the tiletamine and zolazepam 
mix were more predictable than those of other preparations and the authors stated that it appeared to be 
the best immobilizing agent currently available for use. However, comparative studies have not been 
conducted. 
Narcotic analgesics 
Narcotic analgesics have their action in the central nervous system where they alleviate pain and cause 
some degree of central nervous system, cardiovascular and respiratory depression (Gales 1989). Their 
use in other seals has been reviewed by Gales (1989) who concluded that the associated fatalities and 
reports of apnoea probably preclude them, and their reversal agents, from use in pinnipeds. It was 
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recognised, however, that the ability to reverse these agents was an advantage. Despite these 
conclusions the fact remains that no dose-response or other objective studies have been performed in 
pinnipeds using these agents. These drugs may be very useful and further studies using them are 
indicated. 
Inhalation anaesthetics 
Inhalation anaesthetics have not been administered to southern elephant seals. Their use in other seals 
has been reviewed by Gales (1989) who commented that despite their advantages the high level of 
expertise required and financial and logistical restraints often prevent their use in the field. It is, 
however, more likely that their use has been limited simply because they have been unnecessary. 
Field procedures are usually of short duration and only low levels of restraint are required; criteria 
which can now be achieved using injectable agents. 
Anaesthetic reversal agents 
General 
Various antagonists are available for some of the drug combinations used to chemically restrain 
southern elephant seals, however none have been administered. Those most commonly used in other 
animals include: 4-aminopyridine and yohimbine for ketamine and xylazine or xylazine; flumazenil, 
sarmazenil and 4-aminopyridine for benzodiazepine/ cyclohexamine based combinations; and 
naloxone, naltrexone and diprenorphine for narcotic based combinations. The analeptic doxapram has 
also been used nonspecifically to cause arousal. 
Yohimbine 
Yohimbine, an a1 adrenergic antagonist, has been used in preliminary trials in Hooker's sea lions. 
Results suggested that, while it effectively antagonised some of the actions of a ketamine and 
xylazine combination, its administration often caused violent tremors and convulsions (Cawthorn 
1989). Gales (1989) suggested that the yohimbine was primarily antagonising the xylazine, which 
was then failing to mask the side effects of ketamine. He concluded that further trials were required to 
properly determine the efficacy of yohimbine in pinnipeds. 
Narcotic reversal agents 
See Narcotics. 
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Administration of additional drugs 
Administration of additional drugs has been by intramuscular, intravenous or intrapleural injection. 
By necessity, animals that failed to become adequately irrnnobilized after the initial dose of drug have 
had further doses administered intramuscularly. Operators have usually waited for periods of 10 to 20 
minutes before administering additional drug (Ryding 1982, Gales and Burton 1987a). Once 
immobilized, further drug has been administered intravenously or intramuscularly to prolong or 
increase the level of chemical restraint. Despite the reported advantages of intravenous drug 
administration, including lower doses, more rapid induction and good control over the duration and 
degree of immobilization (Englehart 1977), most authors have given further doses of drug 
intramuscularly. Gales and Burton (1987a) found that duration of effect was reduced and response to 
injection less predictable when additional ketamine was administered intravenously rather than 
intramuscularly and, because these animals were required to be immobilized for prolonged periods, 
these workers administered further drugs intramuscularly. However Baker et al. (1990) used 
intravenous administration of small volume increments of tiletamine and zolazepam when deeper 
levels of chemical restraint were required. This subsequent dose took effect in 15 to 30 seconds and 
thus could be used to very accurately adjust the degree of immobilisation. Guidelines for additional 
drug administration were not presented; presumably they were given to effect. 
Specific recommendations have not been made regarding additional doses but they have, however, 
been reported (Table 2.1). Ryding (1982) administered estimated doses of 1.58 mg/kg and 2.93 
mg/kg of ketamine intramuscularly to 2 male southern elephant seals that had received an estimated 
4.48 mg/kg and 4.63 mg/kg ketamine 20 minutes before but had failed to become immobilised. The 
animals were immobilised 7 and 11 minutes later. Bester (1988) administered further ketamine (1.56 
and 1.18 mg/kg) and xylazine (1.20 and 1.13 mg/kg) to 1 post- and 1 pre-part.um female to which 
ketamine (4.92 mg/kg) and xylazine (0.83 mg/kg) had been administered. Immobilization was 
achieved within 4 minutes. Gales and Burton (1987 a) reported doses of drugs used per h to maintain 
immobilization and Baker et al. (1988 and 1990) reported cumulative doses of drugs used to 
immobilize animals to which more than 1 injection had been performed. Mitchell and Burton (1991) 
administered additional doses of approximately 25% of the initial dose ofketamine intramuscularly to 
induce or maintain anaesthesia. 
Additional doses of 500 mg ketamine have been administered to northern elephant seals to maintain 
restraint for up to 4 h (Costa et al. 1986). The route of administration was not stated. 
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Unwanted effects of anaesthetic agents 
Musculoskeletal system 
Tremor, ranging from very slight to tonic convulsions, has been associ::.i.ted with cyclohexamine 
administration in southern elephant seals (Cline et al. 1965, Morgan et al. 1978, Ryding 1982, 
Gales and Burton 1987 a, Bester 1988, Mitchell and Burton 1991). Tremor is alleviated to some 
degree by use of sedatives (Gales 1989) administered with the cyclohexamine (Gales and Burton 1987 
a) or after its onset (Morgan et al. 1978). 
Special senses 
i. Ophthalmic signs 
There is little information on the effect of anaesthetic agents on ophthalmic signs in elephant seals. 
Cline et al. (1969) reported rolling of the eyes in animals to which promazine and phencyclidine had 
been administered. Ryding (1982) observed that corneal reflex was present at maximum 
immobilisation in each of the 5 animals he anaesthetised with ketamine. "Apparently enlarged 
pupils" were noticed by Ross and Saayman (1970) in a young bull immobilized with phencyclidine. 
The eyes also remained open. 
ii. Lacrimation 
Ryding (1982) observed an increase in lacrimation in 3 of 5 seals anaesthetised with ketamine but it 
was considered of doubtful significance as eye swabs were taken in all cases. Cline et al. (1969) also 
reported increased lacrimation associated with phencyclidine use. 
Central nervous system 
There is little information available on the central nervous system effects of anaesthetic agents in 
southern elephant seals. Absolute or relative drug overdose have been implicated as cause of death in 
several animals (below). 
Vergani (1985) reported that the deaths of two pups to which an estimated 4:4 and 6.3 mg/kg xylazine 
had been administered were associated with drug overdose. Though these doses are lower than those 
used for immobilization of some other animals (Booth 1982 c, range 0.5-10 mg/kg) they are higher 
than those used for immobilization of other phocid seals (Erickson et al. 1974, Vergani et al. 1986; 
range 2-3 mg/kg). 
Gales and Burton (1987 a) suggested that an animal in their study died as a result of intravascular 
administration of 8.20 mg/kg ketamine and 0.04 mg/kg diazepam and thus relative drug overdose. 
However, Baker et al. (1988) believed they administered ketamine and diazepam intravascularly to 
two animals; in both cases the induction time was less than one minute but no adverse effects were 
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seen. Baker et al. (1988) did not state the doses of drugs administered to each animal which may 
have been lower, or less rapidly administered, than those admistered by Gales and Burton (1987a). 
Digestive system 
i: Salivation 
Increased salivation has been noticed using several cyclohexamine based drug combinations (Cline et 
al. 1969, Ryding 1982). Neither of these authors administered a parasympatholytic drug. 
ii. Vomiting 
Vomiting or retching has been associated with immobilization of southern elephant seals. It has 
usually been associated with gastric lavage or the use of xylazine (Vergani 1985, Mitchell and Burton 
1991) and has been suggested as the cause of fatalities due to aspiration of stomach contents (Mitchell 
and Burton 1991). Ling et al. (1967) noticed retching in animals immobilized with suxamethonium 
but they believed that the fasting habits of the animals while ashore possibly saved them from 
complications arising from regurgitation of stomach contents. Mitchell and Burton (1991) described 
regurgitation and aspiration of stomach contents in animals anaesthetised with ketamine and xylazine. 
They suggested that the combination of anaesthesia and stomach lavaging were probably responsible, 
although one seal vomited before intubation. They also suggested that regurgitation and aspiration of 
stomach contents in several species of seal was associated with the administration of xylazine. 
iii. Gastric lavage 
Gastric lavage whilst animals were immobilized with ketamine and xyiazine has been reported 
(Mitchell and Burton 1991). It was associated with regurgitation, vomiting, respiratory distress, and 
two deaths. Intubation was not used. 
iv. Defecation 
The effects of anaesthetic agents upon the gastrointestinal system and defecation of southern elephant 
seals have not been discussed. Baker et al. (1990) reported that grey seals frequently defecated large 
volumes after immobilization with ketamine based mixtures, making handling the animals 
unpleasant, and, as the hind flippers were frequently contaminated, blood sampling and tagging carried 
a higher risk of infection. With tiletamine and zolazepam animals did not defecate. It was not 
known whether the ketamine based mixtures caused defecation or whether tiletamine and zolazepam 
inhibited it. 
Respiratory system 
Normal respiratory rates and patterns have been described for wild free-ranging southern elephant seals 
on land (Kenny 1979). Animals were described as showing some form of rhythmic variation of 
24 
Literature review 
breathing rate characterised by some minutes of eupnea followed by a period of apnoea of variable 
duration. There is little information available on respiratory rate and pattern for immobilized southern 
elephant seals. Cline et al. (1965) noted that respiratory rate was noticeably slowed during the 
inspiratory phase with phencylidine use. There was little change in respiratory rate in five animals 
immobilised with ketamine (Ryding 1982). Bull respiratory rates ranged from 3.5 to 4 breaths/min, 
the adult female 4 breaths/min, and the first year female pup 5.5 - 7 breaths/min. Of five pre and 
post-partum cows anaesthetised with ketamine and xylazine by Bester (1988), four breathed regularly 
throughout immobilisation whilst one had a 20 minute period of apnoea, but resumed regular 
breathing 5 minutes after administration of doxapram, the effect of which was equivocal. Mitchell 
and Burton (1991) described respiratory rates of from 4 to 20 breaths/min for animals immobilized 
with ketamine and xylazine that were breathing regularly. 
Apnoea, laryngeal spasm and closure of the nostrils have been reported with a variety of anaesthetic 
agents (Vergani 1985, Baker et al. 1990, Mitchell and Burton 1991). Apnoea is common, has been 
associated with death and is often seen upon induction, after additional drug administration, or 
associated with gastric lavage or the use of suxamethonium (Ling and Nicholls 1963, Candy 1980, 
Mitchell and Burton 1991). Its duration varies but periods of up to 60 minutes have been rep01ted 
(Mitchell and Burton 1991). The total period of apnoea does not appear to be correlated with dose of 
drug administered, however Mitchell and Burton (1991) reported that duration of anaesthesia increased 
with length of apnoeic period. 
Ling et al. (1967) described the recovery from apnoea associated with the use of suxamethonium. 
Over a period of 4 - 9 minutes following apnoea, breathing was initially slow and irregularly at first 
(6 breaths/ minute), becoming rapid and more regular (18 - 22 breaths/ minute), and then slowed again 
slightly. However (Ling et al. 1967) considered normal respiration to be so irregular while the 
animals were sleeping that a basal rate was difficult to determine and considered it somewhat 
meaningless to compare with the hyperventilation response. 
Comparative studies on the effect of anaesthetic drugs upon respiration have not been performed. 
Cardiovascular system 
It has been stated that elephant seals, because of their large size, are difficult to auscultate (Needham 
1978). There is little information available on the cardiovascular response to anaesthetic agents of 
southern elephant seals. Normal resting heart rates on land have been described (Kenny 1979). They 
ranged from 96 beats/min for a 1 month old pup to 23 beats/min for a bachelor bull. Heart rates from 
pups (mean= 81 beats/minute) were significantly higher than those from other sections of the 
population (mean= 53 beats/minute). Heart rates of immature seals were higher than those of adults 
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with the exception of cows after weaning their pups. The differences between the rates observed from 
different adult groups were not significant, except for those cows at the end of lactation and the onset 
of the breeding season; these were significantly higher than other heart rates. Heart rates of females 
ranged from 40 to 62 beats/minute; for males from 36 to 54 beats/minute. Sweeney (1974) gave 
mean heart rate of captive elephant seals as 80 beats/minute. 
Kenny (1979) found that observations at 5 minutes intervals on individual seals showed changes in 
heart rate of up to 10% without alterations in the activity pattern of the individual. No regular pattern 
of heart rate variability relative to breathing rhythms was noted, although Bartholomew (1954) 
observed a 15% reduction of heart rate during apnoeic periods for northern elephant seals. Further, 
differences in heart rate before and after periods of apnoea, similar to those recorded during 
experimental dives of other seal species (Harrison and Kooyman 1968) were not observed. 
There was little change in heart rate in five southern elephant seals immobilised with ketamine 
(Ryding 1982). There was no suggestion of pathological cardiac arrhythm~. Heart rate of the three 
immobilised bulls ranged from 34 - 54 beats/min, the adult female 72 - 76 beats/min, and the first 
year pup 72 - 76 beats/min. Ryding (1982) also used a medical sphygmomanometer to measure 
arterial blood pressure on the front limb of a first year pup immobilised with ketamine alone. 
Repeated estimates gave systolic pressures of 110 - 115 mmHg, and diastolic pressures of 60 - 85 
mmHg. It was not possible to use this technique on larger seals. 
Cardiovascular dynamics have not been been studied in southern elephant seals but have been in 
northern elephant seals during studies of simulated diving in a tank after immobilization with 
phencyclidine (Van Citters et al. 1965). Blood pressure was sampled via polyethylene tubes inserted 
into the aorta via flipper arteries. Aortic blood pressure averaged 120/80 mmHg, and excursions as 
wide as 50 mmHg occurred during respiration. Resting heart rates ranged between 50 and 85, and 
averaged 60. The maximum heart rate during exertion or after atropine. was < 100. During the 
longest dive, which was 40 minutes in duration, the heart rate reached 4. No electrocardiographic 
abnormalities were recorded during diving activity. Aortic blood pressure was maintained ·or was 
slightly elevated during diving bradycardia. Iliac artery blood flow was drastically curtailed, usually to 
25% of resting levels immediately after the onset of diving, and commonly fell to 0 in dives lasting 
longer than 10 minutes. Carotid artery flow fell in proportion to the heart rate, but the velocity and 
volume of blood pumped into this vessel with each beat was only slightly reduced. It was concluded 
that these changes implied that intense vasoconstriction occurred in skeletal muscle bed, but was less 
marked in the distribution to the carotid artery. Diving bradycardia was abolished by atropinization of 
the animal and bradycardia and vasoconstriction identical with that developed during diving was 
provoked by electrical stimulation of the periventricular nucleus in the anterior hypothalamus. The 
resting ECGs were essentially identical in configuration to their counterparts recorded in common 
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laboratory animals or man. All these factors, but in particular heart rate, may have been influenced 
by anaesthesia (Van Citters et al. 1965). 
Thermoregulatory system 
Despite the generally accepted risk of hyperthermia associated with pinniped chemical restraint (Gales 
1989), with the exception of xylazine and combinations containing xylazine, rectal temperatures 
reported during anaesthesia (35.8-38.8°C; Ryding 1982, Mitchell and Burton 1991) compare 
favourably with those presented for non-chemically restrained animals (34.8-38.4°C; Laws 1956, 
Kenny 1979). Cline et al. (1969) suggested that the apparent lack of hyperthermia in their study was 
associated with the relatively cool temperatures under which animals were immobilized. 
Hyperthermia, or clinical signs interpreted as indicating hyperthermia, have been associated with 
deaths in southern elephant seals to which anaesthetic agents have been administered (Vergani 1985, 
Woods et al. 1989). Excluding one animal suspected of dying from hyperthermia, Vergani (1985) 
reported temperatures of weaned pups immobilised with xylazine of approximately 35.3°C to 
40.70C. The animal which was thought to have died from hyperthermia had a high initial rectal 
temperature (approximately 40.40C), which rose to 60.5°C terminally. It was believed that the 
inability to resort to behavioural mechanisms of cooling whilst immobilised prevented heat loss and 
caused the animal's death. He recommended close monitoring of the temperature of immobilized 
animals and moistening with water if necessary. A decrease in body temperature after the effects of 
the drug had passed was seen in animals immobilised in Antarctica, and was believed to have been 
produced spontaneously, presumably due to the cold environmental conditions. 
Despite cold predisposing other anaesthetised animals to hypothermia (Lumb and Jones 1984), 
complications associated with hypothermia have not been recorded. Gales and Burton (1987 a) found 
that despite immobilizing moulting animals for prolonged periods in temperatures as low as - 23°C 
there were no signs of hypothermia. However, as body temperature was not monitored some change 
in core or skin temperature may have occurred. They suggested temperature monitoring should be 
considered in future studies and the effect of anaesthesia on thermoregulation in these animals needs to 
be examined. 
Use of drugs in pregnancy 
There is little information available on use of drugs in pregnancy in -southern elephant seals. 
Southern elephant seals have a 12 month gestation period (including a 3 month period of delayed 
implantation), therefore most females which are immobilized are pregnant. Whether chemical 
restraint or anaesthesia affects the foetus or mother is unknown. Xylazine use has not been fully 
evalp.ated in pregnant animals. Evidence is conflicting; some evidence suggest that it may be 
27 
Literature review 
contraindicated, possibly predisposing to abortion (LeBlanc et al. 1984), other evidence suggests 
otherwise (Gleed 1987). Moreover, its use is usually avoided during the later stages of pregnancy. 
Bester (1988) administered ketamine and xylazine to 3 pre-partum cows 'Yhich gave birth within a 
week to apparently healthy pups. Pups are usually born within a week of cows hauling out (King 
1983). Bester (1988) did not speculate on the possible effects of these drugs on pregnancy, the effects 
of which need to be examined in southern elephant seals. 
Complications associated with chemical restraint and anaesthesia and 
their prevention and treatment 
General 
During anaesthesia complications can occur even when optimal care is provided and generally involve 
one of the following categories: depth of anaesthesia, ventilation, cardiovascular function, or 
temperature regulation (Bicker 1986). Fatality rates and complications have been discussed (Gales 
1989, Mitchell and Burton 1991). Apnoea, aspiration pneumonia, drug ov,erdose, or dive responses 
have been implicated. In many cases the cause of deaths were unknown. Other problems include 
attack by other seals or conspecifics, desertion of pups (Woods et al. 1989), and going to sea and 
drowning (Mitchell and Burton 1991). 
Monitoring 
Various criteria and techniques have been used for monitoring southern elephant seal anaesthesia and 
chemical restraint. However, even the most fundamental of parameters can be difficult to assess. The 
thorax is difficult to auscultate and peripheral pulses are only palpable in young animals (Needham 
1978, Ryding 1982). Preference for light planes of anaesthesia or sedation, rapid recovery and 
performance of non-invasive procedures of short duration using injectable anaesthetic agents, limits 
the time available for placement of monitoring equipment. The inaccessibility of peripheral arteries 
and central venous access coupled with difficulties in supplying power, the delicate nature of some 
equipment and lack of personnel, have made routine monitoring of blood pressure, central venous 
pressure, blood-gases and ECG impractical for southern elephant seals anaesthetised for short periods 
in the field. 
For these reasons there is little information in the literature on monitoring of anaesthetic depth and 
the response of southern elephant seals to anaesthesia. This lack of information compounds the 
problems of monitoring anaesthesia and is further exacerbated by a lack of information regarding 
normal values whilst under anaesthesia for heart rates, respiratory rates, rectal temperatures, 
biochemistry, haemotology, blood pressure, central venous pressure, blood gases and ECG. 
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Cline et al. (1965) determined degree of paralysis by touching the tail and hind flippers of 
immobilized southern elephant seals. This often elicited minor convulsive jerks of the flippers or head 
or body muscles, but responsiveness gradually subsided until the face could be touched without 
eliciting a response. The time interval between initial drug injection and immobilization was recorded 
as the latent period. They did not have sufficient time to observe the animals for more than 2 h 40 
minutes so no other parameters were presented. 
Ryding (1982) defined induction time, duration of maximum immobilization and total 
immobilization time for southern elephant seals as follows. 
• Induction time was measured from the start of the injection until the seal ceased to raise its 
head when approached. 
• Duration of maximum immobilization was defined as the time between induction and the 
onset of uncoordinated provoked voluntary movement. 
• Total immobilization time was defined as the time from induction until the seal was able to 
raise its head when approached. 
It was found that in all cases muscle tone was present throughout immobilization; no cyanosis of 
mucous membranes was observed; corneal reflex was present at maximum immobilization; and a 
minimal withdrawal reaction to painful stimuli was observed in only one animal. 
Vergani (1985), classified the response to different doses of xylazine administered to weaned pups 
according to the reaction to pain caused at the moment of blood extraction. The reactions were divided 
into three categories: without reaction; slight; strong. Gales and Burton (1987 a) recorded induction 
time as the period between injection and failure of the animal to raise its head when patted on the 
back. Duration of immobilization was recorded as the interval from the end of induction to the time 
when the animal regained the ability to resist being handled. Baker et al. (1988) recorded depth of 
anaesthesia on an arbitrary scale of 1 to 5, from a minor degree of sedation to surgical anaesthesia. A 
standard form was completed for each immobilisation, recording the animal's weight and dimensions, 
the times of procedures and details of the anaesthetic. Bester (1988) used Ryding's (1982) definitions 
for induction time, duration of immobilisation. He believed that responses to immobilization may 
vary with methods of recording the behaviour of the seals. Woods et al. (1989) defined sedative 
induction time as the interval from injection until the animal failed to ;espond to head patting. 
Duration of sedation was defined as the time from induction until the animal could raise its head. 
Development of a standardised system of monitoring would allow more accurate assessment of the 
patient and comparisons to be made between anaesthetic agents. 
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Anaesthetic depth 
i. General 
There is little information available on the control of anaesthetic depth. Use of injectable anaesthetic 
agents, lack of anaesthetic reversal agents and the inability to treat all complications associated with 
chemical restraint have made control of anaesthetic depth difficult. 
Problems of anaesthetic depth in southern elephant seals generally fall into three categories: 
inadequate depth, excessive depth and prolonged anaesthesia or recovery. Inadequate anaesthesia 
prevents completion of planned procedures and excessive anaesthesia can lead to various complications 
by depressing the cardiovascular and respiratory systems which may cause tissue or organ injury or 
death, depending upon the duration and degree of depression (Bicker 1986). 
ii. Excessive anaesthetic depth 
This has been associated with relative drug overdosage after suspected intravascular administration of 
anaesthetic drugs (Gales and Burton 1987 a) or absolute drug overdose (Vergani 1985). Increased 
anaesthetic depth, especially in combination with systemic or metabolic disorders has been associated 
with prolonged recovery in other animals which can lead to fatal respiratory depression or ventricular 
fibrillation (spontaneous or induced by hypothermia; Bicker 1986). 
iii. Prolonged recovery 
Bester (1988) stated that a rapid recovery was desirable to minimise the possibility of interference by 
conspecifics, and to promote rapid resumption of pup attendance by lactating cows. Prolonged 
recovery has been seen associated with anaesthetic and sedative use. Morgan et al. (1978) described 
recovery periods of from 65 minutes to > 9 h associated with phencyclidine use and considered this a 
disadvantage. Woods et al. (1989) described an animal sedated for 6 h that failed to recover and died 18 
h after administration of ketamine and xylazine. 
Respiratory system 
i. General 
The role of apnoea in complications associated with anaesthesia is not known. There is evidence to 
suggest that sleep apnoea in the northern elephant seal has physiologic aspects that are similar to 
those seen in freely diving seals (Castellini et al. 1986) and it is possible that circulatory changes 
consistent with those seen during diving occur in some anaesthetised soutliern eleph::mt seals (Gales 
and Burton 1987 a). These changes have been termed "the dive response" (Hubbard and Poulter 1968). 
ii. Apnoea and the dive-response 
Pinnipeds have a respiratory centre that is relatively insensitive to the normal respiratory stimulant 
C02 (Hubbard 1969) and there is greater cerebral tolerance of low oxygen levels than is the case for 
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terrestrial species (Elsner et al. 1970). In southern elephant seals and other phocids, apnoea has been 
compounded by upper airway obstruction or closure of the nostrils, which is their normal relaxed state 
(Baker and Gatesman 1985). Hammond and Elsner (1977) noted that there was a marked difference in 
the level of anaesthesia that produces apnoea in terrestrial and aquatic mammals. It was their 
experience that apnoea occurred almost with the onset of induction and consequently it was found that 
a surgical plane of anaesthesia nearly always required intubation and resuscitation. 
The major physiological changes associated with the dive response have been determined largely under 
laboratory conditions and include bradycardia, and a decrease in cardiac output and peripheral 
circulation (Scholander 1940, Elsner et al. 1966, Elsner 1969, Kooyman et al. 1981, Butler and Jones 
1982). Metabolism is reduced in many tissues (Kooyman et al. 1981). Blood flow to the liver 
decreases and the blood is stored in large venous sinuses (Harrison and Tomlinson 1958). These 
actions conserve oxygen and glucose for the heart and central nervous system (Kooyman 1968, Robin 
et al. 1981). Respiratory acidosis during the dive and metabolic acidosis during recovery have been 
reported (Elsner 1969). 
Blood returning to the heart via the caudal vena cava is restricted by the caval sphincter level with the 
diaphragm and pools in the inferior vena cava and hepatic sinus (Harrison and Tomlinson 1958). This 
system acts as a storage compartment for relatively well-oxygenated blood. In northern elephant seals 
approximately one fifth of the total blood volume can be contained within the inferior vena cava 
(Elsner 1969). In the latter portion of the dive, blood oxygen has been shown to be higher in the 
inferior vena cava than in arterial circulating blood (Elsner 1969). During the dive the caval sphincter 
opens periodically during diastole letting oxygenated blood enter the heart-brain circulation (Butler and 
Jones 1982). 
Natural dives are usually short and aerobic (Kooyman 1981). The blood volume of the adult southern 
elephant seal is considerably higher than that of terrestrial mammals (207 ml/ kg compared with 80 
ml/ kg in an adult human being; Bryden and Lim 1969) and the mean corpuscular volume is also 
larger (four times that of terrestrial animals in northern elephant seals; Wickham et al. 1989). Even 
when combined with low red cell counts this gives the northern elephant seal high packed cell 
volumes that can be twice those of terrestrial animals (Lane et al. 1972, Wickham et al. 1989). The 
larger blood volume, haemotoclit and mean corpuscular haemoglobin concentrations result in a six 
fold increase in blood oxygen capacity in the northern elephant seal compared with the pig (Wickham 
et al. 1989). In addition, the myoglobin content is higher than that of land mammals which affords 
the seal an even greater oxygen capacity (Robinson 1939). The combination of a large total oxygen 
store relative to body size, cerebral tolerance to hypoxaemia, avoidance of anaerobic diving and 
parsimonious use of blood oxygen due to the lowered energy requirements of various organs are 
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mechanisms by which the problems of hypoxia or hypercapnia are decreased (Elsner et al. 1970, 
Kooyman et al. 1980, Kooyman 1981, Hindell et al. 1992). 
Two theories have been used in an attempt to explain deaths under anaesthesia associated with apnoea 
and the dive response. Mitchell and Burton (1991) proposed that the full physiological response 
associated with apnoea may have been affected by anaesthesia, resulting in early development of 
anaerobic conditions and death within the first h of anaesthesia. They also presented an alternative 
hypothesis (Backhouse 1964) that some of the anaesthetic was pooled in venous sinuses during 
"diving" and was not metabolized; when the animal "surfaced" to breath, the anaesthetic agent was 
released and entered the brain to cause a relapse into deeper anaesthesia. 
What stimulates southern elephant seals to enter a dive response is unknown. Fright, anaesthetic 
drug effects, apnoea and upper respiratory tract obstruction, or normal physiological changes 
associated with sleep and breathing on land could all play a role or have been implicated (Backhouse 
1964, Gales and Burton 1987 a, Woods et al. 1989, Mitchell and Burton 1991). The integration of 
reflexes involved and the relationships appear complex (see Figure 1, Blix 1987). The lack of 
knowledge of the cause of apnoea and diving-reflexes in anaesthetised southern elephant seals and the 
effect they have upon the anaesthetised animal have made pharmacological treatment and prevention of 
this problem unsuccessful. These theories appear complex in animals for which safe doses of 
anaesthetic drugs have not been determined. Problems may be as simple as drug overdose and studies 
of drug kinetics and circulation during apnoea are indicated. 
iii. Prevention and treatment of apnoea and the dive-response 
Prevention of apnoea and dive-responses has not been discussed. Van Citters et al. (1965) found that 
diving bradycardia was abolished in northern elephant seals by atropinization of the animal (the dose 
was not stated), however apnoea and dive-responses have been seen in southern elephant seals to 
which a total dose of 1.2 mg (for cows) or 2.4 mg (for bulls) atropine had been administered (Woods 
1989, Woods 1991, Mitchell and Burton 1991; approximately 0.005 mg/kg). Presumably the dosage 
of this drug was inappropriate to prevent the response. 
Various techniques, including use of respiratory analeptics and artificial ventilation, have been used in 
the treatment of apnoea and the dive response, however neither appear to be completely reliable. 
In many respects the diving circulation in the seal is similar to that following circulatory adjustments 
accompanying early hypovolaemic shock in man and other animals (Ronald et al. 1977). It has been 
theorised that due to pooling of blood and slow flow rates in readily accessible vessels, drugs 
administered into the extradural intravertebral vein may not reach their central site of action, 
explaining reports of little effect in apnoeic seals (Baker and Gatesman 1985). It was believed that the 
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tongue was a site where circulation was maintained during apnoea (Baker and Gatesman 1985), 
however the respiratory stimulant doxapram has been administered to apnoeic animals by a variety of 
routes, including intralingually and had little or no effect (Mitchell and Burton 1991). 
Positive pressure ventilation has been used more successfully (Baker et al. 1990), however problems 
have been associated with ventilation of large phocid seals. Hammond and Elsner (1977) stated that 
resuscitation in large phocid seals could be complicated by the flexible thorax. (How large "large" 
was was not stated, however weights were presented of 100 - 400 kg for Harbour and Weddell seals.) 
In phocid seals 10 of the 15 ribs articulate with the sternum. The weight of the thorax, therefore, 
comes to bear on the lung parenchyma which permits lung collapse when the seal is in a prone 
position and in the study of Hammond and Elsner (1977) the ventilation equipment had to inflate the 
lungs against the weight of the thorax. It was found that the inflatory pressure could exceed the 
bursting limits of anaesthetic systems which used a pneumobag for positive pressure. These authors 
reported that the problem could be eliminated by placing the animal on its back or side and using a 
resuscitator with a negative pressure expiratory phase to assist expiration in large phocids though no 
data were presented. 
At present there appears to be no satisfactory, consistently successful pharmacological technique 
available to prevent or antagonise the dive reflex. Intubation and positive pressure ventilation appear 
to be more successful, however size of animals, logistics and other problems limit its use. 
Prevention of problems are also frustrated by the inability to use gaseous anaesthesia and the lack of 
understanding and control of the anaesthetic episode. The respiratory stimulant doxapram may offer 
an alternative in situations where positive pressure ventilation cannot be achieved, however, its 
efficacy and dosage have not been determined. 
Attack by other seals or sympatric species 
Woods et al. (1989) describe the death of a cow that had its skull crushed by a bull during recovery 
from anaesthesia. It has been recommended that seals needed to be protected from attacks by other 
seals or sympatric species whilst anaesthetised or during recovery (Gales 1989). 
Desertion 
Baker et al. (1988) found that 20% of females anaesthetised during the breeding season with ketamine 
and diazepam deserted their pups and many abandoned their pups briefly or showed short term 
confusion. These effects were not observed with the tiletamine and zolazepam combination (Baker et 
al. 1990). Bester (1988) has proposed that a rapid recovery is desirable iri order to promote a rapid 
resumption of pup attendance by lactating cows. It is not known whether anaesthesia of mothers 
with pups increases desertion rate. 
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Escape to sea and drowning 
Mitchell and Burton (1991) reported that females often attempted to reach the sea when disturbed, and 
could not be stopped with boards. Three escaped after receiving anaesthetic agents. Two were rescued 
from deep water. One was anaesthetised and subsequently died after prolonged respiratory distress. 
The other was only sedated and was intermittently surfacing to breath. The third seal was retrieved 
from shallow water before it could inhale any water. No male seals attempted to escape into the sea, 
and could usually be driven away from the water. 
Size and the problem of the bulls 
Few bull southern elephant seals have been anaesthetised (Ryding 1982, Gales and Burton 1987 a). 
Immobilization of these animals appears less successful than of smaller animals; four of eight bulls 
administered ketamine by Woods (unpublished data) died. However, whether they represent a greater 
risk has not been discussed. 
Other problems associated with chemical restraint 
Logistics 
Logistically southern elephant seals can be difficult to work with. They are usually found in isolated 
areas where facilities are limited. Getting equipment to the areas can be difficult, often requiring long 
boat, walking or road trips, or the use of helicopters or amphibious vehicles. In many instances this 
excludes the use of sophisticated monitoring equipment or anaesthetic machines and often equipment 
has to be limited to that which can be easily carried. Field work limits equipment to that which is 
robust, battery powered, has few working parts, can be easily maintained and can be made water, cold, 
and shock-proof. 
Working in the cold 
Working in the cold can be physically demanding. The duration of surgery is constrained by the 
cooling of the surgeon's hands. The worker's attention span can diminish and decision making can 
become impaired. These difficulties can be overcome to varying degrees by acclimatisation and 
forethought. 
At temperatures below o0c anaesthetic chugs can freeze or crystallize out of solution (Cline et al. 
1969, Gales and Burton 1987 a, Baker et al. 1988). This problem is exacerbated by the need to use 
concentrated solutions of chugs in order to avoid injecting large volumes. Hand warmers or keeping 
the chugs held against the body until use has been used to minimise this problem (Baker et al. 1988). 
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Body mass and drug dose 
i. Estimating mass of seal directly 
To determine drug dose an accurate estimate of body mass is required. In most cases wild, free-
ranging southern elephant seals cannot be weighed prior to drug administration and their mass must 
be estimated. Mass can be estimated by eye based on previous experience weighing the animals 
(Cline et al. 1969, Baker et al. 1988, Woods et al. 1989). This is difficult and can lead to incorrect 
dosage. Ross and Saayman (1970) .reported that they had underestimated the body mass of a young 
male elephant seal by 50%. 
ii. Estimating mass from length of seal 
Length-mass relationships have been developed and used for estimating masses of southern elephant 
seals (Laws 1960, Vergani and Spairani 1980, Ling and Bryden 1981, Vergani 1985, Gales and 
Burton 1987 a). However, large fluctuations in fat content during moulting and breeding seasons 
cause marked mass variations leading to inaccuracies (Ryding 1982, Gales a_nd Burton 1987 a, Woods 
et al. 1989). Therefore length-mass relationships may not be valid between animals at different times 
of their yearly cycle. For this reason, Gales and Burton (1987 a) recommended that workers 
estimating body masses of these seals for drug doses should consider the time of the animal's life 
cycle and time of year. 
The snout tail length, a straight line measurement from the tip of the nose 9r proboscus to the tip of 
the tail, is currently used in referring to the length of animals (Laws 1960, Ling and Nicholls 1963, 
Ross and Saayman 1970, Morgan et al. 1978, Gales and Burton 1987 a, Bester 1988). Errors in 
measuring animal length can compound the problem of estimating mass from the length-mass 
relationships (Morgan et al. 1978). For example, Ling et al. (1967) found it almost impossible to 
judge length, and thus dose of suxamethonium, accurately enough to immobilise seals without 
producing apnoea. 
More accurate techniques are required for estimating mass prior to drug administration in these 
animals. 
iii. Estimating dose of drug 
Difficulties in estimating drug dose arise because of both errors in estimation of mass and the 
variability in response to drugs (Ling et al. 1967, Ryding 1982). However, the uniformity of size of 
some southern elephant seal cohorts has encouraged the use of standard dosages as a basis for drug 
administration (Woods et al. 1989). 
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Doses of drugs administered to southern elephant seals have been based on those used for 
immobilisation of northern elephant seals, other pinnipeds or other maminals (Ross and Saayman 
1970, Ryding 1982, Gales and Burton 1987 a). Once anaesthetised, more accurate dose rates have 
been obtained after directly measuring or weighing the animal (Morgan et al. 1978, Vergani 1985, 
Baker et al. 1988). 
Reports of drug dosage have been based on body mass. Lean body mass has not been used for 
estimating drug dosage. 
Variability of response 
i. General 
Variability in response to anaesthetic agents has been reported in the literature (Woods et al. 1989). 
Various factors such as the inability to accurately gauge body mass, the level of arousal of the 
animal, its sex, stage of yearly and life cycle, and the nature of drug administration, have been 
suggested as contributing to this variability (Cline et al. 1969, Bester 1988, Vergani 1985, Woods et 
al. 1989). 
ii. Effect of arousal 
It is well known that animals showing a period of excitement during induction of anaesthesia always 
require more anaesthetic (Lumb and Jones 1984, p 16) and various authors have noticed that drugs 
appeared to have less effect upon excited southern elephant seals. Vergani (1985) noticed that the 
effect of even high doses of xylazine on weaned pup southern elephant seals diminished when the 
injected animal became excited. Bester (1988) suggested that it was likely that response to 
anaesthetics varied with level of activity, stress or emotional state, the level of activity or arousal 
increasing tolerance. He therefore recommended that immobilizing or tranquillizing agents should 
preferably be delivered to undisturbed seals. 
There is evidence to suggest that southern elephant seals can be stressed by administration of some 
immobilization drugs. "Sand-throwing", a displacement or substitution activity engendered in times 
of stress (Laws 1956a, Carrick et al. 1962), was seen by Ling et al. (1967) as animals were 
recovering from immobilization with suxamethonium. Griffith et al. (1979) found that immature 
males became very difficult to approach for injection of suxamethonium after several "bleedings" and 
attempts at immobilisation became less and less successful. 
iii. Variability due to stage of the yearly cycle and sex 
Stage of the yearly cycle appears to be an important determinant of the response to anaesthetic drugs 
(Cline et al. 1985, Woods et al. 1989). Duration of sedation of southern elephant seals that are pre-
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moulting or in the early stages of lactation can be half that of animals which have finished moulting 
or lactating, despite similar dose levels of drugs (Woods et. al 1989). 
Various authors have suggested that responses to drugs may vary with the amounts of blubber and 
muscle as proportions of the total body weight (Bester 1988, Woods et al. 1989), and with 
reproductive state (pregnancy) as well as the size of the animal and therefore probable differences in 
basal metabolic rates (Briggs et al. 1975, Woods et al. 1989). However Ryding (1982) considered 
that as the poorly vascularized blubber is minimally involved in the initial distribution of ketamine 
and hence its concentration in the blood, the fluctuation in amounts of blubber as a proportion of 
body weight at different times of the year may not be of great importance. Which of these factors are 
most responsible is unknown though Woods et al: (1989) did suggest that fluctuations in amounts of 
fat may be an important consideration and should be taken into consideration when deciding upon 
dosage of drug to be administered. Anaesthetic pharmacokinetic studies at different times of the 
animals' life cycle are indicated. 
There is little information available on the effect of sex on the response of southern elephant seals to 
anaesthetic agents. Morgan et al. (1978) found that, in general, female southern elephant seals tended 
to be immobilised for longer than males given similar doses of phencyclidine, though it was not 
stated if the difference was significant. Ling et al. (1967), who used suxamethonium to immobilize 
southern elephant seals, presented results which suggested that with lower doses there were 
proportionally more failures to immobilize males, while at higher levels more deaths occurred among 
females. Whether males were more resistant to the drug could not be established with the data 
available. 
iv. Variations in time of induction and duration 
The time interval between initial drug injection and the point of immobilization can vary greatly 
(Cline et al. 1969). In one study, induction period and duration of anaesthesia were not closely 
correlated with drug dose (Mitchell and Burton 1991). The method of drug administration is thought 
to be partly responsible for this problem. When administering drug, placement of the needle is, by 
necessity, often hurried and the variability in response may be due to misplacing the injection outside 
the muscle mass (Ryding 1982) or injection into different body region~ from which the rate of 
absorption of the drugs/ tranquillizers may vary (Bester 1988, Parry et al. 1981). Needles often bend, 
are not long enough to penetrate the blubber layer or, when attached to darts, are blown off target by 
wind, leading to accidental intra-fat administration (Flyger et al. 1965, Cline et al. 1969, Morgan et 
al. 1978, Vergani 1985). 
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Geographical location has also been implicated in variability in response to drug administration. 
Vergani (1985) found that estimated doses of xylazine required to obtain good immobilisation of 
weaned pups differed between Patagonia and Antarctica. He thought the larger estimated dose used in 
Antarctica may have been due to a delay in sleep induction due to the lower temperatures or to lesser 
precision in dart throwing caused by the strong prevailing wind. Whether the difference was 
significant was not stated. 
Suspected intravascular administration has been implicated in differences in induction times (Gales and 
Burton 1987 a, Baker et al. 1988). In both cases effect upon the animal was more rapid than had 
drugs been administered intramuscularly. 
Recommendations for chemical restraint and anaesthesia 
Few recommendations for chemical restraint have been made for southern elephant seals. Gales 
(1989) however made recommendations for pinniped anaesthesia which are largely applicable, 
including: use of cyclohexamine drug combinations, accurate assessment of mass and physiological 
state of animals prior to drug administration, monitoring temperature and cooling should it rise, 
protection from other seals or sympatrics, use of atropine, and use of doxapram and intubation and 
ventilation if possible for treatment of apnoea. He concluded that tiletamine and zolazepam appeared 
to be the safest cyclohexamine based drug combination for use in pinnipeds, however further trials 
were necessary to determine the overall efficacy of the drug. He commented that combinations of 
ketamine and xylazine, and ketamine and diazepam, were generally recommended for use in pinnipeds. 
It is currently unknown which of the commonly used anaesthetic combinations is most suitable for 
use in southern elephant seals. Fatality rates have been presented for some drug combinations that 
have recently been used; 4.5% for ketamine, 3.0 and 3.3% for ketamine and xylazine, and 1.2% for 
ketamine and diazepam (Mitchell and Burton 1991). The most recently used drug combination, 
tiletamine and zolazepam has been reported as being the most useful by Baker et al. (1991) who 
administered the drug a total of 195 times to 90 animals with no fatalities and only 6 episodes of 
apnoea, however (Mitchell and Burton 1990) reported 2 fatalities and respiratory problems associated 
with its use in 5 animals. Baker et al. (1991) could offer no explanation for the apparent difference 
seen in response. The doses of the 1:1 combination of tiletamine and zolazepam given to the two 
elephant seals that died in the study by Mitchell and Burton (1991) (2.4 mg/kg) were only marginally 
greater than the doses required for anaesthesia. Gray et al. (1974) obtained good immobilization of 
northern elephant seals with doses of 1.0 to 2.0 mg/kg (and 1.0 to 2.5 mg/kg of a 2:1 
combination), Hammond and Elsner (1977) used doses of 0.5 mg/kg on southern elephant seals, and 
Baker et al. (1990) obtained good immobilization of southern elephant seal11 with single injections of 
0.95 ± 0.22 mg/kg and multiple injections totalling 1.15 ± 0.37 mg/kg. 
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Based on these findings ketamine and diazepam or tiletamine and zolazepam would appear to be the 
most useful. However comparative studies have not been done. 
Specific recommendations as to prevention and treatment of apnoea, possible associated dive-response 
and complications have not been made, though Gales (1989) has recommended examination of some 
anaesthetic reversal agents. 
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Chapter 3: General Materials and Methods 
Selection of animals 
The study was largely restricted to mature pre-moulting females, animals considered to be "low-risk" 
by the Ethics Committee. However, the Committee also allowed access to a limited number of 
mature female pre-breeding and post-moult animals specifically for pharmacokinetic work (Chapter 7). 
- Samples were also taken opportunistically from other categories of animals (to which the Ethics 
Committee had allowed access) which were being restrained for other purposes including diving 
recorder and satellite tracking device deployment (and rettj.eval) and gastric lavage (Chapter 6). In all 
cases, the preferred subjects for trials were quiet, somnolent animals which had not previously been 
restrained and were located away from wallows or the sea, in positions where there was safe access and 
little danger to the operator or subject. Animals which were part of small groups were also preferred 
as they often appeared more tractable after needle placement and appeared less likely to react 
aggressively or move away than solitary animals. (See also Classification of animals below) 
Equipment and drugs used 
Sources of equipment and drugs, and specifications, used during trials are presented in Tables 3.1 and 
3.2 respectively. Drugs were stored at room temperature (approximately 10°C) except for 
suxamethonium which was kept refrigerated at 4 to 8°C. 
Drug administration 
Renwte injection technique 
Anaesthetic agents were initially administered to southern elephant seals·using a remote injection 
technique based on that of Ryding (1982) (Plate 3.1). 
A reusable, 3.5 m length of plastic tubing (volume 27 mL) was constructed by joining approximately 
two and a half lengths of blood/ solution infusion set together. An 18 G, 90 mm needle was attached 
to one end and the plastic tubing filled through the other with saline. Part or all of the dose of drug 
to be administered was then introduced into the tubing. The volume of drug varied from 
approximately 2 to 70 mL depending upon the type of drug and the size of the animal. 
(At the end of each work period the plastic tubing was washed in Hibitane Disinfectant [Chlorhexidine 
digluconate 8 g/dL][Coopers Animal Health, Silverwater, New South Wales, Australia], flushed, then 
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Table 3.1. Sources and specifications of equipment used during this study. (OD = outside diameter, FG = French gauge, 
ID = inside diameter.) 
Item 
0.9% Sodium chloride 
Block and tackle 
Blood/ solution infusion set 
Blood gas analyser 
Demand valve 
Duodenal tube 
Endotrachcal tube 
Eye-stream 
Flipper tags 
Hibitane disinfectant 
Hypodennic needle 
Obstetrical lubricant 
Oesophageal stethoscope 
Oxygen cylinder 
Regulator 
Spinal needle 
Surgical catgut, BP 
Suture needle 
Syringe 
Weighing scales 
Weighing slings 
Specifications 
Intravenous infusion BP 
Anchor 1 tonne mini chain block 
with 3m lift 
15 drops/mL 
Coming 16512 pH 
Reagents, gases and parts 
HudsonS090 
FG14 
Non-sterile (reusable} Airc-cuf: 
ID 7.0mm, OD 10.0mm 
ID 9.0mm, OD 12.3mm 
ID 11.0mm, OD 15.7mm 
ID 18.0mm, OD 24.0mm 
ID 22.0mm, OD 30.0mm 
ID 26.0mm, OD 35.0mm 
Balanced salt eye inigating solution 
Jumbo Rototags 
Chlorhexidine digluconate 8g/L 
18Gxl 1(l", l.25x38mm 
25Gx3/4", 0.5x16mm 
14Gx8" 
120cm 
C, D, E, G sim 
c si7.C 
DIFJG size 
18Gx3 l(l", 1.20x90mm 
19Gx8.89cm 
Chromic, Metric 3.5 (2/0} eyeless 
needle sutures cutting 75cm 
Sim 12, half circle cutting 
lmL, 2mL, 5mL,tomL,20mL,50mL 
Challenger 2.5 ton digital scale 
Supplier 
Baxter healthcaie 
Toongabbie, New, South Wales, Australia 
J. Blackwood and son 
Launceston, Tasmania, Australia 
Travenol laboratories 
Old Toongabbie, New South Wales, Australia 
Coming glass works 
Medfield, Massachusetts, USA 
Ciba Coming diagnostics 
Medfield, Massachusetts, USA 
Hudson oxygen sales 
Temecula, California, USA 
lndoplast ' 
Sydney, New South Wales, Australia 
Bivona 
Gary, Indiana, USA 
Alcon laboratories 
Brookvale, New South Wales, Australia 
Dalton supplies 
Woolgoola, New South Wales, Australia 
Coopers animal health 
Silverwaler, New South Wales, Australia 
Terumo 
Tokyo, Japan 
The amalgamated dental Australia 
Carlton, Sydney, Australia 
Parnell laboratories 
Silverwater, New South Wales, Australia 
Portex, Hythe, Kent, England 
CIG Medishield 
Hobart, Tasmania, Australia 
CIG Medishield 
Hobart, Tasmania, Australia 
Terumo 
Tokyo, Japan 
Becton-Dickinson 
Franklin Lakes, New Jersey, USA 
Eth nor 
Sydney, New South Wales, Australia 
P. Spencer and sons 
Redditch, England 
Terumo 
Melbourne, Australia 
Hood sails 
Hobart, Tasmania, Australia 
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Table 3.2. Sources of drugs, specifications and solutions for injection of drugs used during this study. 
Nonpropriet11IY and generic name Preparation 
4-aminopyridine 24 mg/mL 
(Xylex injection) 
Adrenaline tartrale 1 mg/mL 
(Adrenaline tartrate injection) 
Atipamezole hydrochloride S mg/mL 
(Antisedan vet. inject.) 
Atropine sulphate 0.65 mg/mL 
(Atrosine mitis) 
Diazepam 10 mg/2mL 
(Valium) 
Doxapram hydrochloride 20 mg/mL 
(Dopram-V) 
Fentanyl citrate USP SOug/mL 
(Fentanyl Citmte Injection USP) 
Flumazenil 1 mg/IOmL 
(Anexate) For clinical trial use only 
Heparin 5000 U/0.SmL 
(Heparin Injection B. P. Contains no antiseptic) 
Heparin 5000 U/0.SmL 
(Heparin Injection B. P. mucus) 
Ketamine hydrochloride 
Ketamine hydrochloride 
(Ketalar) 
Medetomidine 
(Medetomidin vet inj.) 
Midazolam hydrochloride 
(llypnovel) 
Naltrexone HCL 
Naloxone hydrochloride 
(Naloxone HCl injection USP) 
Pentobarbitone sodium 
(Apex Euthanasia Solution) 
Pethidine hydrochloride 
(Pethidine) 
Sannazenil 
Sodium bicarbonate 
8.4% w/v, injection, B.P. 
Suxamethonium chloride B. P. 
(Scoline) 
Thiopentone sodium powder 
(Pentothal) 
Tiletamine-zolazepam 
(7.oletil 100) 
Water for injections 
Xylazine hydrochloride 
(Rom pun) 
Yohimbine hydrochloride 
(Reverzine Injection) 
186mg/mL 
(160 mg/mL ketamine base) 
100 mg/mL ketamine base 
IOmg/mL 
For investigational veterinary use 
Smg/mL 
1 mg/mL 
0.4mg/mL 
400mg/mL 
SOmg/mL 
Powder 
(made up to 2.5 mg/mL) 
4.2 g sodium bicarbonate 
1000 mmol sodium and 
bicarbonate ions/ L 
50mg/mL 
Sg 
(made up to SO mg/mL) 
250 mg base of each drug 
(made up to 100 mg/mL) 
100 mg/mL xylazine base 
tomg/mL 
Supplier 
Parnell Laboratories 
Caringbah, New South Wales, Austmlia 
Parke Davis 
Caringbah, New South Wales, Austmlia 
Farmos Group 
Turlru, Finland 
Parnell Laboratories 
Caringbah, New South Wales, Austmlia 
Roche Products 
Dee Why, New South Wales, Australia 
Bomac Laboratories 
Castle Hill, New South Wales, Australia 
David Bull Laboratories 
North Clayton, Victoria, Australia 
Roche Products 
Dee Why, New South Wales, Australia 
Commonwealth serum laboratories 
Melbourne, Victoria, Australia 
Commonwealth serum laboratories 
Melbourne, Victoria, Australia 
Parke Davis 
Caringbah, New South Wales, Australia 
Parke Davis 
Caringbah, New South Wales, Australia 
Farmos Group 
Turku, Finland 
Roche Products 
Dee Why, New South Wales, Austmlia 
Sigma Pharmaceuticals 
Clayton, Victoria, Australia 
David Bull Laboratories 
Mulgrave, Victoria, Australia 
Apex Laboratories 
St. Marys, New South Wales, Australia 
Parnell Laboratories 
Caringbah, New South Wales, Australia 
Roche Products 
Dee Why, New South Wales, Australia 
International medication systems 
So. El Monte, CA 91733, USA. 
Glaxo Australia 
Boronia, Victoria, Australia 
Boehringer Ingelheim 
Artannon, New South Wales, Australia 
Virbac 
Pealchurst, New South Wales, Australia 
Abbott Australasia 
Sydney, New South Wales, Australia 
Bayer Austmlia 
Artannon, New South Wales, Australia 
Parnell Laboratories 
Caringbah, New South Wales, Australia 
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Plate 3.1. The remote injection technique used in this study (after Ryding 1982). The needle has just been 
inserted, the operator has moved to the end of the length of tubing and is in the process of removing the 
cover of the needle on the syringe of saline held in his right hand. The end of the tube is held in his left hand. 
Note the needle positioned in the caudal gluteal area, length of tubing and response of the bull. 
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General materials and methods 
heavily sedated, immobilized or anaesthetised its head response (Chapter 4) was assessed to confirm 
the degree of chemical restraint and work commenced with the animal. 
Intravenous access could usually be assured within 10 min of using cyclohexamine drug 
combinations. Using narcotic combinations, or when immobilizing bulls, 15 to 20 min was allowed 
for onset of effect before the animal was approached and assessed. There was concern that if the 
animal was approached prematurely it might become frightened, preventing induction of adequate 
chemical restraint or possibly predisposing to apnoea (Backhouse 1964). 
If at this stage the animal was still only moderately sedated an attempt was made to place a spinal 
needle into the extradural intravertebral vein for an additional drug dose. The needle position was 
chosen based on estimations of the animal's level of sedation, behaviour and location of the vein (as 
palpation for landmarks was often dangerous or would further disturb the seal). If the animal was 
close to heavy sedation (level 3; Chapter 4), intravenous access could usually be accomplished. 
Otherwise intravenous access could not be assured and further drug was administered intramuscularly. 
The procedure was abandoned in cases where the animal was considered to be excessively stressed, or 
behaving abnormally, or was in danger of going to sea, becoming trapped in a wallow or puddle with 
its face under mud or water, or in a head down or dorsally recumbent position. 
Intravenous drug administration 
i. General 
In most instances after intramuscular drug administration, if further drug was needed it was 
administered intravenously into the extradural intravertebral vein which was the preferred sight for 
venipuncture (Plate 3.2 and Figure 3.1). The functional and anatomical features of this vessel have 
been described for other phocid species (Harrison and Tomlinson 1958, Hol et al. 1972, St. Pierre 
1974, Ronald et al. 1974). The plantar venous arch (St. Pierre 1974) was used when extradural 
intravertebral vein access could not be achieved (Plate 3.3 and Figure 3.2). 
Speed of injection varied. Drugs were usually given slowly, but they were administered rapidly if the 
animal was becoming fractious and the operator was in danger of being bitten. Rapid administration 
was generally avoided because of the risk of apnoea. 
ii. Skin preparation 
Sites for venipuncture in southern elephant seals were often found to be contaminated with faeces, 
wallow water or mud. Lavaging with copious buckets of sea water and a scrubbing brush was found 
to be more effective at removing surface contamination than use of small volumes of disinfectant. 
For this reason sea water and not disinfectant was generally used to prepare the skin prior to 
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filled with saline. At the beginning of the next work period the tube was.flushed with fresh saline 
prior to introducing drug.) 
The needle was inserted tangentially into the lumbar or gluteal muscle mass of the animal (Bryden 
1971). If necessary an assistant stood in front of the animal to distract its attention and allow a 
second person to insert the needle and administer the drugs. 
After checking to ensure that the needle was not intravascular by withdrawing on the plunger of the 
syringe, the drugs were administered intramuscularly through the tube and flushed through with 
saline, using a volume larger than the volume of the tube, usually 40 rnL. After injecting each 10 
rnL of saline, a check was made for intravascular administration by withdrawing on the plunger of the 
syringe. If blood flashed back into the hub of the needle or tube, or if the force required to inject the 
drugs was less than usual, administration of drug was stopped and the animal's response observed. If 
intravascular administration was suspected the needle was withdrawn slightly, redirected or reinserted. 
It was found that slight withdrawal usually caused the least disturbance to the animal. The needle was 
left inserted in case further drug had to be administered intramuscularly. Using this technique, time 
for injection of drug and flush varied from 10 s to 2 min depending on the volume delivered and 
response of the animal. 
If possible, the operators then retreated to a position which was out of direct sight, scent and sound of 
the animal but from which the animal's breathing could be observed. In this way the animal was left 
alone for 10 min as the drugs began to take effect. Breathing, as witnessed by opening and closing of 
the external nares, chest movement or sounds of exhalation, was surreptitiously checked every few 
min without entering the animal's flight distance. If the animal stopped breathing within this 10 min 
period, or appeared to be excessively deeply anaesthetised, it was approached and the head or tail 
stimulated, the animal rolled over, or a needle inserted into the extradural intravertebral vein (for 
administration of a drug or for blood sampling) to stimulate breathing. 
At the end of the 10 min period, or if the animal appeared anaesthetised before this time, it was 
slowly and cautiously approached by one person. By walking slowly past along a semicircular route 
the operator would enter the animal's flight distance near its head, observing its response. If the 
animal reared up or attempted to move away, the operator retreated and left the animal for a further 10 
min. If the animal did not rear up or move away, it was approached to within a few feet of its head. 
If the animal still failed to rear up or move away its caudal flipper response (Chapter 4) was checked. 
The cranial end of the animal was then approached by running a hand along its body in a caudal to 
cranial direction. This approach, rather than walking up and touching the head, was used as it allowed 
the operator to further assess the response of the animal to touch whilst Staying out of bite range. 
Moving further cranially the withdrawal response (Chapter 4) was tested. If the animal was considered 
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Figure 3.1. (above). Schematic diagrams of the location of the ex1radural intravertcbral 
vein in a weaner so111hcm elephant seal inclu<ling a cut away median section after Geraci 
and Sweeney (1978) and a cross section of a l11111har venchrac from a 111:1111re bull. 
The hand shows !he approximate location for vcnip1111c!llrc (sec also l'lale 3.2, lcf!). 
Plate 3.2. (left). Vcnipuncturc of 1hc cx1rad11ral in1ravertebral vein of ru1 anaes1hc1ise<l 
wcancr. 
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General materials and methods 
Plate 3.3. Venipuncrure of the plantar venous arch of a bull. The left caudal fluke has been 
rotated outward so that the plantar surface is exposed. The skin is being prepared with alcohol 
and hibitane (operator's right hand). A 20mL syringe with an 18G, 38mrn needle is held in the 
operator's left hand. 
DV 
DI 
Lateral 
.. ' . : : . _._. .-:: ::··_;:_·'.~ -~:-·:-~i.\':.-. •..... 
. ··- . PI Approximate site 
for venipuncrure 
Medial 
Figure J.2. Schematic dfagr:un of the location for venipuncrurc of the left pl:l.Iltar venous :lI'Ch 
(plantar view after St. Pierre 1974). The needle is inrroduced in a cranial direction. paraHel 
to the fluke of Dl (medial to PI) at an :mgle of about 45• to the skin at the junction of the 
imcrdigital webbing, or just cr:l.Ilial to this point. 
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venipuncture. An attempt was made to always introduce needles through relatively uncontaminated 
skin. 
Three steps were used to disinfect the skin at the surgical site prior to surgery. Gross surface 
contamination was removed by scrubbing and lavage with copious amounts of sea water. The skin 
was then scrubbed with an 8 g/L solution of chlorhexidine digluconate. Finally, just prior to making 
the initial incision, the skin was wiped with a solution of chlorhexidine digluconate in alcohol 
(previously prepared by adding 100 mL of 8 g/L solution of chlorhexidine digluconate to 900 mL 
70% alcohol). 
iii. Venipuncture of the extradural intravertebral vein 
Positioning of animals for venipuncture - Venipuncture of the extradural intravertebral vein was most 
easily achieved with the subject in sternal recumbency, in a horizontal plane, with the spine slightly 
flexed. Venipuncture could be achieved in almost any position except dorsal recumbency. However, 
in all positions other than sternal recumbency the fat and muscle layers moved to varying degrees 
with respect to the underlying bony structures, which made location of land marks more difficult. 
Extension of the spine made palpation (and insertion of the needle) between the vertebrae more 
difficult as the diameter of the spaces between them decreased with increased extension of the spine. 
If the animals could not be positioned in a horizontal plane they were positioned with the head up-
hill. 
Landmarks for venipuncture - The dorsal midline, wings of the ilium and intervertebral spaces were 
used as landmarks to locate the extradural intravertebral vein. Landmarks were most easily palpated in 
thin animals after the breeding season or moult. Often in fat animals and bulls (and animals 
insufficiently sedated) no landmarks could be palpated. In these animals the positioning of the animal 
and the location of the black line of hairs down the back were used as guides to the location of the 
vessel. 
The dorsal midline was located by palpating the wings of the ilium and bisection of the distance 
between them. There was often a narrow line of black hair running along the dorsal midline of the 
animal which was used as an aid in locating the dorsal midline. The craniodorsal aspect of the base 
of the sacrum was palpated using firm digital pressure along the dorsal midline between the wings of 
the ilium. The space between any two vertebral bodies in the caudal lillnbar area was used for 
venipuncture, however the preferred sight for placement of needles for drug administration and 
sampling was approximately 30 to 45 cm forward of the proximal end of the sacrum (5 or 6 vertebral 
bodies in a mature female). On dissection of naturally deceased mature pre-moulting female animals 
it was found that at this level the extradural intravertebral vein was paired and approximately 4.5 cm 
in total width. 
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Blood flow in this vessel has not been described in the southern elephant seal but has been described 
in another phocid, the harp seal (Hol et al. 1972, Ronald et al. 1974). In the resting, nonbradycardic 
seal, dye injected into the extradural intravertebral vein at the thoracic, lumbar or sacral level flowed 
anteriorly in the extradural intravertebral vein and returned to the heart via the thoracic intervertebral 
veins, or the cervical vertebral venous sytem. However, in the diving or bradycardic seal, dye flow 
was reversed and the cerebral blood (which was presumed not to be diluted with blood from other 
tissues), flowed along the length of the extradural intravertebral vein, and passed both into the 
anterior, and the posterior vena cava. The resting seal often exhibited a brief bradycardia in 
association with apnoea in which the flow patterns observed closely resembled those of diving. The 
change from a resting to diving pattern of blood flow occurred when the heart rate fell to 40 to 50 
bpm (Ronald et al. 1974). 
Acid-base and blood gas changes were measured in this vessel. To minimise any direct effect, such as 
changing pH, that further drugs administered in to this vessel might have on these variables, needles 
for drug administration needed to be placed so that they were down stream of those for blood 
sampling. This created conflict in location of catheters due to the potential changes in direction of 
flow in this vessel. However, as most animals breathed regularly during chemical restraint it was 
presumed that blood flowed anteriorly in this vessel and drug administration needles were located 
approximately 1 to 2 intervertebral spaces cranial to the blood sampling needles. For trials where 
drugs were administered to apnoeic animals by this route, drug administration needles were located 
approximately 1 to 2 intervertebral spaces caudal to the blood sampling needle. Changes in flow in 
this vessel were taken into account when interpreting acid-base or blood gas values recorded post 
additional drug administration (See: Interpretation of blood gas values below). 
Dissection of the lumbar area of dead seals revealed that needles had to be passed between the dorsal 
laminae of two vertebrae. At this level, spinous processes were small, and the land marks being 
palpated to locate the "intervertebral space" were the concave, cranial edge of the dorsal lamina 
running between the articular processes of the more caudal vertebra and the concave, caudal edge of the 
dorsal lamina running between the caudal articular processes of the more cranial vertebra. A slightly 
flexed spine was found to facilitate palpation, location and placement of needles as the "intervertebral 
spaces" were "opened up". Extension, or straightening, of the spine caused them to "close", 
preventing entry of the needle when the spine was overextended. 
Technique - With the probing finger as a guide, an 18 or 19 G, 90 mm needle was inserted with the 
sty let removed, perpendicular to the skin of the dorsal midline, between 2 vertebral bodies and pushed 
down into the extradural intravertebral vein. Often penetration of the ligamentum flavum was felt and 
blood flashed back into the hub of the needle. In some instances air was heard being drawn into the 
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vein as it was entered or flashing back of blood did not occur* . If so, the hub of the needle was 
immediately capped with a 1 mL syringe, which was then used to test for intravenous access (Plate 
3.2 and Figure 3.1). 
In some cases, despite indications of intravenous access, blood sampling could not be performed, 
presumably because the bevel of needle was blocked by contact with the vessel wall. The needle was 
then rotated, to unblock the needle and allow blood to be taken. It was found that in some animals 
venous pressure was such that 1 mL sampling syringes filled automatically. When this happened the 
1 mL syringe was replaced with a 20 mL syringe; the greater resistance 'of its plunger preventing 
filling. 
Needles used - Eighteen G, 90 mm needles were preferred as blood seemed to flow more freely from 
them and they appeared to become blocked less often than 19 G, 90 mm needles. 
Eighteen G, 90 mm needles were usually, but not always, long enough to allow venipuncture of 
mature cows in good body condition. In most females in good condition the length of the needle 
placed the tip within the lumen of the extradural intravertebral vein when the luer connection was in 
contact with the skin. In some larger females, the hub of the needle had to be pushed down where it 
came in contact with the skin, which created a trough in the skin, up to 3 cm deep, to allow the 
vessel to be reached. In thinner animals after moult or parturition care had to be taken not to punch 
through the base of the vein. On dissection of naturally deceased animals it was found that the spinal 
cord had finished at this level, although four large nerve bundles ran along the base of the spinal 
canal. Thus in thin animals (and pups) needles were introduced cautiously, or with applied suction to 
prevent potential nerve damage from passing the needle through the vein. Excess probing in the area 
was avoided. 
Pups and weaners were bled from the extradural intravertebral vein. Depending upon size; pups were 
usually bled using an 18 G, 38 mm needle, and weaners generally required an 18 G, 90 mm needle. 
It was found to be important to keep needles patent by use of a stylet or anticoagulant (20 ID/ mL 
heparin). 
iv. Plantar venipuncture; the "tail vein" 
In some bulls and COWS, the extradural intravertebral vein could not be reached with an 18 G, 90 mm 
needle due to the animal's size or fat coverage. In these animals venipuncture was achieved using the 
plantar venous arch (arcus venosus plantaris) or "tail vein" (St. Pierre 1974). 
* These observations implied wide variability of various pressure within this vessel even in the 
normal resting, non-apnoeic state. 
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The anatomy of the veins of the caudal flipper has not been described in elephant seals. On dissection 
of the caudal flipper of naturally deceased animals it was found that the vas.culature appeared to have 
similarities to that seen in the harp seal (Pagophilus groenlandicus; St. Pierre 1974). In bulls the 
vein was up to 3 cm deep. It ran on the plantar surface of the flipper, along the medial margin of DI, 
coalescing with other vessels from the dorsal aspect at the junction of the interdigital webbing. With 
the left caudal flipper rotated supine, DV was abducted to form an angle of approximately 70 to 90° 
with DI, venipuncture was achieved with a 38 mm, 18 G needle introduced in a cranial direction, 
parallel to the fluke of DI (medial to PI) at an angle of about 45° to the skin at the junction of the 
interdigital webbing, or just cranial to this point at a spot that can be recognised, on palpation, by the 
proximal portion of the metatarsals which form a relatively immobile group of bones (Plate 3.3 and 
Figure 3.2). 
Further anaesthetic was also administered to one yearling, whose tail and lumbar area were 
contaminated with faeces, using a vein that was found to run obliquely across the palmar surface of 
the left fore flipper (palmar venous arch; St. Pierre 1974). This vessel needed to be occluded to allow 
venipuncture. The "tail vein" did not need to be occluded. 
Endotracheal drng administration 
The animal was intubated with an endotracheal tube, and a sterile, duodenal tube with the proximal 
end cut off was passed down the lumen of the endotracheal tube. The' duodenal tube was inserted 
approximately 5 to 10 cm past the distal end of the endotracheal tube. A syringe, with luer fitting, 
containing doxapram or saline was attached to the proximal end of the duodenal tube and the contents 
administered rapidly. The syringe was removed and the duodenal tube flushed with 50 mL of air. The 
duodenal tube was then removed. 
Intralingual drng administration 
Injections were made intramuscularly into the body of the tongue, by inserting an 18 G, 38 mm 
needle through the lateral surface into the genioglossus muscle (Bryden 1971 b, Evans and DeLahunta 
1980). Ten mL of fluid was the maximum administered in any one spot before the needle was 
removed and relocated. No attempt was made to test for intravascular administration. 
Blood gas analysis 
Blood gas analysis was performed using a Corning 165/2 pH Blood Gas Analyser. All gases and 
reagents used in maintenance and operating procedures were manufactured by, and purchased from, 
Ciba Corning Diagnostics Corporation, Medfield, Massachusetts, USA. 
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Preparation and calibration of analyser 
Daily preparation and calibration procedures were performed according to the Coming Medical 165/2 
pH Blood Gas Analyser Instruction Manual. Each morning and afternoon a complete calibration and 
slope procedure was carried out. Before each series of samples were run a one point calibration check 
was performed. 
To calculate calibration values for gases the ambient barometric pressure was recorded in millibars 
(mb) before each pH and gas electrode calibration. The value was corrected and reduced to station level 
pressure by the bureau of meteorology on the island. Pressure in mb was converted to mmHg using 
the relationship: 
1 mb = 0.7501 mmHg (Halliday and Resnick 1962). 
The water vapour pressure at the humidifying temperature of 37oc (47 mmHg) was then subtracted 
and this value used to find the correct calibration points for CAL and SLOPE gases from a blood gas 
barometric pressure chart supplied by the manufacturer. Gas calibration standards consisted of CAL 
GAS (12% 02, 5% C02, balance N2) and SLOPE GAS (10% C02, balance N1). 
Two commercially prepared buffer solutions were used in the calibration of the pH electrode (Ciba 
Coming Diagnostics, Medfield, Massachusetts, USA). Blood Buffer pH 6.838 contained: disodium 
hydrogen phosphate, 0.025 molar; potassium dihydrogen phosphate, 0.025 molar; and a preservative. 
Blood Buffer pH 7 .382 contained: disodium hydrogen phosphate, 0.0085 molar; potassium dihydrogen 
phosphate, 0.034 molar; and a preservative. 
Quality control was carried out after one point calibration each morning using a commercially 
prepared buffered electrolyte solution (Certain +Level 1 pH/ Blood Gas and ISE Quality Control; 
Ciba Coming Diagnostics, Medfield, Massachusetts, USA) that had been equilibrated prior to packing 
to yield expected values for pH, Pco2 and Po2 in properly functioning analyzers. 
Preparation of blood gas collection syringes 
Syringes were heparinised with 0.4 mL of a 20 IU/ mL heparin sodium, solution (1 mL Heparin 
Injection B.P. 5000 Units in 0.5 mL, added to 500 mL saline). Approximately 0.4 mL of this 
solution was drawn into each plastic 1 mL tuberculin syringe, a 25 G needle applied, air bubbles 
flicked out of the syringe, and the syringe stored at approximately 10°c until required for use. 
Use of concentrations of heparin of greater than 1000 Units/ mL tend to increase Pco2 and reduce pH 
(Adams and Hahn 1979). The 20 IU/ mL solution used during trials wa~ thus considered to have 
negligible effect on these variables. The dilution effect of the heparin solution was unknown. In 
humans the dilution effect of the sample by heparin, causes a fall in Pco2 and HC03 -, but is 
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generally ignored for clinical purposes (Adams and Hahn 1979). As sample volume, and volume and 
concentration of heparin were constant, dilution effects were ignored whilst analysing blood gas data 
during this study. 
Venous blood collection 
It had been hoped that arterial blood could be collected. However, this was found to be impractical 
considering the arterio-venous anastomoses and deep location of vessels, the sampling protocol, depth 
of anaesthesia and use of short acting, injectable anaesthetic agents. For these reasons samples for 
analysis were collected from the extradural intravertebral vein of seals that had previously been sedated 
or immobilised with anaesthetic agents. 
Prior to anaesthesia for blood gas blood collection, the heparinised 1 mL syringes were labelled 1 to 
10 using an indelible ink pen (if further samples were required labelling occurred in the field). An 
18 G, 90 mm needle was placed within the extradural intravertebral vein of an immobilized animal, 
and the first 1 mL syringe attached to the luer fitting of the needle, the heparin solution contained 
within it injected, and 1 mL of blood slowly aspirated. The 25 G needle was replaced, the syringe 
checked for air bubbles which, though rarely seen, were removed if necessary, the needle crimped, and 
the syringe placed in an ice water bath until assayed (usually within 30 to 60 min). 
The next heparinised syringe was immediately attached to the spinal needle and approximately 0.2 mL 
of the heparin solution within it used to flush the spinal needle. Five min later the final 0.2 mL of 
heparin solution remaining within the syringe was injected and 1 mL of blood aspirated as above. If 
possible this procedure was repeated at 5 min intervals for the first 50 min of the anaesthetic episode. 
In many cases sampling had to be terminated before the desired 50 min as animals woke up and 
sampling became dangerous. If anaesthesia was more prolonged the frequency of sampling was 
reduced to every 10 min. 
Assay of samples 
On return to the laboratory each syringe was removed from the ice-water bath, rolled between the 
palms of the hands for several seconds then analysed on the blood gas analyser at 37oc using the 
technique outlined in the manual. After equilibration for 2 min the pH, Pvco2, Pvo2, HC03-, total 
C02, and base excess were recorded. Pvco2 and Pvo2 were measured in mmHg; HC03-, total C02 
and base excess in mmol/L. Base excess was calculated from the formula described by Siggaard-
Andersen (1966): 
Base excess= (1 - 0.014 Hb) [( HC03- - 24) + (9.5 + 1.63 Hb) (pH - 7.4)] 
where Hb represents the patient's haemoglobin value in g/dL. A mean value for the species of 23.3 
g/dL (Lane et al. 1972) was used in this study. 
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Interpretation of blood gas values 
There are difficulties associated with interpretation of venous blood gas values (Haskins 1977). 
Central venous and capillary blood do provide approximate screening values for arterial blood gas data 
but are subject to considerable error in some disease conditions. Central venous blood also does not 
provide any information regarding the ability of the lungs to oxygenate blood but may provide 
reliable values for base deficit. It may provide a better estimate of the status of the interstitial fluids 
of the tissues than will the arterial blood but will yield misleading information in abnormalities 
associated with decreased tissue perfusion (Haskins 1977). Substitution of venous for arterial blood 
might be appropriate if the relationship between the two is constant, however because this 
relationship has not been determined in southern elephant seals, and because of circulatory changes 
during apnoea, blood gas values presented in this study need to be i_nterpreted with caution. 
Furthermore, "abnormalities" in other species may not be such in seals due to their adaptations to 
diving. Venous blood gas values do however present useful information which is easily and quickly 
gathered in situations where arterial sampling is impractical. 
An interesting discussion of the changes in blood flow associated with apnoea in the harp seal 
(another phocid seal) has been presented by Ronald et al. (1977). Angiography studies revealed that 
blood flow in the extradural vein of seals not undergoing bradycardia flowed anteriorly whilst flow 
became posterior with bradycardia (see Figures 9 and 10 in Ronald et al. 1977). Furthermore, there 
appeared to be some control of the ratio of oxygenated blood to deoxygenated blood entering the heart. 
In one case, early in the dive, two heart beats were observed without the emission of boluses of blood 
from the caval sphincter. This would have the effect of reducing the proportion of relatively well 
oxygenated, venous, hepatic sinus blood sent to the brain. If these changes occur in bradycardic, 
apnoeic, anaesthetised seals then interpretation of blood gas values will be difficult to impossible 
without knowledge of flow directions and magnitudes. Blood gas and pH values in the breathing seals 
in this study were taken to give a crude reflection of central arterial values for comparative purposes. 
However, for the previously mentioned reasons, less confidence was placed in values determined in 
apnoeic, bradycardic seals. Despite the difficulties with interpretation, the values determined in these 
animals were considered to give a crude estimate of the direction of changes .in CNS arterial values. 
Intubation and mechanical ventilation 
Intubation technique 
i. General 
The anatomy of the upper respiratory tract of elephant seals has not been described. Intubation was 
performed blind. 
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To hold the mouth open in cows, two 2.5 cm x 110 cm rock climbing tapes were passed around the 
animal's upper and lower jaws immediately behind the canines. The tape for the lower jaws had a 15 
cm diameter loop at each end so that a gumboot could be placed through it. An assistant stood, with 
a gumboot either through each loop or on top of the lower tape (holding the lower jaw down, or 
open), and applied upward force to the tape around the upper jaw (Figure 3.3 and Plate 3.4). This 
opened the jaws and gave the operator some protection against being bitten. Two people were 
required to hold open the mouth of a bu~. Each stood at either side of the mouth on the lower tape 
and hauled up on the upper tape. 
A thin layer of obstetric lubricant was applied to the caudal third of the endotracheal tube. The left 
hand was introduced into the mouth cavity proper with the hand prone and moved from side to side as 
it was advanced towards the pharynx, feeling for the cranial end of the larynx. At the root of the 
tongue resistance was generally encountered from the soft palate which, along with the root of the 
tongue and "palatoglossal arch" appeared to form a "sphincter" separating the mouth cavity proper 
from the pharynx in some animals. Downward pressure was put on the tongue and the hand levered 
under the soft palate. Once into the pharynx, pedunculated masses, presumed to be palatine tonsils, 
could be felt on either side of the pharynx. The cranial end of the larynx was felt on the floor of the 
pharynx as a hard, dorsoventrally elongated cartilagenous "button", approximately 4 cm x 3 cm in a 
mature cow, with the epiglottis covering it. The epiglottis was levered down and the two arytenoids 
and the slit between them palpated. Usually the mouth of the larynx was tightly closed but appeared 
to become more relaxed as level of chemical restraint increased. A flaccid larynx was associated with 
deep anaesthesia. Once the larynx was located the appropriate size endotracheal tube was introduced 
along the underside of the forearm into a funnel formed by the fingers of the left hand. Whilst 
holding the epiglottis down, a forefinger was forced between the arytenoids to open them slightly, a 
second finger inserted and the bevel of the endotracheal tube threaded into the larynx (Figure 3.3). 
This often required considerable force due to the strength with which the arytenoids were held adducted. 
When the arytenoids were separated the animal would often either attempt to shake its head, bite down 
on the operator's arm or vomit. It was found that lightly immobilized (level 4 chemical restraint; see 
Chapter 4) pre-moulting cows would move their heads from side to side whilst biting, while heavily 
immobilized animals (level 5) would bite down. Generally this was not too much of a problem, 
other than causing some discomfort, and could be overcome to some extent by the person holding the 
tapes controlling the head. However, in larger animals and some cows which reacted excessively to 
the procedure intubation was found to be safe only when the animal was heavily immobilized or 
lightly anaesthetised (level 5 or 6) with a cyclohexamine. With narcotic aJ?-d barbiturate anaesthesia 
the larynx appeared more relaxed and in some cases intubation was accomplished with little difficulty 
when animals were lightly immobilized. 
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General materials and methods 
Plate 3.4. Intubation of a mature female southern elephant seal. Note the position of the 
tapes behind the upper and lower canines to restrain the head and hold the jaws open. The 
assistant is standing on the lower tape. 
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During monitoring bulls were found to respond more slowly or sluggishly to stimuli used to assess 
level of chemical restraint than cows. This can be misinterpreted as indicating an adequate level of 
restraint for intubation. This should be considered prior to the decision whether to intubate. 
Gloves were not used as it was found that whilst inside the larynx passing the tube they tended to 
become tangled with the bevel of the endotracheal tube. Mouth gags also tended to get in the way. 
Endotracheal tubes were kept clean by tying within a veterinary rectal glove until required. 
ii. Positioning for intubation 
Intubation could be performed with the animal in almost any position. However, for a right handed 
operator it was found to be easiest to use the left hand to open the arytenoids and the right to feed the 
endotracheal tube in with the animal in ventral or right oblique recumbency with the neck extended. 
Intubation could still be performed with the neck flexed, however this was far more difficult as the 
endotracheal tube had to be passed around a bend made by the mouth cavity proper and the larynx. 
iii. Endotracheal tubes used 
Juvenile animals (approximately 1.65 m snout-tail length) were intubated with 10.0, 12.3 or 
15.7 mm outside diameter endotracheal tube, inflated or not depending upon their fit; mature cows 
(approximately 2.4 m snout-tail length) and young males with 24.0 mm or 30.0 mm outside diameter 
endotracheal tube, not inflated; and bachelor and breeding males with 30.0 mm outside diameter or 
35 .0 mm outside diameter endotracheal tube, inflated or not inflated depending upon fit. When a 
larger tube could not be passed due to tight arytenoid adduction in cows, 15:7 mm outside diameter or 
20.0 mm outside diameter endotracheal tube were used. 
The force with which the arytenoids were held adducted in some bulls made us suspect that the 
commonly used silicon or rubber endotracheal tubes might collapse and become occluded in some 
cases, however this was not seen. A more rigid tube, perhaps made from polyvinylchloride, might be 
necessary in some cases, though care would need to be taken not to damage the lining of the 
respiratory tract. 
Prior to trials involving intubation the mouth and upper respiratory tract of a dead juvenile, mature 
bull and cow were dissected to familiarize the operator with upper respiratory tract anatomy. 
Measurements were made of the diameter of the laryngeal opening, body of the larynx and trachea, and 
endotracheal tube passed to assess sizes of endotracheal tube that might be required in the live animal. 
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Mechanical ventilation technique 
Once intubated, a demand valve was attached to the endotracheal tube and the animals ventilated (see 
Riebold et al. 1980). The demand valve was attached to a C size medical grade oxygen cylinder with 
C size medical oxygen regulator (Plate 3.5). The lever of the demand valve was depressed for 
inspiration. There was concern that the valve might impede expiration of air so it was removed from 
the endotracheal tube for expiration. This allowed unrestricted expiration and allowed the operator to 
assess attempts of the animal to inspire voluntarily by inserting the forefinger into the endotracheal 
tube to feel for passage of air. In cows the inspiratory phase usually lasted as long as it took to 
achieve full chest inflation (usually about 2s and no longer than 4s), and the expiratory phase as long 
as expiration (usually no longer than 3s). The inspiratory: expiratory ratio was thus usually about 
1:1. Attempts were made to shorten the inspiratory phase, but gas flow rates and driving pressure 
made this difficult. Frequency of mechanical ventilation varied depending upon mucous membrane 
colour and level of chemical restraint. Frequency was rapid initially in cyanotic cows until mucous 
membrane colour returned to normal (about 15 inflations/ min). When mucous membrane colour 
returned to normal, the frequency was decreased to a maintenance level (about 6 inflations/ min). To 
aid return to spontaneous ventilation, as level of chemical restraint decreased (< level 6) ventilation 
rate was decreased to 2 - 3 inflations/ min, the time between breaths increasing as level of chemical 
restraint decreased. Periods of several min were occasionally allowed in light animals (<level 6 
restraint) to let Paco2 increase. In animals at levels of restraint ~ 6, administration of doxapram (2 
mg/kg) endotracheally, was often used to stimulate spontaneous ventilation. If spontaneous 
ventilation returned, assisted ventilation continued until approximately level 4 restraint when the 
endotracheal tube was removed. If the animal failed to to initiate spontaneous respiration and was at a 
low level of chemical restraint ( < 6) with impending return ie twitching or opening and closing of the 
nostrils with no inspiration, doxapram was administered endotracheally and the endotracheal tube 
removed. Spontaneous ventilation usually returned within min of removing the endotracheal tube. If 
it did not, in most cases tapping of the face or rolling the animal stimulated breathing. 
The C size cyclinder was rapidly depleted (usually in < 5 min). Its main use was for administration 
of oxygen whilst a larger cylinder (D, E or G) was collected from the ANARE base. G size cylinders 
were generally impractical due to their weight and difficulty in transporting. D size were more 
transportable than E size, however they did not last as long. For this reason E size cyclinders were 
most commonly used and lasted from 7-20 min depending upon the animal's size and frequency of 
ventilation. 
It was found that animals < 1000 kg could be ventilated in most positions, however sternal 
recumbancy or with the animal on its back and side (Hammond and Elsner 1977) on a level plain, 
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Plate 3.5. A demand valve connected to a C size oxygen cyclinder. The cylinder, 
valves and other emergency equipment were carried in the small back-pack pictured. 
An intubated cow, wedged in a wallow, is pictured in the background. Two regulators 
were required; one (pictured attached to the cyclinder) which attached to a C size 
cylinder, and another (lower left) which attached to D, E and G size cylinders. 
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with the neck extended, appeared to give the largest excursions of the body wall, and were presumably 
the most efficient. 
Assisted ventilation was performed on all animals which could be intubated and appeared to have 
'difficulty breathing or were at levels of chemical restraint> 5. If animals with breathing difficulties 
could not be ventilated due to insufficient chemical restraint diazepam, suxamethonium, or further 
anaesthetic was administered. This appeared to improve breathing, and allowed access to the upper 
respiratory tract so that assisted or controlled ventilatiOJ:!. could be performed. It also appeared to 
improve the effectiveness of ventilation*. 
Morphometrics 
Length/ girth measurements 
Length was measured as a straight line from the tip of the nose or proboscis to the tip of the tail 
using a tape measure and was referred to as the snout-tail length. Girth was measured immediately 
behind the axillae by rolling the animal over a tape laid out on the ground at 90° to it. Where the 
terrain or depth of anaesthesia did not allow this, the tape was laid across the animal's back, linking 
points on the ground directly below the axillae, and the distance between the points measured. This 
distance was then added to the straight-line distance between the two points' directly below the axillae 
to estimate the girth. 
Mass 
Once anaesthetised, animals were weighed if terrain and depth of anaesthesia allowed. Two or 3 
people were required to roll each animal onto a purpose built sling constructed of 2 aluminium tubes 
(outside diameter 48 mm; 4.4 mm wall), each 3 m long, between which woven nylon strapping (car 
seat belt webbing and nylon sheeting) was slung. A tripod, constructed of aluminium tubes 4 m in 
height, was erected above the animal lying on the sling in sternal recumbency. A 1 tonne mini chain 
block with 3 m lift was used to suspend the animal from a 2.5-ton digital scale (Plate 3.6). 
Where possible animals were weighed; otherwise length-mass relationships determined in Chapter 5 
were used to estimate mass. 
* It should also be noted that air can also be used and that the gas diving pressure can be provided 
by the operator blowing down the tube in animals weighing up to 1000 kg. More than one 
breath may be required to inflate the lungs. Inflation should be gauged by chest expansion 
(Fedak personal communication 1990). 
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Plate 3.6. Weighing a yearling. A tripod this size was used to weigh animals up to large cow size. 
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Tagging 
Animals were identified with blue plastic flipper tags with a 4 digit number embossed on each flange 
and "Inform Antarctic Australia" on the reverse side of the female flange. Tags were inserted 
approximately 2 to 3 cm into the trailing edge of the interdigital webbing between DI and DII with 
the male flange on the plantar surface. It was believed that by locating the male flange on the plantar 
surface the sharp point of the flange (having been punched through the flipper to the dorsal surface) 
would not excoriate the plantar surface of the opposite flipper when the flippers were opposed. 
Tagging occurred at level 3 restraint (heavy sedation) or deeper. 
Classification of animals 
i. Sex and age 
Categorisation of animals was based on that of Laws (1956a), Carrick et al. (1962) and Hindell and 
Burton (1988). 
Adult males were categorized as (A) young males (too young to take an active part in breeding, 6 to 8 
years old), (B) bachelor bulls (too young or too small to compete in harems) and (C) breeding males 
within or competing for harems, either beachmasters or challengers. Allocation of males to bachelor-
and breeding-male categories was simple during the breeding season when their behaviour differed 
markedly, but at other times these animals were simply defined as adult males. Juveniles were defined 
as animals that had not reached physiological maturity, < 3 - 4 years for females and< 6 years for 
males (Carrick et al., 1962). This was judged on the basis of body length for both sexes (Laws 
1956a). 
ii. Stage of yearly cycle 
Four stages of yearly cycle were recognised. 
Pre-breeding - pre-breeding cows were within an estimated two to three days of birth. The Ethics 
committee restricted the study to cows whose pups had died. Each morning, afternoon and evening 
during the breeding season from September 1 to November 12 each harem on the Isthmus (Carrick et 
al. 1962) was checked for newly dead pups. If a dead pup was found it was dragged out of the harem 
and deposited in the tussock away from the beach. In this way new pup fatalities could be recognised 
each day. If the dead pup was still covered with uterine fluid, its nails were still soft and it had a long 
relatively fresh umbilicus attached, it was considered to have died within 24 hours of birth. Positive 
identification of the mother of a newly dead pup was thus based on either the death of the pup being 
witnessed (by crushing or still birth), or the cow having no live pup, actively protecting or nuzzling/ 
sniffing at the dead pup, or having fresh blood indicating recent birth around the vulva and following 
the dead pup out of the harem when it was dragged away. If the cow fulfilled these criteria it was 
marked with yellow yacht enamel paint and its relationship to the dead pup observed over the next 24 
hours. If it still remained with the dead pup the cow was used as a subject for pre-breeding 
_J 
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phannacokinetic studies. Positive identification of mothers was difficult. Often mothers would go to 
sea or move into the harem before they could be located. Forty seven days were spent checking up to 
2700 cows 3 times daily before 5 suitable pre-breeding cows were be located. 
Male animals at the start of the breeding season in August, prior to the arrival of the females, were 
classed as pre-breeding. During September and October they were classed as breeding, and at the end 
of the breeding season in November, when most of the cows had left, as post-breeding. 
Post-breeding - Post-breeding cows were near the end of lactation and within an estimated 3 days of 
weaning their pups. These animals were usually thin, and often located at the periphery of the harem 
with large moulted or semi-moulted pups. These animals would have little interest in the pup which 
would be active and often stray from the mother. The mothers would often be moving toward the sea 
away from their pup or making repeated glances seaward. Animals witnessed actively moving out of 
the harem and towards the sea were not used in trials as in most cases they appeared a very poor 
anaesthetic risk. Immobilization in the intertidal zone for 3h may have risked aspiration of sea water, 
interference by numerous challenger bulls would have made protection of the animal more difficult 
and the partially sedated animal on recovery may not have been able to protect itself from challenger 
and bachelor bulls whilst trying to get to sea. Thus work on the landward side of the periphery of 
small harems controlled by a stable beachmaster was preferred. 
Pre-moult - Pre-moult animals were those at the beginning of the moult and within 3 days after 
coming ashore. These animals were characterised by a light brown to dark brown/ black coat, good 
body condition and lack of skin sloughing (Stage 0 - I; Ling 1965). Often the first signs of 
moulting, such as loss of hair around the orbits or muzzle, could be seen or the animals were 
observed coming ashore. Animals which had been ashore for two to three days were preferred as 
animals that had been seen to haul out or were still wet appeared highly strung, anxious or frightened 
and in many cases could not be approached closely enough to permit needle placement or panicked and 
headed for the sea when approached or injected. Animals that had been ashore for several days 
appeared more relaxed, had moved into the tussock areas and were generally more quiet and tractable. 
Post-moult - Post-moult animals were thin animals at the end of the moult that had shed their last 
year's coat and had almost completely regrown their new coat. They were silver grey with a hair coat 
approximately 0.5 to I cm long and could often be found along the beach tussock margin or on the 
beach itself. Animals in small groups or, in the case of females, in groups with a large male present, 
appeared more tractable and were the preferred subjects for trails. 
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Monitoring 
A set of standard monitoring techniques was developed and used in all animals (Chapter 4). 
Time zero was defined as the time when injection of the first dose of drugs used for chemical restraint 
had been completed. All times referred to in the text are presented with reference to this time eg 
"antagonists were administered at 20 min" means that antagonists were administered 20 min after 
completion of initial administration of drugs used for chemical restraint. 
Once each animal was immobilized a standard monitoring sheet was completed (Figure 4.1; 
abbreviations and definition of terms used in this sheet are listed in Table 4.1). The following 
responses and reflexes associated with assessment of level of chemical restraint were recorded at 
approximately five min intervals from time zero until level of chemical restraint was inadequate to 
allow safe assessment by the operator: 
head response, palpebral response, withdrawal response, caudal flipper response, muscle tone, righting 
reflex, and capillary refill (Table 4.1). 
Once these variables had been recorded an overall assesssment of the level of chemical restraint was 
made. This was based on the ability to handle the animal, gain intravenous access, take blood, roll or 
weigh animals and assessment of the above responses and reflexes (Table 4.1 ). 
The times from time zero to deepest level of chemical restraint reached and to recovery (defined as 
light sedation, level 1) were recorded. Duration of deepest level of chemical restraint reached and level 
of chemical restraint, and time when the animal first moved forward (level and time of first movement 
forward) were also recorded. 
Periods of apnoea, shaking, vomiting or nystagmus were recorded as were any eventful periods during 
the anaesthetic episode. Times of sampling or when procedures were performed were also recorded. 
Statistical analysis 
The Statistical Mac™ statistical package (StatSoft, Inc., USA, 1991) was used for most statistical 
procedures. SAS/ STAT™ for personal computers, version 6 (SAS Institute Inc., USA, 1989), was 
used to perform two-tailed Fisher's exact tests. Differences were considered significant when P < 
0.05. 
Differences in proportions were compared using x2 test. Because most data did not appear to be 
normally distributed, medians were used to compare groups and tested by Mann-Whitney U test (for 
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two groups) or Kruskall-Wallis H test (for more than two groups). Relationships were compared 
using Spearman rank order correlation (r8) unless predictive equations were required (Chapter 5) and in 
these cases simple or multiple regression analysis was used after loge transformation of data. In 
Chapter 5, analysis of co-variance (ANCOV A) was used to compared Y intercept and slope between 
groups. Paired Student's t-tests were used to compare paired data. 
Curve fitting (Chapter 7) was performed by least squares non-linear regression using SigmaPlot® 
transforms and curve fitting software (Jandell Scientific, USA, 1992). 
Where applicable, specific statistical tests used in each chapter are presented under "Data analysis" at 
the end of each "Materials and Methods" section. 
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Chapter 4: Monitoring during chemical restraint 
Introduction 
There is little information available on the signs and responses of southern elephant seals during 
anaesthesia. A standard technique for monitoring anaesthesia in southern elephant seals was required 
for three reasons. 
• To allow comparisons to be made between different anaesthetic agents. 
• To improve the safety, controllability and understanding of the anaesthetic episode by 
allowing detection of undesirable responses to physiological and pharmacological events, 
facilitating their early prevention or treatment and helping avoid excessively deep anaesthesia 
(Bicker 1986). It would allow the anaesthesiologist to determine wliether the required degree 
of suppression had been achieved (Lumb and Jones 1984 p493). 
• A system of monitoring would also help put anaesthesia into its true perspective as a 
potentially dangerous and life threatening procedure, reinforcing the need to assess the welfare 
of the animal diligently throughout the whole period of anaesthesia. 
A large number of techniques have been used to monitor anaesthesia in anini.als (Steffey 1983b, Lumb 
and Jones 1984 p493, Haskins 1987). A pilot study was performed to develop and select those 
techniques and signs which would be most useful for gauging anaesthetic depth and response to 
anaesthesia in southern elephant seals under field conditions, and to use them to develop a standard 
system of anaesthetic monitoring. As techniques were to be used by people with little experience of 
seal anaesthetics, simple, practical, uncomplicated techniques were required, using the minimum of 
equipment, which could be easily applied and understood under field conditions. 
Materials and methods 
A series of monitoring techniques and signs were assessed in seals at various stages of their life cycle 
which had been chemically restrained with a combination of either ketamine and diazepam (Chapter 6), 
or midazolam, pethidine and ketamine (Chapter 9). The monitoring signs and techniques were based 
on those previously used to gauge anaesthetic depth and response to anaesthesia in southern elephant 
seals and in other mammals (Steffey 1983 b, Lumb and Jones 1984 p493, Gales and Burton 1987 a, 
Haskins 1987, Woods et al. 1989). 
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Cardiovascular system 
Pulse was searched for by digital palpation along the lateral and medial borders of the digits from both 
plantar and dorsal surfaces, the interdigital webbing between the digits, along all aspects of the tibia 
and metatarsus, the ventral midline of the tail, the palmar aspect of the fore flipper, the tongue, the 
ventral border of the jaw, the maxilla, over the jugular groove and the thoracic inlet. 
Heart rate was assessed by watching movement of the curve made by the animal's back, the left and 
right axillae, the area caudal to the sternum when the animal was in lateral or dorsal recumbency, or 
the jugular groove. Palpation using the flat of the hand was also used over these areas to feel for heart 
rate. Auscultation was perfonned with a stethoscope over both lung fields, and an area just caudal and 
dorsal to left and right axillae and the thoracic inlet. An oesophageal stethoscope, alone, wrapped in 
tape or with a stilette, was passed to the level of the heart base. The length of stethoscope to be 
passed to locate the tip approximately over the heart base was estimated before passage by holding the 
tip of the stethoscope level with an area just caudal and dorsal to the left axilla and lining the other 
end up with the tip of the nose where a mark was made on it. The stethoscope was then passed down 
the oesophagus until this mark lined up with the tip of the nose. Dysrhythmias were assessed 
visually and by auscultation. 
Blood pressure was measured percutaneously or after arterial cut-down using an arterial pressure 
monitor (U.S. Catherter and Instrument Corporation, Glens Falls, New York, USA)(see Figure 19 
-17, Lumb and Jones 1984 p511). This was attached to a three way stop cock, connector tubing and 
an 18 G, 37 mm needle or 20 G, 67 mm thin-wall catheter outside the needle system (Angiocath, 
Deseret Company, Sandy, Utah, USA) or, for the area of the thoracic inlet, an 18 G, 90 mm needle 
filled with heparin solution (20 IU/ mL). 
To facilitate location of peripheral arteries for cut-down, fore and hind limbs were collected from 
naturally deceased animals and potentially useful vessels dissected out after placement of catheters 
within their lumen or infusion with indian ink. 
Heavy immobilization with midazolam, pethidine and ketamine was used in the live animal to allow 
cut down over areas where these arteries had been located (Chapter 9). These areas included along the 
medial borders of pJ!alanx 3 on digit one (DI) and DV, on the plantar surface of the hind flipper; just 
cranial to the termination of the interdigital webbing above the first metatarso-phalangeal joint, and 
over the medial aspect of the tarso-metatarsus; and on the medial aspect of the fore flipper, between 
the radius and ulna. Cut-down was also perfonned over the angle of the jaw, and jugular groove at the 
left distal neck base just cranial to the thoracic inlet. 
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Capillary refill was assessed by blanching the mucous membranes at the base of the upper canine and 
counting the time taken, in seconds, for colour to return to the area. 
An attempt was made to measure central venous pressure by jugular cut-down after heavy 
immobilization (~ level 5 restraint) with midazolam, pethidine and ketamine using a technique based 
on that outlined by Haskins (1987) and Sweeney (1974). The animal was placed in right lateral 
recumbency, the jugular groove located by observation of pulsing associated with heart rate, and an 
incision made over the caudal end, just above the thoracic inlet. Blubber was incised and blunt 
dissection used in an attempt to locate the jugular vein. 
Mucus membrane colour was visibly assessed. 
Respiratory system 
Respiratory rate was recorded by watching the chest rise and fall, the external nares open and close, 
listening for sounds of breathing, by feeling for breath with the palm of the hand or cheek over the 
nares, or by resting the index finger of the left hand just within the opening of the left nostril. 
Respiratory depth and nature of ventilatory effort was subjectively assessed by visual observation 
based on the degree of chest expansion during inhalation, force of exhalation, time taken for 
inspiration and expiration, and evidence of stertorous or wheezing breathing sounds. Auscultation of 
both lung fields and upper airway was perf01med using a stethoscope. 
An attempt was also made to measure tidal and respiratory minute volume after intubation using a 
Wright respirometer (physiological model, Harris Calorific Company, Cleveland, Ohio, USA) 
attached to the end of the endotracheal tube or by inserting the inlet into one nostril and holding the 
other closed. 
Protective reflexes such as cough reflex and laryngeal reflex were monitored whilst assessing the 
ability to intubate immobilized animals. 
Attempts were made to collect arterial blood gas samples simultaneously with arterial puncture for 
blood pressure and pulse measurement. Venous blood gas samples were collected from the extradural 
intravertebral vein, taking samples every 5 min during the anaesthetic episode until it became 
dangerous to do so. 
Gastrointestinal system 
Excessive salivation, vomiting, regurgitation or defecation was noted and the oropharyngeal reflex 
checked whilst intubating. 
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Ocular system 
Observation of the pupils, corneal reflex in response to touching the cornea with the tip of a pair of 
curved mosquito haemostats, lacrimation, photomotor reflex using a pen light, palpebral response in 
response to touching the medial canthus, eyeball position and nystagmus were noted. Closure of eyes 
in response to touch of the vibrissae located dorsal and medial to the eye was also tested. 
Musculoskeletal system 
Limb muscle tone (caudal flipper response and withdrawal response), jaw tone, abdominal muscle tone 
and degree of muscle tone in response to rolling of the animal (righting response), and ability to move 
the head were used to assess muscle tone. (For definitions of caudal flipper response, withdrawal 
response, righting response, head response and muscle tone see Table 4.1). Anal tone was assessed 
during placement of a rectal thermometer. 
Nervous system 
Sensorium, pedal reflexes including withdrawal response and caudal flipper response, reaction to 
surgical manipulation, head response and response of muzzle vibrissae to touch were assessed as 
gauges of the status of the central nervous system. 
Thermoregulatory system 
Rectal temperature was assessed using a 12 inch glass/mercury rectal thermometer inserted 
approximately 15 cm into the rectum or a digital thermometer inserted approximately 4 cm into the 
rectum and by checking for signs of heat stress such as moving into wallows, "sand flicking" or 
elevation of the temperature of the skin as assessed by laying the palm of the hand on the back. 
Results and discussion 
General 
The most practicable criteria for monitoring anaesthesia in the field were found to be: 
Heart rate, respiratory rate, rectal temperature, assessment of reflexes and responses (head response, 
palpebral response, withdrawal response, caudal flipper response, muscle tone and righting response as 
well as capillary refill, and degree of shaking) and an overall assessment based on the ability to handle 
the animal, gain intravenous access, take blood, roll or weigh the animal (Table 4.1). 
It was found that level of chemical restraint fell into 9 easily recognisable categories (Table 4.2). 
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Table 4.1. Definitions used to monitor response to chemical restraint of female southern elephant seals 
Response used in monitoring 
Heart rate: 
Respiratory rate: 
Rectal lemperature: 
Head response: 
Palpebral response: 
Withdrawal response: 
Definition 
Measured as excursions of the body wall (beats/ min) 
Measured as each inspiratory/expiratory cycle per min (breaths/ min) , 
Assessed using a 12 inch rectal thermomeler inserted approximately 15 cm into the rectum 
A graded response, based on the speed and degree of withdrawal in response to touching the 
top of the head and the side of the muzzle, and gently lifting up both sides of the muzzle simultaneously 
0 Normal response - cannot approach head without risk of being bitten 
1 Near normal response ie slight slowing of response, high risk of being bitten 
2 Can raise head and shoulders above the ground, rear up, usually bite at operator 
3 Can raise head, often with effort, often allowing it to flop to the ground once stimulus is withdrawn; may bite 
4 Cannot raise head; can move it laterally in horizontal plain away from point of touch on opposite side of muzzle 
5 Cannot raise or pull head away laterally but eyes will follow path of operator walking past the head 
6 Eyes won't follow path of operator walking past the head 
A graded response based on the speed of closure of the lids in response to touching the medial canthus 
0 Lost 
1 Sluggish 
2 Moderale 
3 Brisk (near normal) 
A graded response, based on the speed and degree of withdrawal of the 
fore-limb and body in response to pinching the nail bed of DII of the left fore-flipper 
0 Lost 
. 1 Sluggish 
2 Moderale 
3 Brisk (near normal) 
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Table 4.1. (Continued). Definitions used ro monitor response to chemical restraint of female southern elephant seals 
Response used in moniroring 
Caudal flipper response: 
Muscle tone: 
Righting response: 
Capillary refill: 
Shaking: 
Definition 
A graded response, based on the speed and degree of movement of the caudal flukes, hind 
quarters and body in response to hand pressure applied at the level of phalanx 1 and 2 
across the width of DI of the left caudal fluke. 
0 Lost 
I Sluggish 
2 Moderate 
3 Brisk (near normal) 
Degree of muscle rone in response to rolling, or attempting to roll the animal 
0 Lost (flaccid) 
I Slight 
2 Moderate 
3 Near normal 
Ability ro maintain sternal recumbency when attempting to roll the animal over 
0 Lost 
I Slight, muscle tone increased in response to rolling but able IO roll 
2 Moderate/ fighting (but able to roll over) 
3 Near normal, can't roll 
Time in seconds for colour to return to blanched area of mucus membrane above upper canine 
Degree of shaking 
I Slight/ fine 
2 Coarse 
3 Spasms (clonic-tonic) 
4 Status epilepticus 
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Table 4.2. Definitions of levels of chemical restraint 
Level of chemical reslraint* Definition 
0 Normal behaviour 
1 
2 
3 
4 
Sedation 
Immobilization 
Normal behavioural responses 
Light General slowing of behavioural responses, able to move away 
Moderate Able to rear up, will move away or swivel round in response to touch 
Brisk palpebral response 
Heavy 
Light 
Brisk caudal flipper response and withdrawal response 
Free movement of head, able to bite operator 
Marked slowing of behavioural responses 
Able to raise head when simultaneously lift both sides of muzzle 
gently upwards but generally won't bite operator , 
Sluggish response to tactile stimuli 
Righting response still present and can only rarely be rolled over onto a sling for 
weighing. Caudal flipper response and withdrawal response slowing 
Unable to swivel round and unlikely to move away in response to touch 
Conscious but only able to move head laterally several cm from point of touch 
Withdrawal response present 
Muscle tone pronounced and will often form a U shape when rolling onto a sling is 
attempted, and may paddle with fore-flippers 
Rolling is difficult but can be carried out 
Brisk palpebral response 
*Overall assessment of the level of chemical restraint based on the ability to handle the animal, 
gain intravenous access, take blood, roll or weigh the animal and assessment of reflexes and responses. 
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Table 4.2. (Continued). Definitions of levels of chemical restraint 
Level of chemical restraint* 
S Heavy 
6 Anaesthesia Light 
Definition 
Unable to move head away from point of touch however eyes may follow 
objects passing within the field of vision 
Moderate palpebral response 
Righting response small, muscle tone slight but animal can be rolled over 
Unconscious, and little response to tactile stimuli 
loss righting response 
sluggish palpebral response 
Loss withdrawal response 
Loss muscle tone 
7 Moderate Very hard to detennine this depth however respiratory rate may drop or become 
8 Deep 
more laboured/ apneustic 
Little or no palpebral response 
Complete loss of muscle tone, totally flaccid, "blob of jelly" like with muscle slumping 
to appear pear shaped from head on. 
Heart and respiratory rate may be slow and irregular; often there is apnoea 
*Overall assessment of the level of chemical restraint based on the ability to handle the animal, 
gain intravenous access, take blood, roll or weigh the animal and assessment of reflexes and responses. 
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Monitoring of chemical restraint 
A standard monitoring sheet was made up to record the anaesthetic episode based upon regular 
observation of these variables (Figure 4.1). Columns were also inserted in the monitoring sheet to 
allow comments to be made at various times, such as presence of nystagmus or vomiting, or the use 
of mechanical or assisted ventilation, intubation, any further drugs administered and times of blood 
sampling. This system of monitoring was used throughout this thesis. 
Cardiovascular system 
In mature animals a peripheral pulse could not reliably be located by percutaneous digital palpation at 
any of the locations tried. In pups and weaners a pulse could occasionally be located on the medial 
aspect of the forelimb, in the groove between the ulna and radius. The inability to repeatedly palpate 
a pulse was exacerbated by the cold which made the operator's finger-tips less sensitive. 
Dissection of peripheral arteries of the fore and hind limbs revealed three potentially useful sites for 
pulse detection and arterial puncture after cut-down: along the medial border of phalanx 1 of DV and 
along the medial border of phalanx 1 of DV and metatarsal 5 (MTV), on the plantar surface of the hind 
flipper (common plantar digital arteries); just cranial to the termination of the interdigital webbing 
above the first metatarso-phalangeal joint, and over the medial aspect of the tarso-metatarsus (medial 
plantar artery)(see Figure 18. St. Pierre 1974); and on the palmar aspect of the fore flipper, between 
the radius and ulna (median artery)(see Figure 22. St. Pierre 1974). 
I 
These arteries have not previously been described in southern elephant seals but their location appeared 
similar to those described in the harp seal (Pagophilus groenlandicus) (St. Pierre 1974) and for 
convenience similar nomenculature was used to describe them. They were difficult to locate and 
smaller-than expected in the flippers collected from dead animals. In the live animal they were found 
to be relatively deep, small, hard to visualise and a pulse was detected intermittently with difficulty. 
Difficulty in detecting a pulse in these vessels, even with cut-down, may have been associated with 
partial or complete peripheral shut down associated with heat conservation or apnoea. 
The facial artery and pulse could not be located after palpation of the ventral border and maxilla of the 
jaw. A strong pulse could be detected after cut down over the jugular groove at the left distal neck 
base just cranial to the thoracic inlet. However, due to the depth of blubber and bleeding in the area, 
vessels were not visualised. A lingual pulse could not be located and it was concluded that in mature 
animals use of peripheral pulse for monitoring was impractical. 
Heart rate, in most cases, could be monitored by watching movement of the curve made by the dorsal 
body wall, the left or right axillae, the area caudal to the sternum when th.e animal was in lateral or 
dorsal recumbency, or the jugular groove (palpation using the flat of the hand, or leaning with the 
back against the chest wall also could detect a heart beat in some cases). However, in some cases 
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Figure 4.1. A completed cltllmplc of an elcohant seal anacslheuc record sheet dcvclooc:d in tlus s111dv 
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Monitoring of chemical restraint 
heart beat could not be detected: specifically, if animals were shaking associated with anaesthesia or if 
the silhouette of the animal was not clear, for example when the animal was located within a group of 
other animals. Hear rate was also hard to detect when animals were lying against or on top of each 
other as movement of the body wall tended to be difficult to determine against the background, or 
movement of, other animals. 
A heart beat could not be auscultated using a stethoscope. This was exacerbated by wind which, even 
on relatively still days caused "roaring" in the stethoscope. 
Heart rate could be detected in many cases using an oesophageal stethoscope. However in many cases 
an oesophageal stethoscope could not be passed as animals were too lightly anaesthetised, passage 
caused apnoea, or the tube could not be passed as it was not rigid enough. Tape wrapped around the 
tube did not give sufficient rigidity and a sty let generally could not be withdrawn without withdrawing 
the length of the tube. 
It was concluded that heart rate could be measured routinely more effectively by visualising movement 
of the body wall than by auscultation or use of an oesophageal stethoscope. 
Blood pressure was difficult to measure. Percutaneous arterial puncture was successful on one 
occasion (giving repeated estimations of systolic pressures of 90 to 105 mmHg and diastolic pressures 
of 65 to 85 mmHg), however it was made difficult by lack of palpable pulse and risk of arteriovenous 
anastamosis catheterisation. The depth, size, location of vessels and arteriovenous anastomoses 
prevented routine catheterisation after arterial cut down. Other important limiting factors to this 
technique for routine monitoring in the field included animals being too lightly immobilized to allow 
tail manipulation (even slight movement of the tail would made catheter placement difficult), 
peripheral shut-down of vessels making their localization difficult, and locating the vessels and closure 
of the skin were time consuming (an important consideration when drugs with a rapid termination of 
effect were used). An incision on the palmar aspect of the fore flipper would be in contact with the 
ground when the animal moved away, increasing the chance of infection. Manipulation of catheters, 
instruments and flushing of catheters was difficult under cold conditions. For these reasons it was 
concluded that routine monitoring of blood pressure was impractical under field conditions using 
injectable anaesthetics for procedures of short duration. However, arterial access and blood pressure 
and blood gas monitoring could be very useful under more controlled conditions or if gaseous, or more 
prolonged anaesthesia was used, by catheterising the abdominal aorta via a hind flipper artery (see 
Figure 10., Elsner 1969). Introduction of a 25 G needle into the lingual artery was not attempted due 
to difficulty in locating a pulse and light levels of chemical restraint making work in that area 
dangerous in some circumstances. This technique however could be useful if animals were at greater 
levels of chemical restraint and the lingual arterial pulse could be located. 
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Capillary refill was found to be a useful estimate of peripheral perfusion but central venous pressure 
monitoring was unsuccessful due to insufficient time to place catheters and lack of land marks. 
Passage of catheters via the readily accessible plantar venous arch was not attempted but could be of 
use for central venous pressure monitoring if pressure changes in this vessel could be correlated with 
pressure changes within the anterior vena cava. 
Respiratory system 
Respiratory rate could usually be determined by watching the chest rise and fall, the external nares 
open and close, listening for sounds of breathing or by feeling for breath by placing the palm of the 
hand or cheek over the nares, or by resting the index finger of the left hand just within the opening of 
the left nostril. It was, in some cases, difficult to determine if air was being effectively inspired or 
shunted in the dead space due to very shallow breathing (this was especially evident when using 
pethidine based drug combinations). During apnoea the external nares would be held tightly shut. 
Often the first evidence that an animal was about to commence breathing was twitching of the nostiils 
and facial musculature. Respiratory depth and nature of ventilatory effort could visually assessed based 
on the degree of chest expansion during inhalation, force of exhalation, time taken for inspiration and 
expiration, and evidence of stertorous (indicating upper airway obstruction) or wheezing breathing 
sounds (thought to be associated with bronchial spasm). Upper airway obstruction (such as laryngeal 
spasm) was sometimes associated with neck-arching and/ or heaving respiratory effort, whilst the 
nares were closed or open, with no evidence of inspiration. Auscultation of both lung fields and upper 
airway was unrewarding due to wind causing "roaring" in the stethoscope. 
Breathing stopped when the Wright respirometer was inserted into one nostril or, when it was attached 
to an endotracheal tube and the animal intubated. Once the respirometer or endotracheal tube and 
respirometer were removed breathing commenced. The Wright respirometer has minimal resistance to 
flow so it is unlikely that this was causing apnoea. It was considered more likely that the presence of 
these devices as foreign bodies in the upper airway may have been affecting breathing. The 
respirometer was damaged during removal and not used again. Because an endotracheal tube had to be 
passed and the respirometer attached, and because of the effects it may have had on breathing, it was 
concluded that for routine procedures it was not useful for monitoring. However it could be useful 
under more controlled conditions if intubation and gaseous anaesthesia were used. 
Protective reflexes such as cough reflex and laryngeal reflex could only be assessed whilst the 
operator's hand or arm was in the animal's mouth. Animals would often bite down on the operator's 
arm whilst testing these reflexes so their use under field conditions for routine monitoring was 
considered impractical. Apnoea was also seen associated with manipulat~on of the larynx or when 
passing oesophageal stethoscopes in lightly immobilized animals (level 4 restraint) which could also 
limit their usefulness for routine monitoring of light levels of chemical restraint ($; level 5 restraint). 
However it was found that the presence or absence of these responses when intubating animals gave 
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useful information on level of chemical restraint; presence of reflexes indicated light levels of 
chemical restraint (::;; level 5 restraint) whereas loss of reflexes was of concern and usually indicated 
excessive level of chemical restraint(> level 5 restraint). 
Mucous membrane colour was easily assessed but did not appear to relate well with duration of apnoea 
(presumably reflecting differences in the appropriateness of apnoeic responses (Mitchell and Burton 
1991): pink possibly indicating an appropriate apnoeic response and early cyanosis an inappropriate 
response, see Chapter 13: Apnoea during chemical restraint). However, mucous membrane colour 
was easily assessed, and when combined with assessment of heart rate, respiratory rate and duration of 
apnoea was a useful aid in assessment of the status of peripheral oxygenation and perfusion. Cyanotic 
mucous membranes were of concern during anaesthesia. 
Collection of arterial blood gas samples simultaneously with arterial puncture for blood pressure and 
pulse measurement was difficult due to light levels of restraint (::;; level 4 restraint) and excluded it 
from routine monitoring when using injectable agents for short term procedures. In situations where 
the level of chemical restraint was greater for longer periods it could be useful. Venous blood gas 
samples were easily collected from the extradural intravertebral vein and could be a useful gauge in 
assessment of response to anaesthesia. However the equipment required and knowledge of its use are 
limiting factors for its practicality. A potentially more practical alternative which was not assessed 
was the use of pulse oximetry on the tongue. Of all the techniques used this has the most potential 
for use and it is recommended that future studies examine its use. 
Gastrointestinal system 
Excessive salivation, vomiting, regurgitation or defecation could be noted, however due to the 
anatomy of the oropharynx it was found that vomit was held in the oropharynx and could not always 
be seen. Animals that had vomited would not breathe until close to death (level 8 restraint) unless the 
vomit was removed. For this reason a hand was inserted past the sphincter made by the soft palate 
and the tongue to feel for the presence of vomit rather than relying upon visual assessment or reflux 
of vomited material through the nose. Vomiting was sometimes difficult to differentiate from 
laryngeal spasm as the apnoea and heaving of the body appeared similar. For this reason it was 
considered important to physically palpate the oropharynx and arytenoids to differentiate the two 
conditions. Regurgitation was also seen, often associated with insertion of the hand into the· 
oropharynx (for passage of an endotracheal tube or gastric lavage tube). The first sign of regurgitation 
was usually the feeling of hot fluid on the operators cold hand. This usually occurred at excessive 
levels of chemical restraint(> level 5 restraint). The oropharyngeal reflex could only be checked with 
the arm in the animal's mouth whilst intubating which made its routine use·impractical. 
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Ocular system 
Pupils remained constricted through all episodes of chemical restraint until the animal was near death 
so observation of the pupils and photomotor reflex were not considered useful for monitoring except 
in apnoeic animals. In these animals the pupils dilated when terminal cerebral anoxia was near. At 
this point pupillary dilation was a very useful gauge of the response of the animal to treatment for 
anoxia. As the operator was ventilating the animal the pupils could be watched and changes in their 
diameter noted. Any dilation from the normal slit like pupil was a sign of impending death and a sign 
that blood and tissue oxygenation had to be immediately improved. Usually the more aggressive and 
rapid the response with mechanical ventilation the easier it was to. treat these animals. Pupil dilation 
could be stopped and oxygenation returned until pupils were approximately greater than 1 cm across 
the diameter of the elipse. Once the pupils dilated past this point recovery was unlikely. The rapidity 
with which the pupils dilated was remarkable, occuring over approximately 10 to 30s so the person 
monitoring the animal had to watch the eyes constantly. By sitting at the front of the animal the 
pupils could be observed, the animal ventilated, and the nares observed for impending return to normal 
breathing. In cases where there was concern for the life of the animal it was found more useful just to 
monitor these signs with heart rate, capillary refill and mucous membrane colour to assess the 
animal's condition than to routinely assess the other signs of response to chemical restraint. 
Corneal reflex was not considered useful due to the number of times the cornea would have to be 
touched perhaps increasing the chance of corneal damage. Palpebral reflex was more useful. Because 
eyeballs usually remained fixed in position and nystagmus was noted only occasionally, eyeball 
location was not considered a useful gauge of anaesthetic depth. Closure of eyes in response to touch 
of the vibrissae located dorsal and medial to the eye was useful in those animals with vibrissae but not 
in animals during moult which lose these vibrissae. 
Musculoskeletal system 
Limb muscle tone (caudal flipper response and withdrawal response), jaw tone, head response, 
abdominal muscle tone and degree of muscle tone in response to rolling of the animal were useful in 
assessing muscle tone. Large seals (> 1000 kg) appeared to react more sluggishly to nociceptive 
stimuli aimed at eliciting these responses which should be considered when assessing the level of 
restraint in bulls prior to potentially dangerous procedures and greater pressure or more force used. 
Anal tone was less useful due to intermittent use of a thermometer which could only remain in place 
up to level 3 to 4 restraint before movement would make its withdrawal necessary. 
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Nervous system 
Withdrawal response and caudal flipper response, were useful gauges of level of chemical restraint. 
Reaction to surgical manipulation was less useful due to the lack of surgical intervention and 
concurrent use of local anaesthesia during minor surgical procedures. Response of muzzle vibrissae to 
touch was useful but inconsistent. 
Thermoregulatory system 
Rectal temperature assessment using a 12 inch rectal thermometer was useful but in many cases level 
of chemical restraint was insufficient to allow temperature measurement, and temperatures could not 
be measured after recovery. Use of a rectal probe attached to a telethermometer such as that used by 
Mitchell and Burton (1991)(model YSI 401 telethermometer; Yellow Springs Instruments), would 
improve the ease of monitoring rectal temperature. Telethermometers were not used in this study due 
to a lack of funding. Use of oesophgageal thermometers was not assessed. These thermometers may 
allow a more accurate assessment of core temperature, however given the possibility of foreign bodies 
in the upper airway affecting breathing and it may be wise to approach their use at low levels of 
restraint with caution. 
Temperatures recorded simulataneously by the digital thermometer inserted approximately 4 cm into 
the rectum gave lower readings than for the 12 inch thermometer and for this reason use of these 
them1ometers was not considered appropriate. 
Monitoring during apnoea 
It was found that monitoring anaesthesia in the apnoeic patient was more difficult than in the 
breathing patient. Animals often appeared to be consciously breath-holding. In many cases they 
appeared to be sedated but refused to move away in response to caudal flipper pressure. However, once 
breathing commenced the animal would suddenly move off. There thus appeared to be some effect of 
apnoea on response of the animals to anaesthesia, in most cases making the animals appear more 
deeply anaesthetised than they really were. This was believed to be a conscious "shutting down" or 
"dissociation" from their environment which might have been associated with fright in response to 
light levels of restraint as it was usually only seen in animals at low levels of restraint (:o; level 5 
restraint). Testing of this hypothesis would be interesting and further information could possibly be 
gained by examination of changes in the cortical EEG of these animals during these periods and at 
other times during the anaesthetic episode. 
Bulls, pethidine and unpredictable responses 
Responses were harder to elicit in bulls and animals restrained with drug combinations containing 
pethidine. This was an important finding as these animals would appear to be at greater levels of 
restraint than they in fact were, which made approaching them dangerous in some cases (for example 
when intubating). For this reason these animals were approached more cautiously and greater efforts 
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were used to assess reflexes and responses. In other studies using xylazine or medetomidine, animals 
also appeared deeper than they really were and could react aggressively and unpredictably to monitoring 
of the head response (Chapter 8 and 10). These animals also needed to be approached with caution. 
Monitoring of cyclohexamine anaesthesia differs from monitoring using non-cyclohexamine drugs and 
initially may appear difficult as most people will have had experience based upon the responses and 
reflex changes seen during stages of anaesthesia described for non-cyclohexamine drugs, stages which 
may not be seen when using ketamine (for a discussion of the conventional stages of general or 
surgical anaesthesia see Booth 1982 e). The system of monitoring used in this thesis emphasised the 
lower levels of restraint because of the dissociated nature of the animals response to cyclohexamine 
drugs and low drug dosages administered. However, the techniques used for monitoring were simple, 
practical, uncomplicated, used the minimum of equipment and were easily applied and understood. 
This allowed the level of chemical restraint of the animal and status of the respiratory, cardiovascular 
and thermoregulatory systems to be rapidly and accurately assessed. Five people with no prior 
experience with chemical restraint used this system to monitor level of chemical restraint within days 
of being introduced to it. Though initially appearing complex it was soon understood and in all cases 
improved understanding of the value of monitoring, the response of animals to various anaesthetic 
agents, and supplied a common vocabulary with which to discuss and compare the responses of 
animals to anaesthetic agents. 
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Chapter 5: Length-mass relationships 
Introduction 
The mass of an animal is a fundamental parameter in many types of biological investigation (for 
example growth, energetics and morphometric studies) and an accurate estimate of mass is often also 
required to ensure safe delivery of anaesthetic drugs. However, for large animals such as southern 
elephant seals, logistical problems can prevent weighing under field conditions and for this reason 
relationships based on length and/ or girth have often been used to estimate mass (Ling et al. 1967, 
Ling and Bryden 1981, Gales and Burton 1987a). In previous studies, the relationships were based on 
small sample sizes, only Gales and Burton (1987a) included quantitative measures of the amount of 
variance explained by the models, and none provided estimates of variation about the variables in the 
equations. 
Southern elephant seals undergo large changes in mass through various stages of their life cycle. 
Most of their life cycle is spent at sea, however they come ashore twice each year, once to breed and 
once to moult. During these periods the animals do not feed and can lose up to 50% of their body 
mass, mostly as fat (Gales and Burton 1987b). Thus stage in the yearly cycle determines some 
morphometric parameters of southern elephant seals. 
These factors have lead to errors in the estimation of mass (Morgan et al. 1978, Ryding 1982, 
Woods et al. 1989). The aim of this part of the study is therefore to generate relationships to 
estimate mass based on larger sample sizes, with stage of life cycle taken into account, which could 
be used by workers in the field to estimate mass of southern elephant seals. 
Methods 
Data sets from southern elephant seals weighed at South Georgia (54°19'S 36°25'W; between 1986 
and 1991) and Macquarie Island (54°29'S 157°00'E; between 1963 and 1991) were collected*. These 
data were pooled and subsequently grouped by sex, stage of the yearly cycle and location. Grouping 
of animals was based on classifications of Laws (1956 b), Carrick et al. (1962) and Hindell and 
Burton (1988). Animals were classified as either male or female and pre- or post- breeding or 
moulting. Pre-breeding females were those which had just given birth and pre-breeding males were at 
the beginning of the breeding season; post-breeding animals were nearing the completion of the 
* Data sets were made available by Tom Amborn, Michael M. Bryden, Nick J. Gales, Mark 
Hindell, John K. Ling, Peter J. Mitchell, David J. Slip and Rupert Woods. 
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breeding season; pre-moult animals had just commenced moulting; and post-moult animals had 
completed moulting. The groups used in this study are presented in Table 5.1. Length was 
measured as a straight line from the tip of the nose or proboscis to the tip of the tail (the snout-tail 
length). Girth was measured immediately behind the axillae. 
Comparison of mass between female animals at Macquarie and South Georgia were made using two 
way analysis of variance (ANOV A). There were insufficient values recorded to allow comparisons to 
be made between males from either island. 
For each group (Table 5.1) the relationship between: (1) length and girth, (2) mass and length, (3) 
mass and girth, and (4) mass and girth and length were determined using simple or multiple regression 
analysis. Comparisons of Y intercept and slope between groups of seals were made using analysis of 
co-variance (ANCOV A). 
Usefulness of regression equations for predicting mass 
The usefulness of the relationships for estimating mass was tested by comparing masses estimated 
from morphometric data with actual masses for post-breeding and moulting females weighed at Heard 
Island (53°00'S 73°30'E) in 1987 and 1993, using paired Student's t-tests. The moulting females were 
weighed at any stage of the moult and therefore could not be assigned to pre- or post-moult stage. 
Data analyses 
All data were loge transformed prior to analysis. Many of the seals were weighed on more than one 
occassion, usually before and after breeding or before and after moulting, violating the assumption of 
independence of observations. These animals were randomly allocated to one group or another. 
Differences were considered significant when P < 0.05. 
Results 
A total of 784 records of mass, length and girth was used. At Macquarie Island 294 records were 
collected, 430 were from South Georgia, and 60 were collected at Heard Island. 
Mass comparions between Macquarie Island and South Georgia seals 
The masses of females at Macquarie and South Georgia were not significantly different (F1 ,493 = 
1.781, P > 0.05). Mass varied with stage of yearly cycle CF3,493 = 39.48, P < 0.001) and there was 
a significant interaction effect between status and location CF3,493 = 3.82, P < 0.05) (Figure 5.1). 
The interaction effect was due to the pre-breeding Macquarie group (551 ± 112 kg, n = 19) (mean± 
standard deviation) being heavier than the South Georgia group (514 ± 116, n = 156). The percentage 
85 
Table 5.1. Regression equations in southern elephant seals. Data were Loge transfonned prior to analysis. For all relationships P < 0.05. (Y = Y intercept). 
Location Stage of yearly Relationship Females Males 
cycle y Slope r2 SY.X. n y Slope r2 SY.X. n 
Girth Length Girth Length 
coefficient coefficient coefficient coefficient 
Macquarie Island All Length-girth 0.499 0.645 0.550 0.086 538 0.301 0.878 0.960 0.074 80 
and South Georgia length-mass 3.676 2.546 0.774 0.171 679 3.403 2.950 0.981 0.159 102 
mass-girth 4.574 2.263 0.790 0.172 538 4.231 2.705 0.969 0.201 81 
Multi~le 3.831 1.303 1.488 0.906 0.115 538 3.608 0.885 2.072 0.986 0.133 80 
Macquarie Island Pre-breeding Length-girth 0.547 0.550 0.511 0.054 157 
and South Georgia length-mass 3.833 2.536 0.773 0.105 189 
mass-girth 4.895 1.852 0.724 0.114 157 
Multiple 4.023 0.975 1.595 0.879 0.076 157 
Post-breeding Length-girth 0.619 0.536 0.485 0.053 138 
length-mass 3.431 2.679 0.717 0.121 179 3.834 2.519 0.705 0.115 12 
mass-girth 4.651 2.217 0.812 0.102 138 
Multiple 3.752 1.438 1.454 0.919 0.068 138 
Pre-moult Length-girth 0.240 1.036 0.815 0.068 122 0.271 0.881 0.971 0.062 38 
length-mass 3.724 2.532 0.924 0.114 161 3.357 3.058 0.988 0.120 38 
mass-girth 4.180 2.873 0.884 0.144 122 4.158 2.728 0.985 0.137 38 
, Multiple 3.786 1.173 1.641 0.954 0.091 122 3.693 1.214 1.720 0.994 0.088 38 
Post-moult Length-girth 0.715 0.387 0.336 0.038 40 
length-mass 3.750 2.297 0.476 0.112 63 
mass-girth 4.763 1.965 0.735 0.083 40 
Multiple 3.766 1.425 1.395 0.844 0.064 40 
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Table 5.1. (Continued). Regression equations in southern elephant seals. Data were Loge transformed prior to analysis. For all relationships P < 0.05. 
(Y = Y intercept). 
Location Stage of yearly Relationship Females Males 
cycle y SloQe r2 SY.X. n y Slo~ r2 SYX 
Girth Length Girth Length 
coefficient coefficient coefficient coefficient 
South Georgia Pre-breeding Length-girth -0.212 0.975 0.572 0.064 124 
length-mass 3.699 2.669 0.802 0.100 156 
mass-girth 4.823 1.974 0.751 0.111 124 
Multiple 3.920 0.974 1.705 0.895 0.072 124 
'- P'?s~-br~g Length-girth -0.319 0.946 0.554 0.066 107 
length-mass 3.393 2.713 0.752 0.115 147 3.834 2.519 0.705 0.115 
mass-girth 4.633 2.289 0.847 0.096 107 
Multiple 3.773 1.449 1.434 0.939 0.061 107 
Pre-moult Length-girth -0.106 0.786 0.905 0.048 26 
length-mass 3.801 2.468 0.956 0.102 63 
mass-girth 4.197 2.924 0.962 0.091 26 
Multiple 4.009 1.773 I.OOO 0.977 0.071 26 
Post-moult Length-girth 
length-mass 4.000 2.042 0.411 0.114 20 
mass-girth 
Multiple 
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Table 5.1. (Continued). Regression equations in southern elephant seals. Data were Loge transformed prior to analysis. For all relationships P < 0.05. 
(Y = Y intercept). 
Location Stage of yearly Relationship Females Males 
cycle y Slo~ r2 SY.X. n y Slope r2 SY.X. 
Girth Length Girth Length 
coefficient coefficient coefficient coefficient 
Macquarie Island Pre-breeding Length-girth -0.115 0.927 0.477 0.078 33 
length-mass 4.280 2.093 0.689 0.112 33 
mass-girth 5.031 1.594 0.721 0.107 33 
Multiple 4.394 0.989 1.176 0.834 0.083 33 
Post-breeding Length-girth -0.306 0.985 0.380 0.069 31 
· length-mass 3.429 2.714 0.515 0.143 32 
mass-girth -1.691 0.387 0.804 0.039 31 
Multiple 4.014 1.707 0.957 0.845 0.081 31 
Pre-moult Length-girth -0.015 0.715 0.690 0.060 96 -0.319 1.137 0.939 0.110 
length-mass 3.571 
' 
2.690 0.892 0.117 98 3.284 3.117 0.990 0.121 
mass-girth 4.092 3.001 0.817 0.154 96 3.983 2.873 0.990 0.112 
Multiple 3.576 1.244 1.821 0.943 0.086 96 3.640 1.562 1.445 0.997 0.068 
Post-moult Length-girth -0.241 0.867 0.336 0.057 40 
length-mass 3.662 2.387 0.496 0.113 43 
mass-girth 4.763 1.965 0.735 0.083 40 
Multiple 3.766 1.425 1.395 0.844 0.064 40 
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Table 5.1. (Continued). Regression equations in southern elephant seals. Data were Log e transfonned prior to analysis. For all relationships P < 0.05. 
\'{ = Y intercept). . , 
Examples 
1. To estimate the mass of a mature pre-moult female from Macquarie Island of 2.52m snout-tail length prior to drug administration. 
Using simple linear regression: Yi = bXi +a (Yi= dependent variable; mass, b = slope, Xi =independent variable; length, a= Y intercept) 
lnMass = (2.690*1n2.52) + 3.571 or Mass= e"((2.690*ln2.52) + 3.571) 
lnMass = (2.690*0.924) + 3.571 Mass= 2.718"((2.690*1n2.52) + 3.571) 
lnMass = 6.057 Mass= 427 kg 
Mass=427 kg 
2. Once immobilized the girth is measured and found to be 2.10 m. To estimate mass using length and girth: 
Using multiple linear regression: 
lnMass = ((1.821 *ln2.52) + (l.244*1n2.10) + 3.576) 
lnMass = ((1.683) + (0.923) + 3.576 
lnMass = 6.182 
Mass=484 kg 
or Mass= e"((l.821 *ln2.52) + (l.244*1n2.10) + 3.576) 
Mass= 2.718"((1.683) + (0.923) + 3.576 
Mass=484 kg 
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Length-mass relationships 
600 
550 
500 
450 
400 
350 
300 
0 
19 
I 
l 
38 
156 
I 
147 i 20 
'i 79 I 
I i 
21 21 
Pre-breeding Post-breeding Pre-moult Post-moult 
Figure 5.1. The mean mass of mature female southern elephant seals from South 
Georgia and Macquarie Island at different stages of their yearly cycle. The interaction 
is due to the pre-breeding Macquarie females being heavier than the South Georgia 
females. (Error bars are the standard error of the mean. Sample size is also indicated 
for each location). 
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Length-mass relationships 
mass loss during breeding (mean pre-breeding mass subtract mean post-breeding mass) was 32% for 
Macquarie Island females and 26% for South Georgia females. Similarly, the percentage mass loss 
drning moulting was 12% for Macquarie females and 19% for South Georgia females. 
Descriptive statistics 
The derived equations for estimating mass from girth and length, and examples of how they can be 
used to estimate mass are presented in Table 5.1. Slopes for length-girth relationships in pre- and 
post-breeding females and Y intercept in post-moult females were significantly different between 
animals at Macquarie and South Georgia (Table 5.2). Length-mass relationships were not 
significantly different in post-breeding, pre-moult and post-moult at the islands but were significantly 
different for pre-breeding females (Table 5.2). Mass-girth relationships were significantly different in 
pre-breeding and post-breeding females between the islands (Table 5.2). 
Usefulness of regression equations for predicting mass 
For post-breeding females two regressions (length-mass for post-breeding females from all locations 
and multiple regression for post-breeding females from Macquarie Island) gave estimates of mass 
which were not significantly different from those observed. In all other cases for post-breeding 
animals from Heard Island, regression equations underestimated mass by approximately 10% (Table 
5.3). 
All of the regression equations used to predict mass of moulting females gave values which were 
significantly different from those observed (Table 5.3). 
Discussion 
Mass comparions between Macquarie Island and South Georgia seals 
There was no difference between the mass of female seals from South Georgia or Macquarie. This 
observation is at odds with observations made in the 1960's that the masses of mature females at 
Macquarie Island were only 60% of those at the Falkland Islands (Bryden 1968), interpreted by Ling 
, and Bryden (1992) to indicate that female southern elephant seals grow larger at South Georgia than at 
Macquarie. Because there is no difference between pup birth mass and growth rates between the two 
islands (Hindell, unpublished), it is likely that the significant interaction effect due to the larger mass 
of pre-breeding females at Macquarie compared with South Georgia (551 ± 112 kg compared with 514 
± 116 kg) was due to different techniques or times of measuring of animals at both islands, or 
sampling bias (only 19 animals were measured at Macquarie compared with 156 at South Georgia). 
The data also indicated differences in mass loss between females at Macquarie and South Georgia 
during fasting. (The percentage mass loss during breeding was 32% for Macquarie Island females and 
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Table 5.2. Comparison of relationships for Macquarie Island and South Georgia females using 
ANCOVA (df = 1,1). When slopes were significantly different (SD), Y intercepts were not 
tested. No girths were recorded for South Georgia post-moult females. (NSD = not significantly 
different, F = F values.) 
Stage of yearly Relationship 
cycle Length-girth Length-mass Mass-girth 
Slo~ Y intercep_t _ _____filg~ Y interc~ __ Slo~ X intercept 
Pre-breeding SD SD SD 
F=119.183 F=5.095 F=246.101 
P<0.001 P<0.05 p < 0.001 
Post-breeding SD NSD NSD SD 
F= 35.997 F = 0.0001 F = 2.311 F= 101.225 
p < 0.001 P>0.05 P>0.05 p < 0.001 
Pre-moult NSD SD NSD NSD NSD NSD 
F=0.370 F=2.311 F = 3.180 F = 1.087 F= 0.460 F=0.036 
P<0.001 P>0.05 P>0.05 P>0.05 P>0.05 P>0.05 
Post-moult NSD NSD 
F = 0.253 F = 0.253 
P>0.05 P>0.05 
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Table 5.3. Results of comparison of observed masses and those predicted using length-mass relationships determined in this study, with animals 
from Heard Island. Moulting females were al an unknown stage of moult. 
Heard Island animal Regression equation used t Degrees freedom p Mean difference (± SD) between 
stage of yearly cycle Regression Location Stage of yearly cycle estimated and observed mass 
(Macquarie or (kg) (%) 
South Georgia} 
Post-breeding females Length-mass Both Post-breeding 1.944 6 P>0.05 - 20.0±27.2 - 6.1±8.3 
Multiple Macquarie Island Post-breeding 1.850 6 P>0.05 - 18.7±26.8 - 5.9±8.1 
Multiple South Georgia Post-breeding 3.005 6 P< 0.05 
-
33.7±29.7 - 10.4±8.9 
Multiple Both Post-breeding 2.736 6 P<0.05 - 30.3±29.2 - 9.4±8.8 
Length-mass Both All 3.562 6 P<0.05 - 30.7±25.8 - 10.7±7.8 
Multiple Both All 3.797 6 P<0.01 
-
41.7±29.0 - 12.9±8.8 
Moulting females Length-mass Both pre-moult 3.143 36 P<0.01 17.6±34.1 4.4±8.8 
Multiple Both pre-moult 30.171 36 P<0.001 180.3±36.4 46.4±3.6 
Multiple South Georgia pre-moult 17.913 36 P<0.001 - 127.6±43.3 - 33.1±10.2 
Multiple Macquarie Island pre-moult 29.325 36 p < 0.()()1 142.6±29.6 36.8±4.2 
Length-m~s Both post-moult 24.100 36 P<0.001 128.2±32.3 33.0±5.7 
Multiple Both post-moult 8.359 36 P<0.001 34.5±25.1 8.8±6.4 
Multiple Macquarie Island post-moult 8.350 36 P<0.001 34.6±25.l 8.9±6.4 
Length-mass Both All 5.620 36 P<0.001 30.8±33.4 7.8±8.5 
Multiple Both All 2.257 36 P<0.05 9.6±25.9 2.4±6.9 
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Length-mass relationships 
26% for South Georgia females. Similarly, the percentage mass loss during moulting was 12% for 
Macquarie females and 19% for South Georgia females.) However, such a difference was not reported 
in a recent comparison of moulting seals (Hindell et al. In press) again suggesting that sampling bias 
could also be involved. 
The lack of significant differences in relationships of length and mass for post-breeding, pre-moult and 
post-moult females between Macquarie and South Georgia mean that the combined relationships for 
these stages of the yearly cycle can be used to estimate mass. However, for pre-breeding females, and 
in animals at other stages of their yearly cycle where there were other differences between slope or Y 
intercept for other relationships, the estimate can be improved by using the relationship specific to 
that stage of the yearly cycle and location. 
Descriptive statistics 
Length and girth were always highly correlated and both terms were included in the model solely to 
improve predictive ability. 
Although girth was often a better predictor of mass than length it is sometimes less practical to use. 
Girth sometimes cannot be determined prior to chemical restraint of animals and in these 
circumstances length alone may have to be used to predict mass. Girth photographs and digitization 
have been used to estimate girth in northern elephant seals (M. angostirostris) (Haley et al. 1991) 
but this technique is relatively complex and time consuming. 
Overall males yielded better relationships than females. The good fit is partly due to the wide spread 
of data (from immature animals through to adults). Lack of data prevented the generation of 
relationships for all classes of male animals. Therefore, until such time as these data become 
available use of the length-mass relationship presented for post-breeding males could be used for post-
moult males and the pre-moult relationship for males for pre-breeding males (Table 5.1). 
Though the total data set gives reasonable estimates of mass using length, girth, and length and girth, 
accounting for 77.4%, 79.0%, 90.6% of the variance respectively for female animals, the standard 
error about any predicted value is still relatively high. Estimates of mass can therefore be improved 
by using regression equations for sub-groups of the population, as there were significant differences 
between these relationships (Table 5.2). 
Usefulness of regression equations for predicting mass 
Only two regression equations gave reliable estimates when used to predict mass of post-breeding 
females at Heard Island (Table 5.3). One was the Macquarie Island post-breeding female multiple 
regression which gave an estimate within 5.9% of the actual mass (which was not significantly 
different). Interestingly the multiple regression for all post-breeding females gave a poorer estimate of 
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mass (9.4% under-estimate) as did the multiple regression for females from South Georgia (10.4% 
under-estimate). Relationships developed for Macquarie animals may therefore be more useful in 
predicting mass of Heard Island animals than those determined for South Georgia animals. 
It was therefore interesting that the combined length-mass relationship for all post-breeding females 
gave a good estimate of mass. Despite this finding we would caution against the use of length-mass 
relationships rather than multiple regressions for predicting mass when girth is known. 
None of the relationships used to predict the masses of moulting females appeared accurate, under or 
over-estimating mass by up to 36% of mass. The stage of the yearly life cycle (pre- or post-moult) 
of the Heard Island animals was not known, this analysis highlights the need to know the stage of the 
life cycle of the animal before masses can be estimated from equations. For this reason generalized 
equations which do not take these factors into account, despite high r2 values and low Sy.x· values 
will probably be of only very limited use for predicting mass. This conclusion is supported by the 
fact that the ANCOV As indicated that some of the relationships differed between islands. 
The amount of error precludes the use of these relationships for estimating mass during energetics 
studies, and in these studies mass should be determined by weighing. Until more data, or other 
techniques become available, the length-mass relationships presented here, though crude, are however 
the best estimates available for estimating mass of southern elephant seals in situations where mass 
and/ or girth are unknown, for example prior to anaesthetic drug delivery. In these cases the amount 
of error (for example 10% for pre-moult cows in this study) should be considered. Even in cases 
where the relationships do appear to give reasonable estimates of mass these relationships have been 
developed only for animals at a particular stage of their life cycle and not for animals between these 
stages which needs to be considered. 
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Chapter 6: Drug dosage and normal responses to ketamine 
and diazepam 
Introduction 
General 
Anaesthesia of southern elephant seals is complicated by the inability to determine drug dose rates 
accurately and a lack of knowledge of the normal response of animals to anaesthesia. 
At the time of this study ketamine combined with diazepam was most commonly used for chemical 
restraint of southern elephant seals (Gales and Burton 1987 a, Baker et al. 1988, McCann et al. 
1989). These studies reported drug dose rates and some response data but not normal values during 
restraint for basic physiological parameters such as heart rate, respiratory rate and rectal temperature. 
There were also few reports of ketamine and diazepam restraint of particularly large animals (:2: 1000 
kg) (Gales and Burton 1987a) or information regarding additional drug administration. 
This part of the study presents data on responses to a nominal dose of approximately 3 mg/kg (range 
= 2 - 4 mg/kg) ketamine combined with 0.03 mg/kg diazepam (range= 0.02 - 0.04 mg/kg) (100:1 
ketamine: diazepam) in southern elephant seals. Based on these findings, nominal doses are 
recommended for use in animals where mass cannot be accurately estimated. 
There were two parts to the study. 
100: 1 ketamine: diazepam dosage 
Appropriate drug dosage allows the completion of procedures and minimises problems such as 
excessive, inadequate or prolonged restraint. A problem associated with drug administration to wild 
southern elephant seals is the inability to determine mass accurately, and therefore determine the dose, 
prior to drug administration. Length-mass relationships have been used to estimate mass, but have 
been found to be inaccurate in some cases leading to problems of inappropriate dosage (Chapter 5; 
Morgan et al. 1978, Ryding 1982, Woods et al. 1989). Techniques were needed to improve 
ketarnine and diazepam dosage determination. 
Southern elephant seals can readily be categorised according to specific, easily recognisable stages in 
their life and yearly cycle, their sex, and size (Laws 1956 a, Carrick et al. 1962, Hindell and Burton 
1988, Woods et al. 1989). Similarities in response to anaesthetics within categories lead Woods et 
al. (1989) to suggest nominal doses of ketarnine and xylazine. 
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It was decided to determine nominal doses of a 100:1 ratio of ketamine: diazepam (100:1 ketamine: 
diazepam) for each category of animal and use this data to develop a guide for drug administration. It 
was hoped that this would offer a practical alternative to the use of length-mass relationships when 
calculating 100: 1 ketamine: diazepam dosages in animals whose masses were unknown. 
The normal response to 100: 1 ketamine: diazepam 
It is important to understand the normal response to anaesthetics so that the anaesthetic episode can be 
accurately assessed, abnormalities identified and complications treated. 
In other mammals heart rate and respiratory rate decrease as body size increases (Schmidt-Nielsen 
1985). The required anaesthetic dose of ketamine is also known to decrease as body size increases in 
some other animals (Sedgwick 1988). Southern elephant seals vary widely in size. Animals weigh 
approximately 40 kg at birth and can grow to over 3500 kg (Ling and Bryden 1992). It is not known 
what effect size has on the response of southern elephant seals to 100: 1 ketamine: diazepam. Limited 
data presented by Ryding (1982) showed that heart rate was lower in 3 large animals (34 - 54 beats/ 
minute; bpm) than in 2 smaller animals (72 - 74 bpm) which were immobilised with ketamine. 
The aim of this part was to determine normal values for time course of chemical restraint and 
physiological parameters during 100:1 ketamine: diazepam restraint for southern elephant seals. 
Materials and methods 
General 
The study was performed opportunistically on animals being restrained for other purposes. 
i. Classification of animals 
Southern elephant seals were selected in various stages of their life-cycle. Animals were categorised 
by sex, age, stage of yearly cycle and morphometric characteristics including size, snout-tail length, 
and proboscis development (Figure 6.1) (Laws 1956 a, Carrick et al. 1962, Hindell and Burton 1988, 
and Woods et al. 1989). 
Yearlings were small juvenile animals of approximately 2.0 m snout-tail length that had not reached 
physiological maturity. Young males were sexually mature but still too young to take an active part 
in breeding and of approximately the same size range as mature females. (Males of similar size to 
females were differentiated by external genitalia or tooth morphology; we observed that in males 
lower canines are conical and peg like, in females they are narrower, less peg like and more hooked). 
Bachelors were bulls too young or small to compete in harems (snout-tail length - 3.5 m, with small 
proboscis). Breeding males within or competing for harems were divided into challengers (competing 
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Yearling 
(- 2.0 m; I-year old) 
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(- 2.5 m; mature) 
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Figure 6.1. Characteristic size, proponions and appearance of southern 
elephant seals in categories used in this study. Note relative snout-tail 
length (STL) and proboscis development (From Laws 1956 a). 
The figures in brackets are approximate STL (m) and age. 
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98 
Drug dosage and normal responses to ketamine and diazepam 
for, and located around the periphery of the harem; snout-tail length - 4.0 m), and beach masters 
(located within a harem; snout-tail length - 4.5 m) (Figure 6.1). Breeding males had large 
proboscises. 
Animals were divided into pre- and post-fast stages of their yearly cycle. Pre-fasting animals were 
those which had recently come ashore either to moult or breed. Post-fast animals were those which 
had been ashore fasting for a considerable period of time and had lost a large proportion of their body 
mass, mostly as fat, and had completed moulting, were close to weaning a pup, or were at the end of 
the breeding season. Amongst yearlings, only pre-fasting animals were restrained. 
ii. Chemical restraint 
Each animal received a single intramuscular dose of 100:1 ketamine: diazepam. Initially the drug dose 
was based on that found to be useful in pre-moult females (approximately 3 mg/kg (range= 2 - 4 
mg/kg) ketamine and 0.03 mg/kg (range = 0.02 - 0.04 mg/kg) diazepam; Chapter 8). The quantity of 
100: 1 ketamine: diazepam was increased or decreased in subsequent seals until a dose was found which 
induced level 3 - 4 restraint (Table 4.2) in the majority of animals. (Yearling seals received higher 
doses aimed at inducing level 4 - 5 restraint so that gastric lavage could be performed). Dose rates 
were determined in this manner for seals in each category. If animals were insufficiently restrained 
additional ketamine was administered either intramuscularly or intravenously. Additional doses of 
ketamine were based on past experience administering ketamine and xylazine. 
Animals< 3.50 m snout-tail length received 1.3 mg of atropine sulphate, longer animals received 2.6 
mg. 
100: 1 ketamine: diazepam dosage 
Two drug dosages were recorded: 
• The actual drug dose (mg/kg) based on mass. 
• Additional doses of ketamine (% of initial total dose and mg/kg). 
The mass of each animal was determined by weighing, or if this was not possible due to terrain, 
estimated from the appropriate multiple regression incorporating length and girth (Table 5.1). 
At the completion of the trial the nominal dose of drug administered to each category (mg or g) was 
determined by multiplying the median nominal mass of all animals in each category (to the nearest 50 
kg for small animals and 100 kg for large animals) by a nominal initial dose of 3 mg/kg ( 2 - 4 
mg/kg) ketamine and 0.03 mg/kg (0.02 - 0.04 mg/kg) diazepam (found to be effective in most 
animals; below). 
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Normal response to 100: 1 ketamine: diazepam 
A standard monitoring sheet was completed for each animal (Figure 4.1). The level of restraint was 
determined from this information and graded from 1 to 8 (Table 4.1 and 4.2). At 5 min intervals 
beginning 10 min after administration of drugs, blood samples were taken to measure blood gases, 
and each animal's reflexes and responses to stimuli were recorded. The assessment of reflexes and 
responses continued until the animals had recovered (usually within 90 min). (The technique, and 
definitions and abbreviations for the variables used for monitoring and blood gas analysis are 
presented in Chapters 3 and 4). Since several (usually 4 or 5) assessment values were obtained at 
levels 3 or 4, the median was used to give a single value. 
Animals were also assessed for: shaking, apparent hyperthermia (moving into water and/ or flicking 
sand or water over the body) and other notable occurrences. 
Values to describe the normal time course of anaesthesia for each category of animal including 
maximum level of restraint, time to and duration of this level and time to light sedation were 
determined from values recorded for each animal from the standard monitoring sheet. Those variables 
considered most important in monitoring the status of the cardiovascular system (heart rate, capillary 
refill, mucus membrane colour), respiratory system (respiratory rate) and thermoregulatory system 
(rectal temperature) were also determined at level 3 - 4 restraint. 
Data analysis 
Only values for animals which received no other treatment or additional doses of drug were used in the 
data analysis. Groups were compared using the Mann-Whitney U test, relationships were compared 
using Spearman rank order correlation (rs)- Differences were considered significant when P < 0.05. 
Results 
100: 1 ketamine: diazepam dosage 
Two hundred and twenty five animals were immobilized. The actual initial drug doses administered to 
each category of seal are presented in Table 6. lA. The actual initial drug dose level required to 
produce level 3 - 4 restraint remained relatively constant as the mass of the animal decreased and the 
dose of approximately 3 mg/kg ketamine combined with 0.03 mg/kg diazepam induced level 3 - 4 
restraint in the majority of animals to which it was administered. 
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Table 6. lA. Lengths, masses, initial doses of ketamine and diazepam, the maximum level, time and duration of chemical restraint and time to recovery (light sedation, level 1) (median, range) 
for different classes of southern elephant seal at different times in their life cycle. (Levels of chemical restraint are presented in Table 4.2) 
Sex 
Male and 
female 
Female 
Male 
All animals 
Category 
Age Stage of yearly 
Snout-tail 
length 
Mass 
(kg) 
Initial drug dose (mg}kg) Maximum level of chemical restraint Time to recovery n 
Ketamine Diazepam Level TI me Duration (minutes) 
~ ___ ___c:ycle_ - (m) n_ (min_11tes) (minutes) 
Yearling 1.88 190 5.94 0.08 6 7 15 48 32 
Pre fast 
Postfast 
Bachelor Pre fast 
Postfast 
Harem bulls 
I. Challenger Pre fast 
Postfast 
II. Beach master Pre fast 
' 
Postfast 
(1.63-2.30) (119-417) (3.98-8.42) (0.03-0.16) - _(4-6)_ - (l~) (5-37) (6-94) 
I 2.55 (210-2.95) 
I 3.82 (3.43 - 4.05) 
I 4.00 (3.70 -4.24) 
I 4.33 (4.00 - 4.81) 
469 2.60 0.05 3 10 14 50 73 
(283 - 700) (1.71 - 6.12) (0.02 - 0.13) (1- 8) (1 - 39) (1 - 73) (18 - 125) 
366 2.84 0.03 4 7 14 43 46 
(278-576) (1.80-6.81) (0.02-0.07) _(1-61 (1-_17)_____12-26) (30-66) 
1855 2.59 0.02 3 9 20 37 5 
(1806 - 2038) (1.73 - 3.14) (0.01 - 0.02) (1 - 3) (9 - 9) (5 - 24) (28 - 53) 
1334 
(1031 -1567) 
2486 
(1574 - 2635) 
1518 
(1334- 1758) 
2693 
(2068 - 2897) 
2.88 
(2.11 - 4.09) 
2.93 
(243 - 3.66) 
3.16 
(1.48 - 3.81) 
2.32 
(1.93 - 2.55) 
0.04 
(0.03 - 0.04) 
0.04 
(0.02 - 0.04) 
0.03 
(0.03 - 0.04) 
0.02 
(0.01 - 0.05) 
5 
(1-5) 
3 
(1-4) 
4 
(3-5) 
3 
(2-4) 
16 20 90, 
(15-17) (14- 30) (50-110) 
9 20 95 
(9-16) (9- 31) (95 - 95) 
16 15 57 
(10- 43) (6- 30) (40-110) 
14 7 63 
(10 - 18) (7- 8) (21 - 70) 
15 
4 
27 
4 
1854 3.02 0.03 3 14 25 61 19 
(1666- 2416)_ (!.66 - 3.68) (0.02 - 0.05) - (~ (1 - 24) (10- 48) (34- 82) 
2.87 0.03 4 10 15 50 225 
(1.48 - 8.42) (0.01 - 0.16) (l_:_ID (1-4_3_L_(_l - 73) (6- 125) 
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Thirty animals required additional doses of ketamine to adjust the level of restraint from 2 to 3 - 4. 
Five of these animals received a single additional intramuscular dose of ketamine of approximately 
50% of the initial dose of ketamine. The other 25 animals received additional ketamine 
intravenously. Most animals received only 1 additional dose (range= 1 - 8) of approximately 33% of 
the initial dose of ketamine. Subsequent additional doses were usually smaller. Additional ketamine 
administration was associated with slowed or laboured breathing or apnoea, and shaking was seen in 1 
animal. 
Nominal doses of drug for each category of animal based on a nominal dose of 3 mg/kg (2 - 4 mg/kg) 
ketamine and 0.03 mg/kg (0.02 - 0.04 mg/kg) diazepam and calculated from nominal masses recorded 
for animals within each category are presented in Table 6.2. 
A procedure which could be used to determine 100:1 ketamine: diazepam dose to administer to a 
southern elephant seal is presented in Figure 6.2. 
The normal response to 100: 1 ketamine: diazepam 
Variables describing the the time course of restraint for each category of seal are presented in Table 6. 
lA. As mass increased there was a tendency for the time to maximum level of restraint, its duration, 
and time to recovery to increase. 
Seventy nine animals reached level 3 - 4 without any additional drugs or other treatments. Heart rate 
and respiratory rate at level 3 or 4 of restraint in these animals tended to decrease as mass increased 
and heart rate (U = 133.5, P < 0.01) and respiratory rate (U = 205.0, P < 0.05) at level 3 or 4 were 
significantly higher in smaller animals ( < 1000 kg) compared with larger animals (~ 1000 kg) (Table 
6.lB). 
Normal values, and those considered abnormal for large and small seals are presented in Table 6.3. 
Values considered abnormal were those seen when animals were either excessively (> level 5) or 
inadequately ( < level 3) restrained. 
Pvco2 (U = 120.0, P < 0.01) and pH (U = 75.5, P < 0.01) were significantly lower at level 3 or 4 
in larger animals compared with smaller animals. Median Pvco2 was 50 mmHg in small animals 
compared with 57 mmHg in large animals and median pH was 7.35 in small animals and 7.27 in 
large animals. Pvo2 (median = 45 and 39 mmHg respectively) and HC03- (median = 27 and 26 
mmHg respectively) were not significantly different between large and small animals at level 3 or 4 
restraint. There was a tendency for Pvco2 and HC03- to increase as mass increased (P < 0.05), 
though the relationships were not close (r8 :::;; 0.6). 
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Table 6.lB. Heart and respiratory rates (median, range) for different categories of southern elephant 
seal restrained to level 3 - 4 with a single intramuscular dose of ketamine and diazepam at different 
times in their life cycle. Values are also presented for small and large seals. (bpm =beats per minute.) 
Catego!)'. Heart rate Respiratory rate n 
Sex Age Stage of yearly at level 3-4 at level 3-4 
cl'.cle ~Em2 ~reaths/ minute2 
Male and Yearling 100 9 8 
female ~88-1042 ~6 - 202 
Female Prefast 60 5 36 
(34-100) (1 - 16) 
Postfast 56 4 14 
(36- 88) (1 - 10) 
All small (< lOOOkg) animals• 60 5 
~34-1042 p-202 
Male Bachelor Prefast 44 6 3 
(36- 68) (4- 10) 
Postfast 42 45 3 
(40-44) (3 -6) 
Harem bulls 
I. Challenger Prefast 60 4 3 
(60-66) (3 - 10) 
Postfast 44 3 3 
(36- 72) (2-4) 
II. Beach master Prefast 54 2 5 
(48- 66) (1- 2) 
Postfast 48 2 4 
(40- 60) (1- 5) 
All large ~ 1 OOOkg) animals* 48 4 
(36- 72) (1 - 10) 
Total 79 
*Heart and respiratory rates were significantly lower in larger ~als compared with smaller animals 
(see text). 
Notes _ 
1. The median rectal temperature at level 3 or 4 for all animals was 37.0°C (36.0-39.1°C). 
Mucus membrane colour remained pink and capillary refill was < 3s. 
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Table 6.2. Recommended total initial doses ofketamine end diaz.epam (median, range) required to induce approximately 10-15 
minutes o~ level 3-4 restraint in each category of seal, based on an approximate dose of 3 mg/kg ketamine (range = 2 -4 mg/kg) 
and 0.03 mg/kg diazepam (range"' 0.02 - 0.04 mg/kg). Nominal values for snout-tail length and mass for each category 
are also included. 
Catell!!O: Snout-tail Mass• Initial dose of droll 
Sex Age Stage of yearly length (kg) ketamine diazepam 
cycle (m) "(I!) (ml!) 
Male and Yearling 2.0 200 0.60 6 
female (0.40 - 0.80) (4- 8) 
Female Pre fast } 450 1.35 14 2.5 (0.90 - 1.80) (9 - 18) 
Postfast 350 1.0S 11 
(0.70 - 1.40) (7 - 14) 
Male Bachelor Prefast } 1900 5.70 57 3.S (3.80 - 7 .60) (38 - 76) 
Postf ast 1300 3.90 39 
(2.60 - S.20) (26- 52) 
Harem bulls 
I. Challenger Pre fast } 2500 7.50 75 4.0 (S.00 - 10.00) (SO- 100) 
Postfast 1500 4.50 45 
(3.00 - 6.00) (30-60) 
II. Beach master Pre fast } 2700 8.10 81 4.S (S.40 - 10.80) (54- 108) 
Postfast 1900 5.70 57 
(3.80 - 7 .60) (38 - 76) 
•Nominal mass. Median values (Table 6.lA) were rounded to the nearest SOkg for small animals and lOOkg for large animals. 
Notes 
1. For subadult males (2.0 - 3.S m snout-tail length) estimated masses and doses of drug can be based on those used for females 
of similar size and stage of yearly cycle. 
2. Pups at birth weigh approximately 38 kg (Ling and Bryden 1992) and grow to approximately 128 kg 
(range = 36-233 kg, n = 400; Woods, unpublished data) at weaning. In these animals, after physical restraint, 
100: 1 ketamine: diazepam can be administered intravenously to effect based on a dose of 1 to 2 mg/kg ketamine. 
Diazepam is admistered firSL Intramuscular administration can also be used but is less reliable. 
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Mass unknown 
Categorise animal 
(Figure 6.1) 
~-
• Massknown 
~------.. 
Only snout-tail length known Snout-tail length and girth known 
Determine r2* of equation determined 
from length and mass for category and 
stage of life cycle (Table 5.l)t 
r2<0.80 r2~0.80 
~ 
Select nominal dose of 100: 1 ketamine: diazepam 
(Table 6.2):1: 
Small animals 
(snout-tail length< nominal 
snout-tail length) low nominal 
dose 
Average size animals 
(snout-tail length - nominal 
snout-tail length) nominal 
dose 
Large animals 
(snout-tail length > nominal 
snout-tail length) high nominal 
dose 
~ 
Calculate mass using 
equation determined from 
length and girth for 
category and stage of life 
cycle (Table 5.l)t 
~ 
Administer 3 mg/kg ketamine 
~ (2 - 4 mg/kg), and 0.03 mg/kg 
_,r· diazepam (0.02 - 0.04 mg/kg) 
Calculate mass intramuscularly.:!: 
from snout-tail 
length (Table5.I)t 
If animals are insufficiently restrained by these doses, 
administer 50% of initial dose intramuscularly 
(approximately 1.50 mg/kg) or 30% (approximately 
1.00 mg/kg), slowly intravenously to effect after 10-15 
minutes in smaller (< 1000 kg) animals, or after 15-20 
minutes in larger ~ 1000 kg) animals. 
Figure 6.2. Procedure for estimating initial intramuscular dose of 100: 1 ketamine: diazepam. 
Pups and weaners can be physically restrained and 100:1 ketamine: diazepam given 
intravenously to effect based on a dose of 1 - 2 mg/kg ketamin~. 
*r2 = coefficient of determination. 
tlf there is doubt as to the accuracy of the regression, consider use of nominal dose. 
:j:Dose of drug should be modified according to level of arousal, depressed or somnolent animals 
receiving doses at the lower range of those presented. 
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Table 6.3 Summary of expected normal responses (median, range), and those considered abnormal, when restraming large or small animals to level 3 - 4. 
(bpm =beats per mmute). 
Size of seal Response Heart rate Respiratory rate"' Common penods Maximum level Time to (minutes) 
(bpm) (Breaths/ minute) of apnoeat of restrarnt maximum level recovery 
of restraint (level 1 restramt) 
Small(< 1000 kg) 
Normal 60§ 5§ < 10 mmutesll or 3-4 10 <60 
(34 -104) (1 - 20) <60s'Jl (5 - 15) 
Abnormal <40or>80 <4 > 10 minutesll or <3 or>5 < 5 or> 15 >60 
> 60s'[ 
Large(~ 1000 kg) 
Normal 48 4 < 20 mmutesll or 3-4 20 <90 
(36 -72) (1 - 10) <60s'll (15 - 40) 
Abnormal <20or>60 <2 > 20 mmutesll or <2or>5 < 10 or>40 >90 
>60s'[ 
"'When breathmg is stimulated usmg physical techmques (Table 13.4). 
t Apnoea 1s a normal response to anaesthesia in elephant seals (Chapter 8 and 13). However, it can be treated, or prevented usmg physical techmques m the majonty of animals. 
For this reason, m this study apnoea of >60s duration was considered abnormal It is especially important to prevent apnoea in bulls for which there are currently no 
effective techmques available for positive pressure ventilation. 
§Heart and respiratory rates are higher m yearlings, heart rate= 100 bpm (range= 80-100 bpm), respiratory rate= 9 breaths/ mmute (range= 6-20 breaths/ minute). 
II Ifbreathmg is not stlffiulated usmg physical techniques (Table 13.4). 
'[If breathing is stimulated using physical techmques (Table 13.4). 
Notes 
1. Normal rectal temperature 1s 37°C (range= 36 0 - 39.1°C), abnormal 1s > 38.5°C, or a rapid increase. 
2. Respiration is charactensed by qmet regular breathmg interspersed with short penods of apnoea 
3. There should be no shaking It should be treated 1f >level 2 shakrng (see Appendix VI) 
4. Mucus membranes remain dry, or with ffi!Ilimal sahvation, and colour remains pmk with capillary refill < 2-3 s Profuse, thick tacky saliva or 
white, grey or blue mucus membranes are abnormal. 
5. There 1s some muscle tone, and palpebral response remains bnsk. 
6. T!ffie and durat10n of maximum level restraint and time to recovery mcrease as size mcreases; heart and respiratory rates decrease. 
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Discussion 
The fact that neither ketamine or diazepam dose level (mg/kg) decreased as mass increased was 
surprising given that this occurs in some other species (Sedgwick 1988) and indicates that a dose of 3 
mg/kg ketamine combined with 0.03 mg/kg diazepam may be suitable for all sizes of animal. 
In the absence of body mass data, the nominal doses of drug for each category of animal based on a 
dose of 3 mg/kg (2 - 4 mg/kg) ketamine and 0.03 mg/kg (0.02 - 0.04 mg/kg) diazepam presented in 
Table 6.lB are recommended. Drug dosage based on nominal doses of drug for each category of 
animal offers a safe and practical technique which avoids problems associated with the use of length-
mass relationships and may be more appropriate in circumstances where these relationships are not 
close. 
The nominal masses presented in this study (Table 6.2) could be used to determine doses of other 
drugs for each category of seal from known dose rates (mg/kg). However until experience is gained, 
or dose-response studies conducted, it may be preferable to use the lower range of known dose rates of 
these drugs to determine nominal doses in order not to overdose animals. 
Drug dosage determination is based on knowledge of drug dose rates and the mass of the animal. 
However, in practice the final dose administered will have been adjusted according to a variety of 
factors including the desired response, the animal's level of arousal, health and response to injection; 
the assessment of which is largely determined by experience. There is no substitute for experience in 
drug dosage determination, however until more accurate techniques become available for estimating 
mass prior to drug administration, and dose-response studies are performed, the drug dosages presented 
here, coupled with the use of length-mass relationships and caution, could be used to determine 100: 1 
ketamine: diazepam dosage in southern elephant seals (Figure 6.2). 
As apnoea or breathing difficulties were often induced by additional intravenous ketamine 
administration it may be advisable to administer drug slowly to effect and to be prepared to treat any 
ensuing apnoea. 
The values describing the normal time course of restraint and the physiological parameters used in 
monitoring improve understanding of the expected response of southern elephant seals to 100: 1 
ketamine: diazepam restraint and allow deviations from normal responses to be recognised, thus aiding 
assessment of the anaesthetic episode and improving safety. Because responses to different 
anaesthetics vary (Chapter 8), values for these variables need to be determined for large and small 
animals for those drugs commonly used to chemically restraint southern elephant seals. 
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Size had a significant effect on response to 100: 1 ketarnine: diazepam. As the animal's size increased 
so did the time to reach the maximum level of restraint, its duration, and the time to recovery. These 
effects are probably due to pharmacokinetic differences associated with size and have important 
practical ramifications when anaesthetising larger animals. Most smaller animals became handleable 
within 10 to 15 min of initial drug administration, and most larger animals within 15 to 20 min (but 
this was as long as 45 min). Hence one should delay 15 to 20 min before administering additional 
drug to large animals to avoid risk of drug overdose compared with a 10 to 15 minute delay for 
smaller animals. The longer times to recovery also mean that associated problems, such as 
hyperthermia, pup abandonment, and attack by other seals, will be more pronounced as size increases. 
In particular, prolonged recovery of harem bulls can lead to attack by challenger bulls and disruption 
of the structure of the harem during the breeding season. 
The decrease in heart rate and respiratory rate as mass increased was not unexpected (Gibbons et al. 
1988, Sedgwick 1988, Sedgwick and Pokras 1988). The differences in heart rate and respiratory rate 
between small and large animals also has important ramifications during monitoring. For example, a 
respiratory rate of 2 breaths/ minute and heart rate of 40 bpm may be within normal limits for a 2000 
kg bull but would be considered slow if seen in a 200 kg yearling. 
As well as decreasing heait rate and respiratory rate, size appeared to have an effect on the effectiveness 
of respiratory exchange. Pvco2 and pH were significantly lower at level 3 or 4 in larger animals 
compared with smaller animals, and Pvco2 and HC03- increased as mass increased. There are 
problems associated with interpretation of venous blood gas values (Haskins 1977) (Chapter 4) and 
the relationships were not close, so these data need to be interpreted with caution. However, 
Hammond and Elsner (1977) considered that resuscitation in large phocid seals could be complicated 
by the flexible thorax, evolved to allow collapse of the lungs during diving. It is possible that the 
mcreased Pvco2 and HC03- might reflect changes in ventilation and perfusion, possibly associated 
with changes in the rate and/ or depth of ventilation, or alveolar collapse or atelectasis due to an 
increase in compliance as the weight of the animal's thorax comes to bear on the lung parenchyma. If 
this is the case then larger animals may represent a greater anaesthetic risk than smaller animals and 
the use of positive pressure ventilation may be indicated. There are however problems associated with 
positive pressure ventilation in large animals and seals (Chapter 11) and maintenance on oxygen, or 
positioning these animals on their back and sides (a position which may aid resuscitation; Hammond 
and Elsner 1977) may be warranted until such time as arterial blood gas data, or techniques for 
positive pressure ventilation of large animals become available. 
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Chapter 7: 
ketamine 
Introduction 
Pharmacokinetics of intravenously administered 
Female southern elephant seals spend most of their life cycle at sea. However they come ashore twice 
each year, once to breed and once to moult. During these periods the animals do not feed and can lose 
up to 50% of their body mass, mostly as fat (Gales and Burton 1987 b). Woods et al. (1989) showed 
that there were differences in duration of sedation at different times of their life cycle and suggested 
that changes in sedative pharmacokinetics might be a contributing factor. 
The dissociative anaesthetic ketamine is commonly combined with a sedative to chemically restrain 
southern elephant seals (Mitchell and Burton 1991). However there are no data available on the 
distribution of ketamine or other drugs in this species. The present study was to determine basic 
disposition kinetics* for ketamine in this species and investigate any differences with the animal's life 
cycle. 
Materials and methods 
Animals 
Three groups of 5 mature female southern elephant seals of median 2.40 m snout-tail length (range= 
2.20 - 2.95 m) were used in this study. They were: (1) pre-moulting cows, recently hauled ashore to 
moult; (2) post-moult cows, circa 20 days after pre-moult when the coat had been completely shed; 
and (3) pre-breeding cows within 1 day of giving birth (Woods et al. 1989). 
Anaesthetic technique 
To allow access for venipuncture, animals were sedated with a median dose of 5 mg/kg pethidine 
(range= 3 - 10 mg/kg) delivered intramuscularly by a remote injection technique (Ryding 1981). 
Once animals became heavily sedated a blood sampling needle (90mm, 18G spinal needle) was 
inserted into the extradural intravertebral vein approximately four lumbar vertebrae cranial of a line 
drawn between the wings of the ilium. A second drug administration spinal needle was placed 
approximately two vertebrae caudal to the first. 
* An introduction to pharmacokinetics - the disposition and fate of drugs in the body - can be found 
in Booth 1982 a. 
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Ketamine was then administered intravenously via the drug administration spinal needle over 60s. 
Pre-breeding and pre-moult animals received 500 mg ketamine and post-moult animals received 300 
mg ketamine. 
A stop-watch was started at the beginning of drug administration and blood samples were taken into 
10 mL lithium heparin vacutainer blood collection tubes in duplicate at 2, 4, 6, 8, 10, 15, 20, 30, 45, 
60, 75, 90, 120, 150 and 180 min post injection of ketamine. The blood sampling needle was kept 
patent by flushing with heparinised saline. Samples were centrifuged, plasma aspirated, mixed and 
distributed evenly into 2 nonsilanized serum tubes which were held frozen (below -21°C) until 
assayed. 
To maintain sufficient sedation to allow sampling during the 180 min period, up to 5 incremental 
doses of from 1 - 3 mg/kg pethidine (in 10 - 20mL per dose) were administered as necessary 
intramuscularly via a needle placed in the epaxial musculature approximately 20 cm lateral to the 
dorsal midline. The total median dose of pethidine administered over the 180 ruin period for all 
animals was 9 mg/kg (range = 5 - 15 mg/kg). 
Breathing was stimulated using physical techniques (Chapter 13) for the 180 ruin period. Mass was 
estimated using multiple regression relationships determined in Chapter 5. 
Assay 
The plasma was analysed for the presence of ketamine using a gas liquid chromatographic technique 
based upon that described by Waterman et al. (1987). Plasma was thawed at approximately 37°C and 
lmL placed in a 20mL screw-top culture tube (Kimble, Illinois, USA), internal standard added (500 ng 
phencyclidine in 20 µL methanol), made alkaline by the addition of lmL of pH 12.5 Na2C03 buffer 
(20g Na2C03.10H20 in lOOmL distilled water). This was rotated at 30 rpm for 30 min with 5mL 
benzene (Analytical reagent; May and Baker Australia, West Footscray, Victoria, Australia). The 
benzene was separated by centrifugation, aspirated and transferred into a 1 OmL screw-top centrifuge 
tube (Kimble, Illinois, USA). The benzene was rotated at 30 rpm for 10 min with lmL 5M HCL 
then centrifuged, aspirated and discarded. One mL 5N NaOH, lmL Na2C03 buffer and 500µL toluene 
(Nanograde; Mallinckrodt, Clayton, Victoria, Australia), were then added to the HCL and the solution 
rotated at 30 rpm for 10 ruin, centrifuged, and the toluene transferred to a centrifuge tube where it was 
evaporated to approximately 20µL under a gentle stream of N2. Samples of the toluene (lµL) were 
then injected on-column (15m, 0.53mm inside diameter, SE-30 wide-bore Econo-Cap capillary 
column with 1.2µm film thickness; Alltech Associates, Inc., 2051 Waukegan Road, Deerfield, IL 
60015) in a Varian series 3700 gas chromatograph fitted with a thermionic specific detector. The 
carrier gas was helium at a flow rate of 3mL/min and the operating conditions were: injector 
temperature 230°C, detector temperature 300°C, and oven temperature 175°C for 2 min, increasing by 
10°C/min to 300°C, held for 2 min. 
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The areas of the peaks obtained were measured by an integrator (Milton Roy CI-lOB; SGE, 
Ringwood, Victoria, Australia) and the ratio of ketamine to internal standard was read off a calibration 
curve prepared by adding varying amounts of ketamine in 20 µL methanol to 1 mL elephant seal 
plasma to give final concentrations of 50, 100, 200, 250, 300, 400, 500, 1000, 2000, 3000, 4000, 
5000, 6000 and 8000 ng/mL of ketamine/ lmL plasma (500 ng of internal standard in 20 µL 
methanol was added to each). (An example chromatogram of ketamine and phencyclidine extracted 
from southern elephant seal plasma during this study is presented in Figure 7.1). 
The calibration curve was linear over the range 10 ng/mL to 8 µg/mL (r2 = 0.999, n = 18). Recovery 
and repeatability were determined by assaying 5 replicate extracts of high (5000 ng/mL) and low (100 
ng/mL) concentrations of ketamine in plasma where: 
(peak area ratio ketamine [extracted] I internal standard [not extracted]} 
Recovery (%) = (peak area ratio ketamine [not extracted]/ internal standard [not extracted]) 
For extracted samples, high and low concentrations of ketamine (in 20 µL methanol) were added to 1 
mL plasma and extracted (as above) into 500 µL toluene to which 500 ng internal standard (in 20 µL 
toluene) was then added and 1 µL of this solution injected on-column. For samples not extracted, 
high and low concentrations of ketamine (in 20 µL toluene) were added to 500 µL toluene, then 500 
ng internal standard (in 20 µL toluene) was added and 1 µL of this solution injected on-column. 
Recovery (mean± standard deviation) was greater than 70% (5000 ng/mL ketamine = 78±3%, n = 5; 
100 ng/mL ketamine = 72±4%, n = 5). 
Same day repeatability was determined by running 5 replicates of both high and low concentrations 
extracted on the same day. Same day coefficient of variation was 3% (5000 ng/mL ketamine = 3%, n 
= 5; 100 ng/mL ketamine = 3%, n = 5). Between day repeatability was determined by running a 
single replicate of high and low ketamine concentrations extracted on each day that a run was 
performed. The between day coefficient of variation was 8 - 9% (5000 ng/mL ketamine = 8%, n = 27; 
100 ng/mL ketamine = 9%, n = 27). 
Pharmacokinetic and statistical analyses 
i. Determination of appropriate compartment model 
The plasma concentration of ketamine was plotted against time and fitted to a two or three 
compartment model described by bi or triexponential equations of the form: 
or 
f (t) =al e-blt + a2e-b2t+ a3e-b3t 
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Figure 7.1. An example chromatogram ofketamine and phencyclidine extracted from southern 
elephant seal plasma during this study. Ketamine eluted at approximately 4.0 minutes and 
phencyclidine at approximately 45 minutes. The concentration ofketamine in the plasma 
determined from this trace was approximately l.86µg/mL. The sample was collected at 4 minutes. 
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respectively, using SigmaPlot® (Jandell Scientific, USA, 1992) transforms and curve fitting software 
package. 
For each parameter dependencies were determined and used to ascertain the most appropriate model 
after the technique described in the manual (SigmaPlot® 1992) where dependence is defined as 
Dependence = 1 - (variance of the parameter, other parameters constant) (variance of the parameter, other parameters changing) 
Parameter dependencies of greater than 0.99 were taken to indicate that the parameters were dependent 
and that the data had been "over-parameterized". (Parameters with dependencies near 1.0 are strongly 
dependent on one another. This may indicate that the equation(s) used are too complicated and "over-
parameterized" - too many parameters are being used. A model with fewer parameters may be better 
(SigmaPlot® 1992).) The most appropriate model was thus considered to be that with the lowest 
number of curves containing dependent variables. 
ii. Pharmacokinetic analysis 
Based on the results of curve fitting (above) the plasma concentration of ketamine was plotted against 
time and fitted to a two compartment model, analogous to that presented above, and described by the 
biexponential equation: 
where C = concentration in the plasma at time t (in min); A and B are zero time plasma drug 
concentration intercepts of the biphasic intravenous disposition curve (ng/mL) (A is based on the 
disposition and B the elimination phase); a and 13 are the overall distribution and elimination rate 
constants respectively, expressed in units of reciprocal time (min-1 ); and e represents the base of the 
natural logarithm (Baggot 1982 a). These constants were calculated for each animal using a least 
squares, non-linear regression program (SigmaPlot® 1992) and the following kinetic parameters 
calculated using a method described by (Baggot 1982 a): t112a (half life of distribution phase in min) 
= 0.693/a; t11213 (half life of elimination phase in min) = 0.693/j3; V d (apparent volume of 
distribution based on total area under under the plasma drug concentration time curve in mL/kg) = 
Dose/ (A/a+ B/13)13; and ClB (body clearance of a drug, which represents total body plasma clearance 
in mLmin-1kg-l) = 13.v d· 
All values were expressed as the median and range. Data were analysed using the Kruskall-Wallis H 
test for three groups and the Mann-Whitney U test for two groups. Differences were considered 
significant when P < 0.05. 
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Results 
General 
Doses of ketamine administered to each of the 3 groups were not significantly different (median dose 
of ketamine = 1.1 mg/kg, range= 0.8 - 1.6 mg/kg, n = 15). The masses of animals were similar for 
pre-moult and pre-breeding animals (median = 398 kg, range = 322 - 577 kg, n = 10) which were 
significantly heavier than post-moult animals (median= 302 kg, range= 227 - 379 kg, n = 5; U = 
4.0, df = 1, p < 0.05). 
Associated with ketamine administration was an increase in level of chemical restraint from heavy 
sedation (level 3) to light immobilization (level 4; range 4 - 5; light to heavy immobilization) for 
approximately 10 - 15 min. 
The respiratory pattern during chemical restraint was characterised by quiet, regular breathing 
interspersed with regular short (1 - 8 min) periods of apnoea. There were no prolonged periods of 
apnoea (> 10 min). 
Determination of appropriate compartment model 
The standard error and coefficient of variability for each parameter decreased with the addition of a third 
compartment to the model. However, the number of curves in which dependent variables occurred 
increased from 6 (in the 2 compartment model) to 12 (in the 3 compartment model). 
Pharmacokinetic analysis 
In most cases ketamine concentrations fell quickly in a biexponential fashion. When fitted to the 2 
compartment model the initial distribution phase (a) had a median half life of 2.5 min (range= 1 - 11 
min) while the slower elimination (~) phase had a median half life of 43 min (range = 17 - 108 min). 
A ketamine plasma concentration curve is shown in Figure 7 .2. The calculated constants and other 
pharmacokinetic parameters are summarised in Table 7.1, and are characterised by great variability. It 
can be seen that the median apparent volume of distribution was 1475 mL kg-1 and median total body 
clearance was 33 mL kg- lmin-1. 
None of the pharmacokinetic constants or parameters were significantly different between the three 
groups (Kruskall-Wallis test; H range= 0.545 - 4.582, df = 2, P > 0.05), neither were they different 
when animals prior to fasting (pre-moult and pre-breeding) were compared with animals after fasting 
(post-moult) (Mann-Whitney U tests; U range = 12.0 - 22.0, P > 0.05). 
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Figure 7 .2. The plasma concentration of ketamine in a southern elephant seal 
after intravenous administration of drug at a dose rate of 1.55 mg/kg. 
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Table 7 .1. Pharmacokinetic parameters (median, range) for ketamine fitted to a two compartment model in 3 groups of 5 female southern elephant seals. (A and B = zero time 
plasma drug concentration intercepts of the biphasic intravenous disposition curve, A is based on the disposition and B the elimination phase; a and P = the overall 
distribution and elimination rate constants respectively; tl/2a = half life of distribution phase; tlf2P = half life of elimination phase; V d = apparent volume of distribution; 
and Cla = body clearance of drug). 
Group Mass A 
(kg) (ng mL-1) 
Pre-breeding 517 4022.5 
(360-577) (572- 8587) 
Pre-moult 378 5326 
(322 -515) (4325 - 8760) 
Post-moult 302 3815 
(227 -379)' (1110- 29447) 
All animals 5310 
(572 - 29447) 
B 
(ng mL-1) 
387 
(139 -924) 
584 
(381 - 795) 
410 
(174 -906) 
464 
(139 -924) 
a 
(min-1) 
0.195 
(0.066 - 0.276) 
0.463 
(0.146 - 0.816) 
0.392 
(0.155 - 0.61) 
0.281 
(0.066 - 0.820) 
p tl/2a 
(min-1) (min) 
0.014 4 
(0.011 - 0.276) (3 - 11) 
0.024 1 
(0.014 - 0.028) (1 - 5) 
0.015 2 
(0.006 - 0.040) (1 -4) 
0.016 2.5 
(0.006 - 0.040) (1 - 11) 
tlf2P 
(min) 
49 
(17 -49) 
28 
(25 - 51) 
46 
(19- 108) 
43 
(17 - 108) 
Vd 
(mLkg-1) 
1500 
(1493 - 5179) 
1346 
( 1032 - 2226) 
1804 
(830- 9301) 
1475 
(830- 9301) 
Cla 
(mL min-l.kg-1). 
I 
33 
(21- 57) 
37 
(19 - 39) 
25 
(12- 57) 
33 
(12- 57) 
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Discussion 
Without the use of pethidine or other sedatives it would not have been possible to sample over the 
180 min period used in this study. Other techniques for keeping the al}imals immobilized were 
considered such as the use of crush cages, however these were considered impractical given the nature 
of field work with the animals. Whilst sedated with pethidine animals appeared relaxed and 
unconcerned by sampling and the operators and it was a useful technique for maintaining heavy 
sedation. 
The use of pethidine may, however, have affected the ketamine kinetics. Concurrent medication with 
other drugs has been shown to significantly affect ketamine kinetics in other species including 
reduction of volumes of distribution and clearance, and prolonging plasma half life (Waterman 1983 
and 1984, Wood 1991). However there are no data available on the effect of pethidine on ketamine 
kinetics in any species. The duration of ketamine anaesthesia in monkeys is known to be prolonged 
by premedication with pethidine (McCarthy 1971) but it is not clear whether interactions between 
ketamine and other drugs are based on changes in the biodistribution of ketamine or if they reflect 
phannacodynamic factors (White 1982). The effects of pethidine on the cardiovascular system of 
animals also appear to vary (Booth 1982 g), however in most species the cardiovascular system 
remains relatively stable after intramuscular administration (Anderson 1982). For these reasons it is 
difficult to predict the likely direction of effects of pethidine on ketamine kinetics in southern elephant 
seals. Use of physically restrained, previously catheterised animals would help resolve any possible 
effects but could create other problems such as increases in sympathetic tone. For this reason, use of 
conditioned, unrestrained captive animals in future studies might be preferred. 
Despite the difficulties in comparing parameters with other studies this study does allow limited 
comparisons to be made between the groups of seals and shows that some phannacokinetic data can 
be ascertained from wild, free-ranging animals. 
As in most other species studied, plasma ketamine concentrations appeared to follow a biexponential 
decline (Figure 7.2). This observation, coupled with the increase in the frequency of occurrence of 
dependent variables (observed with the addition of a third compartment to the model), indicate that the 
2 compartment model may be more appropriate than a 3 compartment model for describing ketamine 
kinetics in this species. However, dependent variables also occurred in 6 of the 15 curves generated 
using a 2 compartment model, indicating that in these cases a 1 compartment model may have been 
more appropriate (SigmaPlot® 1992). The range of values for parameters were also large and larger 
sample sizes, sampling over more prolonged periods and using differing ketamine dose levels are 
required to determine which model best describes ketamine kinetics in this species. 
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When fitted to a 2 compartment model, the median distribution phase (t 112a) was only slightly more 
rapid in the southern elephant seals treated with pethidine (2.5 min) than in other animals to which 
ketamine had been administered either alone or combined with other drugs (2.8 to 17 min; Baggot and 
Blake 1976, Waterman and Livingston 1978, Kaka et al. 1979, Waterman et al. 1987, Clements and 
Nimmo 1981, Waterman 1984). The median elimination phase (t11213; 43 min) was similar to that 
reported in studies in horses pre-medicated with xylazine (42 min; Kaka et al. 1979) and cats when 
ketamine was administered alone (43 min; Baggot and Blake 1976). The median apparent volume of 
distribution (1475 mL kg-1) was not greatly different to values reported for horses (1625 - 2722 mL 
kg-1; Kaka et al. 1979) and median total body clearance (33 mL min-1 kg-1) was similar to that seen 
in horses (27 - 31 mL min-lkg-1; Kaka et al. 1979, Waterman et al. 1987). 
As the initial steep decline in the plasma drug concentration is attributable mainly to the combined 
effects of intravascular mixing and distribution of the drug into tissues and organs of the body (Baggot 
1982), it is likely that the relatively rapid distribution half life is due to the greater blood volume of 
southern elephant seals relative to other animals (207 mL/kg compared with 80 mL/kg in an adult 
human; Bryden and Lim 1969). There are no data available presenting cardiac output or perfusion of 
fat in southern elephant seals, however body fat content is higher compared with other animals (an 
estimated 26 - 37% in mature female southern elephant seals (M. A. Hindell; results of unpublished 
body composition studies) compared with between 5 and 20% for some other animals; Booth 1982a) 
and this could also account for, or contribute to, differences in initial distribution phase kinetics when 
compared with other species. 
The difference in values were not great, however, and the wide range of values, coupled with the 
differing anaesthetic treatments, suggest that conclusions drawn from these data need to be viewed 
with caution. The wide range of values for the pharmacokinetic variables could be associated with 
changes in cardiac output, perfusion of tissues and fat associated with circulatory changes associated 
with apnoea, or thermoregulation, perhaps associated with warm days or moulting. Other factors 
such as differences in plasma protein and tissue binding at different times may also be involved. 
Plasma binding and tissue distribution studies, perhaps using tritium labelled ketamine (Sass and 
Salvatore 1977), at different times of the animals' life cycles would help clarify these points. Studies 
incorporating standardised sampling techniques and use of sedatives and larger sample sizes may be 
required to determine ketamine pharmacokinetic parameters more accurately in southern elephant seals. 
The findings of this study indicate that intravenous kinetics of ketamine when administered with 
pethidine are similar for the 3 classes of seals. This was surprising given the large fluctuations in 
body mass of these animals at different times of the year and the differences in response to ketamine 
with xylazine between pre and post-fasting animals reported by Woods et al. (1989), and, if correct, 
supports Ryding's (1982) statement that the poorly vascularised blubber is not involved in the initial 
distribution of ketamine. However, the sample size is small, the range of data large and larger 
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samples sizes are required before a lack of difference can conclusively be shown. If, however, this 
finding is correct, it may be more appropriate to base intravenous doses of ketamine on lean rather 
than total body mass as has been suggested for humans (Wulfsohn 1972). Based on body 
composition data determined in pre-breeding and post-breeding females respectively, M. A. Hindell 
(unpublished data) considered total body fat to be 34% of total body mass in pre-fasting and 27% in 
post-fasting mature females. Slip et al. (1992) developed predictive relationships for total blubber 
and body fat in male southern elephant seals > 510 kg which could be used for estimation of lean 
body mass if total body mass was known in large animals (Appendix V). 
The lack of difference in ketamine kinetics in the present study would suggest that the differences in 
durations of sedation reported by Woods et al. (1989) may be due to differences in absorption kinetics 
of the drugs, which were administered intramuscularly in their study, differences in xylazine kinetics, 
or other factors such as differences in sensitivity to drugs, at different times of the animals' life cycles. 
The similarity in intravenous kinetics in the three classes of seals in the present study implies that to 
'minimise variability in response, ketamine should be administered intravenously to southern elephant 
seals. However, Gales and Burton (1987a) reported that response to intravenous incremental doses of 
ketamine was less predictable than when drugs were administered intramuscularly in southern elephant 
seals though no data were presented. This is interesting given the advantages of rapid onset of effect 
and lower dose rate generally associated with intravenous drug administration. A comparison of 
intramuscular and intravenous dose response studies would clarify these points. However, until these 
studies are performed incremental doses of ketamine should be administered intravenously to female 
southern elephant seals to minimise variability in response and allow drugs to be given to effect. 
Chapter 6 offers guidelines to ketamine and diazepam administration in southern elephant seals. 
Seals have developed a range of physiological changes associated with diving, including bradycardia 
and a decrease in cardiac output and peripheral circulation (Scholander 1940, Elsner et al. 1966, Elsner 
1969, Kooyman et al. 1981, Butler and Jones 1982). Metabolism is also reduced in many tissues 
(Kooyman et al. 1981). Blood flow to the liver decreases and blood is stored in large venous sinuses 
(Harrison and Tomlinson 1958). These actions conserve oxygen and glucose for the heart and central 
nervous system (Kooyman 1968, Robin et al. 1981) and have been referred to as the "dive response" 
(Hubbard and Poulter 1968). On land southern elephant seals have been described as showing a 
rhythmic variation of breathing rate characterised by some minutes of eupnea followed by a period of 
apnoea of variable duration (Kenny 1979). There is evidence to suggest that, in the closely related 
northern elephant seal (Mirounga angostirostris), this "sleep apnoea" has physiological aspects which 
are similar to those seen in freely diving seals (Castellini et al. 1986) and it has been theorised that 
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elephant seals (Gales and Burton 1987 a). It is thus possible that the wide range of values found for 
the pharmacokinetic parameters in this study may be associated with these "dive-response" changes. 
Mitchell and Burton (1991) also observed that duration of chemical restraint·in southern elephant seals 
increased as the total duration of apnoea increased. In other animals, redistribution of ketamine from 
the brain to other tissues is primarily responsible for termination of its hypnotic or anaesthetic effect 
(White et al. 1982). It is thus likely that apnoea and the associated changes in blood flow in 
anaesthetised seals affect ketamine pharmacokinetics, perhaps increasing half life by decreasing 
clearance as rate of diffusion from central to peripheral compartment and rate of elimination slow. 
Backhouse (1964) also suggested that when apnoeic, anaesthetised animals start breathing, anaesthetic 
laden blood held pooled in the hepatic sinus might rapidly be released into the heart-brain circulation 
increasing the level and/ or duration of restraint. Acid-base changes in blood and tissues during 
apnoea could also influence ketamine concentrations in the blood of apnoeic animals by affecting 
ionization. It is likely that apnoea will have marked effects on ketamine pharmacokinetics in 
southern elephant seals and these effects need to be examined. Prolonged apnoea was not seen during 
this study. Ketamine kinetics during apnoea are discussed in Chapter 13. 
The bases of rational drug therapy are dose-response and pharmacokinetic studies yet, due to the 
impracticalities of field work there is a lack of this information. Drug dose-response and 
pharmacokinetic studies are indicated using different anaesthetic agents in other seal species. To gain 
the most benefit for comparative use methodology should be standardised and this may be most easily 
achieved using pre-catheterised, conditioned, captive animals. 
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Chapter 8: A comparison of some cyclohexamine based drug 
combinations 
Introduction 
There is limited information about the chemical restraint of elephant seals. The safest, most 
appropriate drug combinations are those which have the lowest fatality rate, and cause the least 
respiratory, central, cardiovascular and thermoregulatory depression. Suitable drug combinations also 
need to have predictable effects with rapid onset and termination of action, and be able to be used 
easily under field conditions by people without advanced training in anaesthetics. 
The drug combinations, ketamine plus diazepam, ketamine plus xylazine, or tiletamine plus 
zolazepam have been administered previously to southern elephant seals (Gales and Burton 1987 a, 
Baker et al. 1988, Bester 1988, McCann et al. 1989, Woods et al. 1989, Baker et al. 1990, 
Mitchell and Burton 1991). Various ratios ofketamine and diazepam have been tried including 20:1 
(Baker et al. 1988), 50:1 (McCann et al. 1989), 100:1 (Chapter 6) and others (Gales and Burton 
1987 a). These reports did not show which of these ratios was most appropriate. However, all 
appeared relatively safe. Ketamine and xylazine use has been associated with fatalities and 
thermoregulatory problems (Vergani 1985, Woods et al. 1989). Ketamine and midazolam has not 
been used before, but midazolam has several potential advantages over diazepam as a sedative 
including water solubility, high lipophilicity at physiologic pH and rapid metabolism (Reves et al. 
1985). The sedative effects of tiletamine and zolazepam were uncertain and therefore required further 
investigation (Baker et al. 1990, Mitchell and Burton 1991). 
This study compared the effects of drug combinations commonly used for chemical restraint of 
southern elephant seals. The main aims were to gather basic information regarding the response of 
the animals to the different combinations, and to determine which were most useful for routine 
chemical restraint. 
Materials and Methods 
Five groups of 15 healthy, quiescent pre-moulting female southern elephant seals were used. The 
median snout-tail length (tip of the nose to the tip of the tail) was 2.52 m (range = 2.10 - 2.92 m). 
Each animal was given a single intramuscular dose of either ketamine and diazepam, ketamine and 
midazolam, ketamine and xylazine, or tiletamine and zolazepam. Ketamine and diazepam was given 
in two ratios to different groups, 100:1 ketamine to diazepam (100:1 ketamine: diazepam) and 50:1 
ketamine to diazepam (50:1 ketamine: diazepam) (Table 8.1). 
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Table 8.1. Doses of drugs administered to 5 groups of female southern elephant seals and some response variables (median and range), and incidence of prolonged 
chemical restraint (time to recovery > 60 minutes). 
Treaunent Number of 
animals 
Drug dose (mg/kg) Maximum level of Time to recovery Number of episodes of 
Anaesthetic Sedative chemical restraint (min) prolonged restraint 
(ketamine or tiletamine) (diazepam, midazolam, 
x:z:lazine or zolazepam) 
Intended Actual Intended Actual 
100:1 ketamine: diazepam 15 3.00 3.08 0.03 0.03 4 
(2.35-3.93) (0.02-0.35) (3-5) 
50: 1 ketamine: diazepam 15 3.00 2.42 0.06 0.06 3 
(1.97-4.78) (0.05-0.12) (1-6) 
Ketamine and midazolam 15 3.00 2.66 0.02 0.02 4 
(2.14-3.67) (0.02-0.03) (2-6) 
Ketamine and xylazine 15 3.00 2.70 0.50 0.48 4 
(2.06-3.14) (0.22-0.54) (2-6) 
Tiletamine and zolazepam 15 0.50 0.48 0.50 0.48 3 
(0.36-0.60) (0.36-0.60) (3-4) 
H = 11.45 H= 19.29 
df=3 df=4 
P<0.01 p < 0.001 
There were no differences between groups in (a) time to maximum level of chemical restraint (median= 10 min, range= 1-30 min), 
(b) duration of maximum level of chemical restraint (median= 11 min, range= 1-60 min), and (c) time to first forward movement 
(mec;Iian = 44 min, range= 18-81 min). 
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Drugs were administered by a remote injection technique ·after Ryding (1982). The doses were 
determined from past experience for ketamine and xylazine and 100:1 ketamine: diazepam (Woods et 
al. 1989, Mitchell and Burton 1991), tiletamine and zolazepam (Baker et al. 1990), and 50:1 
ketamine: diazepam (McCann et al. 1989). The dose of midazolam in ketamine and midazolam was 
based on one administered to walruses (A. I. Webb, personal communication). Preliminary tests 
were made in a number of pre-moulting female seals to find doses to produce level 3 or 4 of chemical 
restraint (Table 4.2), which generally allowed intravenous access or weighing (level 4 only) with 
minimal depressant effects. These doses were then used as the basis for the drug trials, although the 
actual dose was adjusted for each animal, depending on its level of arousal and response to insertion of 
the needle, with the objective of achieving level 3 or 4 of chemical restraint. 
The actual doses (mg/kg) administered were calculated for each animal (Table 8 .1). 
Beginning 10 min after administration of drugs each animal's reflexes and responses to stimuli were 
monitored and recorded at 5 min intervals. Level of chemical restraint was determined from this 
information and was graded from level 1 to level 8 (see Tables 4.1 and 4.2). 
Blood (1 mL, heparinised) was also collected every 5 min from the extradural intravertebral vein. 
Samples were capped and stored in an ice water bath until assayed (within 60 min) and values for pH, 
Pvco2, Pvo2, HC03-, total C02, and base excess determined using the technique described in 
Chapter 3. 
Blood sampling and assessment of reflexes and responses were continued until the animals had 
recovered (usually within 60 min). Since several (usually 4-5, range 1-16) assessment values were 
obtained at levels 3 or 4, the median was used as a single representative figure. 
Table 8.1 shows the maximum level of chemical restraint, time to recovery (level 1) and prolonged 
chemical restraint (recovery in excess of 60 min). Animals were also assessed for shaking, apparent 
hyperthermia (moving into water and/ or flicking sand or water over the body), the duration and 
number of episodes of apnoea, evidence of upper respiratory tract obstruction (stertorous breathing, 
increased respiratory effort), tachypnoea (~ 10 breaths/ min for ~ 10 min not following apnoea), 
excessive levels of restraint (~ level 6, where there was concern for the animal's welfare), and other 
notable occUITences. 
Ambient dry bulb temperatures were recorded at the commencement of each episode of chemical 
restraint. When possible rectal temperatmes were also recorded at 5 min intervals. 
The normal respiratory pattern and heart rate were determined using untreated animals in two groups of 
15, awake and dozing. Each animal was watched for 60 min recording heart rate and respiratory rate 
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every 2 min and any periods of apnoea. A single representative value for each variable for each 
animal was generated by taking the median of the recorded values. 
Data were analysed non-parametrically using the Mann-Whitney and Kruskall-Wallis tests for 
comparison of groups. Differences in frequencies were tested with Chi square analysis, or Fisher's 
exact test when numbers were insufficiently large (Zar 1984). Differences were considered significant 
when P < 0.05. 
Results 
General 
The median weight of animals was 402 kg (range= 250-633 kg, n = 75) and there were no significant 
differences between groups. However, the actual dose ofketamine differed between groups: the 100:1 
ketamine: diazepam group received the highest dose (3.08 mg/kg), followed by ketamine and xylazine 
(2.70 mg/kg), ketamine and midazolam (2.66 mg/kg) and 50:1 ketamine: diazepam (2.42 mg/kg). 
Fatality rate 
There were no fatalities during this study. 
Respiratory depression 
Two patterns of respiration were apparent in undrugged seals. Awake animals breathed regularly for 
the 60 min period compared with dozing seals whose respiratory pattern was regular but punctuated by 
brief periods of apnoea. Respiratory rates were similar for both groups (5 breaths/ min, range = 3-8) 
and the longest period of apnoea was 8 min seen in a dozing seal. 
Respiratory rate and periods of apnoea were similar in the groups to which drugs were administered 
(Table 8.2). Apnoea(> 1 min) occurred in 43 (57%) of the 75 animals. Most apnoeic animals 
underwent a single 5 min period (range= 2 - 58 min) of apnoea approximately 5 min (range= 0-19 
min) after drug administration. The apnoea generally resolved on venipuncture, when animals were 
rolled over for weighing or as a result of stimuli during monitoring. Prolonged periods of apnoea (> 
10 min) were only seen in three 100:1 ketamine: diazepam animals, lasting for 13, 44 and 45 min. 
Many of the blood gas and pH variables (pH, HC03-, total C02 and base excess) differed amongst 
the groups but Pvo2 and Pvco2 did not (Table 8.3). The values usually remained relatively stable 
for the duration of chemical restraint. However, samples collected from two 100: 1 ketamine: 
diazepam animals which were apnoeic for 44 and 45 min showed falls in Pvo2. pH and base excess, 
and increased Pvco2 (Table 8.3). 
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Table 8.2. Descriptive statistics (median and range) for each response used in monitoring at level 3 or 4 of chemical 
restraint for 5 groups of southern elephant seals 
Drug group Response 
Heart rate Head Palpebral Withdrawal Caudal flipper Muscle Righting 
(beats/ min) response response response. n - response tone response 
100:1 ketamine: diazepam 62 4 3 2 2 3 2 
(48-83) (3-4) (2-3) (1-3) (0-3) (2-3) (1-3) 
50: 1 ketamine: diazepam 58 3 3 1 1 2 2 
(48-72) (2-3) (2-3) (0-3) (0-2) (1-3) (0-3) 
Ketamine and midazolam 54 3 3 1 2 2 2 
(46-63) (2-4) (3-3) (1-2) (1-3) (1-3) (1-3) 
Ketamine and xylazine 50 4 2 1 1 1 1 
(37-61) (3-4) (2-3) (0-3) (0-3) (0-3) 0-3) 
Tiletamine and zolazepam 66 3 3 2 1 2 2 
(51-72) (2-4) (1-3) (0-2) (1-2) (1-3) (1-3) 
All animals 59 3 3 1.5 1 2 2 
(37-83) (2-4) (1-3) (0-3) (0-3) (0-3) (0-3) 
H=24.41 H=25.90 H= 15.06 H= 12.75 H= 13.40 H=29.22 H= 15.48 
df=4 df=4· df=4 df=4 df=4 df=4 df=4 
P<0.001 P<0.001 P<0.01 P<0.05 P<0.01 P<0.001 P<0.01 
There were no significant differences between groups in (a) respiratory rate (median= 5 breaths/min, range= 1-10 breaihs/min), 
(b) rectal temperature (median= 36.9°C, range= 35.0-38.0°C), and (c) capillary refill (median= <2 s, range= <1-<3s) . 
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Table 8.3. Descriptive statistics (median and range) for each blood gas variable at level 3 or 4 of chemical 
restraint for 5 groups of seals, all seals, and those which underwent prolonged apnoea for 44 and 45 min. 
D~g_group 
100: 1 ketamine: diazepam 
50: 1 ketamine: diazepam 
Ketamine and midazolam 
Ketamine and xylazine 
Tiletamine and wlazepam 
All animals 
Animals apnoeic 
for44 and45 min* 
Comparison of drug groups 
pH 
7.31 
(7.22-7.40) 
7.35 
(7.32-7.42) 
7.34 
(7 .29-7 .39) 
7.31 
(7 .24-7 .36) 
7.31 
(7 .27-7 .36) 
7.32 
(7.22-7.42) 
7.11 
H= 15.99 
df=4 
P<0.05 
Blood gas variable 
Pv02 PvC02 HC03- Total C02 Base excess 
(mmHg) (mmHg) _ (mmol/L) (mmol/L) (mmol/L) 
43 
(20-56) 
43 
(20-56) 
8 
50 
(30-68) 
50 
(30-68) 
79 
26 28 -1 
(20-34) (22-36) (-6-6) 
27 29 0 
(21-35) (23-37) (-3-7) 
28 30 2 
(26-34) (27-37) (-1-5) 
26 28 -2 
(20-30) (22-32) (-5-2) 
24 26 -3 
(16-29) (17-31) (-8-2) 
26 
(16-35) 
27 
H= 16.23 
df=4 
P<0.05 
28 
(17-37) 
30 
H = 15.43 
df=4 
P<0.05 
-1 
(-8-7) 
-7 
H=22.55 
df=4 . 
P<0.001 
*Average values for two 100:1 ketamine: diazepam animals apnoeic for44 and 45 minjust prior to 
commencement of breathing. 
CJ 
0 ~ §. 
"' § 
g, 
i g. 
~ 
I· 
O' 
~ 
8. 
~ 
8 
~ s· 
~. 
~ 
...... 
N 
0\ 
Comparison of cyclohexamine based drug combinations 
Evidence of upper respiratory tract obstruction was seen in one 100:1 ketamine: diazepam and one 
50:1 ketamine: diazepam animal; both recovered uneventfully. Tachypnea was seen in some (1 - 3) 
animals in all groups except ketamine and xylazine. 
Central depression 
Animals given ketamine and xylazine were more sedated and had better analgesia and skeletal muscle 
relaxation than those given other sedative combinations (Tables 8.1 and 8.2). However there were no 
differences in the proportions of animals in each group which reached the desired, and excessive, levels 
of chemical restraint. 
Three animals in the tiletamine and zolazepam group showed responses during and after restraint that 
appeared to be hallucinatory behaviour. This behaviour was not seen in any other group. Animals 
would either proceed rapidly around the study site, apparently oblivious to operators, other seals and 
local topography, or lose "all inhibitions", licking, smelling and observing the operators, tussock and 
other seals in the area. All 3 animals were also hypersensitive to touch, with erection of all vibrissae, 
and had a dissociated, staring look to their eyes. These animals did not suffer from misadventure and 
appeared to have recovered fully within 2 h of initial drug administration. 
Cardiovascular depression 
Heart rates were similar for awake and dozing undrugged animals (median = 60 bpm, range = 48 - 84 
bpm). 
Heart rate, but not capillary refill, was significantly different between the drug groups. Heart rate was 
lowest for ketamine and xylazine (median = 50 bpm) and was also the easier to monitor in this group 
than in other groups. 
Thermoregulatory depression 
Few rectal temperatures were recorded since rectal thermometers could not be used at restraint levels< 
3. Those rectal temperatures recorded remained relatively constant and were similar in all groups 
(Table 8.2). However, during recovery evidence of hyperthermia was seen in 8 animals given 
ketamine and xylazine and 1 animal given tiletamine and zolazepam, although their rectal temperatures 
could no longer be measured. The ambient temperature was similar for all groups (range= 5.7°C -
7.4°C). However, within the ketamine and xylazine group, the ambient temperature was significantly 
higher when episodes ofhyperthermia were apparent (6.8°C) than for when they were not (5.1°C) (U = 
10.00, p < 0.05). 
127 
Comparison of cyclohexamine based drug combinations 
Unwanted side effects 
Shaking was seen in only one animal given ketamine and xylazine, but in 5-7 animals in all other 
groups. It usually involved a 10 min period (range = 1-33 min) of level 1 shaking (range = 1-3) 
approximately 15 min (range= 7-36 min) after drug administration. 
Other side effects included what appeared to be increased lacrymation in two 100:1 ketamine: diazepam 
animals and one 50: 1 ketamine: diazepam animal. Hypersensitivity to touch as an "intention tremor 
like" coarse, repeated, uncontrolled jerking of the head away from the touch was seen in two 100: 1 
ketamine: diazepam animals. Defecation occurred in one 100:1 ketamine: diazepam animal and 5 
ketamine and xylazine animals. 
Predictability of effects 
The response to tiletamine and zolazepam appeared clinically to be more predictable than for the other 
groups. Assessment of head response in animals given ketamine and xylazine proved difficult since in 
some cases they appeared to be asleep but would suddenly rear up or lunge or attempt to bite when 
disturbed. 
Onset and tennination of action 
The times for onset and duration of maximum level of chemical restraint were similar in all groups, 
but not the time to recovery (Table 8.1). Animals in the ketamine and xylazine group took 
approximately twice as long to recover as animals in other groups (median= 92 min v. 44-53 min). 
Although the time to first forward movement was not significantly different between the groups 
(median= 44 min), 50:1 ketamine: diazepam, ketamine and xylazine, and 'tiletamine and zolazepam 
animals moved forward at deeper levels of chemical restraint (level 2) than 100: 1 ketamine: diazepam 
and ketamine and midazolam animals (level 1; Table 8.1). ketamine and midazolam and 50:1 
ketamine: diazepam animals received a similar dose of ketamine, but the time to maximum level of 
chemical restraint was significantly shorter after ketamine and midazolam than after 50:1 ketamine: 
diazepam (7 v. 12 min; U = 55.50, P < 0.05). 
The incidence of prolonged chemical restraint was significantly different between the groups (Fisher's 
exact test: df = 4, P < 0.001) and was most commonly seen in animals which received ketamine and 
xylazine (12 animals) or tiletamine and zolazepam (6 animals). In the other groups it was seen, at 
most, once. 
Ease of use 
The easiest drug to use was tiletamine and zolazepam. A single bottle contained 250 mg of each drug, 
which at an estimated dose of approximately 1 mL (100 mg) solution per 100 kg body weight made 
its preparation easier than for the other drug combinations. 
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Discussion 
General 
The doses of drugs administered in this study were either lower than those used in other studies (Gales 
and Brirton 1987a, Bester 1988, Baker et al. 1988, Woods et al. 1989, Mitchell and Burton 1991) or 
similar (Baker et al. 1990), and were as low as could be administered to achieve the desired effect. 
This was reflected in the failure of some animals to reach levels 3 or 4 of chemical restraint. Without 
experience it would be difficult to achieve venipuncture in these animals, necessitating additional 
doses of drug. 
The lack of difference between ketamine and diazepam and ketamine and xylazine reported by Gales and 
Burton (1987a) may be due to the larger doses they used. 
Fatality rate 
Other studies have reported fatality rates of 3% for ketamine and xylazine (n = 301), < 1 % for 
ketamine and diazepam (n > 83) (Mitchell and Burton 1991), and 1 % for tiletamine and zolazepam (n 
= 200) (Baker et al. 1990, Mitchell and Burton 1991). However, these fatality rates should be 
interpreted with caution, since dose rates were not standardised and their administration was on a trial 
and error basis by different operators. 
Respiratory depression 
The blood gas and pH values presented suggest that some degree of respiratory depression may have 
been induced in each of the groups. Although there are difficulties associated with interpretation of 
venous blood gas values (Haskins 1977), the values gave useful information which was easily and 
quickly gathered in situations where ruterial sampling was impractical. However, measuring oxygen 
saturation of arterial haemoglobin, perhaps of the tongue, using non-invasive pulse oximetry could be 
a more useful technique for assessment of cardiopulmonary function in these animals. 
The prolonged apnoea and upper respiratory tract obstruction associated with ketamine and diazepam 
use was of concern, and unexpected given the generally good results reported by Baker et al. (1988). 
If the venous blood gas values correlate well with central arterial values, then the fall in Pvo2. pH, 
and base excess and the rise in Pvco2 seen in these animals may be disadvantageous, perhaps causing 
sympathetic stimulation, acidosis and central nervous system depression (Bicker 1986). 
Other investigators have used higher doses of diazepam or ketamine with few problems (Gales and 
Burton 1987a, Baker et al. 1988). In humans diazepam is usually administered with ketamine to 
decrease the likelihood of emergence delirium. Perhaps stress caused by hallucinations or prolonged 
induction can lead to apnoea in animals which receive too little diazepam. If this is the case then 
higher doses or ratios of diazepam:ketamine may be more appropriate. 
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There is currently interest in whether apnoea should be considered an abnormal occurrence whilst 
chemically restraining seals. The respiratory pattern of chemically restrained seals in this study tended 
to be similar to that seen in the dozing control animals: regular respiration punctuated by brief periods 
of apnoea. However, no periods of more than 10 min were seen in dozing control animals suggesting 
that prolonged apnoea in chemically restrained southern elephant seals is likely to be a drug side 
effect. 
Central depression 
All drug combinations produced a degree of central nervous system depress~on which was appropriate 
for the procedures being performed. The slower reflexes and responses after ketamine and xylazine 
indicate either greater central nervous system depression, greater skeletal muscle relaxation or more 
profound analgesia. All of these effects have been described for xylazine in other species (Booth 1982 
c). The greater skeletal muscle relaxation seen with ketamine and xylazine compared with, for 
instance, 100: 1 ketamine: diazepam may be advantageous for surgical purposes. Although surgical 
anaesthesia is rarely required during field work, the improved relaxation did aid in handling animals. 
The hallucinatory behaviour seen with tiletamine and zolazepam has not been reported in seals and, 
though not considered a problem in this study, could lead to misadventure or increase the chances of 
pup abandonment. However pup abandonment was not seen when the drugs were used to chemically 
restrain cows with pups by Baker et al. (1990) who indicated that the rate of abandonment was higher 
for animals to which ketamine and diazepam had been administered. 
Cardiovascular depression 
The lower heart rate recorded for ketamine and xy lazine did not appear to compromise the animals and 
may not represent a problem as long as cardiac output and peripheral perfusion are maintained. 
However xylazine is known to cause cardiovascular depression in other species (Muir and Piper 1977, 
Booth 1982 c, Lumb and Jones 1984 b) and Woods et al. (1989) suggested that the use ofketamine 
and xylazine might predispose animals to enter a dive response. For these reasons drug combinations 
other than ketamine and xylazine were preferred as causing less cardiovascular depression. 
The lower heart rate in ketamine and xylazine animals, coupled with what appeared to be greater 
excursions of the body wall associated with each beat, did, however, have the distinct advantage of 
making heart rate assessment easier than for other groups. This was probably also facilitated by the 
increased muscle relaxation and low incidence of shaking seen with ketamine and xylazine relative to 
the other groups. 
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Thermoregulatory depression 
As ambient temperatures did not vary significantly the high incidence of apparent hyperthermia after 
ketamine and xylazine is likely to be a drug effect, as previously suggested (Vergani 1985, Woods et 
al. 1989). As hyperthermia was more prevalent at temperatures over 5°C'it might be expedient not 
to use ketamine and xylazine unless the temperature is below 5°C or cooling procedures are used. 
However, solar radiation and wind may be more important than ambient temperature in determining 
heat load and for this reason cooling should be instigated if there is doubt as to the animal's 
thermoregulatory status. 
The single episode of apparent hyperthermia for tiletamine and zolazepam was also of concern, 
perhaps more so than for ketamine and xylazine since unexpected. Hyperthermia has not been linked 
to tiletamine and zolazepam use in other species, but hypothermia has been reported in northern sea 
lions (Eumetopias jubatus) (Loughlin and Spraker 1989), and problems of prolonged recovery in non-
pinniped species (Eads 1976, Boever et al. 1977). It is possible that the "sand-flicking" which was 
taken to be a sign of hyperthermia may have been associated with other stress, such as hypothermia or 
prolonged recovery (Laws 1956 b). 
Unwanted side effects 
The shaking associated with administration of diazepam and midazolam in the ketamine and diazepam 
and ketamine and midazolam combinations could indicate that the dose of these benzodiazepines was 
too low. Others investigators have used higher doses of diazepam (0.1 mg/kg) in ketamine and 
diazepam (Gales and Burton 1987a) or a decreased ratio of ketamine to diaiepam (20:1) (Baker et al. 
1988), without reporting shaking, and these doses are probably more routinely useful than the 
ketamine and diazepam doses used in this study. Similarly, the dose of midazolam could also be 
increased, however caution would need to be exercised given midazolam's greater potency relative to 
diazepam in other animals (Reves et al. 1985). 
Predictability of effects 
The response to tiletamine and zolazepam was more predictable than that for ketamine and diazepam 
and ketamine and xylazine, supporting the finding of Baker et al. (1990). However the response to 
the other drug combinations was also generally predictable, perhaps because of the equivalent doses 
and use of similar animals, thus minimising variability. 
The aggression associated with the unpredictable head response seen in some animals with ketamine 
and xylazine was a disadvantage, but once recognised, precautions could be taken to avoid being 
bitten. Though unexpected defensive reactions have been associated with xylazine use in other 
animals (Booth 1982 c), there are no reports in the literature which describe this aggressive behaviour 
in seals. However, B. Joseph (personal communication) observed that captive pinnipeds sedated with 
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xylazine appeared very depressed, but were capable of reacting very aggressively. Possibly the 
benzodiazepine components of the other drug combinations also had a more calming effect (Booth 
1982 d). 
The inability to predict prolonged periods of apnoea or upper respiratory tract obstruction prior to 
ketamine and diazepam administration was also a disadvantage. 
Onset and tennination of action 
Drug combinations having rapid onset and termination of actions are preferred, to minimise problems 
such as pup abandonment associated with prolonged chemical restraint (Bester 1988) and attack by 
other seals or sympatric species, and to facilitate efficient work with the animals. All the 
combinations fulfilled these criteria except for ketamine and xylazine for which time to recovery was 
approximately twice that of other groups. However ketamine and xylazine treated animals moved 
away at similar times to other groups which received ketamine indicating that the xylazine was 
probably responsible for the prolOnged recovery. It has been reported that larger dosages of xylazine 
increase the duration rather than the degree of sedation (Lumb and Jones 1984 b). Possibly the dose of 
xylazine in ketamine and xylazine could be reduced, with a corresponding decrease in time to recovery. 
However, in some cases prolonged recovery could be an advantage, for instance when a data-logging 
apparatus is being glued to the animal. 
Midazolam, which has a faster and briefer action than diazepam in other species (Reves et al. 1985), 
may be preferable as a sedative when combined with ketamine in this species. 
Ease of use 
Tiletamine with zolazepam was the easiest combination to use since the dose calculations were simple 
and volumes were small, enabling doses to be administered quickly. This would be of greater 
advantage still if drug had to be delivered by hand-held, extension, or projectile syringes rather than by 
a modification of Ryding's (1982) remote injection technique. However, smaller volumes of 
concentrated drug also have the potential to increase the likelihood of relative or absolute drug 
overdosage. 
The inability to vary the ratio of components in the commercially available preparations of tiletamine 
and zolazepam, given their different rates of metabolism and elimination (Schobert 1987), represents a 
minor, but perhaps important theoretical disadvantage of its use, for example when animals need to be 
sedated for prolonged periods of time and receive repeated administrations of tiletamine and zolazepam. 
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Safety 
Safety margins for drugs are difficult to determine from this study which used a narrow range of doses. 
The doses of benzodiazepine in the ketamine and diazepam and ketamine and midazolam groups could 
probably be increased with more safety than the xylazine in the ketamine and xylazine group because 
(1) they were low and (2) higher doses of xylazine have depressant effects on the thermoregulatory and 
cardiovascular systems (Lumb and Jones 1984 b). 
Tiletamine with zolazepam was relatively safe at the doses used, as found by Baker et al. (1990). 
Administration of approximately twice this dose was associated with complications and fatalities 
(Mitchell and Burton 1991). This suggests that the therapeutic index of tiletamine and zolazepam in 
this speeies is relatively low, indicating caution, given the difficulties in estimating the mass of 
animals prior to drug administration. However, this study and those of Balcer et al. (1990) and 
Mitchell and Burton (1991), give information on the range of doses that can safely be used: 0.25 - 0.5 
mg/kg of each drug being relatively safe, > 1 mg/kg of each being associated with complications and 
fatalities. The prolonged apnoea and apparent upper respiratory tract problems associated with 
ketamine and diazepam use and the prolonged chemical restraint and apparent hyperthermia associated 
with ketamine and xylazine use indicate that ketamine and midazolam and tiletamine and zolazepam 
may be the "safer" of the drug combinations. 
Most appropriate drug combinations 
The drug combinations trialed could all be used safely to chemically restrain mature, pre-moulting 
female southern elephant seals when coupled with an accurate system of monitoring and early 
recognition and treatment of complications. However, for people without experience in anaesthesia of 
elephant seals tiletamine and zolazepam offered advantages in preparation, predictability and dosage. 
The conficting reports of the safety of tiletamine and zolazepam are probably due to drug over-dose 
d\lling initial trials when safe doses were not known. These initial reports indicate that its safety 
margin may not be large so care should be taken in estimating masses of animals prior to drug 
administration. Though not yet trialed in southern elephant seals, use of antagonists could decrease 
this problem and improve control when using tiletamine and zolazepam or other drug combinations. 
It is likely that the doses of drugs used in this study could be used to chemically restrain other classes 
of southern elephant seals, but variability in response to drugs at different times of the animal's life 
cycle and size related effects on dosage would need to be considered. 
Other than for ketamine and diazepam, the study did not examine changing the ratio of the other drugs 
used, and there is scope for further work on this. 
133 
Midazolam and pethidine use 
Chapter 9: 
thiopentone 
Introduction 
Use of midazolam, pethidine, ketamine and 
Cyclohexamine-based drug combinations are commonly used to restrain southern elephant seals 
(Mirounga leonina) (Gales 1989, Baker et al. 1990, Mitchell and Burton 1991); however, they have 
the disadvantage that the cyclohexamine component cannot be completely antagonised. The 
availability of narcotic antagonists offers potential advantages in improving the control and safety of 
narcotic-based anaesthesia. 
Narcotic-based drug combinations based on pethidine have been used successfully to restrain northern 
elephant seals (Mirounga angostirostris), common seals (Phoca vitulina) and walrus (Odobenus 
rosmarus) (Cornell and Antrim 1987, Joseph and Cornell 1988, A. I. Webb personal 
communication 1989). Intramuscular pethidine was used either alone (0.11 - 0.45 mg/kg), or 
combined with midazolam (0.04 mg/kg and 2 mg/kg pethidine) as a sedative and to allow intravenous 
administration of the barbiturates thiamylal (0.74 mg/kg) or thiopentone (3 - 5 mg/kg) for induction 
of anaesthesia and intubation. These doses of pethidine, and midazolam and pethidine were 
insufficient to allow intravenous access without physical restraint. Additional doses of thiamylal or 
isoflurane were used to maintain anaesthesia, and doxapram and/ or naloxone (0.004 - 0.009 mg/kg) 
were used to speed recovery. 
In the present study the usefulness of sedation with a narcotic-based drug combination was examined 
in southern elephant seals. There are no reports in the literature of narcotic-based drug combinations 
having been administered to these animals. 
The aim was to develop a safe, reversible, versatile technique for chemical restraint, which could also 
be used to prepare animals for anaesthesia with other agents. 
Materials and Methods 
Animals and drug administration 
The animals used were quiescent pre-moulting female southern elephant seals of median snout-tail 
length 2.58 m (range = 2.00 - 2.90 m). Three drug treatments, giving different levels of anaesthesia, 
were studied together with two narcotic antagonists (Table 9.1)~ Each animal was heavily sedated 
with 15 mg midazolam combined with pethidine (750 or 1500 mg) and 1.3 mg atropine delivered 
intramuscularly by a remote injection technique (Ryding 1982). Subsequent doses of saline or other 
134 
Table 9.1. Median (range) of values for response variables in 3 groups of mature female southern elephant seals chemically restrained with midazolam and pethidine based 
drug combinations. Where appropriate, values have been grouped for clarity. The midazolam and pethidine doses are given in mg, see text for full drug dosages. 
The median lev~I of restraint for all groups for the period 10 to 20 minutes was 3 (range = 1 -3, n = 32). (min = minutes.) 
Part Drug group Maximum level of Time to maximum Duration of maximum Duration of 
chemical restraint* level of chemical level of chemical anaesthetic 
restraint (min) restraint (min) effect (min)t 
A 15:750 midazolam, pethidine and saline 3 7 43 
(1 - 3) (5 - 15) (15 - 64) 
15:750 midazolam, pethidine and naloxone 3t St 15t (Not reached) 
(2-3) (4- 12) (10-20) 
15: 1500 midazolam, pethidine and naltrexone 3 12 13 
p-3l ~5 -19} ~5 - 26} 
B 15:1500 midazolam, pethidine, thiapentone } 4.5 } 22 } 6 } 13 and saline (3 - 7) (21-24) (1 - 20) (4-26) 
15: 1500 midazolam, pethidine, thiapentone 
and naloxone 
15:1500 midazolam, pethidine, ketamine 4 24 4 12 
and saline (3 - 6) (22- 26) (3- 6) (10- 14) 
15:1500 midazolam, pethidin", ketamine 4 23 4 20 
and naloxone 
c 15: 1500 midazolam, pethidine and ketamine 5 22 62§ 
for maintenance (4- 6) (21-22) (46- 79) 
----
•t =Light sedation, 2 =moderate sedation, 3 =heavy sedation, 4 = light immobilization, 5 = heavy immobilization, 6 = light anaesthesia, 
7 = moderate anaesthesia. 
t Average values. 
;Time taken to return to their previous level of chemical restraint 
§Median (range) of times for which level of chemical restraint~ 4 was maintained. 
Time to recovery 
(light sedation) 
'• 
(mi,n) . 
88 
(73 -164) 
24t 
(21-26) 
30 
~24-90} 
} 113 (42 -145) 
128 
(110- 170) 
90 
155 
(ll0-205) 
n 
6 
2 
5 
6 
4 
5 
1 
3 
g 
0... [ 
s 
g_ 
>o 
~ 
e: 
9: g 
i= 
~ 
...... 
w 
VI 
Midazolam and pethidine use 
drugs were administered by intravenous injection (over 60 s) into the extradural intravertebral vein. 
All drug doses and responses were recorded. 
There were three parts to the study. 
A. Midazalam combined with pethidine for sedation 
The two doses of pethidine combined with 15 mg midazolam were assessed for producing sedation and 
allowing intravenous access: 750 mg pethidine (15:750 midazolam and pethidine) and 1500 mg 
pethidine (15:1500 midazolam and pethidine). Twenty min after 15:750 midazolam and pethidine 
animals received either 40 mg naloxone (15:750 midazolam, pethidine and naloxone) or saline 
(15:750 midazolam, pethidine and saline); and after 15:1500 midazolam and pethidine, a dose of 1 mg 
naltrexone (15:1500 midazolam, pethidine and naltrexone). The volumes of antagonist and saline 
were similar and were warmed to approximately 37°C. Unless otherwise stated, all times are given 
from administration of midazolam and pethidine. 
B. Midazalam and pethidine combined with thiopentone or ketamine to allow 
intubation 
At approximately 20 min after 15:1500 midazolam and pethidine, a dose of 500 to 2000 mg of either 
thiopentone (15:1500 midazolam, pethidine and thiopentone) or ketamine (15:1500 midazolam, 
pethidine and ketamine) was administered, with the intention of inducing light to heavy 
immobilization (Table 9.1, footnote) to allow intubation. The range of doses was to accommodate a 
range of sizes and demeanours of animals. Thiopentone or ketamine were administered before 20 min 
if animals were insufficiently restrained by 15:1500 midazolam and pethidine and there was concern 
that they would become unapproachable. Lower doses were used in somnolent animals, higher doses 
in excited or aggressive animals. If necessary, additional doses of 500 mg thiopentone or ketamine 
were administered until adequate chemical restraint was achieved. 
Approximately 30 min after midazolam and pethidine, either saline or naloxone (40 mg) was 
administered. Naloxone was administered early if administration of thiopentone or ketamine had 
caused dangerously deep anaesthesia. 
C. Midazalam and pethidine combined with ketamine for prolonged immobilization 
Three animals were used to assess the usefulness of ketamine for maintenance of anaesthesia after 
induction of level 4 - 5 restraint with 15: 1500 midazolam, pethidine and ketamine. An area over the 
plantar venous arch was infiltrated with local anaesthetic and arterial cut-down performed. A level of 
chemical restraint which allowed surgery to proceed was maintained for approximately 60 min by 
administration of 500 mg boluses of ketamine. 
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Animals in Parts B and C were intubated after thiopentone or ketamine administration (usually 
between 20 and 26 min). Intubation was performed blind using a 24 mm outside diameter 
endotracheal tube (not inflated). 
Monitoring responses 
A standard monitoring sheet was completed for each episode of chemical restraint. Blood samples 
were taken from the extradural intravertebral vein for blood gas and pH measurements, and heart rate, 
respiratory rate and level of chemical restraint were monitored (Table 9.2). For each animal the 
maximum level of chemical restraint and its time of onset, duration and recovery to light sedation 
were also recorded. After thiopentone or ketamine administration, the duration of anaesthetic effect 
was taken as the time for animals to return to their previous level of chemical restraint (usually level 
3). 
In order to compare the effects of different drug treatments, single values for heart rate, respiratory 
rate, pH, blood gas values and level of chemical restraint for each animal were calculated as follows. 
(1) The extent of sedation after midazolam and pethidine was measured by the median of values for 
each of these variables at 10, 15 and 20 min. (2) The effect of thiopentone or ketamine was measured 
by the values recorded immediately prior to intubation. (3) The response to saline or narcotic 
antagonist was determined by the median of three values recorded during the 10 min following their 
administration. 
Data were analysed using the Mann-Whitney U test for comparison of groups, Spearman rank order 
correlation (rs) for relationships between variables, and Fisher's exact test for differences in 
frequencies. Differences were considered significant when P < 0.05. 
Results 
General 
The median mass of all 32 animals was 375 kg (range = 225 - 634 kg) and the median dose of 
midazolam 0.04 mg/kg (range = 0.02 - 0.07 mg/kg). The 750 mg dose of pethidine gave a median 
dose of 2.25 mg/kg (range= 1.17 - 2.61 mg/kg, n = 8) and the 1500 mg dose, 3.55 mg/kg (range = 
2.67 - 6.68 mg/kg, n = 24). The median dose of naloxone was 0.094 mg/kg (range= 0.086-0.104 
mg/kg, n = 11). This gave a ratio of pethidine: naloxone of approximately 20: 1 for 750 mg groups 
and 40:1 for 1500 mg groups. Naltrexone was administered to 5 animals sedated with 15:1500 
midazolam and pethidine, at a median dose of 0.002 mg/kg (range= 0.001-0.003 mg/kg) giving a 
ratio of pethidine: naltrexone of approximately 1500: 1. 
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Table 9.2 Level of chemical restraint, heart rate, respiratory rate, blood gas and pH values for 10 min periods before and after each treatment with saline, anaesthetic or antagonist 
for southern elephant seals chemically restrained with midazolam and pethidine based drug combinations. Where appropriate, values have been grouped for clarity. 
Values recorded for animals in Part C remained relatively stable for the 60 min period, however respiratory rate occassionally fell after ketamine administration. 
Part Drug group and 10 min Level of Heart rate Respiratory rate pH Pv02 PvC02 HC03- Total C02 Base excess n 
time period monitored chemical restaint• (beats/ min) (breaths/min) (mmHg) (mmHg) (mmol/L) (mmol/L) (mmol/L) 
A,B and C All animals which received 
midazolam and pethidine 
(before saline, anaesthetic 
or antagonist_ administration) 
3 
(1-3) 
60 
(42-84) 
6 
(2-18) 
7.26 
(7.21-7.34) 
38 
(16-59) 
52 
(38-67) 
25 
(15-30) 
27 
(16-33) 
-4 
(-11-1) 
32 
A 15:750 midazolam, pethidine and saline 3 60 6 7 .27 38 57 27 29 -2 6 
(after saline) (3-3) (48-76) (2-15) (7.22-7.34) (30-43) (49-68) (21-34) (23-36) (-7-3) 
15:750 midazolam, pethidine and naloxone 1 t 74t 6t 7.28t sot 49t 23t 24t -4t 2 
(after naloxone) (1-1) (68-80) (4-8) (7.24-7.32) (49-52) (49-49) (21-25) (23-26) (-7-2) 
15:1500 midazolam, pethidine and naltrexone I 72 8 7.26 49 61 27 29 -3 5 
(after naltrexone) (1-3) (69-84) (4-15) (7.22-7.29) (38-56) (53-66) (25-31) (27-33) (-4-1) 
B 15:1500 midazolam, pethidine, thiopentone } } } 7.30 ) ) 28 30 -1 6 
and saline (after saline) 4.5 62 3 (7.21-7.32) 39 56 (21-30) (24-32) (-8-2) 
(3-7) < 48-80) (O-7) :!3-52) ;o-58) 
15:1500 midazolam, pethidine, thiopentone 7.22 23 25 -7 4 
andnaloxone(afternaloxone) (7.15-7.28) (23-25) (24-27) (-7-5) 
U=20 U= 1.0 U= 1.0 U=20 
P<0.05 P<0.05 P<0.05 P<0.05 
15:1500 midazolam, pethidine, ketamine 3 61 6 7.24 36 52 20 22 -7 s 
and saline (after saline) (3-3) (56-72) (0-7) (7.21-7.24) (13-49) (50-69) (17-30) (19-33) (-10--1) 
15:1500 midazolam, pethidine, ketamine 2 66 6 7.31 58 47 24 26 -2 
and naloxone (after naloxone) 
15:1500 midazolam, pethidine, thiopentone 4 62 3.5 7.26 38 54 23 25 -5 16 
or 15:1500 midazolam, pethidine, ketamine (3-7) (48-80) (0-7) (7.19-7.34) (20-60) (47-58) (18-29) (20-32) (-9-1) 
(after thiopentone or ketamine for both groups 
which received it)i 
•See Footnote Table 9.1. 
tAverage values. 
iFor the period after thiopentone or ketamine administration but prior to intubation. 
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Midazolam and pethidine use 
A. Midazolam combined with pethidine (Parts A, Band C) 
The 15:750 midazolam and pethidine dose allowed intravenous access ~nly in quiet, relaxed or 
somnolent animals and usually produced about 45 min of level 3 chemical restraint. The animals 
took about 10 min to reach this level (range = 5 - 15 min) and animals had usually recovered by 90 
min (Table 9.1). Intravenous access was easier after the 1500 mg pethidine dose, and this was 
subsequently used in Parts B and C. 
Time to recovery was not examined after the 1500 mg pethidine dose. DQe to low drug stocks and 
supply difficulties at Macquarie Island each animal which received 15: 1500 midazolam and pethidine 
was also treated with other drugs (Table 9.2). However, the 15:1500 midazolam and pethidine dose 
produced profound, long lasting sedation, muscle relaxation, and analgesia in most animals. Animals 
entered a sleep-like state from which they could be roused only with difficulty. The respiratory 
pattern was characterised by intermittent short periods of apnoea and/ or panting or shallow 
respiration. Monitoring was sometimes complicated by the opening and closing of the nares without 
apparent inspiration or expiration. This apnoea or shallow respiration could be treated by rousing the 
animals with a gentle tap on the nose or manipulation of the muzzle. After 1500 mg pethidine doses 
animals also appeared to lose all fear, and became oblivious to people and animals around them; two 
animals allowed themselves to be rolled over onto a sling for weighing. 
Reversal of sedation with antagonists 
Naloxone and naltrexone decreased both the duration of maximum chemical restraint and the time to 
recovery to about one third of control values (Table 9.1). The level of chemical restraint during the 
10 minute period after antagonists was lower (level 1) than after saline administration (level 3) (Table 
9.2). Median heart rate and Pvo2 were higher after naloxone and naltrexone (heart rate= 72 - 74 
bpm, Pvo2 = 49 - 50 mmHg) than after saline (heart rate = 60 beats/ min, Pvo2 = 38 mmHg) (Table 
9.2). 
Evidence of relapse was seen in one animal which received naltrexone and recovered by 26 min only 
to relapse to level 3 at 58 min. The animal returned to level 1 by 80 min. Three other animals 
became quieter between 20 and 40 min after antagonist but without a change in level of chemical 
restraint. 
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B. Midazolam and pethidine combined with either thiopentone or ketamine to allow 
intubation 
i. Midazolam, pethidine and thiopentone 
The median initial dose of thiopentone was 1000 mg (3.4 mg/kg, range = 2.23 - 5.93 mg/kg, n = 10). 
One animal required an additional dose of 500 mg thiopentone to allow intubation. The doses of 
pethidine and thiopentone were not significantly different between saline and naloxone groups. 
Thiopentone usually produced level 4 - 5 chemical restraint for approximat~ly 5 min with recovery to 
pre-anaesthetic levels of sedation about 15 min later (shown as the duration of anaesthetic effect in 
Table 9.1). The maximum level of chemical restraint was not closely related to dose of thiopentone 
administered (rs = 0.25, P > 0.4, n =10), but faster injection appeared to give a greater effect. 
With the exception of 3 animals which became apnoeic, heart rate and respiratory rate were usually 
unaffected by thiopentone administration which allowed access to the larynx for intubation within 5 
min of drug administration in all but one case. Intubation did not affect respiratory rate nor did it 
stimulate breathing in the 3 animals which became apnoeic. Two of these animals commenced 
breathing when the endotracheal tube was removed, and the third appeared to respond to naloxone. 
One animal became dangerously deep (level 7) after thiopentone administration. This animal had been 
excited and aggressive at level 2 and consequently a relatively large dose of thiopentone (7 .52 mg/kg) 
had been rapidly administered. The animal was intubated and immediately given naloxone. Breathing 
recommenced and the animal recovered to level 2 at 46 min, but relapsed to level 3 at 82 min before 
eventual recovery. 
Before giving saline or naloxone, all monitored responses were similar for 15:1500 midazolam, 
pethidine, thiopentone and saline and 15: 1500 midazolam, pethidine, thiopentone and naloxone 
groups. After saline or naloxone the heart rate, respiratory rate (Table 9.2), Pvo2 (median = 39 
mmHg) and Pvco2 (median = 56 mmHg) were similar for the two groups; however, pH (median = 
7.30 and 7.22), HC03- (median= 28 and 23 mmol/L), total C02 (median= 30 and 25 mmol/L) and 
base excess (median = -1 and -7 mmol/L) were lower after naloxone (U range = 1.0 - 2.0, P < 0.05) 
(Table 2). 
The time to recovery after 15: 1500 midazolam, pethidine and thiopentone was similar for both the 
saline and the naloxone groups (median= 113 min). 
ii. Midazolam, pethidine and ketamine 
The median initial dose of ketamine was 1000 mg (2.27 mg/kg, range= 0.97 - 3.51 mg/kg, n = 6). 
One animal required two additional doses of 500 mg ketamine to allow intubation. 
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Ketamine administration usually induced level 4 chemical restraint for approximately 4 min and 
animals returned to pre-administration levels 12 min later (Table 9.1). 
The median respiratory rate was significantly reduced after ketamine, from 7 breaths/ minute to 4 
breaths/ minute (U = 24.5, P < 0.05). Apnoea of 1 to 2 min was seen on 2 occasions after 1000 mg 
ketamine administration but ceased when the animals' muzzles were tapped. Two other animals 
appeared to have increased respiratory effort after ketamine. 
All animals were intubated within 5 min of drug administration despite one animal only reaching 
level 3 of chemical restraint. Apnoea for the duration of intubation was seen in 2 animals which 
received 500 mg of ketamine (0.97 and 1.58 mg/kg), and there were 2 episodes of transient 1 - 2 
minute apnoea immediately after intubation in animals to which 1000 mg was administered. 
The animal which received naloxone was at level 3 and moved off at level 2 with a dissociated look 
approximately 4 min afterwards (Table 9.1). Time to recovery was 90 min which was less than that 
of the animals which did not receive naloxone (median= 120 min; Tables 9.1and9.2). 
iii. Comparison of midazolam, pethidine and thiopentone with midazolam, pethidine 
and ketamine 
Doses of midazolam and pethidine were similar for all 15: 1500 midazolam, pethidine, thiopentone and 
saline and 15:1500 midazolam, pethidine, ketamine and saline animals, and heart rate, respiratory rate 
and pH and blood gas values were also similar for the time period prior to thiopentone or ketamine 
administration. 
After thiopentone or ketamine the magnitude and time course of response to the drugs was similar: 
level 4 chemical restraint (range = 3-7) was induced within 5 min and lasted approximately 10 min 
(Tables 9.1 and 9.2). The median heart rate (62 bpm) and respiratory rate (4 breaths/ min) and blood 
gas values were also similar (Table 9.2) and there was no difference in the incidence of apnoea or 
difficulty breathing (3/10 after thiopentone and 4/6 after ketamine) (Fischer's Exact Test, P > 0.18). 
For both groups laryngeal relaxation was good and most animals were easily intubated. The 
proportion of animals which became apnoeic or had difficulty breathing after intubation was also 
similar for animals which received ketamine (4/6) compared with those which received thiopentone 
(3/10) (Fisher's Exact Test, P > 0.18) although the apnoea was more easily treated after ketamine. 
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C. Midazolam and pethidine combined with ketamine for prolonged immobilization 
Level 4 - 5 chemical restraint was maintained for about 1 h by administering 500 mg increments of 
ketamine at approximately 5 - 10 minute intervals, depending upon the response. The median number 
of 500 mg doses of ketamine required was 4 (range = 3 - 9), and the median time between doses was 8 
min (range 3 - 24 min). The median incremental dose of ketamine administered was 1.48 mg/kg 
(range= 1.47 - 1.52 mg/kg, n = 3), or 7.72 mg/kg/h (range= 4.42 - 10.05 mg/kg/h). 
On 3 occasions after ketamine administration respiratory rate slowed or became more shallow, 
including one 3 minute period of apnoea which resolved after the animal's muzzle was touched. No 
evidence of hyperthermia was seen in any of the animals in Parts A, B or C. 
Discussion 
A. Midazolam combined with pethidine for sedation 
The combination ofmidazolam and pethidine at the higher dosage (15:1500 midazolam and pethidine) 
was very useful for sedation and allowing intravenous access. Although others (Cornell and Antrim 
1987, Joseph and Cornell 1988) have gained intravenous access with lower doses of pethidine, their 
animals were physically restrained. 
The chief advantages of 15:1500 midazolam and pethidine were its rapid antagonism, ease of reversal 
of apnoea and the lack of side effects commonly seen with cyclohexamine drug combinations. Some 
animals were sufficiently tractable to be rolled onto a stretcher and weighed, which would not have 
been possible at this level of chemical restraint with cyclohexamine drug combinations. 
There were some problems with 15:1500 midazolam and pethidine. Although intravenous access was 
achieved in all animals, it was difficult in some which were at level 2, and this sometimes 
necessitated further drug administration. (In other studies, unpublished, we have administered 
incremental intramuscular doses of 1000 - 1500 mg [or approximately 2 - 4 mg/kg] pethidine safely, 
and maintained sedation for up to 4 h). The response was slow, as it took up to 20 min to reach 
level 3 chemical restraint, longer than for most commonly used cyclohexamine-based combinations. 
Respiration was shallow, which could make the assessment of ventilation difficult and large dosage 
volumes were required (usually 30 mL, range= 20 - 50 mL). 
Naloxone rapidly antagonised 15:750 midazolam and pethidine but did not antagonise 15:1500 
midazolam, pethidine and thiopentone (Table 9.1) indicating that the 20:1 ratio may be more 
appropriate than the 40:1 ratio. However the formulation of naloxone in vials of 0.4 mg (or 2 mg) 
required many vials to be opened for a 40 mg dose. This was difficult and time consuming and could 
prove fatally slow under emergency conditions, and a more potent narcotic antagonist would be 
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preferable. Other results suggest that naltrexone may be useful in these animals but, since not all 
animals responded, larger doses may need to be used, and dose-response studies are indicated. No more 
naltrexone was available for this study due to supply difficulties at Macquarie Island. 
Given the evidence of relapse after narcotic antagonism in this study it may be preferable to give 
doses of antagonists both intramuscularly and intravenously and, because of the rapidity with which 
some animals recovered, to give the intramuscular dose first. 
Pethidine was chosen instead of a more potent narcotic because of the decreased chance of self inflicted 
injury (Anonymous 1976) or drug overdose. For larger animals, especially bulls, or if administering 
the drugs by projectile syringes, the volume of pethidine required would be prohibitive and a more 
potent narcotic, or different formulation, required. Several potent narcotics have been administered to 
pinnipeds; however, most have been associated with complications (such as apnoea, convulsions, and 
vomiting), unpredictable results and narrow margins of safety (Gales 1989). The safety and 
usefulness of the potent narcotics could be improved by administering appropriate doses of drug, 
combining them with reversible sedative drugs, and using them to sedate animals, rather than as the 
sole source of drug for deeper levels of restraint. If the level of restraint needs to be increased this 
could be accomplished by intravenous administration of a barbiturate or ketamine, or application of a 
nose cone and gas, with or without narcotic antagonism. 
B. Midazolam and pethidine combined with thiopentone or ketamine to allow 
intubation 
The doses of thiopentone and ketamine induced similar levels of chemical restraint, sufficient for 
intubation and there appeared to be little difference in the response of animals to each of the drugs. 
Apnoea or difficulty breathing apeared to be more readily treated after ketamine (by tapping the face) 
which indicated that ketarnine may be preferable to thiopentone for induction prior to intubation. 
The dangerously deep level of chemical restraint seen in one animal was evidently because of the large 
dose of thiopentone and its rapid administration. We are certain that this animal would have died had 
not naloxone been immediately given, or if the ability to intubate and ventilate the animal had not 
been available. Fortunately, the 40 mg of naloxone caused arousal, presumably because it reached its 
sites of action before the circulatory changes associated with apnoea (similar to those seen during 
diving) prevented its effect (Backhouse 1964). In situations where animals' are insufficiently sedated 
and rapid induction is required it may therefore be preferable to administer a number of relatively low 
doses of thiopentone (perhaps 1.5 mg/kg boluses) by rapid intravenous injection rather than 
administering a single large dose rapidly. The other option of slowly infusing the drug to effect also 
seems unsatisfactory since if intravenous doses are given too slowly effective concentrations of drug 
may not be reached in the brain. 
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Given the tractable nature of the animals sedated with midazolam and pethidine, it may be possible to 
use a mask and gaseous anaesthesia to minimise problems of apnoea and/ or deep anaesthesia during 
induction. Alternatively, an antagonist could be administered immediately after intubation (following 
thiopentone or ketamine) to minimise the combined depressant effects of the drugs; the balance of 
anaesthesia being achieved using gas. If this technique is used the possibility of relapse would need 
to be considered. 
The extent of apnoea and central depression associated with intravenous drug administration in this 
study was less than expected from literature reports of sudden death after inadvertent intravascular 
administration of anaesthetics (Gales and Burton 1987a), the depressant effects of narcotics and 
barbiturates reported in other seals (Gales 1989) and our own previous experience of apnoea after 
small incremental doses of cyclohexamines. Possible reasons for this include the use in this study of 
low doses, intubation, antagonists and premedication with midazolam and pethidine. Animals sedated 
with midazolam and pethidine also appeared very relaxed compared with those sedated with 
cyclohexamine-based drug combinations. Backhouse (1964) reported that fright may play a role in 
initiation of apnoea during restraint, and the intravenous administration of appropriate dosages of 
drugs to relaxed, apparently unstressed animals may thus be important in preventing apnoea. 
Intubation under midazolam and pethidine was easier than we have found when using cyclohexamine-
based drug combinations, illustrated by the successful intubation of one animal which was at level 3 
chemical restraint, a procedure which would not have been possible using the other drugs. This may 
be due to the analgesic or spasmolytic effects of pethidine (Hall 1959). 
The results of this study indicate that use of midazolam and pethidine followed by thiopentone or 
ketamine was a useful and controllable technique for intubation and could be used prior to gaseous 
anaesthesia. This was primarily because of the ability to antagonise pethidine: however, there are 
problems associated with antagonist use in seals. Drugs administered in the extradural intravertebral 
vein of apnoeic animals may be ineffective (Backhouse 1964, Baker and Gatesman 1985), and 
intubation and ventilation may be needed. 
The relatively long period required to induce adequate sedation (up to 20 min) compared with 
cyclohexamine drug combinations (10 min) indicates that this technique may be less desirable when 
large numbers of animals are to be immobilized or conditions are poor. 
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C. Midazolam and pethidine combined with ketamine for prolonged immobilization 
Ketamine was chosen rather than thiopentone for maintaining immobilization because it appeared that 
apnoea was more easily treated (Part B). 
Administration of ketamine was very useful for maintenance of chemical restraint for minor surgical 
procedures. The use of local anaesthetic and pethidine probably decreased the absolute requirement for 
ketamine. Care was required with incremental ketamine administration which sometimes caused 
difficult breathing. It is likely that the prolonged recovery associated with this drug combination 
could be largely eliminated by routine use of a narcotic antagonist, but this was not tested. Although 
gaseous anaesthesia may be preferable, ketamine would be useful in situations requiring prolonged 
chemical restraint with good analgesia where gaseous anaesthesia is impractical or unavailable. 
Administration of intravenous boluses of ketamine allowed rapid and accurate adjustment of the level 
of chemical restraint after 15:1500 midazolam and pethidine. Gales and Burton (1987a) preferred 
intramuscular administration of further doses of ketamine in southern elephant seals immobilised with 
ketamine plus diazepam or xylazine because intravenous administration was considered to be often 
unpredictable and short acting. The potential for overdose and the respiratory depression seen in this 
study are disadvantages of intravenous ketamine administration. However, the intravenous route is 
preferable to induce or maintain chemical restraint > level 5 since it can induce a rapid, short term 
increase in level of chemical restraint. 
Use of midazolam and pethidine for sedation and to allow intravenous access for anaesthetic 
administration, when combined with an accurate system of monitoring, use of narcotic antagonists 
and the ability to intubate and ventilate animals provided a safe, reversible, versatile technique for 
chemically restraining mature female southern elephant seals. It is the safest technique we have used 
for allowing intravenous access in these animals. These techniques have potential for use in other 
species of seal, but the interspecific variability in response to pethidine, which has been described in 
other seals (Joseph and Cornell 1988), would need to be considered. 
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Chapter 10: Medetomidine and ketamine use 
Introduction 
Medetomidine is a specific a2 adrenergic receptor agonist having properties which are similar in 
many respects to xylazine (Savala 1989). However it is more potent (Scheinin and MacDonald 
1989), the a2 I a1 selectivity ratio is greater (Virtanen 1989), and its anaesthetic dose reducing 
property far exceeds that seen with other a2 agonists (Doze et al. 1989). (Alpha2 adrenergic agonists 
markedly reduce ketamine requirements by their central nervous system effects and by increasing 
ketamine bioavailability. Mechanisms for this effect have been reviewed by Klein and Klide (1989) 
and may include reduced liver blood flow, direct depression of metabolic function, and decreased 
urinary excretion). The recommended doses for medetomidine in domestic animals range widely 
(0.010 - 0.150 mg/kg). At medetomidine doses higher than the recommended ones, the degree of 
sedation does not increase, only the duration of effect, and vomiting and hypothermia have been 
associated with its use (Vainio 1989). Elimination rate is controlled mainly by liver blood flow 
(Salonen 1989). 
Ketamine has been combined with medetomidine (ketamine and medetomidine) to immobilize a 
variety of zoo and domestic animals. Medetomidine potentiates the anaesthetic effects of ketamine 
and balances its weak muscle relaxing and analgesic effects (Verstegen et al. 1989). The 
cardiovascular stimulating properties of ketamine largely compensate for the bradycardia induced by 
medetomidine (Verstegen et al. 1989). 
Atipamezole is one of the most selective and potent a2 adrenergic antagonists known (Virtanen 
1989), and has been used to antagonise ketamine and medetomidine in a variety of animals. 
Medetomidine and atipamezole have not been administered to pinnipeds. Ketamine and medetomidine 
offers advantages over ketamine and xylazine and other cyclohexamine based drug combinations, 
including smaller doses of ketamine, reversibility, and fewer side effects. Medetomidine could also be 
useful for sedation of large seals, its chief advantages being its potency, small dose volume and 
ability to be antagonised without the risk to the operator of death (Anonymous 1976) or the legal 
restrictions associated with the use of potent narcotic drugs. A successful trial with elephant seals 
would suggest it may also be useful for leopard seals (Hydrurga leptonyx), a species in which 
xylazine use has resulted in fatalities (Mitchell and Burton 1991). 
A pilot study was conducted to assess its usefulness. 
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Materials and methods 
Twelve healthy, quiescent, pre-moulting females of median 2.31 m snout-tail length (range= 2.08 -
2.70 m) and median mass 355 kg (range= 270 - 445 kg) were used. There were three parts to the 
study. 
Sedation with medetomidine 
To assess the effect of medetomidine on the animals and determine a likely starting dose for 
combination with ketamine, two animals were sedated with a single intramuscular dose of 
medetomidine; one received 5 mg the other 10 mg. The dose of medetomidine was based on the 
lowest dose recommended for dogs (0.010 mg/kg; Vainio 1989). 
Medetomidine and ketamine 
Ten animals, in two groups of 5 animals, received ketamine and medetomidine. Twenty minutes after 
the administration of ketamine and medetomidine each group received a similar volume of either 
atipamezole or saline intravenously into the extradural intravertebral vein. The intended dose of 
ketamine (1.5 mg/kg or 675 mg; Table 10.1), was based upon that used to restrain southern elephant 
seals with ketamine and xylazine (Chapter 8), but was decreased because of the anaesthetic reducing 
properties ofmedetomidine (Doze et al. 1989). One animal received 10 mg medetomidine, the others 
5 mg, and the dose of atipamezole was approximately twice (w/w) the medetomidine dose as used in 
other animals (Jalanka 1988 and 1989). 
Atipamezole was -administered at 20 minutes because it was considered that most routine procedures 
performed in these animals could be completed in this time. 
Each animal in Parts 1 and 2 received 1.3 mg atropine combined with the anaesthetic drugs. 
Comparison of ketamine and medetomidine with ketamine and xylazine and other 
cyclohexamine based drug combinations 
Where sample sizes were large enough, data describing the response to ketamine and medetomidine in 
the present study were compared with data describing the response to ketamine and xylazine in a 
previous study (see Chapter 8). 
Anaesthetic drugs were administered intramuscularly after the technique of Ryding (1982) and a 
standard monitoring sheet completed for each animal (Chapter 3 and 4). 
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Table 10.1. Dose of drugs administered to female southern elephant seals, response variables (median and range), and incidence of prolonged chemical restraint. Data for animals restrained with 
ketamine and xylazine are included for comparison. The median dose of atipamezole was 0.04 mg/kg (range = 0.02 - 0.05 mg/kg). None of the values recorded for ketamine and medetomidine 
and ketamine, medetomidine and atipamezol were significantly different (U =result of Mann-Whitney U test) 
Treatment Number Drug dose (mg/kg) Maximum level of chemical restraint Time to (min! Level chemical Number of e!!isodes of 
of Anaesthetic Sedative Maximum Time to Duration of Recovery First resttaint at first Prolonged Suspected 
animals (ketamine) ~medetomidine or x:z:lazine! level (min) (min) movement movement forward resttaint hypenhermia 
Intended Actual Intended Actual forward 
Mede to mi dine 2 0.01* 0.0196* 1.5* 10* 24* 45* 40* 1.5* 0 
Ketamine and medetomidin· 5 i··~ )•m 3 12 22 87.5 41 1 3 2 l 1.90 l Ml1 (1-3) (10-25) (5-43) (15-120) (40-120) (1-2) (1.35-223) (0.012-0.027) 
Ketamine and medetomidin· 5 3 11 13 31 30 2 2 4 
and atipamezol (2-6) (5-18) (7-18) (23-180) (25-80) (1-3) 
Ketamine and xylazinet IS 3.00 2.70 0.50 0.48 4 9 15 91.5 59 2 12 8 
(2.06-3.14) (0.22-0.54) (2-6) (3-6) (S-55) (40-191) (27-81) (1-3) 
U=3.0t U=6.St 
P<0.01 P<0.01 
*Average values .. For individual values see text. 
t Data from Chapter 8. 
tComparison of ketamine and medetomidine and ketamine and xy.lazine. 
f §. 
s-
(1) 
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Results 
Sedation with medetomidine 
The animal which received 10 mg (0.027 mg/kg) medetomidine became more heavily sedated 
(maximum level of chemical restraint = 2 and 1), bad a lower median heart rate for the first 60 
minutes (36 and 60 beats/ min; bpm), and took three times as long to recover fully (level 0 restraint; 
180 and 60 min) than the animal which received 5 mg (0.013 mg/kg) medetomidine. Respiratory rate 
for the first 60 minutes were similar (median = 4 and 3 breaths/ min; ranges = 2 - 4, and 3 - 5 breaths/ 
minute respectively) for the two seals. 
Muscle relaxation was profound in both animals, and they appeared less responsive to nociceptive 
stimuli than animals anaesthetised with other cyclobexamine based drug combinations at similar 
levels of chemical restraint. However, neither was sedated sufficiently to allow intravenous access. 
The animal which received 10 mg responded very aggressively to monitoring and showed evidence of 
byperthermia, while the other animal which had received 5 mg, vomited. 
Medetomidine and ketamine 
The doses of ketamine (median = 1.90 mg/kg, range = 1.35 - 2.23 mg/kg) and medetomidine (median 
= 0.017 mg/kg, range= 0.012 - 0.027 mg/kg) administered to each of the ketamine and medetomidine 
groups were similar. The dose of atipamezole was 0.04 mg/kg (range= 0.02 - 0.05 mg/kg). The 
response to ketamine and medetomidine was inconsistent and unpredictable. 
Administration of 10 mg medetomidine with ketamine to one animal caused light anaesthesia (level 
6). There was a transient 10 minute period of apnoea, and the median heart rate for the first 60 
minutes was 30 bpm (range = 24 - 48 bpm). The 5 mg dose of medetomidine combined with 
ketamine (administered to all other animals) was usually associated with higher heart rates (median= 
48 bpm, range = 30 - 72 bpm), and lower maximum levels of chemical restraint (median = 3, range = 
1 - 6). 
Administration of atipamezole had little effect upon the level and time course of chemical restraint 
(Table 10.1). The median levels of chemical restraint, heart rate and respiratory rate for the 20 minute 
period after atipamezole were similar to those values for the same period after saline. 
Evidence of hyperthermia was seen in 2 ketamine and medetomidine, and 4 ketamine and 
medetomidine/ atipamezole animals. Aggressive reactions, which included growling, biting and 
lunging at the operators, were seen in 4 ketamine and medetomidine and 3 ketamine and 
medetomidine/ atipamezole animals and prolonged chemical restraint (> 60 minutes until recovery; 
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level 1 restraint) was seen in 2 ketamine and medetomidine and 2 ketamine and medetomidine/ 
atipamezole animals. 
Comparison of ketamine and medetomidine with ketamine and xylazine and other 
cyclohexamine based drug combinations 
Response, monitoring and blood gas values for animals restrained with ketamine and medetomidine, 
ketamine and xylazine and grouped values for five commonly used cyclohexamine based drug 
combinations (100: 1 and 50: 1 ketamine: diazepam, ketamine and midazolam; ketamine and xylazine, 
and tiletamine and zolazepam; from Chapter 8) are presented in Tables 10.1, 10.2 and 10.3. 
The median dose of ketamine used with medetomidine in this study (1.90 mg/kg) was lower than the 
median dose of ketamine used with xylazine in the study in Chapter 8 (2. 70 mg/kg), and ketamine and 
medetomidine animals were less sedated (Table 10.1). However the responses to ketamine and 
medetomidine and to ketamine and xylazine were similar in time course of response, level of chemical 
restraint at first movement forward, and number of episodes of prolonged restraint and suspected 
hyperthermia (Table 10.1). Ketamine and medetomidine animals appeared more depressed than 
ketamine and xylazine animals (heart rate and respiratory rate were lower) however ketamine and 
medetomidine animals appeared to react more aggressively to being touched and median values for 
head response, muscle tone, and righting response were greater (Table 10.2). Blood gas values 
recorded at levels 3 and 4 restraint appeared similar for ketamine and medetomidine and ketamine and 
xylazine animals except that values recorded for Pvo2 were higher for ketamine and medetomidine 
animals (Table 10.3). 
Discussion 
Sedation with medetomidine 
Because of the bradycardia reported in animals using xylazine (a less potent a.2 adrenergic agonist) 
combined with ketamine (Chapter 8) we were concerned about the effect of the medetomidine on 
circulation. For this reason low doses of medetomidine were chosen. The dose of medetomidine was 
too low to allow intravenous access and would have to be increased if medetomidine was being used 
as the sole agent for chemical restraint. However, given the relatively low heart rate associated with 
·administration of 10 mg medetomidine (36 bpm), any increase in dose should be done with caution. 
Premedication of animals with a parasympatholytic drug prior to medetomidine administration, rather 
than the simultaneous administration commonly used, may lessen this effect. Rfilha et al. (1989) 
found that atropine (0.04 mg/kg) counteracted medetomidine induced bradycardia in dogs and 
recommended its use prior to medetomidine administration. 
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Table 10.2. Descriptive statistics (median and range) for each response used in monitoring at level 3 or 4 of chemical restraint for seals restrained with ketamine and medetomidine. 
Data for animals restraint with ketamine and xylazine and grouped data for animals restrained with 100:1 ketamine: diazepam, 50:1 ketamine: diazepam, ketamin~ and mfdazolam and 
tiletamine and zolazepam are included for comparison. Neither of the 2 animals sedated with medetomidine reached level 3 or 4 chemical restraint. 
Drug group Number of Response 
animals Heart rate Respiratory rate Temperature Head response Palpebral Withdrawal Caudal flipper Muscle Righting 
(beats/ min) (breaths/ min) (0 C) response response response tone response 
Ketamine and medetomidine 3* 40 2 38.5 3 3 0 1 2 . 2 
(31-48) (1.5-5) (38.0-39.0) (2-3) (3-3) (0-1) (0-1) (0-2) (2-2) 
Ketamine and xylazinet 
100:1 ketamine: diazepam, 
50: 1 ketamine: diazepam, 
ketamine and midazolam, 
ketamine and xylazine and 
tiletamine and zolazepamt 
15 
75 
50 
(37-61) 
59 
(37-82) 
4.5 
(3-6) 
5 
(1-10) 
37.1 
(36.8-38.0) 
36.9 
(35.0-38.0) 
*Only 3 animals which received ketamine and medetomidine reached levels 3 or 4. 
tData from Chapter 8. 
4 
(3-4) 
3 
(2-4) 
2 
(2-3) 
3 
(1-3) 
1 
(0-3) 
1.5 
(0-3) 
1 
(0-3) 
I 
(0-3) 
1 
(0-3) 
2 
(0-3) 
1 
0-3)-
2 
(0-3) 
~ 
S' ~. 
~ 
Cl> 
8. 
I (1) 
~ 
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Table 10.3. Descriptive statistics (median and range) for each blood gas variable at level 3 or 4 of chemical restraint for seals 
restrained with ketamine and medetomidine. Values are presented for seals restrained with ketamine and xylazine and grouped values 
for animals restrained with 100:1 ketamine: diazepam, 50:1 ketamine: diazepam, ketamine and midazolam, ketamine and xylazine, 
and tiletamine and zolazepam for comparison. 
Drug group Number of ___ _ Rlooti !l:l'IS variable 
animals pH Pv02 PvC02 
{mmHg2 {mmHg2 
Ketamine and medetomidine 3* 7.30 50 47 
(7.30-7.31) (46-54) (41-51) 
Ketamine and xylazinet 15 7.31 40 50 
(7 .24-7 .36) (34-49) (38-57) 
100:1 ketamine: diazepam, 75 7.32 43 50 
50: 1 ketamine: diazepam, (7.22-7.42) (20-56) (30-68) 
ketamine and midazolam, 
ketamine and xylazine and 
tiletamine and zolazepamt 
*Only 3 animals which received ketamine and medetomidine reached levels 3 or 4. 
tData from Chapter 8. 
HC03-
{mmol/L2 
24 
(21-26) 
26 
(20-30) 
26 
{16-35) 
----
Total C02 Base excess 
{mmol/Ll {mmol/Ll 
26 -2 
(22-28) (-5-0) 
28 . -2 
(22-32) (-5-2) 
28 -1 
{17-37) (-8-7) 
~ 
~ 
S' 
§. 
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Medetomicline and ketamine use 
Atropine has been administered at a dose of approximately 0.005 mg/kg to southern elephant seals 
(Gales and Burton 1987 a, Woods et al. 1989, Mitchell and Burton 1991) which is a low dose 
relative to the range of doses administered to other animals as premedicants (0.045 - 0.200 mg/kg; 
Booth 1982 f) or seals (0.02 - 0.04 mg/kg; Sweeney 1974, Hammond and Elsner 1977). Atropine is 
known to prevent the bradycardia associated with the dive response in northern elephant seals, 
Mirounga angustirostris (Van Citters et al. 1965), and a dose of 0.02 - 0.04 mg/kg has been 
recommended (Sweeney 1974, Hammond and Elsner 1977). This higher dose may counteract the 
medetomidine induced bradycardia in southern elephant seals. However, atropine use for blocking 
xylazine-induced bradycardia in other animals has been considered controversial (Klein and Klide 
1989). Raising the heart rate in the presence of increased cardiac afterload increases myocardial 
oxygen demand while cardiac output and oxygen supply are reduced after xylazine administration. 
Studies determining the efficacy of atropine in southern elephant seal anaesthesia are required. 
The only advantage medetomidine appeared to have over xylazine when used alone for restraint was in 
its greater potency and a formulation which would allow its delivery using projectile syringes. The 
vomiting, hyperthermia, aggression and low heart rate associated with medetomidine administration in 
this study have also been seen when xylazine was used to sedate southern elephant seals (Vergani 
1985). Given these side effects it is unlikely that medetomicline when used alone, will prove to be a 
useful drug for immobilization of larger southern elephant seals or leopard seals. 
Medetomidine and ketamine 
Although ketamine and medetomidine produced a median level 3 of chemical restraint, the response 
was unpredictable; animals receiving similar doses reached level 1 and level 6. Because the dose of 10 
mg of medetomidine combined with 675 mg ketamine caused excessive restraint and decreased heart 
rate in the first animal to which it was administered, subsequent animals received 5 mg medetomidine 
combined with ketamine. However, as animals were usually insufficiently restrained (< level 3) 
rather than excessively deep (> level 5) the dose of ketamine or medetomidine in this combination 
may need to be increased. Because the animal which received 10 mg of medetomidine had a low heart 
rate, it might be preferable to either use this dose of medetomidine and decrease the dose of ketamine, 
or to use a lower dose of medetomidine and increase the dose of ketamine, rather than increase the 
medetomidine dose. (One study found that increasing the dose ofketamine cancelled the bradycardia 
related to medetomidine administration (Verstegen et al. 1989) so the second option may be 
preferable). 
The failure of atipamezole to antagonise ketamine and medetomidine was unexpected, and was 
possibly because the dose of atipamezole was too low. Given the occasional relapse to sedation seen 
after intravenous administration of atipamezole in other animals (Jalanka 1989) it may be more useful 
to administer the drug divided intravenously and subcutaneously. Atipamezole was given 
intravenously in the present study to assess its duration of effect and look for evidence of relapse. As 
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atipamezole antagonizes some of the effects of medetomidine in other animals (Savola 1989, 
MacDonald et al. 1989) it is likely that the adverse side effects seen during this study could be 
reduced if a suitable dose of antagonist was administered. 
Comparison of ketamine and medetomidine with ketamine and :xylazine and other 
cyclohexamine based drug combinations 
The small sample sizes, difference in maximum levels of chemical restraint, and use of non-
standardised drug dosages in the ketamine and medetomidine and ketamine and xylazine studies mean 
that few direct comparisons or conclusions can be made between the combinations. A dose-response 
study had been planned to compare these two combinations but was cancelled because of the apparent 
lack of benefit of ketamine and medetomidine compared with ketamine and xylazine found during this 
pilot study. However, the response to ketamine and medetomidine appeared to be similar in many 
ways to the response to ketamine and xylazine; sedation and muscle relaxation were profound; heart 
rate was relatively low compared to other cyclohexamine based combinations; aggressive responses to 
monitoring and unwanted side effects such as hyperthernlia, prolonged restraint and vomiting (which 
has been associated with ketamine and xylazine use in other studies; Mitchell and Burton 1991) were 
all seen. Consequently ketamine and medetomidine appeared to offer few advantages over ketamine 
and xylazine or other cyclohexamine based drug combinations for routine chemical restraint. However 
the results also suggested that medetomidine may decrease the dose of ketamine required, as it does in 
other species (Doze et al. 1989), which could be an advantage if a s1:1itable dose of drug and 
antagonist was administered. 
The role of a.2 adrenergic agonists in chemical restraint of pinnipeds is debatable. There are many 
reports of adverse side effects associated with their use including hyperthermia, vomiting, bradycardia, 
apnoea, death and prolonged restraint (Vergani 1985, Woods et al. 1989, Mitchell and Burton 1991, 
Chapter 8). Woods et al. (1989) suggested that excessive doses of xylazine were implicated in 
initiation of diving responses in anaesthetised seals. Despite these problems, ketamine and xylazine 
has been used successfully on many occasions (Woods et al. 1989) and the ability to antagonise the 
adrenergic a.2 agonists is a distinct advantage. To minimise these side effects it may be expedient to 
combine them with other drugs, allowing a reduction in their dosage, rather than relying on them as 
the sole source of drug for immobilization. Prior premedication with a parasympatholytic may be 
useful. It is also possible that their usefulness and safety could be improved by combining them with 
other easily antagonised drugs (such as narcotics) which could allow rapid antagonism of effects and 
lower the requirements of each component. However, possible additive depressant effects of these 
drugs, and the inability to antagonise drugs when circulation has shut down (Chapter 11 and 12) 
would need to be considered and their use approached with caution. 
154 
Medetomidine and ketamine use 
Because the sedative effects of a2 adrenergic agonists vary considerably between species (Stenberg 
1989), caution would need to be exercised in attempting to extrapolate doses of medetomidine used in 
this study to those which may be useful in other pinniped species. 
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Chapter 11: Use of the respiratory stimulant doxapram 
Introduction 
Apnoea is commonly associated with chemical restraint of southern elephant seals (Mitchell and 
Burton 1991) and other pinnipeds (Gales 1989), but there are few specific recommendations regarding 
its treatment. The respiratory stimulant doxapram (Parry et al. 1981, Cornell and Antrim 1987, 
Baker et al. 1988, Bester 1988) and intubation and positive pressure ventilation (Baker et al. 1990) 
have been used. Doxapram's stimulatory effect in other animals is related to direct action upon 
chemoreceptors of the carotid and aortic regions. There may also be some stimulation of the 
medullary respiratory centre (Booth 1982b). In the studies above in which doxapram was used, few or 
no data were presented and intubation and positive pressure ventilation cannot be used effectively in all 
circumstances. For example, logistical problems associated with restraining animals in isolated, 
inaccessible locations may preclude the use of bulky or delicate resuscitation equipment. Even if this 
equipment is available there are problems associated with ventilation of large animals which have 
large tidal and respiratory minute volumes. To deliver the required volume of gas within the desired 
time span increased and/ or prolonged elevated mean airway pressure may be required and this can 
cause significant depression of cardiac function by decreasing thoracic venous inflow, stroke volume, 
cardiac output and aortic blood pressure (Steffey 1983 a). In phocid seals ventilation equipment also 
has to inflate the lungs against the weight of the compressible thorax (Hammond and Elsner 1977); an 
important consideration in southern elephant seals which can weigh up to 3700 kg (Ling and Bryden 
1992). For these reasons effective ventilation of large seals (~ 1000 kg) may be difficult to achieve 
and doxapram may offer an alternative. 
Two aims of this study were thus: (1) to determine whether doxapram was a useful treatment of 
apnoea and (2) to determine the optimum dose and route of administration. As the study proceeded 
results indicated that endotracheal intubation of some study animals could be affecting breathing (see 
below). A third aim was therefore (3) to examine the effect of intubation on respiratory rate in 
southern elephant seals. 
Materials and methods 
There were three parts to the study. Part A refined the dose of doxapram, Part B its route of 
administration and Part C examined the effect of intubation on breathing. 
Doxapram use 
A. Dose of doxapram in eupnoea 
Twenty five healthy, quiescent, pre-moult females of median 2.56 m snout-tail length (range= 2.43 -
2.81 m) and median mass 354 kg (range = 301 - 613 kg) were immobilized (level 4 of chemical 
restraint; Table 11.1 footnote) with a single intramuscular dose ofketamine and xylazine. The median 
dose of ketamine was 3.0 mg/kg (range= 1.6 - 3.5 mg/kg) and of xylazine was 0.5 mg/kg (range= 
0.3 - 0.7 mg/kg). 
Twenty min after ketarnine and xylazine administration each group of seals was given a single fixed 
dose of doxapram or saline of lOOmL volume, ~armed to 37°C, intravenously into the extradural 
intravertebral vein. The seals were randomly assigned to five groups of five which received either 250 
mg, 500 mg, 1000 mg, or 1600 mg doxapram or saline (control) (Table 11.1). 
Respiratory rate was recorded each minute after doxapram or saline until it returned to 4 to 5 
breaths/min. From these data the duration of increase in respiratory rate, the maximum respiratory 
rate and its time were determined. 
B. Route of administration in apnoea 
The optimal dose of doxapram found above (1000 mg) was then assessed as a respiratory stimulant in 
20 mature female pre-moult southern elephant seals which had become apnoeic for 10 min or longer 
whilst chemically restrained (median level chemical restraint = 4, range = 3 - 6) with ketamine and 
xylazine. The median dose of ketamine was 3.3 mg/kg (range= 2.5 - 3.4 mg/kg) and the median dose 
of xylazine was 0.5 mg/kg (range = 0.5 - 0.6 mg/kg). Ten min after the onset of apnoea, animals 
were treated with either doxapram or saline (50 mL, 37°C), administered by one of 3 different routes 
(Table 11.2): 
1. Intralingually: Injections were made intramuscularly into the body of the tongue, by inserting an 
18 G, 38 mm needle through the lateral surface. Ten mL of fluid was the maximum administered in 
any one spot before the needle was redirected or removed and relocated. No attempt was made to test 
for intravascular administration. 
2. Intravenously: Injections were made into the extradural intravertebral vein (as above). 
3. Endotracheally: Each animal was intubated with a 24 mm outside diameter endotracheal tube (not 
inflated) and a sterile duodenal tube, passed down the lumen of the endotracheal tube and advanced 5 -
10 cm past the distal end of the endotracheal tube. A syringe containing doxapram or saline was 
attached to the proximal end of the duodenal tube and the contents administered rapidly. The syringe 
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Table 11.l. Results of Part A. Dose of doxapram (intended and actual), respiratory rate before experimental treatment, maximum respiratory rate after treatment, 
duration of increased respiratory rate after treatment (time taken for respiratory rate to return to pre-treatment level) and level of chemical restraint before 
and after treatment (median, range) for 5 groups of southern elephant seals. Values between groups were compared using Kruskall-Wallis H test; values not 
significantly different have been grouped. 
Group Dose of doxa2ram 
Intended* 
(mg/kg) 
Control 0.0 
250 mg doxapram 0.5 
500 mg doxapram 1.0 
1000 mg doxapram 2.0 
1600 mg doxapram 4.0 
*All dose volumes were 100 mL. 
tExcluding saline group. 
Actual 
(mg/kg) 
0.00 
0.75 
(0.41-0.77) 
1.42 
(0.82-1.51) 
2.9& 
(2.61-3.33) 
4.19 
(2.63-4.90) 
H= 16.92 
df= 3t 
P< 0.001 
Before treatment 
(breaths/ minute) 
' 
5 
(1-7) 
:j:Time taken for respiratory rate to return to pre-administration level. 
Res2iraton: rate 
Maximum after 
treatment 
~reaths/ minute2 
4 
(2-6) 
6 
(5-10) 
10 
(6-14) 
10 
(1-16) 
12 
(12-16) 
H= 13.70 
df=4 
P< 0.01 
§A single value was generated for each animal by taking the median of values at 10, 15 and 20 minutes. 
Duration of increase 
after doxapram(min):j: 
-
2 
(2-5) 
2 
(0-3) 
3 
(0-7) 
4 
(4-7) 
H= 15.26 
df=4 
P< 0.01 
IIA single value was generated for each animal by taking the median of values at 25, 30, 35 and 40 minutes. 
Level chemical restraint 
Before After n 
treatment§ treaunentll 
5 5 
(1-7) 
2 5 
(2-3) 
4 3 5 
(2-6) (2-4) 
3 5 
'' (3-~) . 
1 5 
(1-3) 
H= 11.59 
df=4 
P<0.05 
Level of chemical restraint 
1 = Light sedation 
2 = Moderate sedation 
3 = Heavy sedation 
4 = Light immobilizatior 
ti 
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Table 11.2. Results of Part B. Effect of doxapram (2 mg/kg) or saline on respiratory rate 
of three groups of apnoeic southern elephant seals chemically restrained with 
ketamine and xylazine. 
Route of administration Treatment 
Intralingual Doxapram 
Saline 
Extradural intravertebral vein Doxapram 
Saline 
Endotracheally Doxapram 
Saline 
Effect on respiratory rate 
(1111mber of animals) 
Increased No increase 
I 2 
I 0 
0 5 
0 3 
4 2 
0 2 
w 
.§ 
~ 
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"' 0 
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was removed and the duodenal tube flushed with 50 mL of air. The duodenal tube was then removed 
and the endotracheal tube left in place. 
C. Effect of intubation 
It appeared that the presence of the endotracheal tube in the airway prevented breathing in Part B. It 
was theorised that if this were the case then removal of the endotracheal tube immediately after 
doxapram administration, rather than leaving it in place, might improve the effectiveness of the 
doxapram. This was investigated together with an assessment of the effect of intubation on breathing. 
The trial was carried out in mature female pre-moult southern elephant seals which had been 
chemically restrained (median level chemical restraint= 4, range = 3 - 6) with ketamine and xylazine. 
The median dose of ketamine was 3.1 mg/kg (range= 2.4 - 6.4 mg/kg) and the median dose of 
xylazine was 0.5 mg/kg (range= 0.4 - 0.7 mg/kg). 
The animals used had either been breathing normally for 10 min (n = 31) or had been apnoeic for 10 
min (n = 19), after which each animal was intubated and doxapram, saline or nothing administered 
endotracheally. The endotracheal tube was then either removed immediately or left in place for 10 
min, giving 2 endotracheal tube groups (Table 11.3). For each group the effect of intubation and/ or 
treatment with doxapram or saline upon respiration was recorded. For those animals in which the 
endotracheal tube had been left in place for 10 min, the effect of its removal upon respiration was also 
recorded and is presented as a third group in Table 11.3. 
Endotracheal doxapram/ saline were administered as above. 
General 
For each episode of chemical restraint blood gases and pH (taken from the extradural intravertebral 
vein), respiratory rate and level of chemical restraint were measured every 5 min for the first 50 min 
and, if necessary, every 10 min thereafter. The technique used for pH and blood gas analysis has been 
presented in Chapter 3. 
If at any stage during trials there was concern for an animal's welfare, it was immediately intubated 
and ventilated with oxygen. 
Anaesthetic drugs were administered by a remote injection technique (Ryding 1982) and each animal 
received 1.3 mg atropine sulphate in the same syringe as the ketamine and xylazine. 
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Table 11.3. Results of Part C. Effect of intubation on apnoeic and breathing animals (number of times that breathing started or improved after 
lreatmenl/ number of animals in which the treatment was used). The effect of endotracheal tube removal on animals in the second group is also 
presented (group 3). 
Endotracheal tube group 
1. Immediate removal of endotracheal tube 
after treatment 
2. Endotracheal tube left in for 10 minutes 
after treatment 
3. Effect of endotracheal tube removal on 
the animals in group 2 
Saline 
1/1 
0(1. 
1(1. 
Treatment 
Apnoeic Breathing* 
Doxapram None Saline Doxapram 
3{7t 2(3 1/1 
4/6t 1(3 0/1 4/5 
6/6 0(3 0/1 2/5 
*When intubated breathing stopped or became more difficult in 24 of the 31 breathing animals. 
None 
0/21 
20/21 
tThere was no significant difference in the proportion of animals which commenced breathing after doxapram whether the endotracheal tu.,eiwas 
removed or left in place (see Text). 
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Data were analysed using the Mann-Whitney U test to compare two groups, and the Kruskall-Wallis 
H test for comparison of three or more groups. Correlations were examined with Spearman's r (rs). 
and Fisher's exact tests to compare frequencies. Tests were considered significant when P < 0.05. 
Results 
A. Dose of doxapram in eupnoea 
The masses of animals in each doxapram group, the doses of anaesthetic drugs and the median levels 
of chemical restraint and respiratory rate prior to doxapram administration were not significantly 
different. The actual doses of doxapram administered to the groups were significantly different (Table 
11.1). 
Doxapram usually caused a transient increase in respiratory rate and depth which commenced within 
30 - 60 s of its administration, was maximal after 2 min and lasted less than 5 min. At high doses 
doxapram caused arousal (see below). 
The duration of increase in respiratory rate rose from 2 to 4 min with the dose of doxapram (rs = 0.56, 
n = 20, P < 0.05). The maximum respiratory rate after doxapram was significantly different among 
groups and increased with dose (rs = 0.57, n = 20, P < 0.01). By 25 min the respiratory rate of 
doxapram animals had returned to control values: the median respiratory rate for all groups was 5 
breaths/min (range = 2 - 13 breaths/min) and it remained unchanged to 40 min. 
The median level of chemical restraint was also lower after doxapram (1 - 3)_ than for the control group 
(Table 11.1). 
Tidal volume appeared to increase with dose of doxapram though this was not quantified. In some 
animals the inspiratory phase appeared to be lengthened, and animals would often inspire through both 
nostrils rather than the more usual one. Excursions of the body wall associated with inspiration were 
also often greater. Despite the changes in respiration doxapram had little e.ffect on venous blood gas 
values at 25 min which were not significantly different between the five groups. Median (range) of 
values were: pH= 7.30 (7.23 - 7.39), Pvo2 = 45 mmHg (30 - 58 mmHg), Pvco2 = 50 mmHg (41 -
70 mmHg), HC03- = 26 mmol/L (20 - 32 mmol/L) (n = 24; one animal had recovered and samples 
could not be taken). 
Shaking and aggression were seen in 3 animals given 1600 mg doxapram but not in any other 
animals. 
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B. Route of administration in apnoea 
Table 11.2 shows the lack of effect of extradural intravertebral vein doxapram. Intralingual doxapram 
appeared to stimulate breathing in 1 of 3 animals, but in this case respiration commenced almost 
immediately the needle was inserted into the tongue and before doxapram could be administered. 
When administered endotracheally doxapram stimulated breathing in 4 of 6 animals. One animal in 
which doxapram did not stimulate breathing appeared to be consciously breathholding as its external 
nares were twitching and it was watching the operators as they moved around it. When the 
endotracheal tube was removed it immediately commenced breathing. 
C. Effect of intubation 
The number of times that breathing was stimulated in apnoeic animals after treatment with doxapram 
was similar whether the endotracheal tube was left in place (4 of 6) or immediately removed (3 of 7; 
Fisher's exact test; P = 0.5) (see t Table 11.3). 
The process of intubation caused respiratory difficulties or apnoea in 24 of the 31 breathing animals 
and stimulated breathing in 1 of the 19 apnoeic animals (Table 11.3). When the endotracheal tube 
was removed breathing started or improved in 20 of 21 of the breathing animals which did not receive 
any other treatment and had been intubated for 10 min (Table 11.3). 
Discussion 
A. Dose of doxapram in eupnoea 
It was not possible to measure tidal and minute volume because placement of an endotracheal tube and 
flow meter tended to cause apnoea. However the increase in respiratory rate and depth seen after all 
doses of doxapram show that it stimulates normal (spontaneous) breathing in southern elephant seals 
chemically restrained with ketamine and xylazine (Table 11.1 ). 
The range of doses used in this study included the therapeutic range recommended for intravenous use 
(0.4 - 2 mg/kg; Booth 1982 b), and that shown to cause arousal (4 mg/kg; Soma and Kenny 1967) in 
other animals. Although higher doses of doxapram produced a greater increase in the magnitude and 
duration of respiratory rate, shaking and aggression were seen. A dose of 2 mg/kg provided a better 
balance between stimulation of respiration and side effects. 
Given the increase in respiratory rate, the lack of significant difference in pH and blood gas values at 
25 min was surprising but could be due to the transient nature of the changes in respiratory rate and 
_tidal volume and the fact that venous blood gas and pH values may not accurately reflect arterial 
values (Haskins 1977). 
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The reversal of ketamine and xylazine chemical restraint by doxapram is consistent with the 
observation of Parry et al. (1981) that doxapram aided recovery of grey seals from narcosis with 
etorphine and acepromazine. Our results indicate that doxapram could be used to decrease the level of 
chemical restraint (at 2 mg/kg) or cause arousal (at 4 mg/kg) in animals restrained with ketamine and 
xylazine. 
B. Route of administration in apnoea 
Different routes of doxapram administration were trialled because there was some evidence which 
suggested that drugs administered into the extradural intravertebral vein of apnoeic seals may be 
ineffective (Baker and Gatesman 1985). This was thought to be due to low pressures and flows in this 
vessel associated with adaptations to anoxia during diving. 
The 1000 mg dose of doxapram was used in Parts B and C because it stimulated respiration without 
causing shaking, recovery or aggressive behaviour (Part A). This volume of fluid was not considered 
excessive to be administered into the lungs since 50 mL of saline is routinely used for transtracheal 
aspiration of horses (Rose 1983). 
It is clear that extradural intravertebral vein administration of doxapram cannot be relied upon to treat 
prolonged apnoea (Table 11.2). However, it increased respiratory rate and depth when administered 
into the extradural intravertebral vein of breathing animals (Table 11.1) which implies that the failure 
to have an effect in apnoeic animals is not due to an inherent insensitivity to doxapram. Three 
theories could explain this lack of effect. Firstly, as suggested by Baker and Gatesman (1985), due to 
changes in flow in the extradural intravertebral vein during apnoea the drng may not reach its site of 
action. Secondly, the doxapram may reach its site of action but either a conscious decision not to 
breathe, or thirdly, the inability to breath due to reflex laryngeal spasm, might "over-ride" the effect of 
the drng. 
The theory of Baker and Gatesman (1985) appears the most simple and probable and if this is the case 
then to have an effect in apnoeic animals doxapram (and other drngs) would have to be administered by 
this route before changes in circulation occur, similar to those seen during diving. This is supported 
in other studies (unpublished) in which we have administered diazepam via the extradural intravertebral 
vein to seizuring seals which have been apnoeic for a very short period of time (30 seconds to 2 min); 
in all cases it has been effective indicating that circulation was sufficient to deliver it at a sufficient 
concentration to the brain (its site of action in other animals). 
However, also in other studies (unpublished) we have administered doxapram via the extradural 
intravertebral vein to apnoeic seals and induced what appeared to be attempts at bryathing (ie body 
heaving) without inspiration of air. When the arytenoids were adducted breathing commenced. We 
have also seen evidence in apnoeic seals to which doxapram had been administered which suggested 
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that it was having an effect by increasing level of arousal and causing twitching of the external nares 
(interpreted as indicating imminent return to breathing) but breath-holding was maintained. 
The results of the present study, coupled with these findings make interpretation of the effectiveness 
of docapram very difficult. The key lies in determining blood flow during apnoea in anaesthetised 
animals and in examining the control of breathing. Future studies into anaesthesia of these animals 
should address these areas as a matter of priority. 
The failure of doxapram to stimulate respiration when administered intralingually does however cast 
doubt on the suggestion of Baker and Gatesman (1985) that this route might rapidly deliver drug into 
the circulation during apnoea. The fact that breathing was stimulated by saline and by placement of 
the needle within the body of the tongue prior to doxapram administration in the present study implies 
that the stimulation of breathing seen in this study was due to pain and not the doxapram. 
Endotracheal administration was the most effective route of doxapram administration, and allowed 
maintenance of an airway and the potential to administer positive pressure ventilation. However, it 
was not effective in all cases and for this reason intubation and ventilation are the treatments of choice 
for apnoea. Though equipment is available for ventilation of animals < 1 OOO kg, we are unaware of 
any commercially available equipment able to effectively ventilate animals ~ 1000 kg. However it 
has been suggested that such equipment could be built (F. M. Bird personal communication 1989) 
and effective techniques for ventilation of large seals are required. 
Other routes were considered to deliver doxapram into the heart-brain circulation including intracardiac 
injection. However, though drugs have been administered by this route during anaesthetic 
emergencies in other animals (Lumb and Jones 1984 b), this was considered impractical as it would 
require long needles and large numbers of people to position the seals. 
C. Effect of intubation 
The small sample sizes, differences in drug dose rates, levels of chemical restraint, total durations of 
apnoea and treatments at different times mean interpretation of these results is difficult. However, it 
appeared that the presence of an endotracheal tube tended to compromise breathing in animals which 
were at low levels of chemical restraint ( < 6; light anaesthesia). This is also commonly seen in other 
animals in which anaesthesia is light (Lumb and Jones 1984 c). This response could also be 
exacerbated in an animal which must protect its airway whilst diving, and feeding under water. It was 
therefore of interest that immediate removal of the endotracheal tube after doxapram did not appear to 
stimulate breathing in more cases than when the endotracheal tube was left in place. This implies 
that it is not critical whether the endotracheal tube is left in place or removed when doxapram is 
administered endotracheally. However, leaving the endotracheal tube in place maintains the airway and 
allows positive pressure ventilation (see below for recommendations). It could also be interpreted as 
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suggesting that doxapram will "over-ride" any inhibitory effects which the presence of the endotracheal 
tube may have. Though the data suggest this we would caution against this interpretation; given our 
current knowledge doxapram cannot be relied upon for treatment of apnoea in southern elephant seals 
regardless of route of administration. 
In summary, if apnoea occurs in animals which are at a low level of chemical restraint (eg < 6) in 
which there is little evidence of central depression ( eg capillary refill and palpebral response are rapid 
and brisk, mucous membrane colour is good and heart rate relatively normal) intubation can be 
postponed and other techniques used to stimulate breathing. If animals are at greater levels of 
chemical restraint (> 5), or there is marked central depression, cyanosis, rapid changes toward deeper 
levels of chemical restraint, rapid changes in heart rates, or animals cannot be accurately assessed and 
there is concern for their welfare, then intubation and ventilation are advisable if it is safe to do so. 
The endotracheal tube can be removed once the animal commences spontaneous respiration, or when it 
reaches level 3 - 4 chemical restraint and there is evidence that the endotracheal tube is preventing 
respiration (ie twitching of external nares or gagging or heaving body movements). Though not 
always effective, routine administration of doxapram down the endotracheal tube immediately prior to 
extubation might assist return to spontaneous ventilation. 
If positive pressure ventilation cannot be supplied endotracheal administration of doxapram may be 
helpful; the endotracheal tube being left in place in deep animals (> level 5), or removed when signs 
of imminent return to breathing occur in light animals ( < level 6). 
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Chapter 12: Antagonism of some cyclohexamine based drug 
combinations 
Introduction 
Chemical restraint of southern elephant seals has been difficult to control because of initial 
intramuscular drug administration, variability of response (Woods et al. 1989), and practical 
difficulties associated with working under field conditions. Antagonist drugs have the potential to 
improve control and safety of chemical restraint by lessening central nervous system depression, 
improving ventilation or tenninating the restraint. Their main applications are in preventing 
complications of prolonged chemical restraint (such as pup abandonment and hyperthennia), 
improving efficiency of work with the animals (such as when large numbers of animals need to be 
restrained each day), and in decreasing excessive levels of chemical restraint in animals breathing 
normally. 
Drugs commonly used for chemical restraint in these animals are ketamine and diazepam, ketamine 
and xylazine, or tiletamine and zolazepam (Baker et al. 1990, Mitchell and Burton 1991). In other 
animals ketamine and xylazine has been antagonised using 4-aminopyridine (a releaser of acetylcholine 
and other neurotransmitters) and yohimbine (an a2 adrenergic antagonist) (Kitzman et al. 1984); 
ketamine and diazepam with 4-aminopyridine (Agostons et al. 1980); and tiletamine and zolazepam 
with sarmazenil (a benzodiazepine antagonist) and doxapram (an analeptic) (Hatch et al. 1988). 
However, there are no reports of the use of antagonists in southern elephant seals and few in other 
seals. Cawthorn (1989) used yohimbine to antagonise ketamine and xylazine chemical restraint in 
New Zealand sea lions (Phocarctos hookeri) but found that it caused tremors and convulsions. Gales 
(1989) suggested that this was because yohimbine was primarily antagonising xylazine, which was 
then failing to mask the side effects of ketamine. Doxapram has been used as a respiratory stimulant 
(Parry et al. 1981, Cornell and Antrim 1987, Baker et al. 1988) but it has been suggested that it will 
also speed recovery from narcosis in grey seals (Halichoerus grypus; Parry et al. 1981) and the walrus 
( Odobenius rosmarus; Cornell and Antrim 1987), and results of another trial (Chapter 11) suggested 
that it could be useful for this purpose. 
This study examined the effectiveness of antagonists in uncomplicated episodes of chemical restraint. 
Materials and methods 
Ninety six healthy, mature, premoulting females of median 2.50 m snout-tail length (range= 2.10 -
2.90 m) and 369 kg body weight (range = 215 - 610 kg) were selected for trials. They were divided 
into 4 anaesthetic groups, and given nominal doses of either 100:1 ketamine: diazepam (100:1 ratio of 
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ketamine to diazepam; ketamine = 3.0 mg/kg, diazepam = 0.03 mg/kg), 50:1 ketamine: diazepam 
(ketamine = 3.0 mg/kg, diazepam = 0.06 mg/kg), ketamine and xylazine (3.0 mg/kg, xylazine = 0.5 
mg/kg), or tiletamine and zolazepam (0.5 mg/kg each drug) combined with 1.3 mg atropine sulfate 
(median= 0.004 mg/kg, range= 0.002 - 0.006 mg/kg, n = 96). Initially groups of 5 animals were 
used to test each anaesthetic antagonist against saline controls. Once sedated, animal masses were 
determined by weighing, or use of length-mass relationships if they were insufficiently restrained, and 
the actual doses of drugs administered to each group calculated (Table 12.1). 
The dose of 4-aminopyridine used to antagonise 100: 1 ketamine: diazepam was based on that used in 
humans (0.3 mg/kg; Agoston et al. 1980), the doses of 4-aminopyridine and yohimbine used to 
antagonise ketamine and xylazine on those used in horses and cattle (0.2 - 0.3 mg/kg for 4-
aminopyridine and 0.075 mg/kg for yohimbine; Kitzman et al. 1982 and 1984, Gleed 1987), and the 
dose of doxapram administered to antagonise 50:1 ketamine: diazepam, ketamine and xylazine, and 
tiletamine and zolazepam was determined in another study (Chapter 11). The dose of sarmazenil was 
based upon those used to antagonise climazolam in horses (0.5 - 1 mg/kg; Ludwig et al. 1985) and 
benzodiazepines in large animals (0.25 - 5 mg/kg; Rehm and Schatzmann 1984). 
Approximately 10 min after administration of the anaesthetic drugs, two 18 G, 90 mm needles 
(Terumo, Tokyo, Japan) were inserted into the extradural intravertebral vein. One was used for blood 
sampling and was located 30 to 45 cm cranial of the proximal end of the sacrum (approximately 5 or 
6 vertebral body lengths). The other needle which was used for antagonist or saline was located 
approximately 1 to 2 intervertebral spaces cranial to the blood sampling needle. Every 5 min from 10 
to 60 min blood (1 mL heparinised) was collected for blood gas and pH analysis and heart rate (beats/ 
min: bpm), respiratory rate (breaths/ min) and level of chemical restraint, graded from level 1 (light 
sedation) to level 5 (heavy immobilization) (see Footnote Table 12.3), were recorded. Definitions and 
techniques used for monitoring and blood gas and pH analysis were those presented in Chapter 4. 
Single values for heart rate, respiratory rate, venous blood gases and pH for the 20 min period after 
antagonist or saline administration were generated for each animal by taking the median of values 
recorded at 25, 30, 35 and 40 min. 
Immediately after the 20 min sample, a dose of antagonist or a similar volume of saline was slowly 
administered. Because of their relatively large volumes (80 to 350 mL), doxapram, sarmazenil, and 
their saline controls were warmed to approximately 37°C. Sarmazenil and its saline controls were 
infused via a drip stand, fluid bag and giving-set, run through a water bath at approximately 37°C. 
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Table 12.1. Doses of drugs used for chemical restraint and antagonists (median, range) administered to southern elephant seals. Anaesthetic doses were not significantly 
different (P > 0.05) between control and antagonist groups, and have been combined for clarity. 
Anaesthetic 
100:1 Ketamine: diazepam 
50: 1 ketamine: diazepam 
Ketamine and xylazine 
Tiletamine and zolazepam 
Antagonist or 
control 
Dose or drugs used for chemical restraint (mg/kg) Antagonist dose (mg/kg) 
DiazeJ>_atJ1 _Xylazine Zolazepam Ketamine Tilatamine 4-Aminopyridine Sarmazenil Yohimbine Doxapram 
0.03 
4-Aminopyridine ) 
Control (0.02 - 0.05) ) 
3.10 0.27 
(2.29 - 3.93) (0.14 - o.41) 
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Initially a fixed dose of sarmazenil was administered. However it soon became apparent that the 
required dose could be titrated to effect by infusing the solution until the first signs of shaking or a 
"dissociated look" were seen in the recipient animal. Therefore, in subsequent animals, administration 
of sarmazenil was stopped when this point was reached. 
Data were analysed using the Mann-Whitney U test to compare two groups, and the Kruskall-Wallis 
H test for comparison of 3 or more groups. Differences were considered significant when P < 0.05. 
Results 
The median doses of drugs used to chemically restrain antagonist and control animals within each 
anaesthetic group were not significantly different (Table 12.1). 
Antagonism of 100: 1 ketamine: diazepam 
4-Aminopyridine significantly prolonged the time to first movement forward (from 32 min to 52 min) 
and recovery (from 43 min to 65 min) in animals chemically restrained with 100:1 ketamine: 
diazepam (Table 12.2), but heart rate and respiratory rate were not significantly_ changed (Table 12.3). 
Shaking developed in 6 of 13 animals within 10 min of administration of 4-aminopyridine, but not 
saline. The dose of 4-aminopyridine administered to those animals in which shaking was seen was 
not significantly different to that administered to those in which it was not seen. Two animals were 
shaking prior to 4-aminopyridine administration and this increased within·min of 4-aminopyridine. 
One became hyperresponsive to external stimuli, showed increased muscle tone and began paddling 
movements with the fore-flippers. Ten mg of diazepam was administered slowly into the extradural 
intravertebral vein, and within 2 min muscle tone and shaking had decreased. The shaking was less 
marked in the other animal and gradually subsic:!_ed without treatment. 
One animal which received 4-aminopyridine was more subdued than the others and seemed to be blind 
after recovery. Both eyes appeared normal, pupils were constricted (their normal state) and the corneal 
response was intact, but there was no menace response and the seal behaved strangely. Rather than 
watching the operators and responding to vocalisations of seals around it, it remained immobile but 
repeatedly sniffed tussock and the air. Despite appearing reluctant to move it had disappeared 
approximately 5h after recovery and had presumably gone to sea; it was not sighted again. Before 
dosage the animal did appear to be quieter than other seals, and breathing ahd heart rate were normal 
during restraint. 
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Table 12.2. Time to first movement forwanl and recovery (median, range) for seals trealed with antagonists or 
saline. Times to first movement forwanl for SO:l ketamine: diuepam were not significantly different (P > 0.05) 
between control and antagonist groups and have been combined. (H =result of Kruskall-Wallis H test). 
Anaesthetic Antagonist or 
-control 
100:1 ketamine: diazepam 4-Aminopyrldine 
Control 
SO:l ketamine: diazepam Sannuenil 
Doxapram 
Control 
Ketamine and xylazine 4-Aminopyrldine 
Yohimbine 
Doxapram 
Control 
Tiletamine and zola7.epam Sannuenil 
Doxapram 
Control 
*Level 1 chemical resuaint (light sedation). 
tP < 0.01 veISUs control (U test). 
:j:P < O.OS veISUs control (U test). 
Time ~minl to 
First movement forward Recovery• 
S2t 65t 
(34. 72) (29. 130) 
32 43 
(18. SO) {18. S3) 
so 
(4S. 60) 
} 37 34:t (21 -65) (25 -4S) 
46.S 
(39. 90) 
H = 7.76S, P < O.OS 
Sl 8h§ 
(33. S9) (43. >16h) 
29 42t 
(22. 62) (24. 80) 
24t 24t 
(24. 30) (22. 60) 
S3 90 
(27. 81) (40. 191) 
H = 9.090, P < 0.05 H = 14.386 P < 0.01 
34 40; 
(27. 40) (30. 40) 
S5 so 
(4S. 90) (30. 90) 
44.S so 
(31. 72) (31. 125) 
H = 9.311, P<0.01 H = 6.603, P < 0.05 
§Only 4 values were recorded for ketamine and xylazine antagonised with 4-aminopyrldine; >8h, >16h, >8h 
and 43 min. The animals with prolonged recovery times ( > 60 minutes) left the study site, or 
could not be found after these times. The S th animal went to sea at 34 min, at level 3 restraint (heavily sedated). 
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Table 12.3. Heart rate, respiratory rare, blood gases and pH, and level or chemical restraint ror the 20 minute period after antagonist or saline administration (median, range) 
ror southern elephant seals chemically restrained with 4 different cyclohexamine based drug combinations. Values have been combined where lhey were not significantly 
different (Kruskall-Wallis H test: P > 0. 05) for antagonist and conlrOI groups. CH = result or Kruskall-W all is H tests). 
Anaesthetic Antagonist or Heart rate Respiratory rate l!H or blood gas variable 
control (bpm) (breaths/min) pH Pv02 
{mmll!!l 
100:1 ketamine: diazepam 4-Aminopyridine } 63 } (3 -
6
10) 
} 7.35 }(32~57) (24- 80) (7.23 - 7.44) 
Conlrol 
50:1 ketamine: diazepam Sannazenil 60 1~~~ 7.32t (60- 62) (7.28- 7.34) Doxapram 68 7.38 48 (65- 81) (7.29 - 7.43) (40- 60) Conlrol 60 7.36 
(52- 67) (7.35 - 7.43) 
H = 8.28~ P < 0.05 H = 8.1151 P < 0.05 
Keramine and xylazine 4-Aminopyridine 44 7.26t 
(32-48) (7.21 - 7.28) 
Yohimbine 60* 7.31 
(58- 62) 5 (7.28 - 7.35) 42 
Doxapram 48 (0- 12) 7.30 (rl- 51) 
(28- 56) (7.24 - 7.41) 
Conttol 45 7.31 
(36- 60) (7.26 - 7 .40) 
H = 10.377 Ip < 0.05 H = 8.25~ P < 0.05 
Tiletamine and zolazepam Sarmazenil 7.34 \ 
(7.30- 7.39) 
Doxapram 
) Q 
7 7.38* t 52 (48-78) (3-17) (7.34 - 7.41) (40- 57) 
ConlrOI 7.34 
(7 .29 - 7 .36) 
H = 6.222, P < 0.05 
• 1 = light sedation, 2 = moderate sedation, 3 = heavy sedation, 4 = light immobilization, S = heavy immobilization. 
tP<0.05 versus conlrOI (U test). 
*P<O.O I versus conlrol (U test). 
PvC02 
{mmll!!l 
} so (39- 65) 
:.t9 
(22-62) 
51 
(40- 57) 
\ 
t 42 (29-49) 
Level or chemical 
HC03- resttaint• 
{mmol/L2 
}c2:!31> }c2~S) 
2.5 
(2- 3) 
27 u 
(11- 37) (1- 2) 
2 
(2- 3.5) 
H =7.7191 P<0.05 
2St \ 
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27 ~ co.s \5> (25-27) 24t 
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26 I 
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Antagonism of 50:1 ketamine: diazepam 
Doxapram significantly decreased time to recovery after 50:1 ketamine: diazepam (from 47 min to 34 
min) while sarmazenil had little effect (Table 12.2). Level of restraint for the 20 min period after 
antagonist or saline was lower after doxapram compared with control values (Table 12.3). 
In one animal shaking increased after sarmazenil administration and required an additional 35 mg 
diazepam intravenously to decrease its severity. This animal had a prolonged recovery during which it 
appeared to lose inhibitions and fear of the operators and other animals. Another animal which 
received a relatively large dose of sarmazenil (4.0 mg/kg) became temporarily blind. It first exhibited 
hyperreactivity and apparent hallucinatory behaviour: aimless wandering through tussock, and loss of 
fear. This had diminished by 2.5 h, and after 4 h it was found that the seal had no menace response 
and was behaving like a blind seal (caution in moving, sniffing, appearing to be listening, extension 
of vibrissae before movement forward). The seal was moderately sedated and heart rate and respiratory 
rate were regular during chemical restraint and pupils remained constricted. Twenty-four h after 
administration of sarmazenil there was still no menace response, however by 30 h menace response 
had returned and the seal appeared clinically normal. 
Antagonism of ketamine and xylazine 
Both yohimbine and doxapram decreased the time to recovery but 4-aminopyridine greatly increased 
time to recovery (Table 12.2). Time to recovery was shorter in those· animals which received 
doxapram (24 min) than yohimbine (42 min). Shaking was associated with administration of 
doxapram but not yohimbine. One ketamine and xylazine animal became more responsive after 
doxapram administration, but relapsed by 43 min and returned to the previous level of chemical 
restraint. 
Heart rate was faster after antagonism with yohimbine (median 60 bpm) than for the other groups (44 
- 48 bpm) (Table 12.3). Hyperthermia was not seen in the 5 animals to which yohimbine had been 
administered but was in 4 of the 5 control animals, although ambient temperatures were similar. 
Antagonism of tiletamine and zolazepam 
Sarmazenil decreased the time to recovery (40 min compared with 50 min for the control) after 
tiletamine and zolazepam, while doxapram had little effect. One animal to which sarmazenil was 
administered became hyperresponsive at 33 min, but appeared to have recovered by 45 min. 
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The Overt Response to Antagonists (all trials) 
i. 4-Aminopyridine 
The overt response of animals to 4-aminopyridine was variable, however the drug usually induced 
shaking or prolonged time to recovery compared with control animals. 
ii. Sarmazenil 
The overt response of animals to sarmazenil varied but usually included fine muscle fasciculations, 
yawning, a "dissociated look", and/ or changes in the posture of the caudal flippers which were often 
lifted off the ground, the plantar surfaces tightly pressed together, digits abducted, and held in this 
position for up to 10 min. Often the fasciculations were so fine that they could not be seen but could 
be felt when the open palm was placed upon the animal's back. These responses occurred 10 to 15 
min after sarmazenil administration, were not seen in the control groups and were considered to 
indicate the onset of benzodiazepine reversal. 
iii. Doxapram 
Doxapram induced transient shaking and increased muscle tone in many animals. Some animals 
appeared mentally alert before becoming physically alert. These animals would develop an "anxious 
facial expression", become hyperresponsive with increased muscle tone, "anxiously" observe the 
operators' movements but be unable to move forward. The head response was unpredictable at this 
stage. 
iv. Yohimbine 
Approximately 10 min after administration of yohimbine the animal would yawn, raise its head, look 
around and in many cases make its first movement forward. Animals also appeared much less 
aggressive and their responses more predictable after yohimbine than after saline or other antagonists 
of ketamine and xylazine. 
Antagonists had little effect on respiratory rate except for a transient ( < 5 min) increase in respiratory 
rate and/or depth in most animals after doxapram (Table 12.3). 
There were few changes in pH and blood gas values after antagonist administration relative to their 
controls (Table 12.3). pH was lower after 4-aminopyridine in the ketamine and xylazine group and 
after sarmazenil in the 50: 1 ketamine: diazepam group, and higher after doxapram administration in 
the tiletamine and zolazepam group. HC03- levels were lower in the ketamine and xylazine group 
after 4-aminopyridine and doxapram compared with the control (Table 12.3). 
Table 12.4 presents a summary of the major findings of this study. 
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T1ble 124. Summmy of the major findings of this study on antagonism of cycloheumine based drug combinations commonly used to restrain southern elephant seals including effective dosea ~ of antagonists, effects on time to recovery and respiration, time of onset, side effects, dlsadVlntages 1nd ovmll value. g 
Anaesthetic Ant.a onist 0 e. 
Agent Dose or Elf ect on time Effect on respiration Time of onset• Side effects and Value for Comments 
"' 
antagonist to recovery disadvantages routine anl!lgonism s 
0 
m ":'> 
100: 1 ltetamine: diazepam 4-Aminopyridine 0.2 Prolonged Shaking, loss of Unreliable, possibly Unpredictable. g. 
menace feSl>Onse contraindicated Ma:r: C111Se blindness. ~. SO:l ketamine: diazepam Smmzenil O.S- 1.0 Little effect 10-!Smin lncrellsed muscle tone Unreliable and Oiancteristic respo~ g 
or to effect Shllting use with caution fine nmscle fascicul1tlons, 
dissoci1ted look, yawning, "'1 (1) 
"' changes in caudal flipper posture. q 
Could be of use If higher doses or s· 
lower ntios ofltetmtine to ..... 
diuepam are used. 
Loss ofmen1ce response At high dose (S.O mg/kg). 
May cause blindness. 
Dollllprmn 20 Decreased Trnnslent inaase In <2min Hypcuespoosive Useful for stimulating Antagonism unnccesamy In most 
nte md/or depth Shalting, lnaeased breathing cues.. 
muscle tone 
Keiamine md llylllzine 4-Aminopyridine Prolonged 
Yohlmbine 0.06 Deacased lOmin Useful Oianelerislic response: 
hesd nising, looking lnlllnd, 
y1Wning, lt1d moving ofl: 
Less thermoregulatory problems: 
Less 1ggression. 
Dollllpram 20 Decreased Transient increase in <2min Shaking Useful More useful IC Improved 
rate and/or depth Evidence of relnpse ventilation required. 
Unpredictable or dangerous 
hesd responsef 
lilc:lamine and :r.olazepam Smmazenil o.s -1.0 Decreased S- lOmin Increased muscle tone Maybe of use Characteristic nsponse: 
or to effect Shaking fme muscle fasciculations, 
dissociated look, yawning. 
Could be of use If higher doses or 
repest administrations or drugs. 
Dollapram 20 Little effect Transient increase in <2min Hypem:sponsive Useful for stimulating Mentally alert before physically 1lat. 
rate and/or depth Shaking, Increased breathing Routine antagonism unnecessary 
muscle tone in most cases. 
•From time of administration. 
fllead response= a graded response, based on the speed and degree of withdrawal in response to touching the top of the head and side of the nmzzle. 
-
-....) 
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Discussion 
Antagonists were administered 20 min after the anaesthetic because most routine procedures performed 
in these animals could be completed in this time. Also, arousal from ketamine and diazepam, or 
tiletamine and zolazepam combinations, at the dosages used, usually occurs after 40 to 50 min and 
could confuse the results if antagonist was given any later. It has also been suggested that if ketamine 
and xylazine is antagonised within 20 min, central nervous system stimulation may occur (Short 
1987 a). 
Antagonism of 100: 1 ketamine: diazepam 
Prolongation of 100: 1 ketamine: diazepam chemical restraint by 4-aminopyridine was unexpected 
demonstrating the need for controlled studies of drug usage in all species. Neither we, nor the 
manufacturer of 4-aminopyridine (Parnell Laboratories), are aware of any reports of prolongation of 
sedative or anaesthetic drug effects by 4-aminopyridine in any species. The induction of shaking by 4-
aminopyridine may have been related to its neuroexcitatory actions (Sohn and Uges 1981). Although 
these effects are thought to be dose related the shaking seen in this study did not appear to be related to 
dose of 4-aminopyridine. Given the findings of this study, the normally rapid recovery from 100:1 
ketamine: diazepam, the tendency for animals chemically restrained with 100: 1 ketamine: diazepam to 
have increased muscle tone, and the relatively low levels of chemical restraint required for handling, 4-
aminopyridine seems to be inappropriate for antagonism of 100: 1 ketamine: diazepam in these 
animals and to be contraindicated. 
Sarmazenil was not administered to the 100:1 ketamine: diazepam group as diazepam appeared to have 
minimal effect on recovery time and there was concern that sarmazenil could induce the blindness 
associated with its use to antagonise 50:1 ketamine: diazepam. 
Antagonism of 50:1 ketamine: diazepam 
Doxapram, because it caused arousal, decreased time to recovery, and produced a transient increase in 
respiratory rate, appeared the best of the antagonists used to reverse 50: 1 ketamine: diazepam. 4-
aminopyridine was not administered to the 50: 1 ketamine: diazepam group because of the adverse side 
effects associated with its use after 100:1 ketamine: diazepam. 
Antagonism of ketamine and xylazine 
Yohimbine was a useful drug for antagonising the effects of ketamine and xylazine as shaking was 
absent and there was a reduced incidence of thermoregulatory problems and lessened aggression. These 
properties could prevent hyperthermia on hot days and make monitoring safer for the operator (an 
important consideration). The increase in heart rate caused by yohimbine tyas considered useful but 
could be dangerous in an apnoeic animal because of the increase in myocardial oxygen consumption. 
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The ability to antagonise ketamine and xylazine improves the usefulness of this combination relative 
to other cyclohexamine based drug combinations. 
The doses of yohimbine used to antagonise ketamine and xylazine in this· study (0.06 mg/kg) were 
lower than those which were used to antagonise ketamine and xylazine or xylazine alone in New 
Zealand sea lions (approximately 0.25 mg/kg; M. Cawthorn personal communication). This may 
explain the lack of shaking after yohimbine in the present study. The animals in Cawthorn's study 
received approximately twice as much xylazine as animals in the present study and recovered more 
rapidly (usually within 3 min of yohimbine administration) which might indicate that the dose of 
yohimbine used in the present study could be increased to cause more rapid arousal. However, until 
dose-response studies are performed, to avoid shaking associated with unmasking of ketamine, it may 
be wise to administer the 0.06 mg/kg dose of yohimbine repeatedly to effect rather than give a single 
large dose. 
Doxapram also shortened the time to recovery of ketamine and xylazine animals. However, there were 
undesirable side effects (including shaking, unpredictable head response, and relapse) which have been 
reported previously (Hatch 1983). Doxapram may be useful where an effect upon respiratory rate is 
required, but its effects were transient and it may need to be repeatedly administered. There is evidence 
to suggest that in some species combinations of 4-aminopyridine, yohimbine and doxapram may 
antagonise the effects of ketamine and/ or xylazine more effectively than a single agent (Kitzman et al. 
1982, Zahner et al. 1984), but other studies do not support this (Wallner 1982, Kitzman et al. 1984, 
Hatch et al. 1985). The present study indicates that 4-aminopyridine has a depressant effect upon 
these animals. 
Large doses of doxapram (4 mg/kg) have been associated with hypotension in other animals (Soma 
and Kenny 1967), and repeated administration of lower doses (for example 2 mg/kg) may be preferable 
to a single large dose. This may also decrease the incidence of side effects seen after the larger dose (5 
mg/kg) used in this tudy. 
Antagonism of tiletamine and zolazepam 
The apparent lack of effect of doxapram on recovery after tiletamine and zolazepam was surprising 
given its usefulness in some other animals (Hatch et al. 1988). This may have been due to the 
relatively rapid normal recovery from tiletamine and zolazepam, however the normally rapid recovery 
after 50:1 ketamine: diazepam was hastened by doxapram. The transient effects of doxapram on 
respiratory rate and depth when used to antagonise tiletamine and zolazepam were however useful. 
The onset of fine muscle fasciculations and "dissociated look" after sarmazenil administration also 
suggests that it did appear to antagonise some of the effects of the zolazepam in tiletamine and 
zolazepam and the diazepam in the 50:1 ketamine: diazepam trial group. However the times to first 
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movement forward were unaffected by sarmazenil compared with their respective control groups (Table 
12.2) which might indicate that this variable is controlled primarily by the tilatamine or ketamine in 
the combinations rather than the zolazepam or diazepam. 
Although tiletamine and zolazepam and 50:1 ketamine: diazepam appeared to be antagonised by 
sarmazenil and doxapram, respectively, the low levels of chemical restraint and rapid recoveries 
normally seen with these drug combinations mean that routine antagonism is not indicated. 
Antagonism may be more useful in situations where animals are more deeply anaesthetised, recovery 
is prolonged, or if more benzodiazepine is used. 
The two episodes of blindness seen during this study (one with 4-aminopyridine with sarmazenil) were 
of concern. The menace response of the 50:1 ketamine: diazepam animal which received sarmazenil 
and became blind was intact prior to 50: 1 ketamine: diazepam administration indicating that the drugs 
were responsible for the loss of vision. It is unlikely that the animal given 100: 1 ketamine: diazepam 
and 4-aminopyridine was blind before chemical restraint since, although blind seals are sometimes 
found (Sorensen 1950, King 1983, Lavigne and Kovacs 1988), in our experience southern elephant 
seals which lose vision do so because of obvious trauma and this animal's eyes appeared structurally 
normal. 
The manufacturers of 4-aminopyridine and sarmazenil have received no other reports of blindness 
resulting from administration of these drugs and there appear to be no reports in the literature of this 
effect (Parnell and Roche, respectively personal communication). Both manufacturers stated that the 
loss of menace response was unlikely to be related to 4-aminopyridine or sarmazenil administration 
but was more likely to be a result of residual effects of the anaesthetic used in conjunction with the 
benzodiazepine. Assessment of vision can be difficult when the menace response is lost. We have 
found slowed, or absent, menace responses in some animals which appeared to be hallucinating after 
administration of tiletamine and zolazepam or ketamine combined with diazepam. However, animals 
have usually fully recovered within 2 h of drug administration; 8 h and 30 h seem long periods for 
this effect to be apparent if it is due to the cyclohexamine component of the combinations. 
One of the more common causes of post-anaesthetic blindness is cortical damage resulting from 
reduced brain perfusion or anoxia during anaesthesia, but this seems an unlikely cause given the 
normal heart rate and respiratory rate. We have also never seen blindness in southern elephant seals 
which have recovered from what appeared to be severely anoxic states (cyanotic mucous membranes, 
prolonged apnoea, dramatic changes in venous blood gas values and pupillary dilation possibly 
associated with anoxia) or in apnoeic animals whose heart rates have dropped to < 4 beats/ min. 
Although still unexplained, blindness is highly undesirable and the combinations of drugs in which it 
was seen should be avoided. 
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This trial was limited to drugs which were considered to have the greatest potential for use. Other 
antagonists are available so there is scope for further work with these drugs, dose-response ,studies, 
optimising agonist/ antagonist ratios, and combinations of antagonists. However, until these trials 
are performed the doses of drugs presented here could be used as a guide. Specifically, ketamine and 
xylazine can be antagonised with 0.06 mg/kg yohimbine, and for circumstances during which an 
improvement in ventilation and arousal is required, 2.0 mg/kg doxapram can be used and repeated as 
necessary. Though sarmazenil appeared useful for antagonism of tiletamine and zolazepam at a dose 
of 1.0 mg/kg, the apparent blindness associated with its administration to 50:1 ketamine: diazepam 
animals suggest that its use should be approa~hed with caution until dose-response studies are 
performed. Similarly, until further studies are performed the use of 4-AP for antagonism of 100:1 
ketamine:diazepam should also be approached with caution. 
Finally, the use of antagonists should be put into perspective. Given our current knowledge, their 
real benefit is during routine work when animals are breathing normally, procedures have been 
completed and arousal is required. The pressure and rate of flow in the extradural intravertebral vein 
may be low, as part of the adaptations to anoxia during diving, and in apnoeic animals drugs 
administered by this route may be ineffective (Baker and Gatesman 1985; Chapter 11). For this 
reason antagonists administered by this route cannot be relied upon to treat life threatening 
complications associated with apnoea during chemical restraint and their use at these times may be 
contraindicated (Chapter 11 and 13). 
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Chapter 13: Apnoea during chemical restraint 
Introduction 
Apnoea has been reported as one of the most common side effects of pinniped anaesthesia (Gales 
1989) yet there is little information regarding its cause. Drug over-dose and fright have been 
implicated (Backhouse 1964, Gales and Burton 1987a). 
Mitchell and Burton (1991) discussed fatalities which occurred during chemical restraint of elephant 
seals injected with various cyclohexamine based drug combinations. In several cases death was 
associated with prolonged apnoea. However, prolonged apnoea is normal when seals dive. Southern 
elephant seals dive for periods of up to two hours (Hindell et al. 1992) and apnoea lasting up to 40 
min has been recorded for elephant seals on land (Kenny 1979, Huntley 1984). Mitchell and Burton 
(1991) considered that apnoea during anaesthesia did not necessarily indicate a problem, since many 
elephant seals have undergone prolonged apnoea during anaesthesia without ill effects (Castellini et al. 
1986, Antonelis et al. 1987). 
However, apnoea has been associated with deaths under anaesthesia and two explanations have been 
proposed. The full physiological response associated with the apnoea of sleep or diving may not have 
been elicited, resulting in the early development of anaerobic conditions and death within the first hour 
of anaesthesia (Mitchell and Burton 1991). An alternative hypothesis was proposed by Backhouse 
(1964), that some of the anaesthetic may be pooled in venous sinuses during "diving" apnoea and not 
be metabolized; when the animal "surfaces" to breath, the anaesthetic agent is released and enters the 
brain to cause a relapse to deeper anaesthesia. 
There are also few guide-lines in the literature on if and when apnoea should be considered a problem 
and treatment instigated (Mitchell and Burton 1991). The theoretical aerobic dive limit has been 
defined as the longest breath-hold possible without any increase in blood lactate during or after the 
dive, and is dependent on the available oxygen stores, oxygen consumption rate, degree of peripheral 
vasoconstriction, and rate of lactic acid production and consumption (Kooyman 1989a). It was 
hypothesised that an estimated aerobic dive limit could be used as an indicator of when breathing 
should recommence in apnoeic animals, and therefore the relationship between apnoea and estimated 
aerobic dive limit was examined. 
The apparent conflict in the literature and lack of guide-lines prompted us to perform a study, the aims 
of which were to (1) examine possible initiating causes of apnoea, (2) examine anaesthetic drug 
pharmacokinetics during apnoea, and (3) develop guide-lines for prevention and treatment of apnoea 
during chemical restraint. 
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Materials and Methods 
General 
The animals and general methods used in this study were those used in Chapter 6 (n = 225). The 
study was performed opportunistically on animals being restrained for other purposes. Apnoea was 
defined as breath-holding for> 1 min, and prolonged apnoea as breath-holding for > 10 min. Apnoea 
was treated after 1 min by stimulating the animal (touching its face, manipulating its caudal flukes, or 
rolling it from side to side). 
Three aspects of apnoea during anaesthesia were studied. 
Initiating factors 
i. Dose and level of restraint 
The dose of ketamine was compared in animals which became apqoeic (n = 55) and those which did 
not (n = 81). The incidence of apnoea was compared in animals at low levels ofrestraint (<level 5) 
and those at greater levels of restraint (:2'. level 5). Only animals which did not receive any additional 
drugs or other treatment, such as gastric lavage, were included in the comparison (n = 136). 
ii. Size 
The incidence of apnoea was compared in small ( < 1000 kg) and large (:2'. 1000 kg) animals which did 
not receive any additional drugs or other treatment (n = 136). 
iii. Additional drug administration 
A comparison was made between the incidence of apnoea or breathing difficulties in animals which 
received additional intravenous ketamine (n = 25) with those that did not receive any additional drugs 
or other treatment (n = 136). 
iv. Gastric lavage 
; 
The incidence of apnoea, or breathing difficulties, was recorded in animals during and immediately 
after gastric lavage (n = 16) and a comparison made with those which were not lavaged and did not 
receive any additional drugs or other treatments (n = 136). 
v. Level of arousal 
To examine the relationship between fright and apnoea, the incidence of apnoea was compared in 
animals which were sleeping prior to injection with those which were awake; and after injection by 
comparing the incidence of apnoea in relaxed animals with the incidence in disturbed or aggressive 
animals (considered to be frightened). Only animals which did not receive any additional drugs or 
other treatment were included in the comparison (n = 136). 
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Apnoea and the estimated aerobic dive limit 
All 225 animals restrained with 100: 1 ketamine: diazepam (Chapter 6) were used for this part of the 
study. The total duration of apnoea observed was compared with the estimated aerobic dive limit, 
calculated for each animal using the relationship presented by Hindell et al. (1992): 
Aerobic dive limit (min) = (lean body mass*T02)/ RMR (Kooyman 1989 a) 
where T02 (total available oxygen) = 0.079 L/kg (Kooyman 1989 a), and RMR (resting metabolic 
rate) = 0.0113 (lean body mass0.75) (L 02/min; Schmidt-Nielsen 1983). The method used for 
determination oflean body mass has been presented in Chapter 7 and Appendix V. 
Ketamine pharmacokinetics during apnoea 
i. Animals 
The level of ketamine in plasma was measured in 8 pre-moult female southern elephant seals. Seven 
were restrained with 100: 1 ketamine: diazepam (Chapter 6), and one with ketamine and xylazine. 
These seals were divided into 4 groups of 2 based on the duration of apnoea: (1) no apnoea, (2) apnoea 
of< 10 min duration, (3) apnoea> aerobic dive limit and survived, and (4) apnoea> aerobic dive 
limit and died. 
ii. Samples 
In animals breathing normally, blood samples were taken from the extradural intravertebral vein at 5 
min intervals until 30 min, then at 10 min intervals until the level of restraint was too low for 
sampling. This sampling protocol was also followed in apnoeic animals, however in animals apnoeic 
for greater than their estimated aerobic dive limit samples were taken when possible as procedures 
such as intubation and ventilation often prevented sampling. In one of the seals which died, the 
concentration of ketamine in the hepatic sinus just after death was also measured. Sample collection 
and preparation was the same as that presented in Chapter 7. 
iii. Analysis 
The technique for analysis has been presented in Chapter 7. Two replicate extracts of each sample 
were analysed and the average value determined. Because some animals received drugs other than 
ketamine, gas chromatography - mass spectroscopy was used to check for interfering peaks, of which 
none were found. 
In the two animals which died, packed cell volume was also measured in each of the blood samples 
taken for pharmacokinetic analysis. 
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Data analysis 
Groups were compared using the Mann-Whitney U test. Relationships were examined using 
Spearman rank order correlation (rs) and comparison of frequencies using ·X2 analysis. Differences 
were considered significant when P < 0.05. 
Results 
General 
Of the animals which did not receive any additional drugs or other treatment (n = 136), a median of 
one episode (range = 1-3) of 6 min apnoea (range = 1 - 52 min) was seen in 55 ( 40% ), and evidence of 
upper respiratory tract obstruction, difficulty breathing or shallow respiration in 7 (5%). 
Initiating factors 
i. Dose and level of restraint 
The median dose of ketamine administered to animals which became apnoeic was not significantly 
different to that administered to those which did not (2.91 mg/kg, range= 1.19 - 8.42 mg/kg, n = 
136) (U = 5085.5, P > 0.4). The incidence of apnoea was higher in animals at levels of chemical 
restraint~ 5 (74%) compared with animals at lower levels ofrestraint (36%) (Table 13.1). 
ii. Size 
Apnoea or breathing difficulties were more commonly seen in smaller animals (69% of those< 1000 
kg) compared with larger animals (21%) (Table 13.1). 
iii. Additional drug administration 
Transient apnoea of approximately 4 min (range = 1 - 11 min) duration occurred in 7 of the 25 
animals (28 % ) which received additional intravenous ketamine, and breathing slowed or became more 
laboured in another 3 animals. Apnoea was also seen on 2 of the 5 occasions after additional drug had 
been administered intramuscularly. The proportion of animals which became of apnoeic or had 
difficulty breathing after additional ketamine ( 40%) was the same as the proportion which became 
apnoeic after a single intramuscular dose of 100:1 ketamine: diazepam and had not received any other 
drugs or treatment (40%) (Table 13.1). 
iv. Gastric lavage 
Apnoea for the duration oflavage was seen in 9 of 16 animals (56%) and evidence of upper respiratory 
tract obstruction, difficulty breathing or shallow breathing was seen in 5 others. The incidence of 
apnoea or breathing difficulties was greater in lavaged animals (88%) than in animals which were not 
lavaged and had not received other or additional drugs ( 40%) (Table 13.1). Once lavage was completed 
breathing returned to normal in all but one animal. This animal did not commence breathing and was 
euthanased (see below). 
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Table 13.1. Factors associated with apnoea in southern elephant seals restrained with 100:1 ketamine: diazepam. Of the 136 animals which did not recei~e additional drugs 
or have other procedures performed on them, 55 became apnoeic and 81 did not. Twenty five animals received additional ketamine intravenously and 16 were lavaged. 
The failure of figures to add up under the categories of level of restraint and size is because these values were not determined in all animals. This was usually because 
animals were immobilized in circumstances where determination of these values was dangerous eg when anaesthetising animals at night or in crowded harems, 
usually for data-logger retrieval. 
Apnoea 
No apnoea 
Level of Restraint* 
<5 ;?:5 
32 23 
57 8 
x2 = 13.541 
P<0.001 
*Not measured in 16 animals. 
tNot measured in 17 animals. 
*Apnoea or difficulty breathing. 
§7 apnoeic, 3 difficulty breathing. 
Il9 apnoeic, 5 difficulty breathing~ 
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v. Level of arousal 
The incidence of apnoea in animals which were sleeping (55%) prior to drug administration was not 
significantly different to that seen in animals which were awake (38% ). The incidence of apnoea was 
also similar for animals which were relaxed after drug administration (39%) compared with those 
animals which were disturbed and aggressive (44%) (Table 13.1). Aggressive animals often required 
larger, or additional, doses of drug to induce the required level of restraint which limited work with the 
animals as additional time was spent waiting for drugs to have an effect. 
Apnoea and the estimated aerobic dive limit 
Estimated aerobic dive limits increased with the size of the animals and ranged from 21 to 33 min for 
animals < 1000 kg and 34 to 52 min for animals ;;:: 1000 kg (Table 13.2). 
Of the 55 animals in which apnoea was seen, 52 (95%) began breathing by the time the 
estimatedaerobic dive limit was reached, mostly within 10 min of the onset of apnoea. In most cases 
in these animals pH and blood gas values remained relatively stable with pH of approximately 7.35, 
Pvo2 of approximately 40 mmHg and Pvco2 < 60 mmHg. Example plots of pH, blood gas and 
ketamine concentration in blood taken from the extradural intravertebral vein over time for one animal 
which did not become apnoeic, and one apnoeic for less than 10 min, are presented in Figure 13.lA 
and B respectively. 
Of the 3 animals which received 100: 1 ketamine: diazepam and whose apnoea exceeded their estimated 
aerobic dive limit two survived. In these two animals pH and Pvo2 fell gradually during apnoea to 
between 6.9 and 7.0 (pH) and< 10 mmHg (Pv02), and Pvc02 rose to between 80 and 100 mmHg as 
the duration of apnoea progressed. Once breathing commenced pH and blood gas values returned to 
normal over the next 20 min. An example plot of pH, blood gases and ketamine concentration in 
blood taken from the extradural intrav~rt:ebral vein over time for one animal of these animals is 
presented in Figure 13.lC. 
The third animal which received 100: 1 ketamine: diazepam and exceeded its estimated aerobic dive 
limit died (Figure 13. lD; tag number 3071). The ammal which received ketamine and xylazine and 
died also exceeded it's estimated aerobic dive limit (Figure 13.lE; tag number 3049). In both animals 
pH and Pvo2 fell gradually during apnoea and Pvco2 increased, however animal 3071 received 
4000 mmol/L of bicarbonate at 43 mm, at which time there was a rapid increase in pH, Pvco2 and 
HC03-. This animal appeared to vomit during mtubat:10n though no vomit was observable. 
However on post-mortem vomit was found within the nasopharynx, trapped behind a "sphincter" 
made by the soft palate, base of the tongue and aryepiglottic folds, effectively sealing off the oro-
from the nasopharynx. There was no vomit in other parts of the airway. In both animals the packed 
cell volume increased during the anaesthetic episode; in animal 3071 from 64% initially to 70% just 
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Table 13.2. Nominal snout-tail length (STL), mass and estimated theoretical aerobic dive limits (ADL) 
(median, range) calculated for different categories of southern elephant seals at different 
times of their life cycle. Estimated masses and AD Ls for subadult males could be based on 
those used for females of similar size and stage of yearly cycle. The categories of animals 
are described in Chapter 6. 
Category STL Mass ADL n 
Sex Age Stage of yearly (m) (kg) (min) 
life c cle 
Male and Yearling } 2.0 200 23 32 female (21 - 28) 
Female Pre fast 
) 
450 ) 29 109* 2.5 (26 - 33) Postfast 350 
Male Subadult 2.0- 3.5 
Bachelor Prefast } 1800 ) 36 20 3.5 (34 - 48) 
Postfast 1300 
Harem bulls 
I. Challenger Prefast } 2400 } 38 31 4.0 (34 - 52) Postfast 1500 
II. Beach master Prefast ) 2600 ) 40 21 4.5 (36 - 47) 
Postfast 1800 
*Mass was not determined in 10 animals 
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Figure 13.lA. No apnoea. An example of changes in pH, blood gas values, and the 
concentration of ketmine in blood collected from the extradural intravertebral vein over 
time in a female southern elephant seal restrained with ketamine and diazepam which did 
not become apnoeic. 
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Figure 13.lB. Apnoea for < 10 min. An example of changes in pH, blood gas values, and the 
concentration of ketamine in blood collected from the extradural inu·avertebral vein over time in a 
female southern elephant seal restrained with ketamine and diazepam which became apnoeic for less 
than 10 min. The apnoeic period is represented by the solid horizontal line in the bottom graph. 
(The ADL estimated was 28 min). 
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and the concentration of ketamine in blood collected from the extradural intra vertebral vein over time 
in a female southern elephant seal restrained with ketamine and diazepam which became apnoeic for 
less than its estimated ADL (30 min) and survived. The apnoeic period is represented by the 
horizontal line in the bottom graph. 
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prior to death and in animal 3049 from 69% to 80%. (Case reports describing the time course of the 
anaesthetic episode for each of these animals are presented in Appendix IV.) 
Ketamine pharmacokinetics during apnoea 
The median concentration of ketamine in the blood at the time that the first blood sample was taken 
for all animals was 2.6 µg/mL and the median concentration just prior to the animals moving away 
was 1.2 µg/mL (Table 13.3). 
In animals which breathed throughout the anaesthetic episode ketamine concentrations remained below 
1.7 µg/mL (maximum level for each animal = 1.6 and 1.7 µg/mL) during the episode of restraint. 
The median ketamine concentration at which breathing stopped in all apnoeic animals (2.2 µg/mL, n 
= 8) was not significantly different to that recorded just before breathing commenced (2.8 µg/mL, n = 
6) (Table 13.3). 
In animals apnoeic for less than their estimated aerobic dive limit the duration of apnoea increased as 
concentration of ketamine at the onset of apnoea increased. However, average ketamine 
concentrations at the ~mset of apnoea were significantly higher in the 4 animals apnoeic for less than 
their estimated aerobic dive limit (median = 3.5 µg/mL) than in the 4 which exceeded their estimated 
aerobic dive limit (median = 2.2 µg/mL) (U = 0.00, P < 0.05; Table 13.3). 
There was a rapid fall in the concentration of ketamine with time in one animal which became 
apnoeic for less than 10 min (Figure 13.lB). This animal received 3.01 mg/kg ketamine with 0.027 
mg/kg diazepam, reached a maximum level of restraint of 4 in approximately 2 min, which lasted for 
15 min. The animal had recovered 50 min later. 
There was no clear trend in ketamine concentrations of the animals which were apnoeic for longer 
than their estimated aerobic dive responses and survived. However, in one animal, for which the most 
data were available, ketamine levels decreased until about 20 to 30 min and then increased until 
breathing recommenced when there was a rapid rise in ketamine level followed by a fall (Figure 
13.lC). A fall in ketamine concentration after breathing commenced was also seen in the other 
animal which was apnoeic for longer than 30 min. 
190 
--_Apnoea during chemical restraint 
7.6 
7.4 
0 
0 0 
0 
_o 
00 0 
oocP 
OOo 0 
o > o oo 00o
0 o o 
c..-Q., 
7.2 
7.0 
6.8 0 .5 
6.6 l 
.!!3 6.4.._ __ _,_ ____ .__ __ _._ ____ ...._ __ _._ __ __....._ __ ...._ __ __. ____ ...._ __ __. ____ ...._ __ __. 
0 
100 
v 40 
• 
20 40 60 80 100 120 140 160 180 200 220 240 
Time(min) 
v 
v 
v 
v 
v 
• vv.,. 
.. .,. 
.............. •: . .,. ...... ... 
.,..,. ...... . .. . 
. .... 
•• • • 
V Vv 
v 
v 
• 
v 
vv 
.,. .,. 
• • • 
v 
.,. 
• 
0 '-----'-----..L....----'-----'------ii..---...L..----.&....--....L----...L..-----ii..---...L..------1 
~6000 
C1i 
.s 5000 
§ 
·:s 4000 
5 g 3000 
8 
0 
.!3 2000 
~ ~ 1000 
0 
a 
a 
20 40 60 
c 
a 0 a 
a a a 
c 
c 
80 
a CC 
a 
a 
100 120 140 160 180 200 220 240 
c 
Time(min) 
c 
c 
a 
Ketamine concentration 
in hepatic sinus at post- ""C 
mortem was 3214 ng/mL 
c 
a c 
a ea 
c 
a 
c 0 .__ __ _.. ____ ..i... __ ---11..---...&..----i-----'-----.._ __ _.. ____ ...L.----'-----'-----' 
0 20 40 60 80 100 120 140 160 180 200 220 240 
Tim~(min) 
' 191 
Figure 13.lD. Apnoea for > estimated ADL and died. Changes in pH, blood gas values, and the 
concentration of ketamine in blood collected from the extradural intra vertebral vein over time in a 
female southern elephant seal restrained with ketamine and diazepam which became apnoeic for longer 
than its estimated ADL (29 min) and died. The apnoeic period is represented by the solid horizontal 
line in the bottom graph and the animal's tag number was 3071). (PPV - - - - - - - - =duration of 
positive pressure ventilation; Bicarbonate -- - -- = duration of bicarbonate administration). 
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Figure 13.lE. Apnoea for > estimated ADL and died. Changes in pH, blood gas values, and the 
concentration of ketamine in blood collected from the extradural intravertebral vein over time in a 
? 
female southern elephant seal restrained with ketamine and xylazine which became apnoeic for longer 
than its estimated ADL (31 min) and died. The apnoeic period is represented by the solid horizontal 
line in the bottom graph and the animal's tag number was 3049). (PPV - - - - - - - - =duration of 
positive pressure ventilation). 
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Table 13.3. Ketamine concentration in plasma (average of two or median, range) taken from the extradural intravertebral vein during chemical restraint of 9 southern 
elephant seals chemically restrained with 100: 1 ketamine: diazepam and 1 with ketamine and xylazine. The animal which received ketamine and xylazine died. 
Duration of apnoea 
Less than estimated 
aerobic dive limit 
Greater than estimated 
aerobic dive limit 
All animals 
*Before death. 
tn=2 
:j:n=6 
§n=8 
None 
< 10 minutes 
> 10 minutes 
All animals 
- ~ 
Survived 
Died 
All animals 
Initial 
1.4 
3.0 
4.3 
3.0 
(1.l - 4.7) 
2.2 
2.3 
2.2 
(1.8 - 2.9) 
2.6 
(1.1 - 4.7) 
Ketamine concentration in plasma (µg/mL) n 
At the onset of apnoea At the commencement of breathing Before moving away 
1.2 - 0.9 2 
3.0 
4.3 
3.5 
(2.8 - 4.7) 
2.2 
1.5 
2.0 
(1.3 - 2.3) 
2.2 
(1.1 - 4.7) 
3.0 
2.7 
2.8 
(2.6 - 3.1) 
2.8 
2.8t 
(2.4 - 3.1) 
2.8:j: 
(2.4- 3.1) 
1.1 
1.3 
1.1 
(0.6 - 1.6) 
1.6 
3.0* 
(1.7 - 4.3) 
1.6t 
(1.1 - 2.8) 
1.2§ 
(0.6- 2.2) 
2 
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2 
4 
10 
~ 
15 
~ g. 
s· (IQ 
~ §. 
(") 
~ 
~ e:. 
:::i 
...... 
....... 
ID 
(.;) 
Apnoea during chemical restraint 
Ketamine concentrations in the apnoeic animals which exceeded their estimated aerobic dive response 
and died were characterised by prolonged high concentrations with large fluctuations, either increasing 
or decreasing over time. In animal 3071, for which most data were available, there was a rapid initial 
fall in ketamine concentration followed by apnoea and an increase in ketamine concentration. The 
concentration of ketamine in the hepatic sinus of this ammal after death was 3.2 µg/mL, 
approximately 3 times that last recorded in the venous blood (0.9 µg/mL) (Figure 13.lD). Few 
values were recorded in the other animal, however ketamine concentration fell after several breaths 
were taken at 33 min (Figure 13.lE). (Note that the scales on the abscissae in Figures 13.ID and E 
differ. They are also different to those in Figures 13. lA to C). 
Recommendations for treatment of apnoea 
Table 13.4 presents techniques which can be used to prevent or treat apnoea. Figures 13.2 and 13.3 
present an approach developed to treat apnoea and breathing difficulties in this study. 
Discussion 
General 
Because apnoea was prevented in this study by stimulating animals to breath, the results presented 
need to be interpreted with caution. Apnoea did not appear to be related to dose of ketamine 
administered, but was more commonly associated with deeper (:2: level 5) restr·aint and smaller (< 1000 
kg) animals. This indicates that working at low levels of restraint could be used to decrease the 
incidence of apnoea. However, because the dose of ketamine at which apnoea was seen (median = 
2.83 mg/kg) was the same as that at which it was not seen (median= 2.75 mg/kg), and because this 
dose is the lowest at which intravenous access can be attained in the majority of animals (level 3 - 4 
restraint; Chapter 6), prevention of apnoea at these levels by using lower drug dosage may not be 
possible without compromising the ability to handle the animal, and induction of apnoea should be 
expected as a normal occurrence during restraint. Despite its high incidence, in most cases apnoea can 
be prevented or treated by nociceptive stimuli to the animal or by rolling it over (see Physical 
techniques, Table 13.4). The higher incidence of apnoea in smaller animals was probably due to 
treatment bias. There are problems associated with treatment of apnoea in large animals (Chapter 11) 
and for this reason greater efforts were made to prevent its occurrence in them. 
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Table 13.4. Some tcdmiqucs used ta stimulate breathing or aid respiration in c:hemically restrained southern elephant seals, how they are perfonned and their usefulness. 
TechniQUe 
Physical Repositioning 
Tnpping muzzle 
Head manipulation 
Caudal flipper 
manipulation 
Rocking 
Rolling 
lnttoduction of needles 
Holding narcs open 
Nasophmyngeal tubes 
Adducting atytmoids 
Chi:mical Donpram and 
antagonists 
Intubation and Intubation 
mcchmllcal ventilation 
MC!hod 
Ensure no pressure on 1rachea or chest, extend neck 
and position cows in sternal recumbency, bulls on their 
back and side. 
Genlle tap of eilher side of muzzle. 
Bilher side of muzzle (nose in bulls) grasped fumly In both 
hands and head shaken side to side or lifted upwards and 
allowed ro drop back into a normal resting position. 
Bodi caudal flippers grasped and swung from side to side. 
Pressure applied across the width of Dl of the caudal 
flukes. 
A rocking motion is induced by intermittently 
puning adaxial pressure on !he chest. A$ rocking 
excursions become more marked the animal can be 
rolled over. After 1 or 2 rolls there is a pause to see 
if breathing will commence. 
Into lhe e>.tradural intravertdmll vein (18 0, 90mm) 
or philtrum (18 G, 38nun). 
A f111ger Is inserted into the nostril and pressure 
applied dorsally and abaxially. 
Comments 
Occasionally useful 
Useful for stimulating breathing early in the anaesthetic 
episode or regularly during chemical res1r11int at low levels 
of chemical restraint (eg < S). May also be useful at 
greater levels chemical restrainL 
Use caution in bulls when tapping muzzle or manipulating 
head as they can appear more heavily chemically restnined 
than they are; similarly with kctamine and xylazine 
Immobilized cows. 
Rocking can be achieved with a needle in the cxtradural 
in1nlvertebral vein, for rolling it needs to be removed. 
Useful techniques for deeper levels of restraint as well as 
lower levels. 
Rolling of cows required 2 to 3 people; bulls 6 to 12. 
Some animals cannot be rolled due to positioning. 
Most useful into cx1r11dural lntravertebral vein al low levels 
or chemical restraint (< S). 
Utile use. Can't be sure of maintaining airway, difficult or 
Impossible to hold open In strong cows or bulls for 
prolonged perioda. 
Approximately 2D an x IS nun outside diameter soft Little use. Cannot be passed into nasoplwynx due IO 
plastic lubricated and slid caudally up either nostril. ethmoldal labyrinth occluding the fundus of lhc nasal cavity. 
With mouth held open (Chapter 3) a fmger is slid between Sometimes useful In light animals. These animals may 
the adducted arytenold cartilaacs. cough, bi~ down or shake head. Dangerous in light bulls. 
Chapters 11 and 12. Only useful for sti11D1lation of respiration in breathing 
animals, unreliable in apnocic animals and may be 
contraindicated. 
Chapter 3. Checlc for vomit and clear from baclc 
of throat if necessary. 
May exacerbate problem al deplh < S. 
Occasionally useful and allows positive pressure 
ventilation and maintaincnce of an airway. 
Nasopharyngeal oxygen Chapter 3. Useful for assisted respiration if respiratory rate la 
Assisted Chapter 3. 
Positive pressure Chapter 3. 
low or upper respiratory tract obstnlction, or in animals too 
lighllo intubate. 
Useful with an endotracheal tube if respiratory rate Is low 
or there is evidence of upper respiratory 1ract obstruction. 
Treatment of choice in animals less than 1000 kg but 
there arc difficulties with larger animals and 
practical problems associated with intubation, size 
and use of equipment in isolated area. 
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APNOEA 
t 
Reposition 
/(neck extended, +ori~ntal plain) 
Breathing 
(see Figure 13.3 if 
breathing is difficult) 
Assess: 
Apnoeic. 
(note time) 
t 
Level of restraint 
Mucous membrane colour 
Capillary refill H. rate 
Physical techniques for stimulation of breathing: 
Manipulation 
Needles~ Rocking 
Rolling 
Level of restraint ~ 6 or (Table 13.4) Level of restraint < 6 
Mucous membrane colow: blue or 
Capillary refill> 2 - 3s or 
Heart rate abnormal or undetectable or 
Intubate and ventilate with oxygen 
(position bulls on their side or in oblique 
recumbency and/or roll them over) 
~ 
Mucous' membrane colour pink 
Capillary refill < 2 - 3s 
Heart rate normal 
,. 
Use physical techniques until: 
Animal becomes 
cyanotic 
heart rate abnormal 
or undetectable 
level of restraint ~ 6 
Mucous membrane colour pink H too light to intubate, continue 
Capillary refill < 2 - 3s physical techniques and prepare 
Heart rate> 30 bpm "" IO llttuba!e. 
Remove endotracheal tube 
when breathing or if conscious 
breath-holding (< level 5, 
nostrils twitching, good colour), 
or if gagging or heaving) 
Endotracheal doxapram 
(2 mg/kg) and repeat if 
necessary 
-
-------•~ Apnoea persists 
Figure 13.2 A flow chart for treatment of apnoea in southern elephant seals. Normal and 
abnormal values for heart rate can be found in Table 6.3, and appropriate sizes of endotracheal tube for 
particular categories of animal in Chapter 3 and Table VI.2. Effective ventilation of bulls may not be 
possible. In these animals doxapram could be administered endotracheally whilst the animal is still 
cyanotic (Chapter 11). (Level of chemical restrain 6 =light anaesthesia; Chapter 4). 
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DIFFICULTY BREATIIING 
Slow, or shallow, or stertorous Acute onset of gagging, heaving 
or slridor 
Reposition; neck extended, horizontal plain 
' Physical techniques; manipulation, needles, rocking, rolling (Table 13.4) 
Difficult to gain access to animal 
whilst gagging and heaving. If 
possible give nasopharyngeal 
oxygen. Also give diazepam to 
Deep~6 
Light<6 
effect into the exttadural intravertebral 
vein if< level 6 (15 - 25 mg/ 450 kg). 
+ Wait until gagging or heaving finishes, 
reposition, and assess depth 
~-............ 
Usually no treatment necessary. 
Monitor, or if concerned 
If light< 6 
I 
If deep <::6 
i 
Administer more :-----..._ 
anaesthetic, diaupam ----..._ 
I or neuromuscular blocking drug eg suxamethonium 
(0.5 - 2.0 mg/kg) 
N~g\~ygm i 
Intubate and assisted 
or mechanical ventilation 
Administer antagonist or 
doxapram (2 mg/kg) into the 
exttadural intravertebral vein 
Check for 
vomit and 
clear 
Figure 13.3. A flow chart for treatment of breathing difficulties in southern elephant seals. 
Doses of antagonists can be found in Chapter 11. (Level of chemical restraint 6 = light 
anaesthesia.) Because it can be difficult to differentiate between vomiting and laryngeal 
spasm due to the anatomy of the upper respiratory tract, it is recommended that examination 
for the presence of vomit is made if animals become apnoeic. (Level of chemical restraint 6 
= light anaesthesia; Chapter 4.) 
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Apnoea and additional drug administration 
Despite the incidence of apnoea being no greater after additional intravenous ketarnine administration, 
apnoea was often observed and it may be expedient to administer further ketamine as repeated, small 
doses, slowly over 30 - 60 s to effect, rather than rapidly as a single large bolus, and to be prepared to 
treat any ensuing apnoea. 
Apnoea and gastric lavage 
Apnoea and breathing difficulties were commonly associated with gastric lavage. Once the lavage 
tube was removed breathing returned to normal indicating that the presence of the tube was 
responsible for the breathing difficulties. Therefore, if animals need to be lavaged and the duration of 
apnoea minimised, lavage should be carried out as rapidly as possible. Prevention of breathing by 
foreign bodies in the airway was also seen when intubating animals with an endotracheal tube 
(Chapter 11). The animals in this study were not intubated because this was considered to increase 
the level of restraint required and predispose to apnoea. The light levels of restraint used, tight 
adduction of the arytenoids and presence of a swallowing reflex would allow the airway to protect 
itself. HOWEVER, THE TWO ANIMALS WHICH DIED DURING THIS STUDY HAD VOMITUS IN THE 
UPPER AIRWAY WHICH WAS NOT VISIBLE AND FOR THIS REASON IT IS RECOMMENDED THAT AN 
ENDOTRACHEAL TUBE BE IN PLACE WHILST LA VAGING SEALS. If this is not possible due to 
msufficient restraint, the animal should be positioned head down to allow drainage of vomitus during 
the procedure; the gastric lavage tube should be emptied as much as possible and "kinked over" upon 
withdrawal to prevent fluid entering the oro- and nasopharynx; appropriate volumes of fluid used*. 
The airway should also be checked for the presence of fluid if this is suspected ( eg if there is evidence 
of vomiting or regurgitation of fluid) and intubation performed. 
Apnoea and level of arousal 
Surprisingly, level of arousal appeared to have little effect on the incidence of apnoea. However, 
aggressive animals often required larger, or additional, doses of drug to induce the required level of 
restraint. Administration of drug to quiet, somnolent animals was therefore preferred as time was not 
spent waiting for additional doses of intramuscular drug to have an effect. 
Apnoea and the estimated aerobic dive limit 
Only three of the 55 animals which became apnoeic after a single dose of 100: 1 ketamine: diazeparn 
exceeded their estimated aerobic dive limit (5% of apnoeic animals and 2% of all animals). It is 
unknown if a larger number would have exceeded this limit if allowed to remain apnoeic and not 
stimulated to breath. It could therefore be argued that apnoea for periods less than the estimated 
aerobic dive limit is a normal occurrence and should not need to be treated. This is correct in the 
majority of cases, however some apnoeic animals will go on to exceed their estimated aerobic dive 
* Three to 4 lavages of approximately 3 to 4 Leach is usually adequate for cows, 2 - 3 L for 
yearlings, and 4 - 6 L for bulls. 
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limit and some of these will progress to death; others will become cyanotic and excessively deeply 
anaesthetised inside their estimated aerobic dive limit. Furthermore the aerobic dive limit is often 
predicted based on oxygen stores and availability and a predicted rate of utilization. What this 
utilization rate is during the highly irregular conditions of anaesthesia is impossible to guess (Fedak 
personal communications 1994). For these reasons other indicators, such as mucous membrane colour 
and degree of central nervous system depression, are probably better indicators of whether apnoea 
should be treated. 
Ketamine pharmacokinetics during apnoea 
The small sample sizes make interpretation of these results difficult. Also, ketamine concentrations 
in the extradural intravertebral vein may not reflect central nervous system concentrations (below). 
The median concentration of ketamine at which apnoea was induced (2.2 µg/mL, n = 8) was greater 
than the highest concentrations recorded in the two animals in which apnoea was not seen (less than 
1.7 µg/mL) which implies that induction of apnoea may be dependent on ketamine concentration in 
the blood. However, the average concentration of ketamine at which apnoea was seen in the two 
animals which died was 1.5 µg/mL. This implies that other factors may be responsible for its 
induction and maintenance. In the animals which died gastric lavage, intubation, and vomit in the 
upper respiratory tract were all implicated. 
The rapid fall in the concentration of ketamine with time in one animal which became apnoeic for 
less than 10 min (Figure 13.IB) suggest that the drugs may have been administered intravascularly. 
Gales and Burton (1987a) reported a fatality after suspected intravascular drug administration of 8.20 
mg/kg ketamine with 0.04 mg/kg diazepam to a southern elephant seal; presumably the 3.01 mg/kg 
ketamine with 0.027 mg/kg diazepam administered to the animal in the present study was a safer 
intravascular dose. It did however, appear to induce apnoea and for this reason care should be taken 
to avoid initial intravascular drug administration. Blood did not flash back into the hub of the needle 
when testing for intravascular location of the needle prior to drug administration in this animal. 
Presumably the lumen of the needle was blocked with tissue or the bevel occluded by the vessel wall. 
If this is the case, then slow administration of drug whilst repeatedly checking for intravascular access 
during intramuscular drug administration may be wise. If blood flashes back into the hub of the 
needle or less resistance to injection is felt then administration could be delayed, the animal's response 
observed, and administration rate, dose of drug, or needle location adjusted accordingly. 
The most striking finding in animals which underwent prolonged apnoea were the fluctuations in 
ketamine concentrations with time and the prolonged high concentrations of ketamine during apnoea 
compared with those for breathing animals. However, these data need to be interpreted with caution 
because (1) free drug was not measured in plasma and (2) because ketamine concentration was not 
measured in the brain. These data may therefore not accurately reflect concentration of free drug in the 
brain or plasma. It is however, interesting to speculate on possible causes for the fluctuations. There 
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are many factors which influence drug concentration in the blood after an intramuscular dose including 
rates of absorption, distribution and elimination, each of which in turn is influenced by lipid 
solubility of the drug, extent of binding to plasma proteins ( 47% for ketamine in humans; Martindale 
1989) and extravascular tissue constituents, and blood flow rates through organs and tissues (Baggot 
1982 a). 
Seals have developed a range of physiological changes associated with diving, including bradycardia 
and a decrease in cardiac output and peripheral circulation (Scholander 1940, Elsner et al. 1966, Elsner 
1969, Kooyman et al. 1981, Butler and Jones 1982). Metabolism is also reduced in many tissues 
(Kooyman et al. 1981). Blood returning to the heart via the caudal vena cava is restricted by the caval 
sphincter level with the diaphragm and pools in the inferior vena cava and hepatic sinus; blood flow 
to the liver decreases (Harrison and Tomlinson 1958). This system acts as a storage compartment for 
relatively well-oxygenated blood. In northern elephant seals approximately one fifth of the total 
blood volume can be contained within the inferior vena cava (Elsner 1969). In the latter portion of 
the dive, blood oxygen has been shown to be higher in the inferior vena cava than in arterial 
circulating blood (Elsner 1969). During the dive the caval sphincter opens periodically during diastole 
letting oxygenated blood enter the heart-brain circulation (Butler and Jones 1982). These actions 
conserve oxygen and glucose for the heart and central nervous system (Kooyman 1968, Robin et al. 
1981) and have been referred to as the "dive response" (Hubbard and Poulter 1968). On land southern 
elephant seals have been described as showing a rhythmic variation of breathing rate characterised by 
some min of eupnoea followed by a period of apnoea of variable duration (Kenny 1979). There is 
evidence to suggest that, in the closely related northern elephant seal (Mirounga angustirostris), this 
"sleep apnoea" has physiological aspects which are similar to those seen in freely diving seals 
(Castellini et al. 1986) and it has been theorised that circulatory changes consistent with those seen 
during diving can occur during anaesthesia in southern elephant seals (Gales and Burton 1987 a). It is 
likely that some of these changes would affect anaesthetic drug kinetics. 
In other animals, redistribution of ketamine from the brain to other tissues is primarily responsible 
for termination of its hypnotic or anaesthetic effect (White et al. 1982). The findings of this study 
suggest that clearance of ketamine decreased with apnoea, leading to prolonged high levels of 
ketamine in the peripheral venous blood. If the caval sphincter opens periodically during diastole 
(letting oxygenated blood enter the heart-brain circulation as it does in diving seals; Butler and Jones 
1982), then ketamine concentrations within the central nervous system may be prolonged at high 
concentrations as anaesthetic laden blood is periodically released from the hepatic sinus; a possible 
mechanism for the prolongation of anaesthesia associated with apnoea reported by Mitchell and 
Burton (1991). Decreased hepatic blood flow associated with apnoea (Harrison and Tomlinson 1958), 
decreasing the rate of ketamine metabolism, and changes in circulation decreasing rate of distribution 
of drug could also contribute to this effect. 
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Backhouse (1964) also suggested that when apnoeic, anaesthetised animals start breathing, 
anaesthetic-laden blood held pooled in the hepatic sinus might rapidly be released into the heart-brain 
circulation increasing the level and/ or duration of restraint. Though speculative, the rapid rise in 
ketamine concentration at the time ofreturn to breathing in one animal (Figure 13.lC), coupled with 
the relatively high concentration of ketamine found in the hepatic sinus of animal 3071 which died 
relative to that last recorded in its venous blood, could be interpreted as supporting this theory. The 
changes in blood gases in this animal ie progressive respiratory acidosis during apnoea (suggesting 
minimal muscle perfusion) followed by metabolic acidosis at the end of apnoea (suggesting washing 
out of muscle compartment) could also be interpreted as supporting this suggestion. 
However, as previously stated, without levels of free drug in the brain and hepatic sinus being 
measured these data need to be interpreted with caution and inferences of central arterial blood gas 
values based on peripheral venous values are very tenuous (Chapter 3). Sampling from the brain and 
hepatic sinus during apnoea, and measurement of free drug, would help clarify these points, although 
the data do indicate that apnoea has an effect on ketamine kinetics. For this reason it is important 
that, until further knowledge is gained, apnoea should be avoided if possible. It also suggests that the 
use of anaesthetics, anaesthetic antagonists and analeptics during apnoea may be contraindicated, their 
kinetics being affected and concentrations possibly becoming excessive when circulation returns. 
Other factors which could be influencing ketamine concentrations include changes in the absorption 
rate of ketamine from muscle, associated with circulatory and perfusion changes during apnoea. 
Ketamine has a pKa of 7.5 which indicates that the concentration of free drug in plasma could also be 
effected by changes in blood pH; ionization increasing as the pH of the plasma decreases and drug 
theoretically becoming trapped within the central compartment, decreasing distribution and clearance 
as elimination increasingly relies upon renal excretion, also possibly decreased due to decreased 
glomerular filtration rate associated with apnoea. The changes in packed cell volume in the animals 
which died could also affect ketamine concentrations by altering volume of distribution. 
The direction of flow in the extradural intravertebral vein could also affect ketamine kinetics. Ronald 
et al. (1977) measured the velocity and direction of blood flow in the extradural intravertebral vein of 
the harp seal (Pagophilus groenlandicus). Blood flow varied directly with increasing and decreasing 
heart rates. Furthermore, when heart rate was above 50 beats/min, dye mjected into the extradural 
intravertebral vein at, and posterior to the fourth thoracic vertebra, passed anteriorly. Between 40 and 
50 beats/min, dye boluses in the thoracic and lumbar regions were observed to stop, and then 
sluggishly reverse direction as the heart rate further decreased, moving posteriorly. With acceleration 
of the heart, the blood immediately flowed anteriorly. There also appears to be some control of the 
ratio of oxygenated blood to deoxygenated blood entering the heart in the bradycardic seal (Ronald et 
al. 1977). In one case, early in the dive, two heart beats were observed by these authors without the 
emission of boluses of blood from the caval sphincter. This would have the effect of reducing the 
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proportion of relatively well oxygenated, venous, hepatic sinus blood sent to the brain and affecting 
ketamine concentrations. These mechanisms may offer an explanation for the fluctuations in 
ketamine concentrations during prolonged apnoea in the animals in the present study. Interpretation 
of anaesthetic drug kinetics in these animals may therefore require simultaneous determination of 
blood flow (direction and rate) at multiple sampling sites. Though speculative, it is possible that 
changes in flow occured at approximately 30 min in the animal presented in Figure 13.lC. 
Both animals which died received bicarbonate (Appendix IV) which could also have contributed to 
trapping of ionized ketamine within the central nervous system if "paradoxical" intracellular brain 
acidosis occurred (Shapiro et al. 1989). Sodium bicarbonate treats metabolic not respiratory acidosis. 
Bicarbonate was administered to these animals as we had found that when it was administered 
previously to an apnoeic animal, the animal commenced breathing almost immediately. We theorised 
that this may have been because of an increase in arterial C02, which has been associated with its 
administration in other animals (Shapiro et al. 1989), stimulating the se~l's respiratory centre which 
is relatively insensitive to C02 (Hubbard 1969). The theory behind its use was thus to increase 
arterial C02 to stimulate breathing. Despite the potential for "paradoxical" intracellular brain acidosis 
(Shapiro et al. 1989), if this was effective it had the potential to be very useful because it would 
mean that breathing could be stimulated at will and intubation and positive pressure ventilation, 
which might be difficult for people with little experience with anaesthetics or in some situations, 
may not be necessary. The administration of bicarbonate to both animals did not stimulate breathing 
and may have induced intracellular brain acidosis, possibly increasing ketamine trapping. Its use as a 
respiratory stimulant is thus probably contraindicated. If neutralization of acid is required, for 
example in treatment of cardiac arrest, therapy with Carbicarb (a recently formulated buffer that is a 
combination of 0.33 M sodium carbonate and 0.33 M sodium bicarbonate), which results in systemic 
alkalinization without major changes in arterial C02 and intracellular brain alkalinisation (Shapiro et 
al. 1989), may be useful. However, this treatment may only be useful when breathing commences 
and metabolic acidosis occurs: intubation and ventilation with 02 is the treatment of choice for 
respiratory acidosis. 
Summary and conclusions 
Despite their ability to survive apnoea during chemical restraint, apnoea should ALWAYS be 
considered abnormal and ANY change in breathing pattern is cause for concern. The ability to 
intubate and ventilate animals should always be available when using chemical restraint. 
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Chapter 14: Synthesis and conclusions 
This study set out to test the unifying hypothesis that: 
the safety to the animals of the anaesthetic episode could be improved by using 
the most appropriate drugs, more accurately refining dose rates and developing 
techniques for the early recognition and treatment of complications. 
Previously reported fatality rates in southern elephant seals anaesthetised with various drug 
combinations ranged from up to 3% for smaller animals (Chapter 8) to up to 50% for larger animals 
(Chapter 2). The techniques developed in this study improved the safety of anaesthetic use, with 
fatality rates of less than 1 % for both small and large seals restrained with a variety of drugs. 
Use of a standardised system of monitoring by a dedicated operator allowed early recognition and thus 
prevention or treatment of complications. It also provided a common vocabulary with which to 
discuss and compare particular anaesthetic episodes, anaesthetics and other findings. Future studies on 
chemical restraint of southern elephant seals should use a standardised system of monitoring to allow 
comparisons to be made between drug doses and types. 
Monitoring pH and blood gas changes in the extradural intravertebral vein was a rapid and useful 
technique; however, the values determined may not accurately reflect changes occurring centrally and 
for this reason comparative studies of venous with arterial pH and blood gas values are required. This 
comparison was attempted but without success because of the relatively low levels and short durations 
of restraint and the cold working conditions. Greater restraint of animals, for longer periods, and 
moving them to enclosed, warmer areas for catheter placement and sampling would be required. For 
this purpose maintenance on gas, or the use of small, incremental doses of ketamine administered 
intravenously after midazolam and pethidine sedation, may be useful. 
Although it gave useful information, pH and blood gas analysis required some expertise and more 
simple, practical techniques are required for routine assessment of central blood gas and pH values. 
An alternative technique, which needs to be assessed, is pulse oximetry of the tongue. Under field 
conditions the status of the respiratory and cardiovascular systems can be determined by monitoring 
breathing, heart rate, mucous membrane colour and capillary refill. 
Given the length-mass relationships developed (Chapter 5) and nominal dosages for different categories 
of animals at different stages of their life and yearly cycles (Chapter 6), a safe dose of ketamine and 
diazepam to chemically restrain southern elephant seals can be determined. Estimation of mass, 
however, remains a problem for other stages of the animals' life cycle. Photogrametry may be an 
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alternative. However, the accuracy improves with expe1ience of a particular category and in most 
cases operators can quickly estimate mass to within about 5% of the actual value. Until this stage is 
reached it would be wise to under-dose animals. 
Despite the success of the doses used to restrain bulls (Chapter 6), these animals still represent a poor 
risk group, primarily because there are no techniques to ventilate them effectively (Chapter 11). Until 
such time as these techniques become available it may be wise to approach bull anaesthesia with care 
and be rigorous in attempting to prevent apnoea. Size also appeared to affect some variables 
associated with monitoring and the effect of size on respiratory exchange, vaiious physiological 
parameters and drug dosage requirements during anaesthesia needs to be examined. 
All drug combinations assessed could be used safely to restrain southern elephant seals and choice of 
an anaesthetic agent is probably at the discretion of the particular operator. Tiletamine and zolazepam 
offered some advantages over other commonly used combinations; however, this combination needs to 
be used with caution until its safety margin can be determined using dose-response studies(Chapter 8). 
Until the effect of tiletamine and zolazepam is examined in larger seals it may be wise for 
inexperienced operators to use the doses of ketamine and diazepam presented in this study as they are 
known to be safe and effective. 
The ability to antagonise ketamine and xylazine improved its usefulness relative to other commonly 
used agents (Chapter 12). Similarly, because of the ability to antagonise pethidine, combinations 
based on this drug were also very useful, relatively safe and versatile. However, they had the 
disadvantages of slow onset of maximum effect and large dose volumes which could preclude their use 
under field conditions (Chapter 9). Medetomidine combined with ketamine appeared to offer few 
advantages over xylazine combined with ketamine (Chapter 10). Because of the improvement in 
control of the anaesthetic episode, future studies examining the use of antagonisable drug 
combinations are indicated; specifically to develop techniques for restraint in situations where gaseous 
anaesthesia cannot be used or animals cannot be ventilated. 
Despite the problems, elephant seal anaesthesia becomes relatively straight forward with experience. 
Most investigators have achieved reasonable results with each of the drug combinations which they 
have used. The real difficulty comes in recognising and treating complications. 
Treatment of complications revolves around prevention and treatment of apnoea. Mitchell and Burton 
(1991) stated that the apnoea during anaesthesia of southern elephant seals does not necessarily 
indicate a problem as many elephant seals have undergone prolonged apnoea during anaesthesia 
without apparent ill effects. Results of this study indicate that the anim'als do appear to have an 
amazing ability to survive prolonged apnoea and can, with the use of mechanical ventilation, recover 
from what appear to be severely anoxic states. However, the pharmacokinetic and blood gas data 
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indicate that these parameters are affected during apnoea and, because it can be difficult to predict 
which animals will survive, apnoea during anaesthesia should be avoided. 
The data also indicate that apnoea should be expected during restraint (Chapter 13). However, in most 
cases it can be prevented or treated using physical stimulation (Chapter 13); further indicating the need 
to consider any period of apnoea to be abnormal and warrant treatment. In cyanotic or deep animals 
the only reliable treatment for apnoea is intubation and ventilation. The ability to intubate and 
ventilate seals always needs to be available when restraining them and therefore techniques for 
ventilation of large seals need to be developed as a matter of priority. It should also be stressed that 
some animals can die without signs of cyanosis or central depression; it can be very difficult to tell 
which animals these will be even with experience and therefore when in doubt animals should be 
intubated and ventilated. 
It is still not understood why some animals die during anaesthesia and others survive. This study has 
implicated a number of associated factors including presence of vomitus and instruments in the upper 
respiratory tract, variations in anaesthetic concentrations in the blood and changes in venous blood gas 
values associated with apnoea. However, pH, blood gas and anaesthetic drug concentrations measured 
in the extradural intravertebral vein may not accurately reflect central values and to further research the 
relative contribution of these factors toward death blood samples will need to be assayed from the 
extradural intravertebral vein at the cervical level (reflecting brain concentration) hepatic sinus 
(reflecting the reservoir concentration) and arterial supply to the brain whilst correlating levels with 
pharmacodynarnic changes. The evidence does, however, suggest that death is associated with apnoea, 
prolonged high peripheral anaesthetic concentrations and radical changes in blood gas values in the 
extradural intravertebral vein. These data suggest that the theory of anaesthetic drugs pooling in the 
hepatic sinus during apnoea and being released into the central circulation at high concentrations, 
during and at the termination of apnoea, and inappropriate dive responses, and rapid development of 
anaerobic conditions, may all be factors contributing to death during anaesthesia (Backhouse 1964, 
Mitchell and Burton 1991). 
The key to management of apnoea during anaesthesia may depend upon either finding the stimulus for 
it and blocking it, or finding the stimulus to recommence breathing and activating it. Future work 
should examine the control of respiration during anaesthesia in these animals and the changes in 
circulation during apnoea. The use of neuromuscular blocking drugs to routinely allow intubation and 
ventilation of all restrained animals may be preferable to allowing animals to breath spontaneously. 
Control of the duration of restraint can be improved by using antagonists (Chapter 12), and breathing 
can be stimulated by using doxapram (Chapter 11), however neither of these treatments can be relied 
upon to treat apnoea. If the kinetics of these drugs are similar to those of ketamine during apnoea 
(concentrations being prolonged in peripheral blood at high levels), their use at these times may be 
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contraindicated, as it could possibly predispose to myocardial ischemia, or drug over-dose if circulation 
returns. 
The time when invasive data-logging devices will be used to research various aspects of seal ecology 
is rapidly approaching. Deployment of these data-loggers may require surgical implantation 
necessitating deeper and more prolonged anaesthesia. Concerns about the safety of the anaesthetic 
episode should not preclude their use but need to be considered and the use of a dedicated anaesthetist 
in these studies is indicated. Gaseous anaesthesia after sedation with one of the drug combinations 
mentioned in this study may improve the safety and control of the anaesthetic episode and, with 
planning and foresight, could be used in any but the most remote and inaccessible locations. 
Finally it is hoped that this work has helped put anaesthesia of these animals into its true perspective 
as a potentially dangerous and life threatening procedure. It is, however, a procedure which, with 
experience and the ability to intubate and ventilate animals, can be performed safely and routinely in 
the majority of cases. 
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for the 1989-90 field season. It appears that the production of a summary of 
committee approval was not introduced until 1990-91. 
I hope these papers fulfil your requirements, if not please contact me again. 
With best regards. 
Rupert Summerson 
Secretary 
25 June 1992 
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Burton, Mr Harry 
90 
The Life of the Southern Elephant Seal in the Southern 
Ccean -
Macqu~rie -island 
Experimentation involving animals. 
Anaesthetisation, blood sampling and attachment of 
devices. 
Mirounga leonina 
60 juveniles/adults (maximum) to have time-depth 
recorders fitted. 
30 juveniles/adults (maximum) to have satellite 
transmitters attached. 
90 animals in total to be anaesthetised and have blood 
samples taken as part of the above procedures. 
Not applicable. 
The Committee requested that field personnel involved are 
appropriately qualified and experienced in the techniques 
to be used. 
In the event that an animal dies during an anaesthetic 
episode a full post-mortem must be provided for the 
Committee's consideration as soon as possible after the 
death. 
27 April 1990 
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INVESTIGATOR 
PROJECT NO 
PROJECT NAME 
LOCATION 
TYPE 
ACTIVITY INVOLVED 
ANAESTHETIC(S) 
RADIO ISOTOPE 
SPECIES 
Bunon, Mr Harry 
520 
An anaesthetics assessment study of Elephant seals at 
Macquarie Island 
Macquarie Island 
Experimentation involving animals. 
-
Weighing, pharmokinetics, tagging· 
See summary below 
Not applicable. 
Southern Elephant seal ( Mirounaa leonina) 
The following is the Committee's agreed position regarding animal usage, animal numbers listed 
here are as requested: 
Southern Elephant seal CMirounga leoninal 
Total to be affected is 152 Adults and 500 pups and/or weaners .. 
Adults (mal_es) 
Adults (females) 
Pharmokinetics: 1 O 
Tagged: 10 
Pre moult adults: 11 O 
Pharmokinetics: 11 O 
Tagged: 110 
Post oartum to be affected· 12 (See remarks below) 
Pups (new born and 
weaners) 
Pharmokinetics: 12. 
Tagged: {same) 12. 
Late lactating to be affected: 20. (See remarks below) 
Pharmokinetics: 20. 
Tagged: (same) 20. 
Total to be affected: 600. (See remarks below) 
Weighing: 600. 
Tagging: (same) 600. 
Part 1. Pharmokinetlc studies 
A summary of animals to be anaesthetised at Macquarie Island in 1991-1992 including age, sex, 
physiological state and drugs to be.use.d .. 
Anaesthetic 
combination 
--·--: 
Dose 
mg/kg 
· No. of - - sex 
animals . 
age 
years 
. physio. state_: -
1. ZoletiV ketamine and diazep~m comparison and attempted drug reversal 
i. Ketamine HCI 4-6 combined with diazepam 0.1. 
attempt reversal with: 
a. 4-AP 
b. Ao15-1788 
0.3 5 I 20 20 
f 
f I 
4-5 
4-5 
pre moult 
pre moult 
A3 
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ii. Zoletil 0.8-1.0 
attempt reversal with: 
a. Ro15-1788 5 
b.Normal saline/control 
20 
20 
f 
f 
4-5 
4-5 
pre moult 
premoul~ 
iii. Zoletil 0.8-1.0 increase sample size 
8 f 4-5 pre moult_ 
2. Pethedine reversal trial 
Midazolam 15 mg total dose combined with pethidine 1.5 g total dose, give thiopentone sodium 5% IV 
to effect then: · 
-
a. Diprenorphine 5mltotal dose·5 f 
f 
4-5 
4-5 
premoult: · 
b.Normal saline/control 5 pre moult 
3. Adjusting the ratio of ketamine to diazepam 
Administer 1.2 g ketamine and 30 mg diazepam 
a 12 4-5 pre moult 
4. Positioning trial 
Ketamine HCI 
diazepam 
4-6 combined with 
0.1 10 m 6-9 pre moult 
5. Completion of pharmacokinetics trials begun in 1990 
Ketamine HCI 4-6 combined with 
diazepam 0.1 12 f 4-5 
4-5 
post partum 
late lactation 20 f 
Total animals to be anaesthetised: ill 
Note: all animals will receive 0.005 mg/ kg atropine sulphate combined with these drugs as a 
parasympatholytic. 
Part 2. Studies In temporal and and geographic changes In maternal 
investment by weighing pups at birth and at weaning. 
Summary of young animals to be handled: 
Pups (new born and 
weaners) 
Field personnel 
AREG advice 
Total to be affected: 600. (See remarks below) 
Weighing: 600. 
Tagging: (same) 600. 
Dr R Woods, Ms Lynne Robinson, Mr Peter Lynch 
1. Anaesthetics The meeting considered the anaesthetics 
component of the project to be well thought out and noted that the 
questions raised by the Ethics Committee regarding drug dosages etc 
need to be resolved. It supported the completion of this component of_ 
the proposal. 
2. Pup17 Dilation The sub~committee 'agreed with the Ethics Committee-. 
that the objectives for the pupil-dilation component are not clearly - _- -
identified. It was considered 1hat there is some scientific merit in 
undertaking this study but-recommended that the study be 
undertaken on weaners as these animals are less important in the . 
population structure and are sedentary at this stage, and will therefore--
be easy to study. Care should be taken to protect the animals from · · 
excessive ultra-violet light. One suggestion was that the animals 
should be enclosed in a covered cage. The sub-committee 
recommended that a maximum of five animals should be studied. · 
A4 
Remarks/conditions 
Date of Ethics 
Consideration 
3. Tagging/Weighing The. meeting endorsed the Ethics Committee 
recommendation that the cold-branding technique be evaluated. 
AREG advised that this technique is not suitable for new born pups, 
and recommended that they should be tagged. The sub-committee 
endorsed the questions raised by Ethics and supported the 
suggestion that they be passed back to the proponent for clarification. 
Part 1. The Committee feels that the project has made great 
progress in an important direction ancf wishes to encourage 
further research. The use of premoult adults is approved. The 
committee does now approve the-use of l~ctating/post-partum 
- females. 
The view of the Committee is that abandoned pups shoulld 
be subjected to euthanasia unless in the view of the vet or 
responsible person that the pup has a high chance of 
survival. Should an abandonment occur the researcher should 
inform the committee without delay. 
Part 2. Approved. 
The Committee did not approve the pupil dilution 
component of this project. A letter setting out the 
committee's reasons will be forwarded to the Cheif 
Investigator. 
1 August 1991 
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It has been conventional in veterinary medicine to express the doses of drugs as quantities per unit of body weight. This principle 
works well if applied to individuals of approximately the same size and usually of the same species. However, if the dose is stated as 
quantity of drug to be given per kcal per day (MEC dose), then it can be used for all species of all sizes that absorb, metabolise 
and distribute the drug in the same way (Gibbons et al. 1988). Table Appendix II presents drug dosages used during this study 
in mg/kg and l!S MEC dose. 
'Appendix II. Drug dose rates (mg/kg and mg/kcal/day; minimum energy cost (MEC) dose) determined using lean or total body 
m~ss and based on doses fo1U1d to be useful in a model 400 kg pre-moult female southern elephant seal of estimated MEC = 6261 
kcal/day. (MEC (kcal/day) = K (mass[kg)l\().75) where K is the energy group for placental mammals = 70 kcal/kg (Gibbons et al. 
· 1988, Sedgwick and Pokras 1988)). Lean body mass for animals of other categories or at other times of their yearly life cycle can 
be estimated using the relationships presented in Appendix V. 
Drug combination Route Model dose (mg/kg) MEC dose (mg/kcal/day) 
Based on Based on 
Total bod:z: mass Lean bod:z: mass• Total bod:z: mass Lean bod:z: mass• 
100: 1 kctamine: i.m. 3.00 0.19 
diazel!!!!!! 0.03 0.0019 
50: 1 ketamine: i.m. 3.00 0.19 
diazel!!!!!! 0.06 0.0038 
Ketamine and i.m. 3.00 0.19 
X:z'.lazine 0.50 0.032 
Ketamine and i.m. 3.00 0.19 
midazolam 0.02 0.0013 
Tiletamine and i.m. 0.50 0.032 
. 'zot~am 0.50 0.032 
Mida:r.olam, i.m. 0.04 0.0026 
pdhidine and 4.00 0.26 
thio£!!:ntone i.v. 3.00 4.SS 0.19 0.17 
Mida:r.olam, i.m. 0.04 0.0026 
pethidine and 4.00 0.26 
ketamine i.v. 3.00 4.55 0.19 0.17 
Doxa2ram i.v. 2.00 0.13 
Yohimbine i.v. 0.06 0.0038 
Naloxone i.v. 0.01 0.0064 
Additional dosages required to induce level 3-4 restraint in animals at level 1 or 2 restraint 
For 100:1 ketamine: diazepam 
Ketamine i.m 1.50 0.096 
Ketamine i.v. 1.00 1.52 0.064 0.058 
•L~n body mass= total body mass - (34 (total body mass }/100) (M. Hindell unpublished data). 
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Appendix ill: Contents of emergency kit. These items were carried in a small back pack whenever an animal was to be chemically restrained (Plate 3.5). 
All attachments and fittings should be checked prior to use to ensure that they are the correct size and work. (OD =outside diameter). 
Item , , Description 
Container 
,Assorted syringes and needles Syringes 
45 x20x lOcm 
metal tool box 
2x50mL 
2x20mL 
Needles 
Equipment for intubation T~pes 
Endotracheal tubes 
Nasal oxygen tubes 
Obstetrical lubricant 
2x lOmL 
lOx 18 Gx38mm 
3x 18Gx90mm 
2x lOOcm 
26mmOD 
12mm0D 
9mmOD 
2 x 20 cm soft plastic 
about 15 mm OD 
50mL 
, , " Artery forceps 
&iuipment for ventilation '', Demand valve and connector 
Regulators C size 
D/E/Gsize 
C size oxygen cylinder Medical grade 
Drugs Doxapram 5 x 20 mL 5 x 20 mL 
Diazepam 10 x 2 mL 10 x 2 mL 
Adrenaline tartrate injection 1 x 5 mL 
Pentobarbitone sodium , 1 x 100 mL 
Suxamethonium chloride 3 x 2 mL 
Other Duodenal tube 
Oesophageal stethoscope 
Comment 
Strong (so as to resist trampling by bulls), light, transportable and easy to open 
and close. 
Useful for doxapram 
To hold jaws open (38 mm climbing tape is useful). 
1 for top jaw, 1 for bottom jaw. Knots, or loops tied in end give better purchase. 
Cows/bulls ' 
Yearlings/ laryngeal spasm 
Yearlings/ laryngeal spasm (kept in rectal gloves) 
To clamp cuff of endotracheal tube though usually not necessary. 
Hudson 5090 is ideal for cows 
To fit C size 02 cylinder 
To fit D, E, and G size 02 cylinder 
With knob to open it 
With end cut off or modified for luer fitting; for introduction of doxapram. 
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Appendix IV: Fatalities A8 
Appendix IV: Fatalities 
There were two fatalities during this study (Chapter 13). A blief summary of each anaesthetic episode 
and discussion are presented below. 
Animal 3071 (Figure 13.lD) 
Anaesthetic episode 
Drug doses: ketamine = 3.96 mg/kg, diazepam = 0.04 mg/kg. This animal became apnoeic at 13 min 
(level 6 restraint) when gastlic lavage was performed. Heart rate was relatively high, 103 bpm at 18 
min. The animal was intubated at 21 min during which, and immediately after, there was arching of 
the neck and opening of the jaws which clinically resembled the physical process of vomiting, though 
no vomitus could be seen in the buccal cavity. Two min later heart rate had dropped to 64 bpm. 
Palpebral response remained brisk. The animal was able to respond to external stimuli and was 
considered to be at level 5 restraint. There was frequent quivering of the external nares and facial 
musculature. At 42 min heart rate had dropped further to 16 bpm. The animal was given 4000 mmol 
bicarbonate intravenously as a bolus into the extradural intravertebral vein, then an infusion of 
Hartman's solution was administered and positive pressure ventilation commenced at a rate of 12/ 
min. At this stage the animal appeared lightly immobilized (level 4) and responded to vocalisations 
made by other seals around her. The palpebral response was brisk and there was constant twitching of 
the external nares and facial musculature. There was a rapid increase in pH and HC03-. Pvo2 
increased over the next 15 min then remained relatively stable (approximately 15 - 20 mmHg) except 
for falls at 82 min (immediately after 1000 mg doxapram had been administered) and at 145 min when 
the frequency of ventilation was decreased to allow C02 to build up. Heart rate fell to 3 bpm or was 
undetectable. Mental state as judged by palpabral response and response to external stimuli continued 
to decline. At 155 min 0.2 mg isoprenaline was given intralingually in an attempt to increase 
strength and rate of contraction of the heart. There was no observable effect. The animal's mental 
state continued to decline until at 180 min responses were hard to elicit, mucous membranes were 
muddy and cyanotic and a heart rate could only be detected with difficulty. At 190 min 30 g of 
pentobarbital sodium was administered into the extradural intravertebral vein. The animal died 3 min 
later. Packed cell volume rose from 64% at 10 min to 69% just prior to death. On post mortem 
vomit was found in the oro and nasopharynx but not in the mouth or trachea. Blood was pooled in 
the abdominal sinuses. 
Discussion 
It was puzzling at the time why this animal would not commence spontaneous respiration. It 
appeared to be only lightly anaesthetised, the airway was being held open by the endotracheal tube and 
there appeared at least initially to be minimal central nervous system depression. There was response 
Appendix IV: Fatalities 
to vocalisations of animals around her. This, coupled with the twitching of her external nares and 
sporadic relaxing and contracting of the facial musculature indicated an animal with both a desire and 
the ability to breath. Ketamine concentrations, at least initially were not excessively high (about 
3000 ng/mL, similar to initial concentrations seen in animals breathing normally), and dropping to 
levels which did not prevent restraint in other seals (< 1500 ng/rnL) indicating that some factor other 
than ketamine concentration was responsible for preventing breathing. In this animal apnoea was 
induced by gastric lavage and may have been maintained by passage of the endotracheal tube (shown 
to prevent breathing in light animals Chapter 11). The animal appeared to vomit on intubation 
though no vomitus was evident in the buccal cavity on examination. It was thus interesting that 
vomitus was found within the buccal cavity and upper oesophagus on post-mortem. This fluid could 
not be seen per os as the caudal margin of the soft palate and the base of the tongue make a seal 
between the buccal cavity and the entrance to the larynx. The entrance to the larynx appears to open 
directly into the nasal choanae forming an airway that can effectively be shut off form the buccal 
cavity. This observation is important as it shows that because of the anatomy of the upper 
respiratory tract, vomited or regurgitated material may not be seen on examination per os despite its 
presence. Therefore if an anaesthetised animal appears to vomit but no vomitus can be seen per os 
the possibility of vomitus being present in the nasopharynx should be considered and the animal 
intubated to protect the airway until the swallowing reflex is regained. It shows the importance of an 
endotracheal tube in animals which vomit, the tube allowing the airway to be maintained and lungs 
protection from aspiration of stomach contents, bronchospasm and aspiration pneumonia. This may 
be why this animal did not breath. 
The post-mortem findings in this animal which were thought to indicate that death was associated 
with a "dive-reponse" are questionable. Over a five year period we have post-mortemed many 
southern elephant seals which have been found dead from causes unrelated to anaesthesia on the 
beaches at Macquarie Island. In all cases the same evidence of circulatory changes ie pooling of blood 
in the abdominal and thoracic sinuses were seen. This leads us to suspect that this is nonspecific 
agonal change and to question what in fact a "dive-response" really is. In our opinion it appears more 
likely to be a consequence of drug over-dose or other factors induced by anaesthesia such as vomiting, 
rather than a normal part of seal anaesthesia. 
It is likely that the vomitus in the nasopharynx, intracellular brain acidosis induced by administration 
of bicarbonate and the failure to intubate and mechanically ventilate the animal before it became 
anoxic contributed to its death. The only effective treatment for respiratory acidosis in these animals 
is intubation and ventilation (preferably with 02) to remove the cause: C02. This animal could have 
been saved if the upper airway had been checked, intubation postponed and bicarbonate and other drugs 
not administered. 
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Animal 3049 (Figure 13.lE) 
Anaesthetic episode 
Drug doses: ketamine = 3.47 mg/kg, xylazine = 0.36 mg/kg. This animal became apnoeic 4 min 
after the drugs had been administered. Gastric lavage was performed at 10 min, the animal weighed 
and yohimbine (approximately 0.1 mg/kg) and 4-aminopyridine (approximately 0.3 mg/kg) 
administered into the extradural intravertebral vein at 25 min. A bicarbonate and saline infusion 
(lOOOmmol/L HC03-) was commenced at 27 min and several deep breaths taken at 33 min. At 35 
min 1000 mg doxapram was administered into the extradural intravertebral vein, breathing stopped and 
at 37 min violent muscular fasciculations and extensor muscle rigidity commenced. The animal was 
unapproachable during this period. At 56 min shaking stopped and the pupils began to dilate. The 
animal lost all muscle tone and a heart rate could not be detected. The relaxed musculature allowed 
iinmediate intubation and the animal was ventilated with oxygen. Pupils returned to their normal 
miotic state by 58 min. Breathing commenced at 62 min and assisted ventilation continued with each 
breath until 80 min when respiratory pattern became erratic and it was decided to further assist 
respiration. Consequently mechanical ventilation was recommenced. Shortly after this time there 
was pupillary dilation, loss of all muscle tone and a heart rate could not be detected. Positive pressure 
ventilation continued for a further 5 min when at 85 min the animal was declared clinically dead. 
Packed cell volume rose from 69% at 5 min to 80% just before death. There was pooling of blood in 
the abdominal sinuses on post-mortem. 
Discussion 
This animal could not be intubated until 56 min because it would have bitten the operator. Use of 
skeletal muscle relaxants enabling safe access to the larynx to allow intubation of lightly 
anaesthetised animals might have helped (see Ling et al. 1967). (We have found that if diazepam or 
suxamethonium are administered within min of the onset of apnoea they will usually have an effect 
' and allow intubation in anoxic, light cows; presumably circulation to the brain and tissues is still 
maintained and talces time before shutting down?) 
The effect of the yohimbine, 4-aminopyridine and doxapram was distressing. The animal went into 
opisthotonus, the front flippers were held raised, supine in extensor rigidity and the whole body shook 
violently. It is likely that their administration compounded the problem of anoxia and use of 
antagonists and central nervous system stimulants may be contraindicated in apnoeic animals. 
Gastric lavage, use of antagonists and the inability to intubate and ventilate the animal before it 
exceeded its aerobic dive limit may have contributed to its death. This animal could have been saved 
if it had immediately been intubated and ventilated with oxygen. 
AlO 
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Appendix V: Lean body mass 
Lean body mass has been calculated for male southern elephant seals> 510 kg using the relationship: 
Lean body mass = total body mass - total body fat (Slip et al. 1992) 
Where: 
Total body fat= { [l.178] [total blubber mass]} + 0.591 
and 
Total blubber mass= -574.518 + { [225.802][C3)} + { [85.628][snout-tail length]} 
(C3 = maximum girth, C3 and snout-tail length in m, body mass in kg). 
There is little information on body composition in female and male seals< 510 kg. Based on body 
composition data determined in post-partum and post-breeding females respectively, M. A. Hindell 
(unpublished data 1987) considered total body fat to be 34% of total body mass in pre-fast and 27% in 
post-fast mature females. These figures could be used for males< 510 kg until further data become 
available. 
All 
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Appendix VI: Complications during chemical restraint 
This appendix presents the anaesthetic related complications most commonly encountered during this 
study, and the techniques which were used to recognise, prevent, and treat them. 
Recognition of problems 
Expected normal responses, and those considered abnormal, when restraining animals to level 3 or 4 
restraint have been presented in Table 6.3. 
General guidelines to prevent complications 
Most complications during southern elephant seal anaesthesia can be avoided or minimised by 
observing the following general guide-lines. 
• Use the lowest dose of drug, and work at the lowest level of chemical restraint appropriate for 
the procedure being performed. 
• Maintain restraint for the minimum possible time. 
• Monitor the anaesthetic closely. 
• Select quiet, somnolent animals, away from water or wallows. 
• Position animals in a horizontal plane, with the neck extended. Consider positioning larger 
(:2: lOOOkg) animals in oblique recumbency. 
General guidelines to facilitate treatment of complications 
• Ensure that there is easy, safe access to the animal. 
• Be able to recognise problems, know how to treat them, and have equipment available to do 
so. 
• Place an intravenous catheter immediately it is safe to do so. 
Anaesthetic related complications 
Inappropriate anaesthetic depth 
Levels of chemical restraint required for various procedures in southern elephant seals are: 
venipuncture = level 3 - 4, intubation (small seals ( < 1000 kg) = level 5, large seals (:2: 1000 kg) = 
level 6), weighing (small seals = level 4-5, large seals =level 6), gastric lavage (small seals =level 4 
- 5, large seals = level 5 - 6), minor surgery (level 4 - 5, when combined with local anaesthesia or 
level 6 alone). 
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Problems of anaesthetic depth fall into three categories: (1) inadequate depth, (2) excessive depth and, 
(3) prolonged anaesthesia or recovery. 
Appropriate anaesthetic depth can be achieved by administration of appropriate drug doses. If mass is 
not known, an estimate can be made from length and girth measurements (Chapter 5), or nominal 
total dose rates (Chapter 6), or MEC-dosages (Appendix Il) can be used. 
Excessive levels of chemical restraint can be treated by administration of analeptics or antagonists to 
decrease or terminate restraint in animals which are breathing (dosages of these drugs are presented in 
Table VI.1), and I or the use of assisted or positive pressure ventilation (Chapter 3). Administration 
of antagonists and analeptics to apnoeic animals may exacerbate anoxia and until more information 
becomes available, should be avoided if possible. 
Ventilatory problems 
The three most common ventilatory problems in southern elephant seals are: (1) apnoea, (2) slow, 
shallow or stertorous breathing and, (3) laryngeal spasm. 
Treatment of apnoea has been discussed (Chapter 13, see Figure 13.2). The most important indicators 
for intubation and ventilation with oxygen during apnoea are cyanosis and deep anaesthesia. 
Intubation and positive pressure ventilation (Chapter 3 and 13) is the treatment of choice. 
Appropriate endotracheal tube sizes are presented in Table Vl.2. 
Laryngeal spasm is usually associated with an acute onset of whole body heaving, gagging, and/ or 
stridor which may last up to 2 min. There are multiple attempts at inspiration with simultaneous 
whole body heaving* and stridor can progress to apnoea. Animals rapidly become cyanotic and death 
can follow. It is uncommon, occurring in < 1 % of all anaesthetic episodes. Vomiting can also cause 
these signs so it is important to differentiate between the two problems by inserting the hand into the 
oropharynx and feeling for vomit. A flow chart for treatment of breathing difficulties has been 
presented in Chapter 13, Figure 13.3. 
Poor cardiac function 
The most common circulatory problems during anaesthesia are cyanosis, bradycardia and tachycardia 
associated with apnoea which is best prevented or treated. 
* These signs can be seen in animals to which drugs have not been administered though the 
incidence appears few; we have seen them in 2 cases over 4 field seasons work with these 
animals. This suggests that these signs are anaesthetic related. 
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Table VI.I. Drug dosages used in treatment of complications associated with chemical restraint in southern elephant seals. 
The incremental dose of tilatamine and zolazepam is the dose of each constituent 
Drug 
Diazepam 
Doxapram 
Midazolam 
Naloxone 
Pethidine 
Suxamethonium 
Yohimbine 
Dose 
(mg/kg) 
0.04-0.06 
2.00 
0.1-0.2 
0.01 
2.0-4.0 
0.5-2.0 
0.06 
Comment 
Total dose for a cow is 15 - 25 mg, to effect 
Transient effect in breathing animals so may need to be repeated. 
Avoid in apnoeic animals, however if positive pressure ventilation is not 
available it can be administer endotracheally. · 
Total dose to sedate a 50 kg pup is 5 - 10 mg i.m (n = 5; maximum 
sedation in 10 - 15 minutes). Caution if administered intravenously as it 
can cause apnoea (n = 2). 
Give intravenously. Use a concentrated preparation. 
Total dose to sedate an anxious cow (level 2 - 3), previously 
restrained with 3.0 mg/kg ketamine and 0.03 mg/kg diazepam is 1 - 2 g 
intramuscularly (2 mg/kg). A similar dose can be used with 15 mg midazolam 
to calm cows used for fostering. 
Give to effect. Onset indicated by fine muscle fasciculations, 
facilities for intubation and positive pressure ventilation must be available 
(see Ling et al. 1967) 
Further anaesthetic All are given to effect, preferably intravenously. Avoid rapid intravenous 
administration. 
Ketamine 1.00 30% of initial dose. 
Thiopentone 1.0 - 3.0 When combined with midazolam and pethidine. 
Tiletamine and zolazeparn 0.025 - 0.100 5 - 20% of initial doselntravenously. 
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Appendix VI: Complications A15 
Table VI.2. Lengths. masses, and endottacheal tube sizes for different classes of southern elephant 
seal at different times of their life cycle. Endotracheal tubes are usually left uninflated, however they 
can be inflated if necessary. Categories of animals are described in Chapter 6. 
Cateso~ Snout-tail Mass Endotracheal tube 
Sex Age Stage_of yearly length (kg) size (outside diameter) 
cl'.cle - (m) (mm) 
Male and Yearling 1.88 190 10:0• 12..3 or 15.7 
female (1.63-2.30) (119-417~ 
Female Prefast 469 
} 2.55 (283-700) (2.10-2.95) 24.0* Postfast 366 
(278-576) 
Male Subadult 24.0 or 30.0 
Bachelor Prefast 3.82 1855 
(3.43-4.05) (1806-2038) 
Postfast 1334 
(1031-1567) 
Harem bulls 
I. Challenger Prefast 4.00 2486 
(3.7-4.24) (1574-2635) 30.0 or35.0 
Postfast 1518 
(1334-1758) 
II. Beach master Prefast 4.33 2693 
(4.0-4.81) (2068-2897) 
Postfast 1854 
(1666-2416) 
*Endotracheal tube size is similar for similar sized males. When a larger tube can not be passed due to 
tight arytenoid adduction, 15.7 or 20.0 mm outside diameter tubes can be used. 
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Detection of decreased ventilation, abnormal breathing pattern or apnoea, soft, slow (< 10 bpm), 
irregular or absent heart sounds, prolonged capillary refill time, cyanosis, dilated pupils, and 
depression or loss of consciousness are important indicators of impending arrest or poor cardiac 
function. During cardiopulmonary arrest there is profound muscle relaxation, no ventilation, and no 
detectable heart beat. Pupils become dilated and nonresponsive to light. Pupillary dilation is a very 
poor prognostic sign, however in most cases this can be reversed by ventilating the animal, observing 
the pupil size and mucous membrane colour to determine the effectiveness of ventilation. Positive 
signs include return of detectable heart beat, improved membrane perfusion and colour, and pupillary 
constriction. 
Hyperthennia 
Hyperthermia occurs rarely, in an estimated <1 % of all immobilizations. Cooling should occur if 
hyperthermia is suspected (using water and supplying shade; rectal enemas of cold water could also be 
considered). If rectal temperatures cannot be taken then cooling should be instigated immediately it is 
safe to do so when working at temperatures 2': 5°C or on sunny days. Shaking should be minimised. 
Vomiting, regurgitation and aspiration of stomach contents 
Vomiting is usually preceded by any or all of the following; gagging, heaving body movements, an 
arched neck, opening of the mouth, apnoea, stertorous breathing, and vomitus may spill out of the 
mouth or nose. Vomiting is seen in <1 % of all animals immobilized unless they are intubated or a 
gastric lavage tube passed. In these cases the frequency increased to< 10 % of these animals. 
Vomiting can be difficult to recognise as in some cases vomit will be trapped in the nasopharynx, 
will not flow from the nose, and cannot be visualised by mouth. If vomiting is suspected, and no 
vomitus is apparent, it is thus important to insert a hand into the mouth, through the sphincter made 
by the base of the tongue, the soft palate and aryepiglotic folds and to feel for vomitus to enable a 
differentiation to be made between vomiting and laryngeal spasm, the presenting signs of which can 
be similar. Vomitus is usually fluid containing squid beaks and parasites and thus not usually made 
up of food. It will feel hot when a cold hand is introduced into the oropharynx. 
Vomiting tends to occur at light levels of chemical restraint (::;; level 5), and is most commonly 
associated with intubation or passage of a gastric lavage tube. Regurgitation is also seen but is 
usually associated with deeper levels of chemical restraint (> level 5), vomitus is usually clearly 
visible, and there are usually no signs of body heaving or gagging. 
Minimising the incidence of vomiting is difficult because it is safest to work with animals at low 
levels of restraint. Starving of animals prior to chemical restraint may decrease its incidence, however 
we have seen vomiting or regurgitation of fluid in post-moult females which had been starving whilst 
ashore for up to 3 weeks. Premedication may also be useful however this can be difficult under field 
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conditions. Use of xylazine has also been implicated in deaths due to aspiration of stomach contents 
(Mitchell and Burton 1991) and this drug could be avoided. 
To decrease the chances of regurgitation during gastric lavage, use of excessive volumes of water at 
any one time should be avoided as this fluid can reflux back around the tube (Chapter 13). The 
chances of aspiration pneumonia occuring can be decreased by positioning the patient with the head 
slightly down hill or by endotracheal intubation prior to gastric lavage. Regurgitation can also be 
minimised by avoiding deep levels of anaesthesia. 
Evidence suggests that animals will not breath if vomitus impinges upon the opening of the larynx. 
Remove vomit form the mouth and treat for apnoea. If possible the animal can be placed slightly 
head down to aid drainage of vomitus. 
Shaking 
Shaking requiring treatment occurs in < 1 % of all immobilizations and is seen under three 
circumstances during chemical restraint of southern elephant seals: (1) The most common occurrence 
is during routine chemical restraint when using cyclohexamine based drug combinations. Shaking is 
usually mild (fine muscle fasciculations; level 1) and resolves spontaneously; (2) Less commonly 
level 1 shaking may progress to become coarse (level 2), which may or may not be followed by 
whole body spasming (level 3) and/ or status epilepticus (level 4); (3) Shaking can be seen after 
anaesthetic antagonism or use of respiratory stimulants in breathing animals (usually level 1) or 
within minutes of return of breathing in apnoeic animals previously treated with these drugs. 
If cyclohexamine drugs are used they should be combined with an appropriate dose of sedative to 
minimise shaking. The incidence of shaking appears to be lower if ketamine and xylazine, tiletamine 
and zolazepam, or pethidine based drug combinations are administered. To prevent progression of 
level 1 shaking, diazepam can be administered at the first sign of level 2 shaking. Shaking can be 
minimised after administration of antagonists or respiratory stimulants by using appropriate doses of 
drugs and by administering antagonists after the anaesthetic has mostly worn off. Partial antagonism, 
or repeat administration of low doses of drugs may also be more appropriate than complete 
antagonism using high doses of drugs. 
Prevention of shaking after return to breathing in apnoeic animals pre-treated with antagonists or 
respiratory stimulants can be difficult. Avoidance of apnoea and use of intubation and positive 
pressure ventilation rather than chemical techniques for stimulating breathing in apnoeic animals may 
lessen this problem. 
A flow chart for treatment of shaking in mature female southern elephant seals is presented in Figure 
VI.1. Caution should be exercised in administering diazepam to apnoeic, deeply anaesthetised shaking 
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Level 1 
Usually resolves spontaneously 
and requires no treatment. Level 
1 can progress to 2 so monitor. 
Shaking continues or worsens 
(usually in animals in which 
shaking is associated with 
prolonged apnoea or upper 
respiratory tract obstruction). 
Prepare to intubate and 
administer postive pressure 
ventilation. 
t 
Immediately shaking stops 
intubate, administer positive 
pressure ventilation and watch 
pupils carefully. 
SHAKING 
Level 2 or greater 
Give diazepam intravenously into the 
extradural intravertebral vein in 5 mg 
doses to effect (15 - 25 mg total dose). 
Rapid recovery 
(usually in breathing animals 
or if diazepam administered 
within minutes of the onset of 
apnoea). 
Check upper respiratory 
tract for vomit and treat 
if necessary. 
Recovery from chemical 
restraint may be prolonged. 
Protect from other seals and 
monitor rectal temperature 
which may be elevated. If 
> 38.5°C commence cooling. 
Figure VI.l. A flow chart for treatment of shaking in mature female southern elephant seals. 
(Shaking: Level 1 ~slight/ fine, 2 =Coarse, 3 =Spasms (clonic-tonic). 4 =Status epilepticus). 
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animals as it can further depress the animal and lead to prolonged recovery. In these cases positive 
pressure ventilation or assisted ventilation may be required immediately breathing returns. 
It is important to distinguish between drug induced shaking and the body heaving which may be 
associated with vomiting or upper respiratory tract obstruction obstruction as treatments differ. The 
heaving associated with vomiting or upper respiratory tract obstruction obstruction has an acute 
onset, is usually associated with the commencement of apnoea not its termination, and there may be 
gagging, stertorous breathing, an arched neck, and/ or the presence of vomitus in the upper respiratory 
tract. 
Desertion of pups 
During desertion either the mother can leave the pup (which usually occurs after recovery), or the pup 
can leave the mother (which usually occurs during the anaesthetic episode), the latter occurrence is far 
more common. It is normal for the pup to wander away from the mother. The pup usually wakes up 
to suckle and when it cannot find a teat, or the mother does not respond to its vocalisations it will 
move away, often with great determination, into the harem. 
There are several techniques which can be used to rninirnise pup abandonment: (1) don't wake the pup 
up, (2) sedate the pup (Table VI.l), (3) roll the female on her side so that the pup has access to a teat 
and place it near the teat, (4) work with sedated cows only who can still interact with the pup, (5) 
place the pup at the cows head end so that they can interact, (6) physically restrain the pup (this can 
be difficult for prolonged procedures with large pups if holding the tail or using the dog house 
position and can be stressful for the pup, a cage is therefore preferred), (7) keep the cow light and 
ensure recovery is rapid, (8) avoid the use of large doses of antagonists to speed recovery in cows as 
this may excite the animal, (9) stop other cows biting the pup. 
Pups should be handled as gently as possible and one person designated to be responsible for the pup 
(it is remarkable how rapidly and how far a pup can move away searching for its mother). 
Little can be done to prevent the mother abandoning the pup. We suspect that the chances of this 
happening may be increased when: (1) Young or inexperienced mothers are anaesthetised, so select 
older, more experienced cows if possible, (2) in small or unstable harems where cows are constantly 
harassed by bulls, (3) on hot days when cows may over heat and try to go to sea to cool down, (4) if 
people are present when they wake up which might frighten them, and (5) with the use of some drugs 
such as ketamine and xylazine which appear to affect the animal's psyche. Cows are also more likely 
to leave their pups towards the end of lactation however this is usually less of a problem for the pup 
which has larger stores of fat than if deserted early in lactation. 
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If desertion occurs the pup may be cross fostered to cows known to have lost their pup recently. 
These cows may remain next to the carcass of their dead pup for one or two days and may accept an 
orphaned pup. The chances of acceptance may improve the younger the de~d pup is, the younger the 
mother, the more rapidly the two can be put together and if the skin of the dead pup is tied on to the 
foster pup. Caution should be exercised during attempted cross fostering as the mother may attack the 
new pup. In these cases sedation of the mother with pethidine (2 mg/kg) or rnidazolam and pethidine 
(15 mg rnidazolam combined with 2 mg/kg pethidine) may be useful. The pup may also try to find 
its deserted mother and not be interested in the new mother. In these cases the pup can be sedated 
with midazolam (Table VI.1). Whether anaesthesia increases the frequency of pup abandonment is 
unknown. 
Going to sea and drowning 
Animals going to sea should be expected when animals are excited or anxious and are given drugs 
close to the sea: the closer to the sea the more likely the animals are to fly to it. Animals which 
have just hauled out appear to have more chance of going to sea than those that have been ashore and 
are settled, as do single animals compared with those in groups or if there is a large bull as part of the 
group (this seems to give the animals confidence and make them feel more secure). Cows with pups, 
and bulls, appear less likely to go to sea than animals recently hauled ashore. Cows in harems, 
anaesthetised at the end of lactation however appear more likely to wean their pups early and go to sea 
than cows anaesthetised at earlier times. Although this will often be prevented by challengers/ bulls, 
these animals can and do kill cows on their way to sea whilst attempting to mate with them. This 
needs to be prevented. 
Somnolent animals in stable circumstances away from the sea are suitable for anaesthesia. (An 
advantage of the remote injection technique is that once the needle is placed the reaction of the animal 
can be assessed. Drug administration can be stopped in animals which appear frightened or 
immediately flee for the sea.) Make sure they are calm, relaxed and that stress is minimised. Baffle 
boards, people, a tennis ball on a stick, or waving plastic sheet can be used to try to stop animals 
from going to sea. However some will go to sea regardless of obstacles in their path. 
Once animals which have just received drugs are at sea they should be monitored for breathing. 
Animals at level 2-3 restraint have a characteristic swimming pattern and breathing technique. The 
back is often arched out of the water, expiration occurs underwater as the· head is slowly raised for 
inspiration. Sometimes the animal will float with the head submerged in this position, breathing in 
these cases can often be stimulated by tossing rocks in front of or onto the animal. The animals we 
have seen go to sea all survived, probably because of low levels of restraint. However if possible the 
animals should be removed from the water by boat or using a lasso. Swimming with the animals 
should be considered a last resort and is contraindicated in cold conditions or during the breeding 
season when there is the likelihood of attention from challenger bulls. Bulls will attempt to mate 
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with cows in the water during the breeding season and for this reason cows should be prevented from 
going to sea whilst sedated at this time. 
Attack by other animals 
Skuas may attempt to remove the eyes of anaesthetised seals. The retractor bulbi muscle and 
powerful lids prevents this in even deeply anaesthetised animals however skuas should be kept away. 
The most common problem with attack by other seals is during the breeding season. Anaesthetised 
harem bulls will be attacked by challengers, or allow challengers into the harem, causing disruption. 
For this reason all challengers should be kept away from the harem if a harem bull is anaesthetised. 
Similarly if a challenger is anaesthetised too close to a harem it will be attacked by the harem bull 
and these animals should be anaesthetised away from the harem to prevent this happening. 
Bulls will also attack anaesthetised females. It can be very difficult to keep a bull away from an 
anaesthetised female, particularly if she is in oestrus (about 18 days after birth). One technique is to 
go to the opposite side of the harem and try to move a challenger into the harem. The Beach master 
will usually leave the cow alone to chase the intruder, however this is a short term solution and may 
need to be repeated. In circumstances where there is fear for the anaesthetised cow's welfare and the 
bull cannot be kept away it can be anaesthetised, however by doing this there is the risk of harem 
disruption by challengers. However challengers are usually easier to keep out of a harem than to keep 
the harem bull away from a female. An alternative might be to place a visual barrier around the 
female. 
Challengers will also kill females leaving harems by drowning them in the surf or suffocating them 
by lying on them. It is thus important to prevent females from going to sea at these times if 
possible until fully recovered. 
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